|
G |
Aars1 |
alanyl-tRNA synthetase 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of AARS1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr19:55,906,694...55,930,499
Ensembl chr19:38,999,163...39,021,147
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions decreases expression increases expression |
ISO |
[[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in increased expression of ABCB1 mRNA; [[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in increased expression of ABCB1 protein; [Paclitaxel results in increased expression of ABCB1] which results in decreased susceptibility to Fluorouracil; ABCB1 gene SNP affects the susceptibility to [Cisplatin co-treated with Fluorouracil]; ABCB1 protein affects the susceptibility to [Cyclophosphamide co-treated with Methotrexate co-treated with Fluorouracil]; ABCB1 protein affects the susceptibility to [Fluorouracil co-treated with Epirubicin co-treated with Cyclophosphamide] Fluorouracil results in decreased expression of ABCB1 mRNA Fluorouracil results in increased expression of ABCB1 protein |
CTD |
PMID:12576456 PMID:15239124 PMID:17287894 PMID:21332314 PMID:21833476 PMID:32800223 More...
|
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb6 |
ATP binding cassette subfamily B member 6 |
decreases expression decreases response to substance |
ISO |
Fluorouracil results in decreased expression of ABCB6 mRNA ABCB6 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:20737486 PMID:25202056 |
|
NCBI chr 9:76,668,554...76,677,263
Ensembl chr 9:76,668,554...76,676,924
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
multiple interactions |
ISO |
[[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in increased expression of ABCC1 mRNA; ABCC1 protein affects the susceptibility to [Fluorouracil co-treated with Epirubicin co-treated with Cyclophosphamide] |
CTD |
PMID:12576456 PMID:32800223 |
|
NCBI chr10:1,022,041...1,162,431
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
affects response to substance multiple interactions |
ISO |
ABCC2 protein affects the susceptibility to Fluorouracil [[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in increased expression of ABCC2 mRNA |
CTD |
PMID:16217747 PMID:32800223 |
|
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc5 |
ATP binding cassette subfamily C member 5 |
decreases response to substance multiple interactions |
ISO |
ABCC5 protein results in decreased susceptibility to Fluorouracil 5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [ABCC5 protein results in decreased susceptibility to Fluorouracil]; ABCC5 protein results in increased export of and results in decreased susceptibility to Fluorouracil |
CTD |
PMID:15897250 PMID:19077464 |
|
NCBI chr11:93,975,579...94,071,659
Ensembl chr11:80,473,872...80,567,253
|
|
G |
Abcc6 |
ATP binding cassette subfamily C member 6 |
affects response to substance increases expression |
ISO |
ABCC6 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of ABCC6 protein |
CTD |
PMID:15352031 |
|
NCBI chr 1:96,447,224...96,501,464
Ensembl chr 1:96,447,251...96,501,464
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
multiple interactions |
ISO |
[[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in increased expression of ABCG2 mRNA; [[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in increased expression of ABCG2 protein; [ERBB2 results in increased expression of ABCG2] which results in decreased susceptibility to Fluorouracil; [Paclitaxel results in decreased expression of ABCG2] which results in decreased susceptibility to Fluorouracil; ABCG2 mutant form inhibits the reaction [ERBB2 results in decreased susceptibility to Fluorouracil]; ABCG2 protein affects the susceptibility to [Fluorouracil co-treated with Epirubicin co-treated with Cyclophosphamide] |
CTD |
PMID:12576456 PMID:21712253 PMID:21833476 PMID:32800223 |
|
NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Abhd12b |
abhydrolase domain containing 12B |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ABHD12B mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 6:88,668,627...88,696,435
Ensembl chr 6:88,668,642...88,696,458
|
|
G |
Abi1 |
abl-interactor 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of ABI1 mRNA |
CTD |
PMID:19272435 |
|
NCBI chr17:85,098,837...85,179,829
Ensembl chr17:85,098,550...85,179,792
|
|
G |
Abi2 |
abl-interactor 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ABI2 mRNA |
CTD |
PMID:19272435 |
|
NCBI chr 9:69,321,072...69,490,630
Ensembl chr 9:61,827,139...61,905,699
|
|
G |
Acad9 |
acyl-CoA dehydrogenase family, member 9 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ACAD9 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 2:118,943,170...118,966,150
Ensembl chr 2:118,943,174...118,966,547
|
|
G |
Acadl |
acyl-CoA dehydrogenase, long chain |
increases expression |
ISO |
Fluorouracil results in increased expression of ACADL protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr 9:75,783,689...75,822,077
Ensembl chr 9:68,333,980...68,372,220
|
|
G |
Ackr3 |
atypical chemokine receptor 3 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ACKR3 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 9:98,247,300...98,258,877
Ensembl chr 9:90,799,686...90,811,237
|
|
G |
Acot13 |
acyl-CoA thioesterase 13 |
affects response to substance |
ISO |
ACOT13 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr17:40,240,378...40,252,851
Ensembl chr17:40,240,378...40,252,851
|
|
G |
Acot7 |
acyl-CoA thioesterase 7 |
affects response to substance |
ISO |
ACOT7 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 5:162,686,562...162,779,309
Ensembl chr 5:162,684,645...162,779,309
|
|
G |
Acsm3 |
acyl-CoA synthetase medium-chain family member 3 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SAH mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:174,133,260...174,159,966
Ensembl chr 1:174,133,288...174,160,184
|
|
G |
Actb |
actin, beta |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ACTB protein |
CTD |
PMID:21296659 |
|
NCBI chr12:16,776,664...16,779,634
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Actc1 |
actin, alpha, cardiac muscle 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ACTC1 protein |
CTD |
PMID:21296659 |
|
NCBI chr 3:121,266,291...121,271,827
Ensembl chr 3:100,811,987...100,817,523
|
|
G |
Actg2 |
actin gamma 2, smooth muscle |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ACTG2 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 4:116,021,832...116,046,475
Ensembl chr 4:116,021,832...116,046,465
|
|
G |
Acy1 |
aminoacylase 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ACY1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 8:107,072,354...107,077,756
Ensembl chr 8:107,072,358...107,077,682
|
|
G |
Adam10 |
ADAM metallopeptidase domain 10 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ADAM10 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 8:80,226,862...80,358,728
Ensembl chr 8:71,345,837...71,477,889
|
|
G |
Adam3a |
ADAM metallopeptidase domain 3A |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ADAM3A mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr16:67,299,949...67,349,970
Ensembl chr16:67,299,949...67,349,968
|
|
G |
Adamts9 |
ADAM metallopeptidase with thrombospondin type 1 motif, 9 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ADAMTS9 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 4:126,847,726...127,019,924
Ensembl chr 4:125,291,490...125,462,929
|
|
G |
Adcy9 |
adenylate cyclase 9 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ADCY9 mRNA |
CTD |
PMID:19219653 |
|
NCBI chr10:11,645,373...11,768,462
Ensembl chr10:11,139,446...11,262,066
|
|
G |
Add3 |
adducin 3 |
affects response to substance |
ISO |
ADD3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:252,147,341...252,255,126
Ensembl chr 1:252,147,386...252,255,124
|
|
G |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
affects response to substance |
ISO |
ADGRG1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr19:10,003,963...10,041,122
Ensembl chr19:10,003,975...10,041,108
|
|
G |
Adgrg6 |
adhesion G protein-coupled receptor G6 |
affects response to substance |
ISO |
ADGRG6 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:8,812,889...8,954,239
Ensembl chr 1:8,812,904...8,954,123
|
|
G |
Adgrl2 |
adhesion G protein-coupled receptor L2 |
affects response to substance |
ISO |
ADGRL2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 2:237,696,055...238,327,141
Ensembl chr 2:237,696,056...238,327,141
|
|
G |
Adm |
adrenomedullin |
affects response to substance |
ISO |
ADM protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Adss2 |
adenylosuccinate synthase 2 |
decreases expression increases expression |
ISO |
Fluorouracil results in decreased expression of ADSS2 mRNA Fluorouracil results in increased expression of ADSS2 protein |
CTD |
PMID:15585135 PMID:16709241 PMID:16803524 |
|
NCBI chr13:92,301,302...92,331,638
Ensembl chr13:89,769,244...89,799,604
|
|
G |
Afp |
alpha-fetoprotein |
increases expression decreases expression |
ISO |
Fluorouracil results in increased expression of AFP protein Fluorouracil results in decreased expression of AFP; Fluorouracil results in decreased expression of AFP mRNA |
CTD |
PMID:20448262 PMID:21296659 PMID:26272751 |
|
NCBI chr14:17,857,584...17,875,645
Ensembl chr14:17,573,412...17,591,480
|
|
G |
Agap3 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of AGAP3 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 4:10,674,746...10,724,848
Ensembl chr 4:10,674,064...10,725,244
|
|
G |
Agr2 |
anterior gradient 2, protein disulphide isomerase family member |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of AGR2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 6:52,708,602...52,729,378
Ensembl chr 6:52,708,602...52,729,371
|
|
G |
Ahnak |
AHNAK nucleoprotein |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of AHNAK protein AHNAK protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 1:205,882,225...205,970,934
Ensembl chr 1:205,882,273...205,970,926
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
multiple interactions increases expression |
ISO |
[Doxorubicin co-treated with Paclitaxel co-treated with Fluorouracil] results in increased expression of AIFM1 protein [Fluorouracil co-treated with casticin] results in increased expression of AIFM1 protein Fluorouracil results in increased expression of AIFM1 protein |
CTD |
PMID:16168113 PMID:32270916 |
|
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Akap12 |
A-kinase anchoring protein 12 |
affects expression |
ISO |
Fluorouracil affects the expression of AKAP12 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 1:40,730,123...40,819,863
Ensembl chr 1:40,730,123...40,819,886
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
affects expression |
ISO |
Fluorouracil affects the expression of AKR1B10 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
affects expression affects response to substance |
ISO |
Fluorouracil affects the expression of AKR1C1 mRNA AKR1C1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 PMID:16584549 |
|
NCBI chr17:70,720,397...70,747,285
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
affects response to substance |
ISO |
AKR1C2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr17:70,669,684...70,717,935
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
affects expression affects response to substance |
ISO |
Fluorouracil affects the expression of AKR1C3 mRNA AKR1C3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 PMID:16584549 |
|
NCBI chr17:71,020,884...71,037,779
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions increases phosphorylation affects phosphorylation decreases phosphorylation affects expression |
ISO |
[Apigenin co-treated with Fluorouracil] results in decreased expression of AKT1 protein; AG 1879 inhibits the reaction [Fluorouracil results in increased phosphorylation of AKT1 protein]; Fluorouracil results in decreased expression of and results in decreased phosphorylation of and results in decreased activity of AKT1 protein; Nicotine affects the reaction [Fluorouracil affects the phosphorylation of AKT1 protein] Fluorouracil inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of AKT1 protein] Fluorouracil results in decreased phosphorylation of AKT1 protein Fluorouracil affects the expression of AKT1 mRNA |
CTD |
PMID:16724238 PMID:17918158 PMID:18794807 PMID:19885610 PMID:24095863 PMID:30542770 PMID:34151400 More...
|
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Akt2 |
AKT serine/threonine kinase 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of AKT2 protein |
CTD |
PMID:16803524 |
|
NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:82,883,547...82,933,817
|
|
G |
Alb |
albumin |
multiple interactions |
ISO |
[Leucovorin co-treated with Cisplatin co-treated with Fluorouracil] results in decreased expression of ALB protein |
CTD |
PMID:20180123 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Alcam |
activated leukocyte cell adhesion molecule |
affects response to substance decreases expression |
ISO |
ALCAM protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of ALCAM protein |
CTD |
PMID:15352031 |
|
NCBI chr11:48,336,123...48,536,296
Ensembl chr11:48,336,169...48,537,954
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
affects response to substance |
ISO |
ALDH1A1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
affects response to substance decreases expression |
ISO |
ALDH1A3 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of ALDH1A3 protein |
CTD |
PMID:15352031 |
|
NCBI chr 1:119,982,272...120,017,416
Ensembl chr 1:119,982,277...120,017,436
|
|
G |
Aldh3a2 |
aldehyde dehydrogenase 3 family, member A2 |
affects response to substance |
ISO |
ALDH3A2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:46,427,789...46,448,449
Ensembl chr10:45,908,524...45,949,281
|
|
G |
Alg3 |
ALG3, alpha-1,3- mannosyltransferase |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ALG3 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr11:80,300,487...80,306,014
Ensembl chr11:80,300,498...80,307,912
|
|
G |
Alkbh8 |
alkB homolog 8, tRNA methyltransferase |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ALKBH8 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 6:378,779...449,382
Ensembl chr 6:378,100...452,165
|
|
G |
Amfr |
autocrine motility factor receptor |
multiple interactions |
ISO |
AMFR mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr19:10,996,705...11,032,260
Ensembl chr19:10,996,099...11,032,247
|
|
G |
Ampd2 |
adenosine monophosphate deaminase 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of AMPD2 mRNA |
CTD |
PMID:19219653 |
|
NCBI chr 2:195,707,609...195,720,454
Ensembl chr 2:195,707,610...195,720,271
|
|
G |
Amt |
aminomethyltransferase |
increases expression |
ISO |
Fluorouracil results in increased expression of AMT protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr 8:117,859,700...117,866,692
Ensembl chr 8:108,976,472...108,988,126
|
|
G |
Ang |
angiogenin |
affects response to substance |
ISO |
ANG protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr15:26,786,233...26,796,883
|
|
G |
Angpt1 |
angiopoietin 1 |
multiple interactions increases expression |
ISO |
ANGPT1 protein promotes the reaction [Fluorouracil results in increased expression of IFNA1 protein] Fluorouracil results in increased expression of ANGPT1 protein |
CTD |
PMID:17786339 |
|
NCBI chr 7:75,415,959...75,668,696
Ensembl chr 7:73,531,486...73,784,067
|
|
G |
Angpt2 |
angiopoietin 2 |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of ANGPT2 protein ANGPT2 protein promotes the reaction [Fluorouracil results in decreased expression of IFNA1 protein] |
CTD |
PMID:17786339 |
|
NCBI chr16:77,790,760...77,841,241
Ensembl chr16:71,088,364...71,138,804
|
|
G |
Angptl2 |
angiopoietin-like 2 |
multiple interactions |
ISO |
ANGPTL2 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] |
CTD |
PMID:17327601 |
|
NCBI chr 3:16,517,185...16,547,024
Ensembl chr 3:16,517,420...16,548,178
|
|
G |
Angptl3 |
angiopoietin-like 3 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ANGPTL3 mRNA |
CTD |
PMID:32535746 |
|
NCBI chr 5:118,818,494...118,825,531
Ensembl chr 5:113,703,012...113,709,957
|
|
G |
Angptl4 |
angiopoietin-like 4 |
affects response to substance |
ISO |
ANGPTL4 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Ankrd1 |
ankyrin repeat domain 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of ANKRD1 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919
|
|
G |
Ankrd11 |
ankyrin repeat domain containing 11 |
increases expression affects expression |
ISO |
Fluorouracil results in increased expression of ANKRD11 mRNA Fluorouracil affects the expression of ANKRD11 mRNA |
CTD |
PMID:16510598 PMID:16584549 |
|
NCBI chr19:50,940,284...51,098,962
Ensembl chr19:50,940,299...51,098,962
|
|
G |
Anln |
anillin, actin binding protein |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of ANLN mRNA TP53 protein affects the reaction [Fluorouracil results in decreased expression of ANLN mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of ANLN mRNA] |
CTD |
PMID:15016801 PMID:17982676 |
|
NCBI chr 8:20,858,227...20,921,602
Ensembl chr 8:20,858,228...20,921,538
|
|
G |
Anp32e |
acidic nuclear phosphoprotein 32 family member E |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ANP32E mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 2:183,472,600...183,489,057
Ensembl chr 2:183,472,609...183,489,054
|
|
G |
Anxa1 |
annexin A1 |
affects response to substance decreases expression |
ISO |
ANXA1 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of ANXA1 protein |
CTD |
PMID:15352031 PMID:16217747 |
|
NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Anxa2 |
annexin A2 |
decreases response to substance increases expression multiple interactions |
ISO |
ANXA2 mRNA results in decreased susceptibility to Fluorouracil Fluorouracil results in increased expression of ANXA2 mRNA TP53 protein affects the reaction [Fluorouracil results in increased expression of ANXA2 mRNA] |
CTD |
PMID:15152939 |
|
NCBI chr 8:78,986,252...79,022,638
Ensembl chr 8:70,105,253...70,141,658
|
|
G |
Anxa3 |
annexin A3 |
increases expression |
ISO |
Fluorouracil results in increased expression of ANXA3 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr14:13,031,675...13,085,678
Ensembl chr14:12,719,795...12,781,617
|
|
G |
Anxa4 |
annexin A4 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ANXA4 mRNA |
CTD |
PMID:15109396 |
|
NCBI chr 4:119,184,378...119,241,183
Ensembl chr 4:119,184,374...119,241,161
|
|
G |
Ap2s1 |
adaptor related protein complex 2 subunit sigma 1 |
multiple interactions |
ISO |
[Fluorouracil co-treated with irinotecan] results in decreased expression of AP2S1 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr 1:86,545,601...86,557,007
Ensembl chr 1:77,417,477...77,428,905
|
|
G |
Ap3s1 |
adaptor related protein complex 3 subunit sigma 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of AP3S1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr18:41,649,321...41,718,221
Ensembl chr18:39,462,765...39,531,622
|
|
G |
Ap4s1 |
adaptor related protein complex 4 subunit sigma 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of AP4S1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 6:69,133,403...69,174,488
Ensembl chr 6:69,133,373...69,175,496
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
increases expression affects expression |
ISO |
Fluorouracil results in increased expression of APAF1 mRNA Fluorouracil affects the expression of APAF1 mRNA |
CTD |
PMID:16557594 PMID:34151400 |
|
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Apba2 |
amyloid beta precursor protein binding family A member 2 |
affects response to substance |
ISO |
APBA2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:118,053,270...118,286,858
Ensembl chr 1:118,103,219...118,285,699
|
|
G |
Apbb2 |
amyloid beta precursor protein binding family B member 2 |
affects response to substance |
ISO |
APBB2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr14:41,557,918...41,878,622
Ensembl chr14:41,557,972...41,877,495
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
increases response to substance |
ISO |
APEX1 protein mutant form results in increased susceptibility to Fluorouracil |
CTD |
PMID:19470598 |
|
NCBI chr15:26,618,146...26,620,330
Ensembl chr15:24,144,362...24,146,785
|
|
G |
Apob |
apolipoprotein B |
multiple interactions decreases expression decreases secretion |
ISO |
ursodoxicoltaurine inhibits the reaction [Fluorouracil results in decreased expression of APOB mRNA] Fluorouracil results in decreased secretion of APOB protein |
CTD |
PMID:32535746 |
|
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:30,844,368...30,892,497
|
|
G |
Apoc1 |
apolipoprotein C1 |
affects response to substance |
ISO |
APOC1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:88,475,018...88,479,052
Ensembl chr 1:79,346,136...79,350,375
|
|
G |
Apoc3 |
apolipoprotein C3 |
decreases expression decreases secretion |
ISO |
Fluorouracil results in decreased expression of APOC3 mRNA Fluorouracil results in decreased secretion of APOC3 protein |
CTD |
PMID:32535746 |
|
NCBI chr 8:55,428,172...55,430,352
Ensembl chr 8:46,531,478...46,533,583
|
|
G |
Aqp6 |
aquaporin 6 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of AQP6 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 7:130,732,216...130,735,149
Ensembl chr 7:130,633,579...130,735,194 Ensembl chr 7:130,633,579...130,735,194
|
|
G |
Aqp9 |
aquaporin 9 |
increases uptake |
EXP |
AQP9 protein results in increased uptake of Fluorouracil |
CTD |
PMID:9733774 |
|
NCBI chr 8:80,678,027...80,718,273
Ensembl chr 8:71,797,234...71,837,395
|
|
G |
Areg |
amphiregulin |
affects response to substance increases expression |
ISO |
AREG affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of AREG mRNA |
CTD |
PMID:15067352 PMID:16709241 |
|
NCBI chr14:17,256,384...17,265,641
Ensembl chr14:16,972,187...16,981,535
|
|
G |
Arf1 |
ARF GTPase 1 |
multiple interactions |
ISO |
ARF1 protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] |
CTD |
PMID:18927307 |
|
NCBI chr10:43,997,983...44,014,461
Ensembl chr10:43,997,986...44,014,434
|
|
G |
Arf3 |
ARF GTPase 3 |
affects response to substance |
ISO |
ARF3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 7:129,886,082...129,912,022
Ensembl chr 7:129,886,082...129,912,002
|
|
G |
Arfgap1 |
ARF GTPase activating protein 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of ARFGAP1 protein |
CTD |
PMID:15331170 |
|
NCBI chr 3:168,084,560...168,099,948
Ensembl chr 3:168,084,614...168,099,933
|
|
G |
Arhgdib |
Rho GDP dissociation inhibitor beta |
affects expression |
ISO |
Fluorouracil affects the expression of ARHGDIB mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 4:169,822,951...169,841,884
Ensembl chr 4:169,822,952...169,841,658
|
|
G |
Arid5b |
AT-rich interaction domain 5B |
affects response to substance |
ISO |
ARID5B protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr20:20,305,693...20,489,689
Ensembl chr20:20,307,731...20,487,433
|
|
G |
Arl4c |
ARF like GTPase 4C |
increases expression |
ISO |
Fluorouracil results in increased expression of ARL4C mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 9:89,300,335...89,303,770
Ensembl chr 9:89,298,005...89,304,513
|
|
G |
Arl6ip5 |
ARF like GTPase 6 interacting protein 5 |
multiple interactions |
ISO |
ARL6IP5 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with Cisplatin]; ARL6IP5 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with oxaliplatin] |
CTD |
PMID:22452940 |
|
NCBI chr 4:131,365,320...131,395,311
Ensembl chr 4:129,810,645...129,838,608
|
|
G |
Armcx1 |
armadillo repeat containing, X-linked 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ARMCX1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr X:97,898,969...97,902,874
Ensembl chr X:97,898,883...97,903,299
|
|
G |
Arpc3 |
actin related protein 2/3 complex, subunit 3 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ARPC3 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr12:39,833,569...39,847,436
Ensembl chr12:34,172,780...34,186,651
|
|
G |
Asah1 |
N-acylsphingosine amidohydrolase 1 |
affects response to substance multiple interactions |
ISO |
ASAH1 protein affects the susceptibility to Fluorouracil TP53 protein affects the reaction [Fluorouracil results in decreased expression of ASAH1 mRNA] |
CTD |
PMID:15016801 PMID:16217747 |
|
NCBI chr16:50,966,404...50,997,827
Ensembl chr16:50,966,229...51,008,233
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
multiple interactions |
ISO |
[Fluorouracil co-treated with irinotecan] results in decreased expression of ASS1 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr 3:35,144,765...35,194,632
Ensembl chr 3:14,747,368...14,796,903
|
|
G |
Atf3 |
activating transcription factor 3 |
affects expression increases expression multiple interactions |
ISO |
Fluorouracil affects the expression of ATF3 mRNA Fluorouracil results in increased expression of ATF3 mRNA; Fluorouracil results in increased expression of ATF3 protein TP53 protein affects the reaction [Fluorouracil results in increased expression of ATF3 mRNA] |
CTD |
PMID:14665630 PMID:15016801 PMID:15205334 PMID:16557594 PMID:16709241 |
|
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atf4 |
activating transcription factor 4 |
increases expression |
ISO |
Fluorouracil results in increased expression of ATF4 protein |
CTD |
PMID:29879413 |
|
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atf6 |
activating transcription factor 6 |
affects expression |
ISO |
Fluorouracil affects the expression of ATF6 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr13:85,460,312...85,639,959
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atg12 |
autophagy related 12 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ATG12 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr18:41,638,841...41,649,311
Ensembl chr18:39,452,191...39,462,418
|
|
G |
Atm |
ATM serine/threonine kinase |
decreases response to substance |
ISO |
ATM protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:35608750 |
|
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atoh8 |
atonal bHLH transcription factor 8 |
affects expression |
ISO |
Fluorouracil affects the expression of ATOH8 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 4:104,259,992...104,292,168
Ensembl chr 4:104,259,992...104,292,168
|
|
G |
Atp5f1d |
ATP synthase F1 subunit delta |
multiple interactions affects expression |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ATP5F1D mRNA] Fluorouracil affects the expression of ATP5F1D mRNA |
CTD |
PMID:15016801 PMID:34151400 |
|
NCBI chr 7:10,211,260...10,218,989
Ensembl chr 7:9,560,608...9,565,929
|
|
G |
Atp5pb |
ATP synthase peripheral stalk-membrane subunit b |
affects expression |
ISO |
Fluorouracil affects the expression of ATP5PB mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 2:196,112,459...196,123,737
Ensembl chr 2:193,424,047...193,435,418
|
|
G |
Atp5pf |
ATP synthase peripheral stalk subunit F6 |
increases expression |
ISO |
Fluorouracil results in increased expression of ATP5PF mRNA |
CTD |
PMID:34151400 |
|
NCBI chr11:37,368,045...37,375,721
Ensembl chr11:23,881,592...23,889,119
|
|
G |
Atp5po |
ATP synthase peripheral stalk subunit OSCP |
multiple interactions |
ISO |
ATP5PO mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] |
CTD |
PMID:17327601 |
|
NCBI chr11:44,651,171...44,657,483
Ensembl chr11:31,165,217...31,171,592
|
|
G |
Atp7b |
ATPase copper transporting beta |
increases response to substance |
ISO |
ATP7B mRNA results in increased susceptibility to Fluorouracil |
CTD |
PMID:18593893 |
|
NCBI chr16:76,654,725...76,726,092
Ensembl chr16:69,951,778...70,023,636
|
|
G |
Atp9a |
ATPase phospholipid transporting 9A (putative) |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of ATP9A protein ATP9A protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 3:157,360,354...157,467,628
Ensembl chr 3:157,360,359...157,467,818
|
|
G |
Atxn10 |
ataxin 10 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ATXN10 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 7:116,441,768...116,565,093
Ensembl chr 7:116,441,613...116,565,087
|
|
G |
Aurka |
aurora kinase A |
decreases expression |
ISO |
Fluorouracil results in decreased expression of AURKA mRNA |
CTD |
PMID:15205334 PMID:16557594 PMID:16709241 PMID:17039268 PMID:19272435 |
|
NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:161,128,313...161,144,390
|
|
G |
Aven |
apoptosis and caspase activation inhibitor |
decreases expression increases expression |
ISO |
Fluorouracil results in decreased expression of AVEN mRNA Fluorouracil results in increased expression of AVEN mRNA |
CTD |
PMID:16510598 PMID:16709241 |
|
NCBI chr 3:99,299,009...99,431,635
Ensembl chr 3:99,298,930...99,431,634
|
|
G |
Axin1 |
axin 1 |
multiple interactions |
EXP |
5-fluorouracil inhibits the reaction [N-methyl-N-nitrosourea decreases expression of Axin1 mRNA in colon] |
RGD |
PMID:28032729 |
RGD:150530464 |
NCBI chr10:15,667,894...15,720,092
Ensembl chr10:15,163,684...15,215,615
|
|
G |
Bad |
BCL2-associated agonist of cell death |
multiple interactions |
EXP |
Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased expression of BAD mRNA] |
CTD |
PMID:31129132 |
|
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bag3 |
BAG cochaperone 3 |
affects response to substance |
ISO |
BAG3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:192,533,460...192,557,281
Ensembl chr 1:183,102,871...183,126,858
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
increases expression increases response to substance multiple interactions |
ISO |
Fluorouracil results in increased expression of BAK1; Fluorouracil results in increased expression of BAK1 mRNA; Fluorouracil results in increased expression of BAK1 protein BAK1 mRNA results in increased susceptibility to Fluorouracil mithramycin A inhibits the reaction [Fluorouracil results in increased expression of BAK1 protein] |
CTD |
PMID:9792140 PMID:15489892 PMID:16557594 PMID:18593893 |
|
NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Barx2 |
BARX homeobox 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of BARX2 protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr 8:30,251,132...30,319,105
Ensembl chr 8:30,251,132...30,319,013
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases response to substance decreases expression increases expression affects expression |
ISO EXP |
[[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in decreased expression of BAX mRNA; [[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in decreased expression of BAX protein; [Docosahexaenoic Acids co-treated with Fluorouracil] results in increased expression of BAX mRNA; [Fluorouracil co-treated with gamma-Tocopherol] results in increased expression of BAX mRNA; [Fluorouracil co-treated with Irinotecan co-treated with Vorinostat] results in increased expression of BAX protein; [SM-1 compound co-treated with Fluorouracil] results in increased expression of BAX protein; [wogonin co-treated with Fluorouracil] results in increased expression of BAX protein; Aspirin promotes the reaction [Fluorouracil results in increased expression of BAX protein]; Cadmium Chloride affects the reaction [Fluorouracil affects the expression of BAX mRNA]; Fluorouracil affects the reaction [Cadmium Chloride affects the expression of BAX mRNA]; Fluorouracil affects the reaction [rebamipide results in decreased expression of BAX protein]; Fluorouracil promotes the reaction [[Doxorubicin co-treated with Paclitaxel] results in increased expression of BAX protein]; Fluorouracil promotes the reaction [andrographolide affects the folding of BAX protein]; Fluorouracil promotes the reaction [Aspirin results in increased expression of BAX protein]; Fluorouracil promotes the reaction [Plant Extracts results in increased expression of BAX protein]; IFNA1 protein promotes the reaction [Fluorouracil results in increased expression of BAX mRNA]; rebamipide inhibits the reaction [Fluorouracil results in increased expression of BAX protein]; SM-1 compound promotes the reaction [Fluorouracil results in increased expression of BAX mRNA] BAX protein results in increased susceptibility to Fluorouracil Fluorouracil results in decreased expression of BAX mRNA; Fluorouracil results in decreased expression of BAX protein [Fluorouracil co-treated with Chitosan co-treated with polyaspartate] results in increased expression of BAX protein; casticin inhibits the reaction [Fluorouracil results in increased expression of BAX protein]; IL1RN protein affects the reaction [Fluorouracil results in increased expression of BAX protein] Fluorouracil results in increased expression of BAX mRNA; Fluorouracil results in increased expression of BAX protein Fluorouracil results in increased expression of BAX; Fluorouracil results in increased expression of BAX mRNA; Fluorouracil results in increased expression of BAX protein Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased expression of BAX mRNA] |
CTD |
PMID:9388485 PMID:9792140 PMID:11062132 PMID:11750847 PMID:12442003 PMID:15641988 PMID:15754201 PMID:15986848 PMID:16168113 PMID:16686938 PMID:16888818 PMID:17045692 PMID:17056233 PMID:17589894 PMID:18567086 PMID:18834353 PMID:19015929 PMID:19097688 PMID:19116755 PMID:20570612 PMID:20844880 PMID:22525470 PMID:23941782 PMID:25824412 PMID:28599477 PMID:29054700 PMID:30542770 PMID:31129132 PMID:31587439 PMID:32270916 PMID:32800223 PMID:38078205 PMID:38423379 More...
|
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
increases response to substance increases expression multiple interactions |
ISO |
BBC3 protein results in increased susceptibility to Fluorouracil Fluorouracil results in increased expression of BBC3 mRNA; Fluorouracil results in increased expression of BBC3 protein [[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in decreased expression of BBC3 mRNA; mithramycin A inhibits the reaction [Fluorouracil results in increased expression of BBC3 protein]; TP53 protein affects the reaction [Fluorouracil results in increased expression of BBC3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of BBC3 protein] |
CTD |
PMID:14665630 PMID:15016801 PMID:15489892 PMID:16481741 PMID:16557594 PMID:22525470 PMID:32800223 More...
|
|
NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bbs4 |
Bardet-Biedl syndrome 4 |
multiple interactions |
ISO |
BBS4 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr 8:59,731,912...59,765,408
Ensembl chr 8:59,731,912...59,765,607
|
|
G |
Bbx |
BBX high mobility group box domain containing |
affects response to substance |
ISO |
BBX protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr11:50,381,249...50,628,934
Ensembl chr11:50,381,247...50,623,251
|
|
G |
Bcar3 |
BCAR3 adaptor protein, NSP family member |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of BCAR3 protein BCAR3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 2:210,525,260...210,638,674
Ensembl chr 2:210,525,260...210,638,798
|
|
G |
Bcat1 |
branched chain amino acid transaminase 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of BCAT1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 4:179,695,662...179,777,973
Ensembl chr 4:177,964,834...178,046,597
|
|
G |
Bckdha |
branched chain keto acid dehydrogenase E1 subunit alpha |
affects expression |
ISO |
Fluorouracil affects the expression of BCKDHA mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 1:90,266,731...90,295,521
Ensembl chr 1:81,138,947...81,167,862
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases response to substance decreases expression increases expression increases phosphorylation affects response to substance affects expression |
ISO EXP |
[[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in increased expression of BCL2 mRNA; [[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in increased expression of BCL2 protein; [Docosahexaenoic Acids co-treated with Fluorouracil] results in decreased expression of BCL2 mRNA; [Fluorouracil co-treated with gamma-Tocopherol] results in decreased expression of BCL2 mRNA; [Fluorouracil co-treated with Irinotecan co-treated with Vorinostat] results in decreased expression of BCL2 protein; [Fluorouracil co-treated with Irinotecan] results in decreased expression of BCL2 mRNA; [Fluorouracil co-treated with Irinotecan] results in decreased expression of BCL2 protein; [Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2 mRNA; [Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2 protein; [SM-1 compound co-treated with Fluorouracil] results in decreased expression of BCL2 mRNA; [SM-1 compound co-treated with Fluorouracil] results in decreased expression of BCL2 protein; [wogonin co-treated with Fluorouracil] results in decreased expression of BCL2 protein; BAY 11-7085 inhibits the reaction [[Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2 mRNA]; Cadmium Chloride affects the reaction [Fluorouracil affects the expression of BCL2 protein]; Fluorouracil affects the reaction [Cadmium Chloride affects the expression of BCL2 mRNA]; Fluorouracil affects the reaction [rebamipide results in increased expression of BCL2 protein]; Fluorouracil promotes the reaction [gambogic acid results in decreased expression of BCL2 mRNA]; Gemcitabine inhibits the reaction [Fluorouracil results in decreased expression of BCL2 mRNA]; Gemcitabine inhibits the reaction [Fluorouracil results in decreased expression of BCL2 protein]; rebamipide inhibits the reaction [Fluorouracil results in decreased expression of BCL2 protein]; SM-1 compound promotes the reaction [Fluorouracil results in decreased expression of BCL2 mRNA] BCL2 protein results in decreased susceptibility to Fluorouracil Fluorouracil results in decreased expression of BCL-2 protein; Fluorouracil results in decreased expression of BCL2; Fluorouracil results in decreased expression of BCL2 mRNA; Fluorouracil results in decreased expression of BCL2 protein Fluorouracil results in increased expression of BCL2 mRNA Fluorouracil results in increased phosphorylation of BCL2 protein [Fluorouracil co-treated with casticin] results in decreased expression of BCL2 protein; [Fluorouracil co-treated with Chitosan co-treated with polyaspartate] results in decreased expression of BCL2 protein; IL1RN protein inhibits the reaction [Fluorouracil results in decreased expression of BCL2 protein] Fluorouracil results in increased expression of BCL2 mRNA; Fluorouracil results in increased expression of BCL2 protein BCL2 protein affects the susceptibility to Fluorouracil Fluorouracil inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 mRNA]; Fluorouracil inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein] |
CTD |
PMID:7654318 PMID:9388485 PMID:14503796 PMID:15177426 PMID:15754201 PMID:15996812 PMID:16332177 PMID:16391804 PMID:16407826 PMID:16412276 PMID:16557594 PMID:16596200 PMID:16603448 PMID:16888818 PMID:16929163 PMID:17287894 PMID:17439414 PMID:17589894 PMID:18161298 PMID:18205257 PMID:18567086 PMID:18949393 PMID:19015929 PMID:19084572 PMID:20570612 PMID:20844880 PMID:23941782 PMID:28599477 PMID:29054700 PMID:30542770 PMID:31129132 PMID:31587439 PMID:32270916 PMID:32800223 PMID:37625625 PMID:38078205 More...
|
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions decreases response to substance affects expression decreases expression increases expression affects response to substance |
ISO EXP |
3-methyladenine inhibits the reaction [Fluorouracil results in increased expression of BCL2L1 protein]; [Fluorouracil co-treated with IFNA1 protein] results in decreased expression of BCL2L1 mRNA; [Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2L1 mRNA; [Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2L1 protein; BAY 11-7085 inhibits the reaction [[Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2L1 mRNA]; BCL2L1 protein inhibits the reaction [BID protein results in increased susceptibility to Fluorouracil]; Fluorouracil affects the reaction [rebamipide results in increased expression of BCL2L1 protein]; Gemcitabine inhibits the reaction [Fluorouracil affects the expression of BCL2L1 mRNA]; Gemcitabine inhibits the reaction [Fluorouracil affects the expression of BCL2L1 protein]; IFNA1 promotes the reaction [Fluorouracil results in decreased expression of BCL2L1 mRNA]; rebamipide inhibits the reaction [Fluorouracil results in decreased expression of BCL2L1 protein] BCL2L1 protein results in decreased susceptibility to Fluorouracil Fluorouracil affects the expression of BCL2L1 mRNA; Fluorouracil affects the expression of BCL2L1 protein Fluorouracil results in decreased expression of BCL2L1; Fluorouracil results in decreased expression of BCL2L1 mRNA; Fluorouracil results in decreased expression of BCL2L1 protein Fluorouracil results in increased expression of BCL2L1 mRNA; Fluorouracil results in increased expression of BCL2L1 protein 3-methyladenine inhibits the reaction [Fluorouracil results in increased expression of BCL2L1 protein]; casticin promotes the reaction [Fluorouracil results in decreased expression of BCL2L1 protein]; Fluorouracil promotes the reaction [casticin results in decreased expression of BCL2L1 protein]; IL1RN protein inhibits the reaction [Fluorouracil results in decreased expression of BCL2L1 protein] BCL2L1 protein affects the susceptibility to Fluorouracil Fluorouracil inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 mRNA]; Fluorouracil inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 protein] |
CTD |
PMID:12442003 PMID:15289866 PMID:15767554 PMID:16407826 PMID:16557594 PMID:16596200 PMID:16875599 PMID:16929163 PMID:17033717 PMID:17045692 PMID:17399942 PMID:17439414 PMID:19116755 PMID:20844880 PMID:21474236 PMID:29054700 PMID:29879413 PMID:31129132 PMID:32270916 PMID:34151400 More...
|
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
multiple interactions increases expression |
ISO |
Fluorouracil affects the reaction [rebamipide results in decreased expression of BCL2L11 protein]; rebamipide inhibits the reaction [Fluorouracil results in increased expression of BCL2L11 protein] |
CTD |
PMID:29054700 |
|
NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Bcl2l12 |
Bcl2 like 12 |
multiple interactions |
ISO |
[Docosahexaenoic Acids co-treated with Fluorouracil] results in decreased expression of BCL2L12 mRNA |
CTD |
PMID:19015929 |
|
NCBI chr 1:95,472,272...95,480,991
Ensembl chr 1:95,472,272...95,480,991
|
|
G |
Bdh1 |
3-hydroxybutyrate dehydrogenase 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of BDH1 protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr11:82,806,125...82,848,133
Ensembl chr11:69,302,534...69,337,671
|
|
G |
Bdkrb2 |
bradykinin receptor B2 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in increased expression of BDKRB2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 6:130,237,055...130,267,205
Ensembl chr 6:124,472,566...124,502,497
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
decreases expression |
EXP |
Fluorouracil results in decreased expression of BDNF protein |
CTD |
PMID:18702703 |
|
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Bean1 |
brain expressed, associated with NEDD4, 1 |
increases expression affects response to substance |
ISO |
Fluorouracil results in increased expression of BEAN1 protein BEAN1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr19:739,551...786,395
Ensembl chr19:739,551...787,537
|
|
G |
Becn1 |
beclin 1 |
multiple interactions increases expression |
ISO |
BECN1 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] Fluorouracil results in increased expression of BECN1 protein Apigenin promotes the reaction [Fluorouracil results in increased expression of BECN1 protein]; Fluorouracil promotes the reaction [Apigenin results in increased expression of BECN1 protein] |
CTD |
PMID:16896004 PMID:28025107 |
|
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bglap |
bone gamma-carboxyglutamate protein |
increases expression |
EXP |
Fluorouracil results in increased expression of BGLAP mRNA |
CTD |
PMID:16888818 |
|
NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:173,838,518...173,839,495
|
|
G |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
affects response to substance |
ISO |
BHLHE41 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 4:178,834,264...178,838,618
Ensembl chr 4:178,834,271...178,838,468
|
|
G |
Bid |
BH3 interacting domain death agonist |
multiple interactions increases response to substance decreases expression decreases response to substance increases expression |
ISO |
[Fluorouracil co-treated with irinotecan co-treated with vorinostat] results in increased cleavage of BID protein; BCL2L1 protein inhibits the reaction [BID protein results in increased susceptibility to Fluorouracil]; Fluorouracil results in increased cleavage of and results in increased activity of BID protein; IFNA1 promotes the reaction [Fluorouracil results in increased cleavage of and results in increased activity of BID protein] Fluorouracil results in decreased expression of BID protein BID protein mutant form results in decreased susceptibility to Fluorouracil casticin inhibits the reaction [Fluorouracil results in increased expression of BID protein] |
CTD |
PMID:15095271 PMID:15289866 PMID:15754201 PMID:21474236 PMID:32270916 |
|
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of BIRC2 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:4,968,842...4,988,732
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
increases expression affects expression |
ISO |
Fluorouracil results in increased expression of BIRC3 mRNA Fluorouracil affects the expression of BIRC3 mRNA |
CTD |
PMID:16557594 PMID:34151400 |
|
NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases response to substance affects response to substance multiple interactions decreases expression increases expression |
ISO |
BIRC5 protein results in decreased susceptibility to Fluorouracil; BIRC5 results in decreased susceptibility to Fluorouracil BIRC5 affects the susceptibility to Fluorouracil; BIRC5 protein affects the susceptibility to Fluorouracil [Fluorouracil co-treated with RNF34 protein] results in increased expression of BIRC5 protein; [SM-1 compound co-treated with Fluorouracil] results in decreased expression of BIRC5 mRNA; Gemcitabine inhibits the reaction [Fluorouracil results in decreased expression of BIRC5 mRNA]; Gemcitabine inhibits the reaction [Fluorouracil results in decreased expression of BIRC5 protein]; SM-1 compound inhibits the reaction [Fluorouracil results in increased expression of BIRC5 mRNA]; SM-1 compound promotes the reaction [Fluorouracil results in decreased expression of BIRC5 protein] Fluorouracil results in decreased expression of BIRC5 mRNA; Fluorouracil results in decreased expression of BIRC5 protein Fluorouracil results in increased expression of BIRC5 mRNA; Fluorouracil results in increased expression of BIRC5 protein |
CTD |
PMID:15067352 PMID:15109396 PMID:15685548 PMID:16217747 PMID:16546719 PMID:16596200 PMID:16709241 PMID:16929163 PMID:17399942 PMID:18714155 PMID:19618606 PMID:28599477 PMID:29054700 More...
|
|
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Birc6 |
baculoviral IAP repeat-containing 6 |
affects response to substance decreases response to substance |
ISO |
BIRC6 protein affects the susceptibility to Fluorouracil BIRC6 results in decreased susceptibility to Fluorouracil |
CTD |
PMID:18239605 PMID:21542283 |
|
NCBI chr 6:26,474,843...26,668,275
Ensembl chr 6:20,722,922...20,916,434
|
|
G |
Birc7 |
baculoviral IAP repeat-containing 7 |
decreases response to substance |
ISO |
BIRC7 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:17437058 |
|
NCBI chr 3:168,047,824...168,052,606
Ensembl chr 3:168,047,824...168,052,606
|
|
G |
Blm |
BLM RecQ like helicase |
decreases expression |
ISO |
Fluorouracil results in decreased expression of BLM mRNA |
CTD |
PMID:19272435 |
|
NCBI chr 1:143,819,072...143,905,300
Ensembl chr 1:134,409,857...134,484,312
|
|
G |
Blvrb |
biliverdin reductase B |
affects response to substance |
ISO |
BLVRB protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
|
|
G |
Bnip1 |
BCL2 interacting protein 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of BNIP1 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr10:16,386,876...16,399,124
Ensembl chr10:16,386,841...16,399,157
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
multiple interactions affects response to substance |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of BNIP3 mRNA] BNIP3 affects the susceptibility to Fluorouracil |
CTD |
PMID:15016801 PMID:15067352 |
|
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Bnip3l |
BCL2 interacting protein 3 like |
affects response to substance increases expression decreases expression |
ISO |
BNIP3L affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of BNIP3L mRNA Fluorouracil results in decreased expression of BNIP3L mRNA |
CTD |
PMID:15067352 PMID:15109396 PMID:16557594 PMID:16709241 PMID:17039268 |
|
NCBI chr15:45,350,081...45,373,213
Ensembl chr15:41,174,594...41,197,803
|
|
G |
Boll |
boule homolog, RNA binding protein |
multiple interactions |
ISO |
BOLL mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] |
CTD |
PMID:17327601 |
|
NCBI chr 9:56,734,890...56,859,917
Ensembl chr 9:56,733,584...56,859,916
|
|
G |
Bop1 |
BOP1 ribosomal biogenesis factor |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of BOP1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 7:108,172,062...108,195,875
Ensembl chr 7:108,172,066...108,195,931
|
|
G |
Bora |
bora, aurora kinase A activator |
decreases expression |
ISO |
Fluorouracil results in decreased expression of BORA mRNA |
CTD |
PMID:17374387 |
|
NCBI chr15:75,797,624...75,835,599
Ensembl chr15:75,797,891...75,821,322
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
decreases expression |
ISO |
Fluorouracil results in decreased expression of BRAF mRNA |
CTD |
PMID:38423379 |
|
NCBI chr 4:69,329,772...69,476,931
Ensembl chr 4:68,384,649...68,510,463
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
increases expression multiple interactions decreases expression |
ISO |
Fluorouracil results in increased expression of BRCA1 mRNA TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of BRCA1 mRNA] |
CTD |
PMID:15607317 PMID:16101138 PMID:16557594 PMID:17982676 |
|
NCBI chr10:86,917,693...86,978,012
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Brix1 |
biogenesis of ribosomes BRX1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of BRIX1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 2:59,450,608...59,461,486
Ensembl chr 2:59,450,614...59,461,495
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
increases expression multiple interactions |
ISO |
Fluorouracil results in increased expression of BTG2 mRNA TP53 protein affects the reaction [Fluorouracil results in increased expression of BTG2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of BTG2 mRNA] |
CTD |
PMID:15016801 PMID:17982676 |
|
NCBI chr13:48,083,931...48,087,690
Ensembl chr13:45,531,925...45,535,628
|
|
G |
Btg3 |
BTG anti-proliferation factor 3 |
multiple interactions |
ISO |
BTG3 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr11:30,517,068...30,532,981
Ensembl chr11:17,030,160...17,046,170
|
|
G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
decreases expression |
ISO |
Fluorouracil results in decreased expression of BUB1 mRNA |
CTD |
PMID:16709241 PMID:19272435 |
|
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
|
|
G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
decreases expression |
ISO |
Fluorouracil results in decreased expression of BUB1B mRNA |
CTD |
PMID:16557594 PMID:16709241 PMID:19272435 |
|
NCBI chr 3:126,017,019...126,069,470
Ensembl chr 3:105,563,138...105,615,547
|
|
G |
Bub3 |
BUB3 mitotic checkpoint protein |
affects response to substance decreases expression |
ISO |
BUB3 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of BUB3 protein |
CTD |
PMID:15548681 PMID:15585135 PMID:16803524 |
|
NCBI chr 1:186,330,358...186,340,969
Ensembl chr 1:186,327,931...186,395,036
|
|
G |
C10h1orf35 |
similar to human chromosome 1 open reading frame 35 |
affects expression |
ISO |
Fluorouracil affects the expression of C1ORF35 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr10:43,993,809...43,997,287
Ensembl chr10:43,993,668...43,997,289
|
|
G |
C1h11orf24 |
similar to human chromosome 11 open reading frame 24 |
affects response to substance |
ISO |
C11ORF24 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:200,945,188...200,953,953
Ensembl chr 1:200,945,180...200,962,585
|
|
G |
C4bpb |
complement component 4 binding protein, beta |
affects expression |
ISO |
Fluorouracil affects the expression of C4BPB mRNA |
CTD |
PMID:16584549 |
|
NCBI chr13:42,120,798...42,131,515
Ensembl chr13:42,120,798...42,131,817
|
|
G |
C6h14orf132 |
similar to human chromosome 14 open reading frame 132 |
increases expression |
ISO |
Fluorouracil results in increased expression of C14ORF132 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 6:124,365,466...124,398,449
|
|
G |
Cabyr |
calcium binding tyrosine phosphorylation regulated |
affects response to substance |
ISO |
CABYR protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr18:3,892,062...3,904,391
Ensembl chr18:3,892,132...3,903,840
|
|
G |
Cad |
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CAD mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 6:31,012,091...31,035,098
Ensembl chr 6:25,292,133...25,319,861
|
|
G |
Calb2 |
calbindin 2 |
increases response to substance increases expression |
ISO |
CALB2 protein results in increased susceptibility to Fluorouracil Fluorouracil results in increased expression of CALB2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr19:55,023,849...55,050,858
Ensembl chr19:38,114,424...38,141,438
|
|
G |
Canx |
calnexin |
multiple interactions |
ISO |
CANX results in decreased susceptibility to [Fluorouracil co-treated with Capecitabine]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CANX mRNA] |
CTD |
PMID:15016801 PMID:18678097 |
|
NCBI chr10:35,124,941...35,157,954
Ensembl chr10:34,625,191...34,656,821
|
|
G |
Cap2 |
cyclase associated actin cytoskeleton regulatory protein 2 |
affects response to substance |
ISO |
CAP2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr17:18,054,234...18,203,453
Ensembl chr17:18,054,431...18,203,373
|
|
G |
Car12 |
carbonic anhydrase 12 |
multiple interactions |
ISO |
CA12 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440
|
|
G |
Car14 |
carbonic anhydrase 14 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CA14 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 2:183,442,263...183,449,231
Ensembl chr 2:183,441,667...183,449,693
|
|
G |
Casd1 |
CAS1 domain containing 1 |
affects expression |
ISO |
Fluorouracil affects the expression of CASD1 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr 4:32,659,196...32,739,228
Ensembl chr 4:32,658,748...32,739,202
|
|
G |
Casp1 |
caspase 1 |
increases cleavage |
ISO |
Fluorouracil results in increased cleavage of CASP1 protein |
CTD |
PMID:15162350 |
|
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp2 |
caspase 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of CASP2 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
|
|
G |
Casp3 |
caspase 3 |
increases expression multiple interactions increases activity decreases expression increases cleavage decreases cleavage affects expression |
ISO EXP |
Fluorouracil results in increased expression of CASP3; Fluorouracil results in increased expression of CASP3 mRNA; Fluorouracil results in increased expression of CASP3 protein; Fluorouracil results in increased expression of CASP3 protein modified form 3-methyladenine promotes the reaction [Fluorouracil results in increased cleavage of and results in increased activity of CASP3 protein]; Apigenin promotes the reaction [Fluorouracil results in increased activity of CASP3 protein]; casticin inhibits the reaction [Fluorouracil results in increased activity of CASP3 protein]; Fluorouracil promotes the reaction [Apigenin results in increased activity of CASP3 protein]; Fluorouracil results in increased cleavage of and results in increased activity of CASP3 protein; IL1RN protein affects the reaction [Fluorouracil results in increased expression of CASP3 protein modified form] Fluorouracil results in decreased expression of CASP3 mRNA Fluorouracil results in increased cleavage of CASP3 protein 3-methyladenine promotes the reaction [Fluorouracil results in increased cleavage of and results in increased activity of CASP3 protein]; [10-hydroxycamptothecin co-treated with Fluorouracil co-treated with Leucovorin] results in increased activity of CASP3 protein; [[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in decreased expression of CASP3 mRNA; [[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in decreased expression of CASP3 protein; [Doxorubicin co-treated with Paclitaxel co-treated with Fluorouracil] results in increased activity of CASP3 protein; [Fluorouracil co-treated with aloe emodin] affects the expression of CASP3; [Fluorouracil co-treated with Cisplatin] results in increased activity of CASP3 protein; [Fluorouracil co-treated with Cisplatin] results in increased expression of CASP3 protein; [Fluorouracil co-treated with IFNB1 protein] results in increased activity of CASP3 protein; [Fluorouracil co-treated with olaparib] results in increased cleavage of CASP3 protein; [Fluorouracil co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein; [S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased activity of CASP3 protein; [SM-1 compound co-treated with Fluorouracil] results in increased cleavage of CASP3 protein; [wogonin co-treated with Fluorouracil] results in increased activity of CASP3 protein; Apigenin promotes the reaction [Fluorouracil results in increased activity of CASP3 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Fluorouracil co-treated with olaparib] results in increased cleavage of CASP3 protein]; CA 074 methyl ester inhibits the reaction [Fluorouracil results in increased cleavage of CASP3 protein]; CASP8 affects the reaction [Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP3 protein]]; Celecoxib inhibits the reaction [Fluorouracil results in increased expression of CASP3 protein]; chan-yu-bao-yuan-tang promotes the reaction [Fluorouracil results in increased cleavage of and results in increased expression of CASP3 protein]; FAS protein affects the reaction [Fluorouracil results in increased activity of CASP3 protein]; Fluorouracil promotes the reaction [aloe emodin results in increased expression of CASP3 protein modified form]; Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP3 protein]; Fluorouracil promotes the reaction [chan-yu-bao-yuan-tang results in increased cleavage of and results in increased expression of CASP3 protein]; Fluorouracil promotes the reaction [gambogic acid results in decreased expression of CASP3 mRNA]; Fluorouracil promotes the reaction [Sirolimus results in increased expression of CASP3 mRNA]; Fluorouracil promotes the reaction [temsirolimus results in increased expression of CASP3 mRNA]; Fluorouracil promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP3 protein]; Fluorouracil results in increased activity of and results in increased cleavage of CASP3 protein; Fluorouracil results in increased cleavage of and results in increased activity of CASP3 protein; Fluorouracil results in increased cleavage of and results in increased expression of CASP3 protein; HK2 protein affects the reaction [Fluorouracil results in increased activity of CASP3 protein]; IFI6 protein inhibits the reaction [Fluorouracil results in increased activity of CASP3 protein]; IFNA1 protein promotes the reaction [Fluorouracil results in increased activity of CASP3 protein]; PTGS2 protein inhibits the reaction [Fluorouracil results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [Fluorouracil results in decreased cleavage of CASP3 protein]; RNF34 protein inhibits the reaction [Fluorouracil results in increased activity of CASP3 protein]; Sirolimus promotes the reaction [Fluorouracil results in increased expression of CASP3 mRNA]; temsirolimus promotes the reaction [Fluorouracil results in increased expression of CASP3 mRNA]; TNFRSF10B mutant form inhibits the reaction [Fluorouracil results in increased cleavage of CASP3 protein] [diacerein co-treated with Fluorouracil] inhibits the reaction [Trichloroacetic Acid results in decreased cleavage of CASP3 protein]; Bosentan inhibits the reaction [Fluorouracil results in increased cleavage of CASP3 protein]; Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP3 mRNA]; Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP3 protein]; Silybin inhibits the reaction [Fluorouracil results in increased expression of CASP3 protein] Fluorouracil affects the expression of CASP3 mRNA |
CTD |
PMID:10891390 PMID:11300326 PMID:12414664 PMID:12934351 PMID:12941601 PMID:14503796 PMID:15120327 PMID:15282376 PMID:15585135 PMID:15685448 PMID:16080519 PMID:16168113 PMID:16407826 PMID:16803524 PMID:17016659 PMID:17056233 PMID:17219956 PMID:17399942 PMID:17461495 PMID:17498489 PMID:17589894 PMID:18161298 PMID:18205257 PMID:18608205 PMID:18772588 PMID:18830594 PMID:19084572 PMID:19097688 PMID:19116755 PMID:19764996 PMID:19815060 PMID:19816940 PMID:19885610 PMID:19928967 PMID:20570612 PMID:20844880 PMID:20876774 PMID:21036698 PMID:21461573 PMID:25940438 PMID:26310874 PMID:26544897 PMID:28025107 PMID:28599477 PMID:29678497 PMID:31129132 PMID:31288002 PMID:32270916 PMID:32634519 PMID:32800223 PMID:34151400 PMID:34794354 PMID:34800596 PMID:36203040 PMID:37335224 PMID:37625625 More...
|
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp4 |
caspase 4 |
increases expression affects response to substance |
ISO |
Fluorouracil results in increased expression of CASP4 protein CASP4 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 PMID:16217747 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Casp6 |
caspase 6 |
multiple interactions affects expression |
ISO |
Fluorouracil results in increased cleavage of and results in increased activity of CASP6 protein; resveratrol affects the reaction [Fluorouracil results in increased activity of CASP6 protein]; TP53 affects the reaction [resveratrol affects the reaction [Fluorouracil results in increased activity of CASP6 protein]] Fluorouracil affects the expression of CASP6 mRNA |
CTD |
PMID:18497562 PMID:34151400 |
|
NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:218,466,076...218,478,502
|
|
G |
Casp7 |
caspase 7 |
multiple interactions increases cleavage increases expression |
ISO |
[Doxorubicin co-treated with Paclitaxel co-treated with Fluorouracil] results in increased activity of CASP7 protein Fluorouracil results in increased cleavage of CASP7 protein Fluorouracil results in increased expression of CASP7 mRNA |
CTD |
PMID:16168113 PMID:26544897 PMID:34151400 |
|
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
multiple interactions increases activity increases expression decreases expression increases cleavage |
ISO |
[Cadmium Chloride co-treated with Fluorouracil] affects the expression of CASP8 protein; [Doxorubicin co-treated with Paclitaxel co-treated with Fluorouracil] results in increased activity of CASP8 protein; [Fluorouracil co-treated with aloe emodin] affects the expression of CASP8; [Fluorouracil co-treated with Cisplatin] results in increased activity of CASP8 protein; [Fluorouracil co-treated with Cisplatin] results in increased expression of CASP8 protein; [Fluorouracil co-treated with olaparib] results in increased cleavage of CASP8 protein; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Fluorouracil co-treated with olaparib] results in increased cleavage of CASP8 protein]; Cadmium Chloride affects the reaction [Fluorouracil results in decreased expression of CASP8 mRNA]; CASP8 affects the reaction [Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP3 protein]]; CASP8 affects the reaction [Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP9 protein]]; CASP8 results in increased susceptibility to [andrographolide co-treated with Fluorouracil]; FAS protein affects the reaction [Fluorouracil results in increased activity of CASP8 protein]; Fluorouracil affects the reaction [Cadmium Chloride results in decreased expression of CASP8 mRNA]; Fluorouracil promotes the reaction [aloe emodin results in increased expression of CASP8 protein modified form]; Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP8 protein]; Fluorouracil promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP8 protein]; IFNA1 promotes the reaction [Fluorouracil results in increased expression of CASP8 protein]; IFNA1 protein promotes the reaction [Fluorouracil results in increased activity of CASP8 protein]; isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Fluorouracil results in increased activity of CASP8 protein]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of CASP8 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of CASP8 protein] Fluorouracil results in increased expression of CASP8 mRNA; Fluorouracil results in increased expression of CASP8 protein Fluorouracil results in increased cleavage of CASP8 protein |
CTD |
PMID:10779637 PMID:10891390 PMID:12414664 PMID:14607657 PMID:15585135 PMID:16168113 PMID:16803524 PMID:17016659 PMID:17056233 PMID:17637740 PMID:18830594 PMID:19097688 PMID:19816940 PMID:19928967 PMID:20876774 PMID:21474236 PMID:23941782 PMID:26544897 PMID:32270916 PMID:34151400 More...
|
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases cleavage increases expression increases activity decreases expression |
ISO EXP |
[Docosahexaenoic Acids co-treated with Fluorouracil] results in decreased expression of CASP9 mRNA; [Fluorouracil co-treated with aloe emodin] affects the expression of CASP9; [Fluorouracil co-treated with Cisplatin] results in increased activity of CASP9 protein; [Fluorouracil co-treated with Cisplatin] results in increased expression of CASP9 protein; Cadmium Chloride promotes the reaction [Fluorouracil results in decreased expression of CASP9 mRNA]; CASP8 affects the reaction [Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP9 protein]]; FAS protein affects the reaction [Fluorouracil results in increased activity of CASP9 protein]; Fluorouracil inhibits the reaction [Cadmium Chloride results in increased expression of CASP9 mRNA]; Fluorouracil promotes the reaction [[Doxorubicin co-treated with Paclitaxel] results in increased activity of CASP9 protein]; Fluorouracil promotes the reaction [aloe emodin results in increased expression of CASP9 protein modified form]; Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP9 protein]; Fluorouracil promotes the reaction [Arsenic Trioxide results in decreased expression of CASP9 protein]; Fluorouracil results in increased cleavage of and results in increased activity of CASP9 protein; IFNA1 protein promotes the reaction [Fluorouracil results in increased activity of CASP9 protein]; N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in increased cleavage of and results in increased activity of CASP9 protein]; PTGS2 protein inhibits the reaction [Fluorouracil results in increased activity of CASP9 protein]; RNF34 protein inhibits the reaction [Fluorouracil results in increased activity of CASP9 protein]; TP53 protein inhibits the reaction [Fluorouracil results in increased cleavage of and results in increased activity of CASP9 protein]; TP53 protein inhibits the reaction [N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in increased cleavage of and results in increased activity of CASP9 protein]] Fluorouracil results in increased cleavage of CASP9 protein Fluorouracil results in increased expression of CASP9 protein Apigenin promotes the reaction [Fluorouracil results in increased activity of CASP9 protein]; casticin promotes the reaction [Fluorouracil results in increased activity of CASP9 protein]; Fluorouracil promotes the reaction [Apigenin results in increased activity of CASP9 protein] Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP9 mRNA]; Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP9 protein] |
CTD |
PMID:10779637 PMID:12414664 PMID:15546879 PMID:15996812 PMID:16168113 PMID:16407826 PMID:16803524 PMID:17016659 PMID:17056233 PMID:17498489 PMID:18830594 PMID:19015929 PMID:19097688 PMID:19816940 PMID:19928967 PMID:22963400 PMID:23941782 PMID:28025107 PMID:31129132 PMID:32270916 More...
|
|
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions decreases activity decreases expression |
ISO EXP |
Fluorouracil inhibits the reaction [casticin results in increased expression of CAT protein]; Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein]; Fluorouracil promotes the reaction [Luteolin results in decreased activity of CAT protein]; Fluorouracil promotes the reaction [Valsartan results in decreased activity of CAT protein]; Luteolin promotes the reaction [Fluorouracil results in decreased activity of CAT protein]; Valsartan promotes the reaction [Fluorouracil results in decreased activity of CAT protein] [Fluorouracil co-treated with Arsenic Trioxide] results in decreased activity of CAT protein [Fluorouracil co-treated with Leucovorin co-treated with 1,2-Dimethylhydrazine] results in increased expression of CAT protein; Silybin inhibits the reaction [Fluorouracil results in decreased expression of CAT protein] |
CTD |
PMID:27836789 PMID:29117755 PMID:31288002 PMID:32270916 PMID:32524861 PMID:32752303 PMID:33634982 PMID:35235860 PMID:37335224 More...
|
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cav1 |
caveolin 1 |
affects response to substance decreases expression increases expression |
ISO |
CAV1 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of CAV1 protein Fluorouracil results in increased expression of CAV1 mRNA |
CTD |
PMID:15352031 PMID:24737281 |
|
NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:45,634,918...45,673,705
|
|
G |
Cav2 |
caveolin 2 |
decreases expression increases expression |
ISO |
Fluorouracil results in decreased expression of CAV2 mRNA Fluorouracil results in increased expression of CAV2 mRNA |
CTD |
PMID:16510598 PMID:24737281 |
|
NCBI chr 4:46,582,681...46,590,058
Ensembl chr 4:45,616,712...45,624,244
|
|
G |
Cbr3 |
carbonyl reductase 3 |
affects expression |
ISO |
Fluorouracil affects the expression of CBR3 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr11:33,008,615...33,016,877
Ensembl chr11:33,008,615...33,016,875
|
|
G |
Cbs |
cystathionine beta synthase |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CBS mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr20:9,709,394...9,733,925
Ensembl chr20:9,708,090...9,732,764
|
|
G |
Cbx1 |
chromobox 1 |
affects response to substance |
ISO |
CBX1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:82,266,746...82,286,431
Ensembl chr10:81,770,342...81,791,096
|
|
G |
Ccdc186 |
coiled-coil domain containing 186 |
increases expression |
ISO |
Fluorouracil results in increased expression of CCDC186 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 1:255,831,663...255,871,954
Ensembl chr 1:255,839,595...255,871,935
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of CCL2 mRNA Fluorouracil promotes the reaction [Valsartan results in decreased expression of CCL2 mRNA]; Valsartan promotes the reaction [Fluorouracil results in decreased expression of CCL2 mRNA] |
CTD |
PMID:35235860 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccn1 |
cellular communication network factor 1 |
increases expression affects response to substance |
ISO |
Fluorouracil results in increased expression of CCN1 mRNA; Fluorouracil results in increased expression of CCN1 protein CCN1 affects the susceptibility to Fluorouracil |
CTD |
PMID:15067352 PMID:17699798 PMID:24737281 |
|
NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Ccn2 |
cellular communication network factor 2 |
affects expression |
ISO |
Fluorouracil affects the expression of CCN2 mRNA |
CTD |
PMID:15205334 |
|
NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccn3 |
cellular communication network factor 3 |
increases expression |
ISO |
Fluorouracil results in increased expression of CCN3 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 7:86,094,000...86,101,022
Ensembl chr 7:86,094,000...86,101,019
|
|
G |
Ccna1 |
cyclin A1 |
multiple interactions affects expression |
ISO |
[Cadmium Chloride co-treated with Fluorouracil] affects the expression of CCNA1 protein; Cadmium Chloride affects the reaction [Fluorouracil affects the expression of CCNA1 mRNA]; Fluorouracil affects the reaction [Cadmium Chloride affects the expression of CCNA1 mRNA] Fluorouracil affects the expression of CCNA1 mRNA; Fluorouracil affects the expression of CCNA1 protein |
CTD |
PMID:23941782 |
|
NCBI chr 2:141,383,352...141,428,205
Ensembl chr 2:139,201,074...139,243,157
|
|
G |
Ccna2 |
cyclin A2 |
multiple interactions decreases expression affects expression affects response to substance |
ISO |
N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in decreased expression of CCNA2 protein]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of CCNA2 protein]; TP53 protein inhibits the reaction [N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in decreased expression of CCNA2 protein]] Fluorouracil results in decreased expression of CCNA2 mRNA; Fluorouracil results in decreased expression of CCNA2 protein Fluorouracil affects the expression of CCNA2 mRNA CCNA2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15205334 PMID:15546879 PMID:15548681 PMID:16557594 PMID:18383818 |
|
NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions decreases expression |
ISO |
N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in decreased expression of CCNB1 protein]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CCNB1 mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of CCNB1 mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of CCNB1 protein]; TP53 protein inhibits the reaction [N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in decreased expression of CCNB1 protein]] Fluorouracil results in decreased expression of CCNB1 mRNA; Fluorouracil results in decreased expression of CCNB1 protein |
CTD |
PMID:15016801 PMID:15205334 PMID:15546879 PMID:16557594 PMID:17982676 |
|
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnb2 |
cyclin B2 |
multiple interactions decreases expression |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CCNB2 mRNA] Fluorouracil results in decreased expression of CCNB2 mRNA; Fluorouracil results in decreased expression of CCNB2 protein |
CTD |
PMID:15016801 PMID:16557594 PMID:16709241 PMID:17982488 PMID:19272435 |
|
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
|
|
G |
Ccnc |
cyclin C |
decreases expression |
ISO |
Fluorouracil results in decreased expression of CCNC mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 5:35,266,828...35,284,943
Ensembl chr 5:35,266,823...35,296,584
|
|
G |
Ccnd1 |
cyclin D1 |
affects response to substance multiple interactions decreases expression affects expression |
ISO |
CCND1 protein affects the susceptibility to Fluorouracil [allose co-treated with Fluorouracil] results in decreased expression of CCND1 protein; [Cadmium Chloride co-treated with Fluorouracil] affects the expression of CCND1 protein; [Fluorouracil co-treated with gamma-Tocopherol] results in decreased expression of CCND1 mRNA; Cadmium Chloride affects the reaction [Fluorouracil affects the expression of CCND1 mRNA]; Fluorouracil affects the reaction [Cadmium Chloride affects the expression of CCND1 mRNA]; Fluorouracil promotes the reaction [allose results in decreased expression of CCND1 mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of CCND1 protein] Fluorouracil results in decreased expression of CCND1 mRNA; Fluorouracil results in decreased expression of CCND1 protein Fluorouracil affects the expression of CCND1 mRNA; Fluorouracil affects the expression of CCND1 protein Fluorouracil promotes the reaction [Luteolin results in decreased expression of CCND1 protein]; Luteolin promotes the reaction [Fluorouracil results in decreased expression of CCND1 protein] |
CTD |
PMID:15352031 PMID:17982676 PMID:18930000 PMID:23941782 PMID:31288002 PMID:31587439 More...
|
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd2 |
cyclin D2 |
increases expression affects response to substance multiple interactions decreases expression |
ISO |
Fluorouracil results in increased expression of CCND2 protein CCND2 protein affects the susceptibility to Fluorouracil TP53 protein affects the reaction [Fluorouracil results in decreased expression of CCND2 mRNA] |
CTD |
PMID:15016801 PMID:15352031 PMID:19272435 |
|
NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Ccnd3 |
cyclin D3 |
affects response to substance increases expression |
ISO |
CCND3 affects the susceptibility to Fluorouracil; CCND3 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of CCND3 mRNA |
CTD |
PMID:15067352 PMID:15548681 PMID:16709241 PMID:18383818 |
|
NCBI chr 9:20,891,696...20,987,199
Ensembl chr 9:13,394,169...13,489,371
|
|
G |
Ccne1 |
cyclin E1 |
decreases expression increases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of CCNE1 mRNA Fluorouracil results in increased expression of CCNE1 mRNA; Fluorouracil results in increased expression of CCNE1 protein [Fluorouracil co-treated with gamma-Tocopherol] results in decreased expression of CCNE1 mRNA; [Leucovorin co-treated with Fluorouracil] results in increased expression of CCNE1 mRNA |
CTD |
PMID:9930367 PMID:15342418 PMID:16101138 PMID:18930000 PMID:31587439 |
|
NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Ccne2 |
cyclin E2 |
affects response to substance |
ISO |
CCNE2 affects the susceptibility to Fluorouracil |
CTD |
PMID:15067352 |
|
NCBI chr 5:29,082,169...29,094,879
Ensembl chr 5:24,284,922...24,297,632
|
|
G |
Ccnf |
cyclin F |
affects response to substance |
ISO |
CCNF affects the susceptibility to Fluorouracil |
CTD |
PMID:15067352 |
|
NCBI chr10:13,253,073...13,279,140
Ensembl chr10:13,253,380...13,279,101
|
|
G |
Ccng1 |
cyclin G1 |
affects response to substance decreases expression multiple interactions increases expression |
ISO |
CCNG1 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of CCNG1 mRNA TP53 protein promotes the reaction [Fluorouracil results in increased expression of CCNG1 mRNA] |
CTD |
PMID:15152939 PMID:16217747 PMID:16557594 PMID:16709241 PMID:17982676 PMID:19272435 PMID:22525470 More...
|
|
NCBI chr10:25,678,503...25,684,876
Ensembl chr10:25,176,234...25,181,641
|
|
G |
Ccng2 |
cyclin G2 |
affects response to substance increases expression decreases expression |
ISO |
CCNG2 affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of CCNG2 mRNA Fluorouracil results in decreased expression of CCNG2 mRNA |
CTD |
PMID:15067352 PMID:16510598 PMID:16557594 PMID:17039268 PMID:18754885 PMID:19272435 More...
|
|
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
|
|
G |
Ccnjl |
cyclin J-like |
affects expression |
ISO |
Fluorouracil affects the expression of CCNJL mRNA |
CTD |
PMID:16584549 |
|
NCBI chr10:27,995,682...28,053,428
Ensembl chr10:27,995,679...28,053,426
|
|
G |
Cd109 |
CD109 molecule |
affects response to substance |
ISO |
CD109 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:37661780 |
|
NCBI chr 8:79,454,480...79,569,195
Ensembl chr 8:79,454,480...79,569,194
|
|
G |
Cd24 |
CD24 molecule |
increases expression |
ISO |
Fluorouracil results in increased expression of CD24 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662
|
|
G |
Cd274 |
CD274 molecule |
increases expression |
ISO |
Fluorouracil results in increased expression of CD274 protein |
CTD |
PMID:17920123 |
|
NCBI chr 1:236,526,215...236,549,956
Ensembl chr 1:227,116,649...227,134,450
|
|
G |
Cd34 |
CD34 molecule |
increases expression |
ISO |
Fluorouracil results in increased expression of CD34 protein |
CTD |
PMID:21296659 |
|
NCBI chr13:109,008,786...109,029,317
Ensembl chr13:106,480,043...106,499,832
|
|
G |
Cd38 |
CD38 molecule |
affects expression |
ISO |
Fluorouracil affects the expression of CD38 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr14:71,384,532...71,424,794
Ensembl chr14:67,172,063...67,211,986
|
|
G |
Cd40 |
CD40 molecule |
decreases response to substance multiple interactions |
ISO |
CD40 results in decreased susceptibility to Fluorouracil Fluorouracil inhibits the reaction [[CD40LG protein co-treated with CD40 protein] inhibits the reaction [EIF4E protein binds to EIF4EBP1 protein]] |
CTD |
PMID:15611226 PMID:20188757 |
|
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cd40lg |
CD40 ligand |
multiple interactions |
ISO |
Fluorouracil inhibits the reaction [[CD40LG protein co-treated with CD40 protein] inhibits the reaction [EIF4E protein binds to EIF4EBP1 protein]] |
CTD |
PMID:15611226 |
|
NCBI chr X:140,164,341...140,176,057
Ensembl chr X:135,126,969...135,138,306
|
|
G |
Cd44 |
CD44 molecule |
multiple interactions |
EXP |
[gimeracil co-treated with Fluorouracil] results in decreased expression of CD44 |
CTD |
PMID:12364819 |
|
NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cd52 |
CD52 molecule |
affects expression multiple interactions |
ISO |
Fluorouracil affects the expression of CD52 mRNA TP53 protein affects the reaction [Fluorouracil results in decreased expression of CD52 mRNA] |
CTD |
PMID:15016801 PMID:16584549 |
|
NCBI chr 5:146,319,789...146,321,348
Ensembl chr 5:146,319,969...146,321,348
|
|
G |
Cd63 |
Cd63 molecule |
decreases expression |
ISO |
Fluorouracil results in decreased expression of CD63 |
CTD |
PMID:15485462 |
|
NCBI chr 7:1,909,538...1,924,937
Ensembl chr 7:1,325,103...1,399,178
|
|
G |
Cd8a |
CD8 subunit alpha |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CD8A mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 4:104,924,116...104,928,353
Ensembl chr 4:103,365,804...103,370,040
|
|
G |
Cd8b |
CD8 subunit beta |
affects response to substance decreases expression |
ISO |
CD8B protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of CD8B protein |
CTD |
PMID:15352031 |
|
NCBI chr 4:104,870,911...104,886,838
Ensembl chr 4:103,312,578...103,328,553
|
|
G |
Cd9 |
CD9 molecule |
decreases expression |
ISO |
Fluorouracil results in decreased expression of CD9 protein |
CTD |
PMID:21296659 |
|
NCBI chr 4:159,942,553...159,975,463
Ensembl chr 4:158,256,328...158,289,222
|
|
G |
Cda |
cytidine deaminase |
multiple interactions |
EXP |
[CYP2B1 co-treated with CDA] results in increased susceptibility to [Ifosfamide co-treated with Fluorouracil]; [CYP2B1 co-treated with CDA] results in increased susceptibility to Fluorouracil |
CTD |
PMID:10811482 |
|
NCBI chr 5:155,839,929...155,866,541
Ensembl chr 5:150,556,615...150,583,231
|
|
G |
Cdc20 |
cell division cycle 20 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CDC20 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
|
|
G |
Cdc25a |
cell division cycle 25A |
decreases expression |
ISO |
Fluorouracil results in decreased expression of CDC25A mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 8:118,742,824...118,761,190
Ensembl chr 8:109,864,478...109,882,701
|
|
G |
Cdc25b |
cell division cycle 25B |
decreases expression |
ISO |
Fluorouracil results in decreased expression of CDC25B mRNA |
CTD |
PMID:16709241 PMID:19272435 |
|
NCBI chr 3:138,860,148...138,870,287
Ensembl chr 3:118,407,128...118,417,272
|
|
G |
Cdc25c |
cell division cycle 25C |
affects response to substance decreases expression |
ISO |
CDC25C protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of CDC25C mRNA |
CTD |
PMID:15548681 PMID:19272435 |
|
NCBI chr18:26,608,483...26,630,292
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdc34 |
cell division cycle 34, ubiquitin conjugating enzyme |
affects response to substance |
ISO |
CDC34 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 7:10,017,588...10,023,586
Ensembl chr 7:10,017,588...10,023,186
|
|
G |
Cdc40 |
cell division cycle 40 |
increases expression |
ISO |
Fluorouracil results in increased expression of CDC40 protein |
CTD |
PMID:16803524 |
|
NCBI chr20:44,273,080...44,325,605
Ensembl chr20:44,273,089...44,325,358
|
|
G |
Cdc42ep1 |
CDC42 effector protein 1 |
affects response to substance |
ISO |
CDC42EP1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 7:110,395,287...110,403,203
Ensembl chr 7:110,395,332...110,403,200
|
|
G |
Cdc45 |
cell division cycle 45 |
multiple interactions affects expression decreases expression |
ISO |
[Leucovorin co-treated with Fluorouracil] results in increased expression of CDC45 mRNA Fluorouracil affects the expression of CDC45 mRNA Fluorouracil results in decreased expression of CDC45 mRNA |
CTD |
PMID:15342418 PMID:16557594 PMID:19272435 |
|
NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619
|
|
G |
Cdc6 |
cell division cycle 6 |
affects expression decreases expression increases expression multiple interactions |
ISO |
Fluorouracil affects the expression of CDC6 mRNA Fluorouracil results in decreased expression of CDC6 mRNA Fluorouracil results in increased expression of CDC6 mRNA [Leucovorin co-treated with Fluorouracil] results in increased expression of CDC6 mRNA |
CTD |
PMID:15342418 PMID:16557594 PMID:16709241 PMID:17039268 PMID:19272435 |
|
NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011
|
|
G |
Cdc73 |
cell division cycle 73 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of CDC73 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr13:57,897,924...58,000,031
Ensembl chr13:55,357,226...55,449,656
|
|
G |
Cdca5 |
cell division cycle associated 5 |
increases expression |
ISO |
Fluorouracil results in increased expression of CDCA5 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 1:203,378,550...203,392,027
Ensembl chr 1:203,378,577...203,392,023
|
|
G |
Cdca7 |
cell division cycle associated 7 |
affects expression |
ISO |
Fluorouracil affects the expression of CDCA7 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr 3:57,322,718...57,333,353
Ensembl chr 3:57,322,708...57,333,353
|
|
G |
Cdca8 |
cell division cycle associated 8 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of CDCA8 mRNA |
CTD |
PMID:17374387 |
|
NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:137,176,417...137,198,629
|
|
G |
Cdh1 |
cadherin 1 |
affects response to substance multiple interactions decreases expression |
ISO |
CDH1 protein affects the susceptibility to Fluorouracil resveratrol inhibits the reaction [Fluorouracil results in decreased expression of CDH1 protein] |
CTD |
PMID:15352031 PMID:26310874 |
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh5 |
cadherin 5 |
increases expression multiple interactions |
ISO |
Fluorouracil results in increased expression of CDH5 protein Fluorouracil inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in decreased expression of CDH5 mRNA]; Fluorouracil inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in decreased expression of CDH5 protein] |
CTD |
PMID:21296659 PMID:31404653 |
|
NCBI chr19:815,415...854,478
Ensembl chr19:815,411...854,368
|
|
G |
Cdh6 |
cadherin 6 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of CDH6 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 2:62,079,139...62,225,298
Ensembl chr 2:62,079,137...62,225,228
|
|
G |
Cdipt |
CDP-diacylglycerol--inositol 3-phosphatidyltransferase |
affects expression |
ISO |
Fluorouracil affects the expression of CDIPT mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 1:181,583,098...181,587,409
Ensembl chr 1:181,583,141...181,587,408
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression affects expression increases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of CDK1 mRNA Fluorouracil affects the expression of CDK1 mRNA Fluorouracil results in increased expression of CDK1 mRNA [Leucovorin co-treated with Fluorouracil] results in increased expression of CDK1 mRNA |
CTD |
PMID:15152939 PMID:15205334 PMID:15342418 PMID:16557594 PMID:17039268 PMID:26272751 More...
|
|
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
affects response to substance increases expression multiple interactions |
ISO |
CDK2 protein affects the susceptibility to Fluorouracil; CDK2 protein modified form affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of CDK2 mRNA [Leucovorin co-treated with Fluorouracil] results in increased expression of CDK2 mRNA |
CTD |
PMID:15342418 PMID:15548681 PMID:16557594 PMID:18383818 |
|
NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk5r1 |
cyclin-dependent kinase 5 regulatory subunit 1 |
affects expression |
ISO |
Fluorouracil affects the expression of CDK5R1 mRNA |
CTD |
PMID:15205334 |
|
NCBI chr10:65,981,692...65,985,831
Ensembl chr10:65,483,941...65,488,456
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
affects response to substance increases response to substance decreases response to substance multiple interactions decreases expression decreases degradation increases expression |
ISO |
CDKN1A affects the susceptibility to Fluorouracil; CDKN1A protein affects the susceptibility to Fluorouracil CDKN1A protein results in increased susceptibility to Fluorouracil CDKN1A protein results in decreased susceptibility to Fluorouracil [Fluorouracil co-treated with Genistein] results in increased expression of CDKN1A mRNA; [Fluorouracil co-treated with Irinotecan co-treated with Vorinostat] results in increased expression of CDKN1A protein; [Fluorouracil co-treated with Plant Extracts] results in increased expression of CDKN1A protein; [Leucovorin co-treated with Fluorouracil] results in increased expression of CDKN1A mRNA; CDKN1A protein affects the reaction [Fluorouracil promotes the reaction [E2F4 protein binds to UBE2C promoter]]; CDKN1A protein affects the reaction [Fluorouracil results in decreased expression of UBE2C protein]; Fluorouracil promotes the reaction [[Doxorubicin co-treated with Paclitaxel] results in increased expression of CDKN1A protein]; Fluorouracil promotes the reaction [[TP53 protein binds to SP1 protein] which binds to CDKN1A promoter]; Fluorouracil promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of CDKN1A protein]; Fluorouracil promotes the reaction [Sirolimus results in increased expression of CDKN1A mRNA]; Fluorouracil promotes the reaction [temsirolimus results in increased expression of CDKN1A mRNA]; mithramycin A inhibits the reaction [Fluorouracil results in increased expression of CDKN1A protein]; Pravastatin inhibits the reaction [Fluorouracil results in decreased degradation of CDKN1A protein]; Simvastatin inhibits the reaction [Fluorouracil results in decreased degradation of CDKN1A protein]; Sirolimus promotes the reaction [Fluorouracil results in increased expression of CDKN1A mRNA]; temsirolimus promotes the reaction [Fluorouracil results in increased expression of CDKN1A mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of CDKN1A mRNA]; TP53 protein promotes the reaction [Fluorouracil promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of CDKN1A protein]]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of CDKN1A mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of CDKN1A protein] Fluorouracil results in decreased expression of CDKN1A mRNA; Fluorouracil results in decreased expression of CDKN1A protein Fluorouracil results in increased expression of CDKN1A; Fluorouracil results in increased expression of CDKN1A mRNA; Fluorouracil results in increased expression of CDKN1A protein Fluorouracil promotes the reaction [Luteolin results in increased expression of CDKN1A protein]; Luteolin promotes the reaction [Fluorouracil results in increased expression of CDKN1A protein] |
CTD |
PMID:14646558 PMID:14665630 PMID:15016801 PMID:15067352 PMID:15205334 PMID:15331170 PMID:15342418 PMID:15375580 PMID:15489892 PMID:15546879 PMID:15625077 PMID:15754201 PMID:15896711 PMID:16168113 PMID:16434701 PMID:16557594 PMID:16584549 PMID:16686938 PMID:16709241 PMID:16949053 PMID:17039268 PMID:17207318 PMID:17355264 PMID:17699798 PMID:17982676 PMID:18834353 PMID:19098008 PMID:19764996 PMID:24211769 PMID:27129209 PMID:27163855 PMID:31288002 PMID:38423379 More...
|
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
affects response to substance decreases expression |
ISO |
CDKN1B protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of CDKN1B mRNA |
CTD |
PMID:17217824 PMID:18930000 |
|
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
affects response to substance increases expression |
ISO |
CDKN1C affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of CDKN1C mRNA |
CTD |
PMID:15067352 PMID:19272435 |
|
NCBI chr 1:208,084,801...208,087,680
Ensembl chr 1:198,655,407...198,658,048
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
decreases expression |
ISO |
Fluorouracil results in decreased expression of CDKN2A protein |
CTD |
PMID:17982676 |
|
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cdkn2aip |
CDKN2A interacting protein |
affects response to substance |
ISO |
CDKN2AIP protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr16:44,536,147...44,546,216
Ensembl chr16:44,536,234...44,540,033
|
|
G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C |
decreases expression |
ISO |
Fluorouracil results in decreased expression of CDKN2C mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 5:124,411,123...124,416,278
Ensembl chr 5:124,411,124...124,416,278
|
|
G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CDKN3 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945
|
|
G |
Cdx2 |
caudal type homeo box 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of CDX2 protein Fluorouracil results in decreased expression of CDX2 mRNA |
CTD |
PMID:21296659 PMID:24737281 |
|
NCBI chr12:7,726,798...7,733,142
Ensembl chr12:7,726,798...7,733,142
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
increases expression |
ISO |
Fluorouracil results in increased expression of CEBPB mRNA |
CTD |
PMID:16557594 PMID:16584549 PMID:34151400 |
|
NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cenpq |
centromere protein Q |
affects response to substance increases expression |
ISO |
CENPQ protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of CENPQ mRNA |
CTD |
PMID:15331170 |
|
NCBI chr 9:19,957,122...19,972,807
Ensembl chr 9:19,957,048...19,972,789
|
|
G |
Cenpu |
centromere protein U |
affects response to substance |
ISO |
CENPU protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr16:45,715,821...45,739,038
Ensembl chr16:45,714,294...45,738,823
|
|
G |
Cenpx |
centromere protein X |
affects response to substance |
ISO |
CENPX protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:105,991,469...105,994,310
|
|
G |
Cep55 |
centrosomal protein 55 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of CEP55 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr 1:235,832,823...235,848,401
Ensembl chr 1:235,832,878...235,848,394
|
|
G |
Cer1 |
cerberus 1, DAN family BMP antagonist |
increases expression decreases expression |
ISO |
Fluorouracil results in increased expression of CER1 mRNA Fluorouracil results in decreased expression of CER1 mRNA |
CTD |
PMID:24737281 PMID:26272751 |
|
NCBI chr 5:97,306,427...97,309,783
Ensembl chr 5:97,306,431...97,309,783
|
|
G |
Ces2h |
carboxylesterase 2H |
multiple interactions increases expression |
ISO |
Fluorouracil promotes the reaction [TP53 protein binds to CES2 intron]; TP53 protein affects the reaction [Fluorouracil results in increased expression of CES2 mRNA] |
CTD |
PMID:15205334 PMID:16963839 PMID:17287894 |
|
NCBI chr19:49,884,164...49,898,764
Ensembl chr19:32,974,242...32,988,830
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
multiple interactions increases expression decreases expression affects response to substance |
ISO |
[Fluorouracil co-treated with IFNA1 protein] results in decreased expression of CFLAR protein; [Fluorouracil results in decreased expression of CFLAR protein] which results in increased susceptibility to TNFSF10 protein; CFLAR protein alternative form inhibits the reaction [Fluorouracil results in increased activity of TNFSF10 protein]; CFLAR protein inhibits the reaction [Fluorouracil results in increased susceptibility to TNFSF10 protein]; IFNA1 protein promotes the reaction [Fluorouracil results in decreased expression of CFLAR mRNA] Fluorouracil results in increased expression of CFLAR mRNA Fluorouracil results in decreased expression of CFLAR mRNA; Fluorouracil results in decreased expression of CFLAR protein CFLAR protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15152939 PMID:15548681 PMID:16217747 PMID:16373718 PMID:17045692 PMID:20876774 More...
|
|
NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Chek1 |
checkpoint kinase 1 |
affects response to substance multiple interactions increases expression decreases expression |
ISO |
CHEK1 protein affects the susceptibility to Fluorouracil [CHEK1 protein co-treated with TP53 protein] affects the susceptibility to Fluorouracil; Fluorouracil results in increased phosphorylation of and results in increased activity of CHEK1 protein; TP53 protein affects the reaction [CHEK1 protein affects the susceptibility to Fluorouracil]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CHEK1 mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in increased expression of CHEK1 protein] |
CTD |
PMID:15016801 PMID:18698031 PMID:19272435 PMID:21613406 PMID:22194930 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Chek2 |
checkpoint kinase 2 |
multiple interactions |
ISO |
Fluorouracil results in increased phosphorylation of and results in increased activity of CHEK2 protein |
CTD |
PMID:21613406 |
|
NCBI chr12:51,448,838...51,481,159
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Chi3l1 |
chitinase 3 like 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of CHI3L1 mRNA |
CTD |
PMID:15205334 |
|
NCBI chr13:48,193,839...48,201,822
Ensembl chr13:45,641,802...45,649,787
|
|
G |
Chrna4 |
cholinergic receptor nicotinic alpha 4 subunit |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CHRNA4 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:168,136,266...168,156,957
|
|
G |
Chst7 |
carbohydrate sulfotransferase 7 |
affects response to substance |
ISO |
CHST7 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr X:2,396,260...2,432,828
Ensembl chr X:2,393,874...2,432,840
|
|
G |
Ciao1 |
cytosolic iron-sulfur assembly component 1 |
affects response to substance |
ISO |
CIAO1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 3:114,458,671...114,465,928
Ensembl chr 3:114,458,655...114,467,009
|
|
G |
Cideb |
cell death-inducing DFFA-like effector b |
increases expression |
ISO |
Fluorouracil results in increased expression of CIDEB protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr15:29,252,208...29,256,482
Ensembl chr15:29,252,213...29,256,605
|
|
G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
affects response to substance |
ISO |
CITED2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
|
|
G |
Ckb |
creatine kinase B |
affects response to substance |
ISO |
CKB protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:130,729,423...130,732,315
|
|
G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of CKS2 mRNA |
CTD |
PMID:17374387 PMID:19272435 |
|
NCBI chr17:13,722,360...13,727,519
|
|
G |
Clcn3 |
chloride voltage-gated channel 3 |
affects response to substance |
ISO |
CLCN3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr16:29,127,152...29,200,133
Ensembl chr16:29,127,419...29,200,119
|
|
G |
Cldn2 |
claudin 2 |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of CLDN2 protein resveratrol inhibits the reaction [Fluorouracil results in decreased expression of CLDN2 protein] |
CTD |
PMID:26310874 |
|
NCBI chr X:108,248,383...108,258,847
Ensembl chr X:103,459,780...103,474,838
|
|
G |
Cldn4 |
claudin 4 |
affects response to substance decreases expression |
ISO |
CLDN4 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of CLDN4 protein |
CTD |
PMID:15352031 |
|
NCBI chr12:27,388,160...27,389,958
Ensembl chr12:21,751,331...21,753,436
|
|
G |
Clec11a |
C-type lectin domain containing 11A |
affects response to substance decreases expression |
ISO |
CLEC11A protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of CLEC11A protein |
CTD |
PMID:15352031 |
|
NCBI chr 1:94,800,456...94,809,002
Ensembl chr 1:94,801,496...94,804,633
|
|
G |
Clic1 |
chloride intracellular channel 1 |
affects response to substance |
ISO |
CLIC1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr20:3,769,522...3,778,367
Ensembl chr20:3,761,461...3,773,712
|
|
G |
Cltc |
clathrin heavy chain |
multiple interactions |
ISO |
CLTC protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CLTC mRNA] |
CTD |
PMID:15016801 PMID:18927307 |
|
NCBI chr10:72,014,984...72,073,308
Ensembl chr10:71,517,663...71,573,737
|
|
G |
Coch |
cochlin |
affects response to substance |
ISO |
COCH protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 6:69,031,139...69,045,124
Ensembl chr 6:69,031,167...69,045,109
|
|
G |
Col12a1 |
collagen type XII alpha 1 chain |
decreases expression |
ISO |
Fluorouracil results in decreased expression of COL12A1 mRNA |
CTD |
PMID:15205334 PMID:16510598 |
|
NCBI chr 8:80,547,592...80,665,665
Ensembl chr 8:80,547,593...80,665,686
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of COL1A1 mRNA; Fluorouracil results in decreased expression of COL1A1 protein Fluorouracil promotes the reaction [Valsartan results in decreased expression of COL1A1 mRNA]; Valsartan promotes the reaction [Fluorouracil results in decreased expression of COL1A1 mRNA] |
CTD |
PMID:21296659 PMID:35235860 |
|
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
affects expression |
ISO |
Fluorouracil affects the expression of COL1A2 mRNA |
CTD |
PMID:24704097 |
|
NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Col2a1 |
collagen type II alpha 1 chain |
decreases expression |
ISO |
Fluorouracil results in decreased expression of COL2A1 protein Fluorouracil results in decreased expression of COL2A1 mRNA |
CTD |
PMID:21296659 PMID:24737281 |
|
NCBI chr 7:130,977,561...131,006,627
Ensembl chr 7:129,098,786...129,127,546
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
affects response to substance |
ISO |
COL3A1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Col4a2 |
collagen type IV alpha 2 chain |
affects response to substance decreases expression |
ISO |
COL4A2 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of COL4A2 protein |
CTD |
PMID:15352031 |
|
NCBI chr16:84,749,672...84,885,520
Ensembl chr16:78,047,602...78,183,839
|
|
G |
Col5a2 |
collagen type V alpha 2 chain |
affects response to substance |
ISO |
COL5A2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 9:54,940,768...55,090,151
Ensembl chr 9:47,448,736...47,598,154
|
|
G |
Col6a3 |
collagen type VI alpha 3 chain |
affects response to substance multiple interactions |
ISO |
COL6A3 protein affects the susceptibility to Fluorouracil TP53 protein affects the reaction [Fluorouracil results in decreased expression of COL6A3 mRNA] |
CTD |
PMID:15016801 PMID:16217747 |
|
NCBI chr 9:98,809,171...98,887,060
Ensembl chr 9:91,361,583...91,439,471
|
|
G |
Cox14 |
cytochrome c oxidase assembly factor COX14 |
affects expression |
ISO |
Fluorouracil affects the expression of COX14 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 7:130,852,226...130,854,316
|
|
G |
Cox5b |
cytochrome c oxidase subunit 5B |
affects expression |
ISO |
Fluorouracil affects the expression of COX5B mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 9:46,417,735...46,419,664
Ensembl chr 9:38,921,967...38,925,052
|
|
G |
Cox6c |
cytochrome c oxidase subunit 6C |
affects expression |
ISO |
Fluorouracil affects the expression of COX6C mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 7:69,014,410...69,027,145
Ensembl chr 7:67,111,024...67,141,963
|
|
G |
Cox7c |
cytochrome c oxidase subunit 7C |
affects expression |
ISO |
Fluorouracil affects the expression of COX7C mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 2:18,577,145...18,579,170
Ensembl chr 2:16,840,837...16,843,760
|
|
G |
Cp |
ceruloplasmin |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CP mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:102,439,624...102,498,075
|
|
G |
Cpa4 |
carboxypeptidase A4 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of CPA4 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 4:59,188,284...59,212,255
Ensembl chr 4:59,188,284...59,212,255
|
|
G |
Cpd |
carboxypeptidase D |
affects response to substance multiple interactions |
ISO |
CPD protein affects the susceptibility to Fluorouracil TP53 protein affects the reaction [Fluorouracil results in decreased expression of CPD mRNA] |
CTD |
PMID:15016801 PMID:16217747 |
|
NCBI chr10:61,623,528...61,687,491
Ensembl chr10:61,623,526...61,687,491
|
|
G |
Cpe |
carboxypeptidase E |
affects response to substance increases expression |
ISO |
CPE protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of CPE protein |
CTD |
PMID:15352031 |
|
NCBI chr16:29,796,707...29,908,647
Ensembl chr16:25,030,276...25,142,233
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
affects response to substance |
ISO |
CPT1A protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Cpxm1 |
carboxypeptidase X (M14 family), member 1 |
affects expression |
ISO |
Fluorouracil affects the expression of CPXM1 mRNA |
CTD |
PMID:15205334 |
|
NCBI chr 3:117,588,532...117,595,330
Ensembl chr 3:117,588,532...117,595,330
|
|
G |
Crabp1 |
cellular retinoic acid binding protein 1 |
affects response to substance increases expression |
ISO |
CRABP1 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of CRABP1 protein |
CTD |
PMID:15352031 |
|
NCBI chr 8:55,138,363...55,159,360
Ensembl chr 8:55,151,285...55,159,360
|
|
G |
Crabp2 |
cellular retinoic acid binding protein 2 |
affects expression |
ISO |
Fluorouracil affects the expression of CRABP2 protein |
CTD |
PMID:21296659 |
|
NCBI chr 2:175,714,862...175,719,208
Ensembl chr 2:173,416,857...173,421,379
|
|
G |
Crhbp |
corticotropin releasing hormone binding protein |
affects expression |
ISO |
Fluorouracil affects the expression of CRHBP mRNA |
CTD |
PMID:15205334 |
|
NCBI chr 2:26,692,403...26,704,710
Ensembl chr 2:26,692,403...26,704,710
|
|
G |
Crim1 |
cysteine rich transmembrane BMP regulator 1 |
affects response to substance decreases expression increases expression |
ISO |
CRIM1 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of CRIM1 mRNA Fluorouracil results in increased expression of CRIM1 protein |
CTD |
PMID:15352031 PMID:16510598 |
|
NCBI chr 6:16,695,864...16,870,264
Ensembl chr 6:16,697,829...16,870,259
|
|
G |
Cripto |
cripto, EGF-CFC family member |
decreases expression |
ISO |
Fluorouracil results in decreased expression of CRIPTO protein Fluorouracil results in decreased expression of CRIPTO mRNA |
CTD |
PMID:21296659 PMID:24737281 |
|
NCBI chr 8:110,924,774...110,938,545
Ensembl chr 8:110,925,024...110,930,308
|
|
G |
Crk |
CRK proto-oncogene, adaptor protein |
affects response to substance |
ISO |
CRK protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:61,028,736...61,054,971
Ensembl chr10:60,530,464...60,553,406
|
|
G |
Crygs |
crystallin, gamma S |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CRYGS mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr11:78,207,170...78,212,273
Ensembl chr11:78,207,170...78,212,273
|
|
G |
Cryl1 |
crystallin, lambda 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CRYL1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr15:31,427,011...31,545,997
Ensembl chr15:31,427,054...31,545,997
|
|
G |
Cryz |
crystallin zeta |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of CRYZ mRNA TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of CRYZ mRNA] |
CTD |
PMID:17982676 |
|
NCBI chr 2:243,552,037...243,580,369
Ensembl chr 2:243,552,119...243,579,758
|
|
G |
Cse1l |
chromosome segregation 1 like |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CSE1L mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 3:155,641,104...155,678,866
Ensembl chr 3:155,641,166...155,678,865
|
|
G |
Csf1 |
colony stimulating factor 1 |
affects response to substance |
ISO |
CSF1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 2:198,065,400...198,084,774
Ensembl chr 2:195,377,215...195,411,704
|
|
G |
Csf2 |
colony stimulating factor 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of CSF2 mRNA |
CTD |
PMID:18344199 |
|
NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Csnk1e |
casein kinase 1, epsilon |
affects expression |
ISO |
Fluorouracil affects the expression of CSNK1E mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 7:110,983,322...111,006,926
Ensembl chr 7:110,983,318...111,006,794
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
affects response to substance |
ISO |
CSRP1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr13:49,709,928...49,731,141
Ensembl chr13:47,167,789...47,179,384
|
|
G |
Cst7 |
cystatin F |
affects response to substance decreases expression |
ISO |
CST7 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of CST7 protein |
CTD |
PMID:15352031 |
|
NCBI chr 3:139,396,830...139,405,557
Ensembl chr 3:139,396,850...139,405,557
|
|
G |
Cst8 |
cystatin 8 |
affects expression |
ISO |
Fluorouracil affects the expression of CST8 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 3:136,244,586...136,255,412
Ensembl chr 3:136,244,636...136,251,273
|
|
G |
Cstf3 |
cleavage stimulation factor subunit 3 |
affects response to substance increases expression |
ISO |
CSTF3 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of CSTF3 mRNA |
CTD |
PMID:15331170 |
|
NCBI chr 3:90,966,415...91,037,669
Ensembl chr 3:90,966,354...91,042,196
|
|
G |
Ctbp2 |
C-terminal binding protein 2 |
multiple interactions |
ISO |
[Fluorouracil co-treated with irinotecan] results in decreased expression of CTBP2 mRNA; CTBP2 protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] |
CTD |
PMID:16391804 PMID:18927307 |
|
NCBI chr 1:197,208,536...197,348,802
Ensembl chr 1:187,782,682...187,920,222
|
|
G |
Ctnnd2 |
catenin delta 2 |
multiple interactions |
ISO |
CTNND2 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr 2:81,168,525...82,016,495
Ensembl chr 2:81,167,117...82,015,764
|
|
G |
Ctps1 |
CTP synthase 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of CTPS1 mRNA |
CTD |
PMID:19219653 |
|
NCBI chr 5:139,372,349...139,440,441
Ensembl chr 5:134,125,025...134,154,180
|
|
G |
Ctsb |
cathepsin B |
multiple interactions increases cleavage |
ISO |
CA 074 methyl ester inhibits the reaction [Fluorouracil results in increased cleavage of CTSB protein] |
CTD |
PMID:19816940 |
|
NCBI chr15:41,565,607...41,586,479
Ensembl chr15:37,389,629...37,410,500
|
|
G |
Ctsh |
cathepsin H |
affects response to substance increases expression |
ISO |
CTSH protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of CTSH protein |
CTD |
PMID:15352031 |
|
NCBI chr 8:99,488,756...99,507,639
Ensembl chr 8:90,608,941...90,627,824
|
|
G |
Cttn |
cortactin |
decreases expression |
ISO |
Fluorouracil results in decreased expression of CTTN protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr 1:209,029,048...209,064,577
Ensembl chr 1:199,599,710...199,635,164
|
|
G |
Cul4a |
cullin 4A |
affects response to substance |
ISO |
CUL4A protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16467204 |
|
NCBI chr16:76,385,298...76,422,316
Ensembl chr16:76,384,546...76,422,330
|
|
G |
Cul4b |
cullin 4B |
increases expression |
ISO |
Fluorouracil results in increased expression of CUL4B protein |
CTD |
PMID:16803524 |
|
NCBI chr X:117,287,481...117,326,688
Ensembl chr X:117,287,484...117,326,688
|
|
G |
Cul5 |
cullin 5 |
increases expression |
ISO |
Fluorouracil results in increased expression of CUL5 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 8:54,012,963...54,066,751
Ensembl chr 8:54,016,006...54,066,666
|
|
G |
Cutc |
cutC copper transporter |
affects response to substance multiple interactions |
ISO |
CUTC protein affects the susceptibility to Fluorouracil TP53 protein affects the reaction [Fluorouracil results in decreased expression of CUTC mRNA] |
CTD |
PMID:15016801 PMID:16217747 |
|
NCBI chr 1:242,622,281...242,637,048
Ensembl chr 1:242,622,276...242,637,047
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
increases expression affects expression |
ISO |
Fluorouracil results in increased expression of CXCL12 mRNA Fluorouracil affects the expression of CXCL12 mRNA |
CTD |
PMID:16337237 PMID:18344199 |
|
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
multiple interactions increases expression |
ISO |
3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Fluorouracil results in increased expression of CXCL2 mRNA]; 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [Fluorouracil results in increased expression of CXCL2 mRNA]; Bortezomib inhibits the reaction [Fluorouracil results in increased expression of CXCL2 mRNA]; Curcumin inhibits the reaction [Fluorouracil results in increased expression of CXCL2 mRNA] |
CTD |
PMID:27194111 |
|
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
multiple interactions increases expression |
ISO |
3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Fluorouracil results in increased expression of CXCL1 mRNA]; 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [Fluorouracil results in increased expression of CXCL1 mRNA]; 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [Fluorouracil results in increased expression of CXCL1 protein]; Bortezomib inhibits the reaction [Fluorouracil results in increased expression of CXCL1 mRNA]; Curcumin inhibits the reaction [Fluorouracil results in increased expression of CXCL1 mRNA]; Curcumin inhibits the reaction [Fluorouracil results in increased expression of CXCL1 protein] Fluorouracil results in increased expression of CXCL1 mRNA; Fluorouracil results in increased expression of CXCL1 protein |
CTD |
PMID:27194111 |
|
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcr1 |
C-X-C motif chemokine receptor 1 |
multiple interactions |
ISO |
CXCR1 gene SNP affects the susceptibility to [oxaliplatin co-treated with Fluorouracil] |
CTD |
PMID:16098254 |
|
NCBI chr 9:75,766,894...75,771,079
Ensembl chr 9:75,766,770...75,771,084
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
affects expression |
ISO |
Fluorouracil affects the expression of CXCR4 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr13:42,630,383...42,634,288
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cyc1 |
cytochrome c-1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CYC1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 7:109,947,750...109,950,142
Ensembl chr 7:108,067,115...108,069,479
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
ISO |
[[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in decreased expression of CYCS mRNA |
CTD |
PMID:32800223 |
|
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyfip2 |
cytoplasmic FMR1 interacting protein 2 |
affects response to substance increases expression multiple interactions |
ISO |
CYFIP2 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of CYFIP2 mRNA TP53 protein affects the reaction [Fluorouracil results in increased expression of CYFIP2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of CYFIP2 mRNA] |
CTD |
PMID:15016801 PMID:16217747 PMID:17039268 PMID:17982676 |
|
NCBI chr10:30,621,318...30,741,113
Ensembl chr10:30,621,318...30,741,113
|
|
G |
Cyld |
CYLD lysine 63 deubiquitinase |
increases response to substance |
ISO |
CYLD protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:21109933 |
|
NCBI chr19:34,487,491...34,547,311
Ensembl chr19:18,314,019...18,373,658
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases metabolic processing |
EXP |
CYP1A1 protein results in increased metabolism of Fluorouracil |
CTD |
PMID:17230597 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
multiple interactions |
EXP |
[CYP2B1 co-treated with CDA] results in increased susceptibility to [Ifosfamide co-treated with Fluorouracil]; [CYP2B1 co-treated with CDA] results in increased susceptibility to Fluorouracil |
CTD |
PMID:10811482 |
|
NCBI chr 1:90,646,098...90,669,762
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
affects expression |
ISO |
Fluorouracil affects the expression of CYP2F1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 1:82,416,107...82,429,897
Ensembl chr 1:82,416,130...82,429,896
|
|
G |
Cyp2s1 |
cytochrome P450, family 2, subfamily s, polypeptide 1 |
affects expression |
ISO |
Fluorouracil affects the expression of CYP2S1 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr 1:81,309,948...81,325,303
Ensembl chr 1:81,310,451...81,325,303
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
affects expression |
ISO |
Fluorouracil affects the expression of CYP3A4 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
affects response to substance |
ISO |
CYP51A1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 4:30,991,693...31,010,147
Ensembl chr 4:30,036,865...30,055,410 Ensembl chr 6:30,036,865...30,055,410
|
|
G |
Cyth3 |
cytohesin 3 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of CYTH3 protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr12:10,840,137...10,933,792
Ensembl chr12:10,840,157...10,933,812
|
|
G |
Dapk1 |
death associated protein kinase 1 |
affects expression increases expression |
ISO |
Fluorouracil affects the expression of DAPK1 mRNA Fluorouracil results in increased expression of DAPK1 protein |
CTD |
PMID:20421339 PMID:30177839 |
|
NCBI chr17:3,935,826...4,096,858
Ensembl chr17:3,930,213...4,090,991
|
|
G |
Dars1 |
aspartyl-tRNA synthetase 1 |
affects expression |
ISO |
Fluorouracil affects the expression of DARS1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr13:42,410,351...42,465,467
Ensembl chr13:39,857,936...39,913,116
|
|
G |
Dbf4 |
DBF4-CDC7 kinase regulatory subunit |
decreases expression |
ISO |
Fluorouracil results in decreased expression of DBF4 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 4:25,676,570...25,701,152
Ensembl chr 4:25,676,634...25,701,066
|
|
G |
Dbndd2 |
dysbindin domain containing 2 |
affects response to substance |
ISO |
DBNDD2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 3:153,216,300...153,220,651
Ensembl chr 3:153,191,090...153,220,651
|
|
G |
Dcc |
DCC netrin 1 receptor |
multiple interactions |
ISO |
DCC protein results in increased susceptibility to [Fluorouracil co-treated with Levamisole] |
CTD |
PMID:15148649 |
|
NCBI chr18:67,144,272...68,248,159
Ensembl chr18:64,873,898...65,972,740
|
|
G |
Dck |
deoxycytidine kinase |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of DCK mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr14:19,305,218...19,326,247
Ensembl chr14:19,305,218...19,326,247
|
|
G |
Dclk1 |
doublecortin-like kinase 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of DCLK1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 2:139,417,234...139,710,956
Ensembl chr 2:139,417,163...139,710,956
|
|
G |
Dct |
dopachrome tautomerase |
affects expression |
ISO |
Fluorouracil affects the expression of DCT mRNA |
CTD |
PMID:15205334 |
|
NCBI chr15:101,469,159...101,508,029
Ensembl chr15:95,062,003...95,100,836
|
|
G |
Dcx |
doublecortin |
decreases expression |
EXP |
Fluorouracil results in decreased expression of DCX protein |
CTD |
PMID:18702703 |
|
NCBI chr X:112,227,455...112,370,291
Ensembl chr X:107,430,767...107,507,476
|
|
G |
Dcxr |
dicarbonyl and L-xylulose reductase |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of DCXR mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr10:106,006,404...106,008,293
|
|
G |
Ddah2 |
DDAH family member 2, ADMA-independent |
affects response to substance |
ISO |
DDAH2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr20:3,761,460...3,764,718
Ensembl chr20:3,761,465...3,764,511
|
|
G |
Ddb2 |
damage specific DNA binding protein 2 |
affects response to substance multiple interactions increases expression |
ISO |
DDB2 protein affects the susceptibility to Fluorouracil TP53 protein promotes the reaction [Fluorouracil results in increased expression of DDB2 mRNA] |
CTD |
PMID:15331170 PMID:16584549 PMID:17982676 PMID:22525470 |
|
NCBI chr 3:97,640,923...97,667,617
Ensembl chr 3:77,185,109...77,207,631
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
Fluorouracil results in increased expression of DDIT3 mRNA; Fluorouracil results in increased expression of DDIT3 protein |
CTD |
PMID:17355264 PMID:29879413 PMID:32535746 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
increases expression |
ISO |
Fluorouracil results in increased expression of DDIT4 mRNA |
CTD |
PMID:16510598 PMID:16557594 PMID:17039268 |
|
NCBI chr20:28,434,938...28,437,037
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Ddx39b |
DExD-box helicase 39B |
increases expression |
ISO |
Fluorouracil results in increased expression of DDX39B mRNA |
CTD |
PMID:16510598 |
|
NCBI chr20:3,577,200...3,589,651
Ensembl chr20:3,572,056...3,584,996
|
|
G |
Ddx4 |
DEAD-box helicase 4 |
increases expression |
ISO |
Fluorouracil results in increased expression of DDX4 protein |
CTD |
PMID:21296659 |
|
NCBI chr 2:44,227,946...44,282,867
Ensembl chr 2:44,227,946...44,282,723
|
|
G |
Dennd2c |
DENN domain containing 2C |
affects expression |
ISO |
Fluorouracil affects the expression of DENND2C mRNA |
CTD |
PMID:20421339 |
|
NCBI chr 2:190,622,357...190,690,489
Ensembl chr 2:190,622,940...190,690,488
|
|
G |
Depdc7 |
DEP domain containing 7 |
affects expression |
ISO |
Fluorouracil affects the expression of DEPDC7 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr 3:91,099,111...91,121,152
Ensembl chr 3:91,099,835...91,121,124
|
|
G |
Des |
desmin |
decreases expression |
ISO |
Fluorouracil results in decreased expression of DES protein |
CTD |
PMID:21296659 |
|
NCBI chr 9:84,299,626...84,307,344
Ensembl chr 9:76,850,982...76,858,699
|
|
G |
Dffa |
DNA fragmentation factor subunit alpha |
decreases expression |
ISO |
Fluorouracil results in decreased expression of DFFA mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 5:159,540,715...159,553,639
Ensembl chr 5:159,540,715...159,553,633
|
|
G |
Dhfr |
dihydrofolate reductase |
affects expression increases expression |
ISO |
Fluorouracil affects the expression of DHFR mRNA Fluorouracil results in increased expression of DHFR mRNA |
CTD |
PMID:15109396 PMID:16557594 PMID:21814787 |
|
NCBI chr 2:25,320,895...25,346,004
Ensembl chr 2:23,586,031...23,613,713
|
|
G |
Dhx15 |
DEAH-box helicase 15 |
increases expression |
ISO |
Fluorouracil results in increased expression of DHX15 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr14:58,787,147...58,825,083
Ensembl chr14:58,787,127...58,825,088
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
increases response to substance increases expression |
ISO |
DIABLO protein results in increased susceptibility to Fluorouracil Fluorouracil results in increased expression of DIABLO mRNA |
CTD |
PMID:16557594 PMID:18031615 |
|
NCBI chr12:38,716,668...38,731,285
Ensembl chr12:33,055,263...33,070,387
|
|
G |
Dicer1 |
dicer 1 ribonuclease III |
decreases expression |
ISO |
Fluorouracil results in decreased expression of DICER1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 6:129,392,298...129,457,252
Ensembl chr 6:123,631,250...123,693,965
|
|
G |
Dimt1 |
DIM1 rRNA methyltransferase and ribosome maturation factor |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of DIMT1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 2:38,343,086...38,368,242
Ensembl chr 2:38,354,854...38,368,227
|
|
G |
Dkk1 |
dickkopf WNT signaling pathway inhibitor 1 |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of DKK1 protein DKK1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 PMID:16217747 |
|
NCBI chr 1:237,794,969...237,798,650
Ensembl chr 1:228,381,521...228,385,202
|
|
G |
Dkk4 |
dickkopf WNT signaling pathway inhibitor 4 |
increases expression |
ISO |
Fluorouracil results in increased expression of DKK4 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr16:69,403,215...69,406,580
Ensembl chr16:69,402,989...69,406,580
|
|
G |
Dlc1 |
DLC1 Rho GTPase activating protein |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of DLC1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr16:61,954,177...62,374,819
Ensembl chr16:55,291,584...55,671,439
|
|
G |
Dlg1 |
discs large MAGUK scaffold protein 1 |
multiple interactions |
ISO |
DLG1 protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] |
CTD |
PMID:18927307 |
|
NCBI chr11:82,416,853...82,607,797
Ensembl chr11:68,911,883...69,102,689
|
|
G |
Dlk1 |
delta like non-canonical Notch ligand 1 |
multiple interactions increases expression |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of DLK1 mRNA] Fluorouracil results in increased expression of DLK1 mRNA |
CTD |
PMID:15016801 PMID:24737281 |
|
NCBI chr 6:128,410,216...128,417,518
Ensembl chr 6:128,410,316...128,417,522
|
|
G |
Dnah2 |
dynein, axonemal, heavy chain 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of DNAH2 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr10:54,641,450...54,766,502
Ensembl chr10:54,142,737...54,267,298
|
|
G |
Dner |
delta/notch-like EGF repeat containing |
increases expression |
ISO |
Fluorouracil results in increased expression of DNER mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 9:85,586,985...85,902,461
Ensembl chr 9:85,586,987...85,902,637
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
decreases expression |
ISO |
Fluorouracil results in decreased expression of DNMT3B protein |
CTD |
PMID:21296659 |
|
NCBI chr 3:162,590,777...162,629,313
Ensembl chr 3:142,130,592...142,169,124
|
|
G |
Dpagt1 |
dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 |
affects response to substance |
ISO |
DPAGT1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 8:44,664,055...44,671,102
Ensembl chr 8:44,664,071...44,671,087
|
|
G |
Dpy19l1 |
dpy-19 like C-mannosyltransferase 1 |
affects response to substance |
ISO |
DPY19L1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 8:22,933,163...23,021,461
Ensembl chr 8:22,933,163...23,021,751
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
increases response to substance multiple interactions affects metabolic processing affects response to substance affects degradation decreases metabolic processing increases degradation affects activity increases expression increases activity decreases response to substance increases metabolic processing decreases expression decreases activity |
ISO EXP |
DPYD gene mutant form results in increased susceptibility to Fluorouracil; DPYD gene polymorphism results in increased susceptibility to Fluorouracil; DPYD mRNA results in increased susceptibility to Fluorouracil [Cisplatin co-treated with Fluorouracil] results in decreased expression of DPYD mRNA; [docetaxel co-treated with Fluorouracil] results in decreased expression of DPYD mRNA; [Leucovorin co-treated with Fluorouracil] results in decreased activity of DPYD protein; Camptothecin inhibits the reaction [Fluorouracil results in increased expression of DPYD mRNA]; Cisplatin inhibits the reaction [Fluorouracil results in increased expression of DPYD mRNA]; docetaxel inhibits the reaction [Fluorouracil results in increased activity of DPYD protein]; DPYD protein affects the susceptibility to [Fluorouracil co-treated with Epirubicin]; DPYD results in increased susceptibility to [Fluorouracil co-treated with gimeracil]; Fluorouracil inhibits the reaction [docetaxel results in increased expression of DPYD protein]; gimeracil affects the reaction [DPYD protein results in increased susceptibility to Fluorouracil]; gimeracil inhibits the reaction [DPYD protein results in decreased susceptibility to Fluorouracil]; gimeracil inhibits the reaction [DPYD protein results in increased degradation of Fluorouracil]; gimeracil inhibits the reaction [DPYD protein results in increased metabolism of Fluorouracil] DPYD affects the metabolism of Fluorouracil; DPYD protein affects the metabolism of Fluorouracil DPYD gene polymorphism affects the susceptibility to Fluorouracil; DPYD gene SNP affects the susceptibility to Fluorouracil; DPYD intron polymorphism affects the susceptibility to Fluorouracil; DPYD mRNA affects the susceptibility to Fluorouracil; DPYD promoter modified form affects the susceptibility to Fluorouracil; DPYD protein affects the susceptibility to Fluorouracil; DPYD protein mutant form affects the susceptibility to Fluorouracil DPYD protein affects the degradation of Fluorouracil DPYD gene polymorphism results in decreased metabolism of Fluorouracil; DPYD protein mutant form results in decreased metabolism of Fluorouracil Fluorouracil metabolite affects the activity of DPYD protein Fluorouracil results in increased expression of DPYD mRNA; Fluorouracil results in increased expression of DPYD protein DPYD mRNA results in decreased susceptibility to Fluorouracil DPYD mRNA results in decreased susceptibility to Fluorouracil; DPYD protein results in decreased susceptibility to Fluorouracil Fluorouracil results in decreased expression of DPYD mRNA Fluorouracil results in decreased activity of DPYD protein |
CTD |
PMID:3335642 PMID:7503095 PMID:8680084 PMID:9470816 PMID:9816193 PMID:9893640 PMID:10099659 PMID:11148247 PMID:12044515 PMID:12562666 PMID:12635664 PMID:14689231 PMID:15017333 PMID:15109396 PMID:15239142 PMID:15246190 PMID:15591715 PMID:15655543 PMID:15737843 PMID:15858133 PMID:15865071 PMID:15890242 PMID:15930747 PMID:15949589 PMID:15993511 PMID:16033824 PMID:16115930 PMID:16282729 PMID:16361556 PMID:16525674 PMID:16557585 PMID:16568373 PMID:16646564 PMID:16761622 PMID:17046731 PMID:17064846 PMID:17121937 PMID:17330233 PMID:17377791 PMID:18075467 PMID:18197934 PMID:18225548 PMID:18299612 PMID:18383874 PMID:18443386 PMID:18600527 PMID:18619742 PMID:18846242 PMID:18986760 PMID:19020767 PMID:19093184 PMID:19104657 PMID:19105824 PMID:19219653 More...
|
|
NCBI chr 2:209,293,902...210,159,777
Ensembl chr 2:206,609,122...207,474,982
|
|
G |
Dpysl3 |
dihydropyrimidinase-like 3 |
affects expression |
ISO |
Fluorouracil affects the expression of DPYSL3 mRNA |
CTD |
PMID:15205334 |
|
NCBI chr18:35,374,427...35,480,228
Ensembl chr18:35,377,181...35,480,157
|
|
G |
Dram1 |
DNA-damage regulated autophagy modulator 1 |
multiple interactions increases expression |
ISO |
TP53 protein promotes the reaction [Fluorouracil results in increased expression of DRAM1 mRNA] Fluorouracil results in increased expression of DRAM1 protein Fluorouracil promotes the reaction [Luteolin results in increased expression of DRAM1 protein]; Luteolin promotes the reaction [Fluorouracil results in increased expression of DRAM1 protein] |
CTD |
PMID:17982676 PMID:31288002 |
|
NCBI chr 7:22,742,794...22,776,888
Ensembl chr 7:22,742,849...22,776,765
|
|
G |
Drd5 |
dopamine receptor D5 |
multiple interactions |
ISO |
DRD5 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] |
CTD |
PMID:17327601 |
|
NCBI chr14:72,487,950...72,491,050
Ensembl chr14:72,489,347...72,490,774
|
|
G |
Dst |
dystonin |
affects response to substance |
ISO |
DST protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 9:43,631,716...44,025,535
Ensembl chr 9:36,135,284...36,529,615
|
|
G |
Dtwd1 |
DTW domain containing 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of DTWD1 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr 3:113,392,402...113,409,322
Ensembl chr 3:113,392,457...113,408,105
|
|
G |
Dtymk |
deoxythymidylate kinase |
affects response to substance increases expression multiple interactions |
ISO |
DTYMK affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of DTYMK mRNA TP53 protein affects the reaction [Fluorouracil results in decreased expression of DTYMK mRNA] |
CTD |
PMID:15016801 PMID:15067352 PMID:15109396 |
|
NCBI chr 9:101,762,899...101,771,733
Ensembl chr 9:94,315,552...94,324,870
|
|
G |
Dusp14 |
dual specificity phosphatase 14 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in increased expression of DUSP14 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr10:68,936,483...68,966,347
Ensembl chr10:68,935,330...68,965,329
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in increased expression of DUSP5 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
increases expression |
ISO |
Fluorouracil results in increased expression of DUSP6 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
|
|
G |
Dut |
deoxyuridine triphosphatase |
decreases response to substance decreases expression |
ISO |
DUT protein results in decreased susceptibility to Fluorouracil Fluorouracil results in decreased expression of DUT mRNA |
CTD |
PMID:16557594 PMID:19015155 |
|
NCBI chr 3:132,952,258...132,963,433
Ensembl chr 3:112,498,982...112,510,771
|
|
G |
E2f1 |
E2F transcription factor 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of E2F1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
E2f2 |
E2F transcription factor 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of E2F2; Fluorouracil results in decreased expression of E2F2 mRNA |
CTD |
PMID:11300326 PMID:34151400 |
|
NCBI chr 5:153,682,789...153,706,087
Ensembl chr 5:148,399,642...148,421,217
|
|
G |
E2f3 |
E2F transcription factor 3 |
multiple interactions |
ISO |
E2F3 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr17:34,810,355...34,887,725
Ensembl chr17:34,601,830...34,676,253
|
|
G |
E2f4 |
E2F transcription factor 4 |
multiple interactions decreases expression |
ISO |
CDKN1A protein affects the reaction [Fluorouracil promotes the reaction [E2F4 protein binds to UBE2C promoter]]; Fluorouracil promotes the reaction [E2F4 protein binds to UBE2C promoter]; TP53 protein affects the reaction [Fluorouracil promotes the reaction [E2F4 protein binds to UBE2C promoter]] Fluorouracil results in decreased expression of E2F4 mRNA |
CTD |
PMID:27129209 PMID:34151400 |
|
NCBI chr19:33,174,396...33,181,806
Ensembl chr19:33,174,410...33,181,806
|
|
G |
E2f8 |
E2F transcription factor 8 |
affects expression |
ISO |
Fluorouracil affects the expression of E2F8 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
|
|
G |
Ebp |
EBP, cholestenol delta-isomerase |
affects response to substance |
ISO |
EBP protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 PMID:16217747 |
|
NCBI chr X:16,971,372...16,977,782
Ensembl chr X:14,299,448...14,305,826
|
|
G |
Echdc3 |
enoyl CoA hydratase domain containing 3 |
affects response to substance |
ISO |
ECHDC3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr17:72,070,697...72,093,519
Ensembl chr17:72,070,668...72,093,516
|
|
G |
Echs1 |
enoyl-CoA hydratase, short chain 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of ECHS1 mRNA |
CTD |
PMID:15152939 |
|
NCBI chr 1:204,324,679...204,333,506
Ensembl chr 1:194,895,036...194,903,884
|
|
G |
Ect2 |
epithelial cell transforming 2 |
multiple interactions decreases expression |
ISO |
TP53 protein promotes the reaction [Fluorouracil results in decreased expression of ECT2 mRNA] |
CTD |
PMID:17982676 |
|
NCBI chr 2:109,975,813...110,037,911
Ensembl chr 2:109,975,813...110,037,911
|
|
G |
Edil3 |
EGF like repeats and discoidin domains 3 |
affects response to substance |
ISO |
EDIL3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 2:21,625,604...22,140,380
Ensembl chr 2:19,890,373...20,405,008
|
|
G |
Edn1 |
endothelin 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of EDN1 mRNA; Fluorouracil results in increased expression of EDN1 protein |
CTD |
PMID:1606078 PMID:19098008 |
|
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Ednra |
endothelin receptor type A |
affects response to substance |
ISO |
EDNRA protein affects the susceptibility to Fluorouracil |
CTD |
PMID:17032313 |
|
NCBI chr19:47,137,360...47,207,961
Ensembl chr19:30,233,571...30,297,049
|
|
G |
Ednrb |
endothelin receptor type B |
decreases expression |
ISO |
Fluorouracil results in decreased expression of EDNRB mRNA |
CTD |
PMID:24737281 |
|
NCBI chr15:87,055,490...87,086,765
Ensembl chr15:80,643,043...80,672,115
|
|
G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
affects expression increases expression multiple interactions |
ISO |
Fluorouracil affects the expression of EEF1A1 protein Fluorouracil results in increased expression of EEF1A1 mRNA TP53 protein inhibits the reaction [Fluorouracil results in increased expression of EEF1A1 mRNA] |
CTD |
PMID:17982676 PMID:21296659 |
|
NCBI chr 8:88,221,839...88,225,688
Ensembl chr 8:79,341,557...79,344,839
|
|
G |
Eeig1 |
estrogen-induced osteoclastogenesis regulator 1 |
affects expression |
ISO |
Fluorouracil affects the expression of EEIG1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 3:15,822,441...15,854,651
Ensembl chr 3:15,823,144...15,854,643
|
|
G |
Efemp1 |
EGF containing fibulin extracellular matrix protein 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of EFEMP1 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr14:106,811,769...106,890,961
Ensembl chr14:102,610,908...102,690,018
|
|
G |
Efhd1 |
EF-hand domain family, member D1 |
affects response to substance |
ISO |
EFHD1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 9:95,386,155...95,432,800
Ensembl chr 9:87,938,284...87,984,917
|
|
G |
Efhd2 |
EF-hand domain family, member D2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of EFHD2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 5:154,160,945...154,176,980
Ensembl chr 5:154,160,946...154,176,980
|
|
G |
Efnb2 |
ephrin B2 |
affects response to substance decreases expression |
ISO |
EFNB2 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of EFNB2 protein |
CTD |
PMID:15352031 PMID:16217747 |
|
NCBI chr16:80,783,389...80,827,420
Ensembl chr16:80,783,417...80,824,391
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO |
[Fluorouracil co-treated with EGF protein] results in increased expression of MT2A mRNA; EGF protein inhibits the reaction [Fluorouracil results in decreased expression of MT2A protein]; EGF protein inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; EGF protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 mRNA]; EGF protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 protein]; MT2A protein affects the reaction [EGF protein inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]]; MT2A protein affects the reaction [EGF protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 protein]] |
CTD |
PMID:28507149 |
|
NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egfr |
epidermal growth factor receptor |
decreases response to substance multiple interactions affects response to substance increases phosphorylation decreases expression |
ISO |
EGFR gene polymorphism results in decreased susceptibility to Fluorouracil [Cisplatin co-treated with Fluorouracil] results in decreased expression of EGFR mRNA; EGFR gene polymorphism affects the susceptibility to [oxaliplatin co-treated with Fluorouracil]; EGFR protein affects the susceptibility to [Cyclophosphamide co-treated with Doxorubicin co-treated with Fluorouracil]; EGFR results in increased susceptibility to [Cisplatin co-treated with docetaxel co-treated with Fluorouracil]; Fluorouracil promotes the reaction [Curcumin results in decreased expression of EGFR protein]; Fluorouracil promotes the reaction [Curcumin results in decreased phosphorylation of and results in decreased activity of EGFR protein]; Fluorouracil results in decreased phosphorylation of and results in decreased activity of EGFR protein; TP53 protein affects the reaction [Fluorouracil results in decreased expression of EGFR protein] EGFR protein affects the susceptibility to Fluorouracil Fluorouracil results in increased phosphorylation of EGFR protein |
CTD |
PMID:15737843 PMID:15981280 PMID:16098254 PMID:16836928 PMID:17169374 PMID:17918158 PMID:17982676 PMID:18794807 PMID:19217205 PMID:21947696 More...
|
|
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egr1 |
early growth response 1 |
multiple interactions decreases expression increases expression affects localization affects expression |
ISO |
EGR1 protein affects the reaction [Fluorouracil results in increased expression of THBS1 mRNA]; EGR1 protein affects the reaction [Fluorouracil results in increased expression of THBS1 protein]; Fluorouracil promotes the reaction [EGR1 protein binds to THBS1 promoter]; SB 203580 inhibits the reaction [Fluorouracil results in increased expression of EGR1 mRNA]; SB 203580 inhibits the reaction [Fluorouracil results in increased expression of EGR1 protein] Fluorouracil results in decreased expression of EGR1 mRNA Fluorouracil affects the localization of EGR1 protein Fluorouracil affects the expression of EGR1 mRNA |
CTD |
PMID:15205334 PMID:16557594 PMID:17039268 PMID:18757417 |
|
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Ehd2 |
EH-domain containing 2 |
affects response to substance |
ISO |
EHD2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:76,639,568...76,658,747
Ensembl chr 1:76,637,482...76,658,783
|
|
G |
Ehf |
ets homologous factor |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of EHF mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 3:89,639,845...89,680,061
Ensembl chr 3:89,641,833...89,679,997
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
increases phosphorylation increases expression |
ISO |
Fluorouracil results in increased phosphorylation of EIF2AK3 protein Fluorouracil results in increased expression of EIF2AK3 mRNA |
CTD |
PMID:29879413 PMID:32535746 |
|
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif2b2 |
eukaryotic translation initiation factor 2B subunit beta |
decreases expression |
ISO |
Fluorouracil results in decreased expression of EIF2B2 protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr 6:104,866,926...104,873,351
Ensembl chr 6:104,866,753...104,873,353
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
increases phosphorylation |
ISO |
Fluorouracil results in increased phosphorylation of EIF2S1 protein |
CTD |
PMID:29879413 |
|
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Eif3h |
eukaryotic translation initiation factor 3, subunit H |
increases expression |
ISO |
Fluorouracil results in increased expression of EIF3H protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr 7:84,980,891...85,064,284
Ensembl chr 7:83,091,039...83,174,451
|
|
G |
Eif4e |
eukaryotic translation initiation factor 4E |
increases expression multiple interactions |
ISO |
Fluorouracil results in increased expression of EIF4E mRNA Fluorouracil inhibits the reaction [[CD40LG protein co-treated with CD40 protein] inhibits the reaction [EIF4E protein binds to EIF4EBP1 protein]]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of EIF4E mRNA] |
CTD |
PMID:15016801 PMID:15611226 PMID:16584549 |
|
NCBI chr 2:227,066,519...227,099,261
Ensembl chr 2:227,066,673...227,098,683
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
multiple interactions |
ISO |
Fluorouracil inhibits the reaction [[CD40LG protein co-treated with CD40 protein] inhibits the reaction [EIF4E protein binds to EIF4EBP1 protein]] |
CTD |
PMID:15611226 |
|
NCBI chr16:71,495,457...71,508,845
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Eif4h |
eukaryotic translation initiation factor 4H |
increases expression |
ISO |
Fluorouracil results in increased expression of EIF4H protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr12:22,083,155...22,099,876
Ensembl chr12:22,082,835...22,099,876
|
|
G |
Eif5 |
eukaryotic translation initiation factor 5 |
increases expression |
ISO |
Fluorouracil results in increased expression of EIF5 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr 6:130,589,162...130,597,656
Ensembl chr 6:130,589,143...130,597,656
|
|
G |
Eipr1 |
EARP complex and GARP complex interacting protein 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of EIPR1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 6:45,388,451...45,502,089
Ensembl chr 6:45,388,376...45,502,083
|
|
G |
Elmo2 |
engulfment and cell motility 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of ELMO2 protein |
CTD |
PMID:16803524 |
|
NCBI chr 3:154,023,661...154,061,259
Ensembl chr 3:154,023,661...154,061,185
|
|
G |
Eln |
elastin |
affects expression |
ISO |
Fluorouracil affects the expression of ELN mRNA |
CTD |
PMID:15205334 |
|
NCBI chr12:27,604,983...27,648,413
Ensembl chr12:21,968,544...22,011,928
|
|
G |
Eloa |
elongin A |
affects expression |
ISO |
Fluorouracil affects the expression of ELOA mRNA |
CTD |
PMID:15205334 |
|
NCBI chr 5:148,231,600...148,246,760
Ensembl chr 5:148,231,596...148,246,765
|
|
G |
Elovl5 |
ELOVL fatty acid elongase 5 |
affects response to substance |
ISO |
ELOVL5 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 8:78,790,846...78,857,307
Ensembl chr 8:78,790,846...78,857,284
|
|
G |
Emc1 |
ER membrane protein complex subunit 1 |
affects expression |
ISO |
Fluorouracil affects the expression of EMC1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 5:151,608,557...151,633,888
Ensembl chr 5:151,608,568...151,633,888
|
|
G |
Eml2 |
EMAP like 2 |
multiple interactions |
ISO |
EML2 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] |
CTD |
PMID:17327601 |
|
NCBI chr 1:78,827,595...78,859,342
Ensembl chr 1:78,828,080...78,859,341
|
|
G |
Emp3 |
epithelial membrane protein 3 |
increases expression |
ISO |
Fluorouracil results in increased expression of EMP3 mRNA |
CTD |
PMID:19272435 |
|
NCBI chr 1:96,388,651...96,391,946
Ensembl chr 1:96,388,652...96,391,988
|
|
G |
Enah |
ENAH, actin regulator |
affects response to substance |
ISO |
ENAH protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr13:93,617,747...93,738,119
Ensembl chr13:93,626,944...93,740,955
|
|
G |
Endog |
endonuclease G |
increases expression multiple interactions |
ISO |
Fluorouracil results in increased expression of ENDOG protein casticin inhibits the reaction [Fluorouracil results in increased expression of ENDOG protein] |
CTD |
PMID:32270916 |
|
NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932
|
|
G |
Enosf1 |
enolase superfamily member 1 |
affects response to substance decreases response to substance |
ISO |
ENOSF1 protein affects the susceptibility to Fluorouracil ENOSF1 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:15548681 PMID:18357371 |
|
NCBI chr 9:113,275,267...113,314,842
|
|
G |
Entpd1 |
ectonucleoside triphosphate diphosphohydrolase 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ENTPD1 mRNA |
CTD |
PMID:19219653 |
|
NCBI chr 1:249,374,810...249,502,310
Ensembl chr 1:239,425,430...239,552,317
|
|
G |
Entrep3 |
endosomal transmembrane epsin interactor 3 |
affects response to substance |
ISO |
ENTREP3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 2:174,588,984...174,595,281
Ensembl chr 2:174,589,337...174,595,281
|
|
G |
Eomes |
eomesodermin |
decreases expression |
ISO |
Fluorouracil results in decreased expression of EOMES protein |
CTD |
PMID:21296659 |
|
NCBI chr 8:118,181,340...118,189,186
Ensembl chr 8:118,181,777...118,188,316
|
|
G |
Ep300 |
E1A binding protein p300 |
multiple interactions |
ISO |
Fluorouracil promotes the reaction [EP300 protein binds to UBE2C promoter] |
CTD |
PMID:27129209 |
|
NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Ep400 |
E1A binding protein p400 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of EP400 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr12:45,891,886...46,002,523
Ensembl chr12:45,891,916...45,998,861
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of EPAS1 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 6:13,543,252...13,626,147
Ensembl chr 6:7,790,647...7,871,228
|
|
G |
Epb41l3 |
erythrocyte membrane protein band 4.1-like 3 |
affects expression |
ISO |
Fluorouracil affects the expression of EPB41L3 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr 9:109,056,178...109,260,607
Ensembl chr 9:109,016,113...109,260,607
|
|
G |
Epha2 |
Eph receptor A2 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in increased expression of EPHA2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 5:153,605,644...153,634,115
Ensembl chr 5:153,605,644...153,634,117
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
affects response to substance increases expression |
ISO |
EPHX1 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of EPHX1 mRNA |
CTD |
PMID:15205334 PMID:16217747 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Epo |
erythropoietin |
increases response to substance increases expression |
ISO EXP |
EPO protein results in increased susceptibility to Fluorouracil Fluorouracil results in increased expression of EPO protein |
CTD |
PMID:2206997 PMID:16103069 PMID:20020992 |
|
NCBI chr12:24,841,285...24,844,725
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Epor |
erythropoietin receptor |
affects response to substance |
ISO |
EPOR gene mutant form affects the susceptibility to Fluorouracil |
CTD |
PMID:16511603 |
|
NCBI chr 8:28,765,738...28,770,371
Ensembl chr 8:20,489,678...20,494,257
|
|
G |
Eppk1 |
epiplakin 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of EPPK1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 7:107,816,919...107,842,946
Ensembl chr 7:107,817,693...107,831,159
|
|
G |
Eprs1 |
glutamyl-prolyl-tRNA synthetase 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of EPRS1 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr13:99,431,955...99,503,510
Ensembl chr13:96,901,575...96,971,966
|
|
G |
Epyc |
epiphycan |
affects expression |
ISO |
Fluorouracil affects the expression of EPYC mRNA |
CTD |
PMID:15205334 |
|
NCBI chr 7:32,436,620...32,474,326
Ensembl chr 7:32,436,620...32,474,135
|
|
G |
Eras |
ES cell expressed Ras |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ERAS protein |
CTD |
PMID:21296659 |
|
NCBI chr X:17,245,915...17,250,301
Ensembl chr X:14,573,987...14,578,374
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
multiple interactions decreases response to substance affects expression affects response to substance decreases expression |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ERBB2 results in decreased susceptibility to Fluorouracil]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [ERBB2 results in decreased susceptibility to Fluorouracil]; [Apigenin co-treated with Fluorouracil] results in decreased expression of ERBB2 protein; [Cisplatin co-treated with Fluorouracil] results in decreased expression of ERBB2 mRNA; [ERBB2 results in increased expression of ABCG2] which results in decreased susceptibility to Fluorouracil; ABCG2 mutant form inhibits the reaction [ERBB2 results in decreased susceptibility to Fluorouracil]; Curcumin promotes the reaction [Fluorouracil results in decreased phosphorylation of and results in decreased expression of and results in decreased activity of ERBB2 protein]; ERBB2 protein affects the susceptibility to [Cyclophosphamide co-treated with pirarubicin co-treated with Fluorouracil]; ERBB2 protein affects the susceptibility to [Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide]; ERBB2 protein affects the susceptibility to [Fluorouracil co-treated with Epirubicin co-treated with Cyclophosphamide]; Fluorouracil results in decreased expression of and results in decreased phosphorylation of and results in decreased activity of ERBB2 protein ERBB2 mRNA results in decreased susceptibility to Fluorouracil; ERBB2 results in decreased susceptibility to Fluorouracil Fluorouracil affects the expression of ERBB2 mRNA ERBB2 mRNA alternative form affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of ERBB2 protein |
CTD |
PMID:9816327 PMID:15205334 PMID:15737843 PMID:15940066 PMID:16446318 PMID:16682728 PMID:17918158 PMID:18337622 PMID:19885610 PMID:21712253 PMID:36639866 PMID:39334374 More...
|
|
NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
multiple interactions |
ISO |
Fluorouracil promotes the reaction [Curcumin results in decreased expression of and results in decreased phosphorylation of and results in decreased activity of ERBB3 protein]; Fluorouracil results in decreased expression of and results in decreased phosphorylation of and results in decreased activity of ERBB3 protein |
CTD |
PMID:17918158 |
|
NCBI chr 7:1,579,079...1,600,379
Ensembl chr 7:996,225...1,015,525
|
|
G |
Erbb4 |
erb-b2 receptor tyrosine kinase 4 |
multiple interactions |
ISO |
ERBB4 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr 9:76,973,386...78,045,633
Ensembl chr 9:69,531,481...70,596,595
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
multiple interactions decreases expression |
ISO |
[Cisplatin co-treated with Fluorouracil] results in decreased expression of ERCC1 mRNA; ERCC1 gene polymorphism affects the susceptibility to [Fluorouracil co-treated with Oxaliplatin]; ERCC1 gene SNP affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with Oxaliplatin]; ERCC1 gene SNP results in increased susceptibility to [Cisplatin co-treated with Fluorouracil]; ERCC1 mRNA affects the susceptibility to [Cisplatin co-treated with Fluorouracil] Fluorouracil results in decreased expression of ERCC1 mRNA |
CTD |
PMID:15173087 PMID:15213713 PMID:15737843 PMID:17016597 PMID:17401013 PMID:18448328 PMID:21286668 More...
|
|
NCBI chr 1:88,099,308...88,135,966
Ensembl chr 1:78,996,390...79,007,963
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
multiple interactions |
ISO |
ERCC2 gene polymorphism affects the susceptibility to [Fluorouracil co-treated with oxaliplatin]; ERCC2 gene SNP affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with oxaliplatin] |
CTD |
PMID:15213713 PMID:17401013 |
|
NCBI chr 1:88,161,342...88,175,102
Ensembl chr 1:79,033,326...79,047,102
|
|
G |
Ereg |
epiregulin |
decreases expression |
ISO |
Fluorouracil results in decreased expression of EREG mRNA |
CTD |
PMID:16510598 |
|
NCBI chr14:17,311,485...17,325,260
Ensembl chr14:17,027,287...17,041,062
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of ERN1 mRNA |
CTD |
PMID:32535746 |
|
NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Erp29 |
endoplasmic reticulum protein 29 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ERP29 protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr12:40,750,177...40,756,607
Ensembl chr12:35,089,707...35,096,376
|
|
G |
Espl1 |
extra spindle pole bodies like 1, separase |
affects response to substance |
ISO |
ESPL1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 7:133,424,027...133,450,984
Ensembl chr 7:133,424,130...133,450,984
|
|
G |
Etf1 |
eukaryotic translation termination factor 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ETF1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr18:26,502,413...26,530,753
Ensembl chr18:26,504,080...26,530,810
|
|
G |
Etfb |
electron transfer flavoprotein subunit beta |
affects response to substance |
ISO |
ETFB protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 1:93,851,908...93,866,072
Ensembl chr 1:93,851,858...93,866,068
|
|
G |
Ets1 |
ETS proto-oncogene 1, transcription factor |
multiple interactions increases expression |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ETS1 mRNA] Fluorouracil results in increased expression of ETS1 protein |
CTD |
PMID:15016801 PMID:30177839 |
|
NCBI chr 8:39,303,936...39,426,022
Ensembl chr 8:31,045,945...31,168,010
|
|
G |
Etv2 |
ETS variant transcription factor 2 |
multiple interactions |
ISO |
Fluorouracil inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in decreased expression of CDH5 mRNA]; Fluorouracil inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in decreased expression of CDH5 protein]; Fluorouracil inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in increased expression of SPN mRNA]; Fluorouracil inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in increased expression of SPN protein] |
CTD |
PMID:31404653 |
|
NCBI chr 1:85,890,562...85,894,025
Ensembl chr 1:85,890,559...85,893,431
|
|
G |
Exo1 |
exonuclease 1 |
affects response to substance |
ISO |
HEXO1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16477629 |
|
NCBI chr13:90,341,947...90,366,861
Ensembl chr13:87,809,810...87,834,654
|
|
G |
Exosc10 |
exosome component 10 |
affects response to substance increases metabolic processing |
ISO |
EXOSC10 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased metabolism of EXOSC10 protein |
CTD |
PMID:18567802 |
|
NCBI chr 5:158,995,313...159,018,940
Ensembl chr 5:158,995,313...159,018,940
|
|
G |
F12 |
coagulation factor XII |
affects response to substance decreases expression |
ISO |
F12 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of F12 protein |
CTD |
PMID:15352031 |
|
NCBI chr17:9,212,819...9,220,664
Ensembl chr17:9,207,683...9,215,530
|
|
G |
F2 |
coagulation factor II, thrombin |
decreases expression |
ISO |
Fluorouracil results in decreased expression of F2 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
F3 |
coagulation factor III, tissue factor |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of F3 mRNA F3 affects the susceptibility to Fluorouracil |
CTD |
PMID:15067352 PMID:16510598 |
|
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
F8 |
coagulation factor VIII |
multiple interactions |
ISO |
F8 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] |
CTD |
PMID:17327601 |
|
NCBI chr18:155,237...187,186
Ensembl chr18:140,955...171,857
|
|
G |
Fabp7 |
fatty acid binding protein 7 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of FABP7 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr20:37,123,193...37,126,725
Ensembl chr20:37,123,193...37,126,880
|
|
G |
Fadd |
Fas associated via death domain |
decreases expression |
ISO |
Fluorouracil results in decreased expression of FADD mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Fads1 |
fatty acid desaturase 1 |
affects response to substance |
ISO |
FADS1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:216,252,605...216,267,618
Ensembl chr 1:206,827,765...206,842,734
|
|
G |
Fah |
fumarylacetoacetate hydrolase |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of FAH mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:147,957,931...147,980,708
Ensembl chr 1:138,548,834...138,571,505
|
|
G |
Fam107b |
family with sequence similarity 107, member B |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of FAM107B mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr17:74,478,608...74,685,027
Ensembl chr17:74,478,608...74,684,989
|
|
G |
Fam114a1 |
family with sequence similarity 114, member A1 |
affects expression |
ISO |
Fluorouracil affects the expression of FAM114A1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr14:43,275,693...43,346,154
Ensembl chr14:43,275,701...43,346,174
|
|
G |
Fam171a1 |
family with sequence similarity 171, member A1 |
affects response to substance |
ISO |
FAM171A1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr17:75,024,582...75,148,348
Ensembl chr17:75,024,575...75,150,255
|
|
G |
Fam20c |
FAM20C, golgi associated secretory pathway kinase |
affects expression |
ISO |
Fluorouracil affects the expression of FAM20C mRNA |
CTD |
PMID:16584549 |
|
NCBI chr12:15,826,864...15,885,423
Ensembl chr12:15,826,871...15,884,543
|
|
G |
Fam234b |
family with sequence similarity 234, member B |
multiple interactions |
ISO |
FAM234B mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr 4:168,048,313...168,124,017
Ensembl chr 4:168,048,396...168,097,338
|
|
G |
Fam76b |
family with sequence similarity 76, member B |
decreases expression |
ISO |
Fluorouracil results in decreased expression of FAM76B mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 8:10,689,396...10,711,847
Ensembl chr 8:10,688,963...10,711,861
|
|
G |
Fancc |
FA complementation group C |
decreases expression |
ISO |
Fluorouracil results in decreased expression of FANCC mRNA |
CTD |
PMID:16557594 |
|
NCBI chr17:1,686,374...1,818,672
Ensembl chr17:1,681,324...1,829,376
|
|
G |
Fancg |
FA complementation group G |
increases expression affects response to substance |
ISO |
Fluorouracil results in increased expression of FANCG mRNA FANCG affects the susceptibility to Fluorouracil; FANCG protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15067352 PMID:15109396 PMID:15548681 |
|
NCBI chr 5:62,027,494...62,037,202
Ensembl chr 5:57,231,685...57,240,029
|
|
G |
Fanci |
FA complementation group I |
affects response to substance |
ISO |
FANCI protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 1:133,327,264...133,383,661
Ensembl chr 1:133,327,297...133,383,640
|
|
G |
Fars2 |
phenylalanyl-tRNA synthetase 2, mitochondrial |
decreases expression |
ISO |
Fluorouracil results in decreased expression of FARS2 mRNA |
CTD |
PMID:16101138 |
|
NCBI chr17:28,319,215...28,746,217
Ensembl chr17:28,319,280...28,746,337
|
|
G |
Fas |
Fas cell surface death receptor |
multiple interactions increases expression |
ISO |
[Docosahexaenoic Acids co-treated with Fluorouracil] results in decreased expression of FAS mRNA; [Fluorouracil co-treated with RNF34 protein] results in increased expression of FAS protein; FAS protein affects the reaction [Fluorouracil results in increased activity of CASP3 protein]; FAS protein affects the reaction [Fluorouracil results in increased activity of CASP8 protein]; FAS protein affects the reaction [Fluorouracil results in increased activity of CASP9 protein]; N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in increased expression of FAS protein]; TP53 protein affects the reaction [Fluorouracil results in increased expression of FAS mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of FAS protein]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of FAS protein]; TP53 protein promotes the reaction [N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in increased expression of FAS protein]] Fluorouracil results in increased expression of FAS; Fluorouracil results in increased expression of FAS mRNA; Fluorouracil results in increased expression of FAS protein |
CTD |
PMID:11300326 PMID:14665630 PMID:15016801 PMID:15034078 PMID:15152939 PMID:15161716 PMID:15546879 PMID:15585135 PMID:16557594 PMID:16596200 PMID:16709241 PMID:16957513 PMID:17039268 PMID:17045692 PMID:17056233 PMID:17982676 PMID:18074150 PMID:19015929 PMID:22525470 PMID:33770205 PMID:34151400 More...
|
|
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
increases response to substance increases expression |
ISO |
FASL results in increased susceptibility to Fluorouracil Fluorouracil results in increased expression of FASL |
CTD |
PMID:11196169 |
|
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fastk |
Fas-activated serine/threonine kinase |
decreases expression |
ISO |
Fluorouracil results in decreased expression of FASTK mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 4:10,732,273...10,736,332
Ensembl chr 4:10,732,256...10,737,430
|
|
G |
Fbln1 |
fibulin 1 |
affects expression increases expression |
ISO |
Fluorouracil affects the expression of FBLN1 mRNA Fluorouracil results in increased expression of FBLN1 mRNA |
CTD |
PMID:15205334 PMID:17039268 |
|
NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075
|
|
G |
Fbxo5 |
F-box protein 5 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of FBXO5 mRNA |
CTD |
PMID:16557594 PMID:19272435 |
|
NCBI chr 1:42,196,068...42,202,437
Ensembl chr 1:42,196,068...42,202,437
|
|
G |
Fdxr |
ferredoxin reductase |
multiple interactions increases expression |
ISO |
TP53 protein affects the reaction [Fluorouracil results in increased expression of FDXR mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of FDXR mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of FDXR protein] Fluorouracil results in increased expression of FDXR mRNA; Fluorouracil results in increased expression of FDXR mRNA alternative form; Fluorouracil results in increased expression of FDXR protein |
CTD |
PMID:14665630 PMID:15016801 PMID:15205334 PMID:16557594 PMID:17982676 PMID:22966307 More...
|
|
NCBI chr10:100,507,863...100,516,649
Ensembl chr10:100,507,865...100,516,658
|
|
G |
Fen1 |
flap structure-specific endonuclease 1 |
affects response to substance increases expression |
ISO |
FEN1 affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of FEN1 mRNA |
CTD |
PMID:15067352 PMID:15109396 |
|
NCBI chr 1:216,270,016...216,274,873
Ensembl chr 1:206,844,884...206,850,003
|
|
G |
Fermt2 |
FERM domain containing kindlin 2 |
affects response to substance |
ISO |
FERMT2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr15:18,682,927...18,751,959
Ensembl chr15:18,682,927...18,751,811
|
|
G |
Fgd6 |
FYVE, RhoGEF and PH domain containing 6 |
affects response to substance |
ISO |
FGD6 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 7:28,597,609...28,712,908
Ensembl chr 7:28,597,609...28,712,456
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of FGF2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fgf4 |
fibroblast growth factor 4 |
affects expression |
ISO |
Fluorouracil affects the expression of FGF4 protein |
CTD |
PMID:21296659 |
|
NCBI chr 1:209,453,229...209,457,085
Ensembl chr 1:200,024,056...200,025,466
|
|
G |
Fgf5 |
fibroblast growth factor 5 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of FGF5 protein |
CTD |
PMID:21296659 |
|
NCBI chr14:11,627,906...11,650,243
Ensembl chr14:11,325,334...11,345,997
|
|
G |
Fgf7 |
fibroblast growth factor 7 |
decreases response to substance multiple interactions |
ISO |
FGF7 protein results in decreased susceptibility to Fluorouracil; FGF7 results in decreased susceptibility to Fluorouracil FGFR2 inhibits the reaction [FGF7 results in decreased susceptibility to Fluorouracil]; FGFR2 protein alternative form inhibits the reaction [FGF7 protein results in decreased susceptibility to Fluorouracil] |
CTD |
PMID:18575591 |
|
NCBI chr 3:133,734,557...133,786,678
Ensembl chr 3:113,281,283...113,332,929
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
multiple interactions |
ISO |
FGFR2 inhibits the reaction [FGF7 results in decreased susceptibility to Fluorouracil]; FGFR2 protein alternative form inhibits the reaction [FGF7 protein results in decreased susceptibility to Fluorouracil] |
CTD |
PMID:18575591 |
|
NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Fgg |
fibrinogen gamma chain |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of FGG mRNA FGG protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 PMID:17039268 |
|
NCBI chr 2:170,652,929...170,660,372
Ensembl chr 2:168,355,013...168,362,322
|
|
G |
Fhl2 |
four and a half LIM domains 2 |
affects response to substance |
ISO |
FHL2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 9:45,388,979...45,462,421
Ensembl chr 9:45,388,981...45,431,192
|
|
G |
Fhl3 |
four and a half LIM domains 3 |
increases expression |
ISO |
Fluorouracil results in increased expression of FHL3 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr 5:136,953,947...136,961,317
Ensembl chr 5:136,950,411...136,961,317
|
|
G |
Fibcd1 |
fibrinogen C domain containing 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of FIBCD1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 3:15,092,682...15,126,371
Ensembl chr 3:15,092,681...15,126,399
|
|
G |
Filip1l |
filamin A interacting protein 1-like |
affects response to substance increases expression |
ISO |
FILIP1L protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of FILIP1L protein |
CTD |
PMID:15352031 |
|
NCBI chr11:42,937,353...43,177,085
Ensembl chr11:42,940,467...43,177,415
|
|
G |
Fkbp11 |
FKBP prolyl isomerase 11 |
affects response to substance |
ISO |
FKBP11 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 7:129,871,870...129,877,760
Ensembl chr 7:129,871,870...129,875,303
|
|
G |
Fkbp1b |
FKBP prolyl isomerase 1B |
affects response to substance |
ISO |
FKBP1B protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 6:27,832,128...27,850,600
Ensembl chr 6:27,838,802...27,848,653
|
|
G |
Fkbp5 |
FKBP prolyl isomerase 5 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of FKBP5 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,457,216...6,541,674
|
|
G |
Fkbpl |
FKBP prolyl isomerase like |
increases expression |
ISO |
Fluorouracil results in increased expression of FKBPL mRNA |
CTD |
PMID:14503796 |
|
NCBI chr20:4,099,845...4,101,315
Ensembl chr20:4,099,806...4,101,368
|
|
G |
Flrt2 |
fibronectin leucine rich transmembrane protein 2 |
affects response to substance |
ISO |
FLRT2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 6:114,777,547...114,872,688
Ensembl chr 6:114,777,599...114,872,785
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of FLT1 protein IFNA1 protein promotes the reaction [Fluorouracil results in decreased expression of FLT1 protein] |
CTD |
PMID:18157009 |
|
NCBI chr12:12,333,050...12,504,750
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Fmod |
fibromodulin |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in increased expression of FMOD mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr13:48,045,567...48,056,184
Ensembl chr13:45,493,517...45,504,133
|
|
G |
Fn1 |
fibronectin 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of FN1 protein |
CTD |
PMID:21296659 |
|
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fnbp1 |
formin binding protein 1 |
affects response to substance |
ISO |
FNBP1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 3:14,309,067...14,424,378
Ensembl chr 3:14,309,640...14,424,881
|
|
G |
Fndc3b |
fibronectin type III domain containing 3B |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of FNDC3B mRNA FNDC3B protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 PMID:16510598 |
|
NCBI chr 2:110,311,439...110,617,504
Ensembl chr 2:110,312,694...110,547,830
|
|
G |
Folr1 |
folate receptor alpha |
decreases expression |
ISO |
Fluorouracil results in decreased expression of FOLR1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 1:165,631,462...165,650,430
Ensembl chr 1:156,219,460...156,230,667
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression affects expression |
ISO |
Fluorouracil results in increased expression of FOS mRNA Fluorouracil affects the expression of FOS mRNA |
CTD |
PMID:15205334 PMID:17039268 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
affects expression |
ISO |
Fluorouracil affects the expression of FOSL1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:202,754,529...202,764,930
|
|
G |
Foxa2 |
forkhead box A2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of FOXA2 protein |
CTD |
PMID:21296659 |
|
NCBI chr 3:155,923,305...155,927,508
Ensembl chr 3:135,470,131...135,474,326
|
|
G |
Foxc1 |
forkhead box C1 |
affects expression |
ISO |
Fluorouracil affects the expression of FOXC1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr17:32,631,379...32,635,361
Ensembl chr17:32,633,142...32,634,803
|
|
G |
Foxd3 |
forkhead box D3 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of FOXD3 protein |
CTD |
PMID:21296659 |
|
NCBI chr 5:114,335,084...114,337,450
Ensembl chr 5:114,335,408...114,336,817
|
|
G |
Foxg1 |
forkhead box G1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of FOXG1 mRNA |
CTD |
PMID:30518710 |
|
NCBI chr 6:66,674,797...66,677,611
Ensembl chr 6:66,666,587...66,678,607
|
|
G |
Foxl2 |
forkhead box L2 |
increases expression |
ISO |
Fluorouracil results in increased expression of FOXL2 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 8:108,392,466...108,395,553
Ensembl chr 8:99,513,303...99,514,427
|
|
G |
Foxm1 |
forkhead box M1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of FOXM1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 4:163,325,628...163,338,100
Ensembl chr 4:161,638,816...161,650,684
|
|
G |
Foxn3 |
forkhead box N3 |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of FOXN3 protein FOXN3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 6:118,462,018...118,842,442
Ensembl chr 6:118,466,025...118,842,401
|
|
G |
Foxo3 |
forkhead box O3 |
affects response to substance |
ISO |
FOXO3 affects the susceptibility to Fluorouracil |
CTD |
PMID:15067352 |
|
NCBI chr20:47,251,968...47,348,254
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Fpgs |
folylpolyglutamate synthase |
increases response to substance |
ISO |
FPGS protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:15542523 |
|
NCBI chr 3:36,370,505...36,391,314
Ensembl chr 3:15,972,800...15,993,563
|
|
G |
Fut1 |
fucosyltransferase 1 |
affects response to substance |
ISO |
FUT1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15649251 |
|
NCBI chr 1:96,086,934...96,090,352
Ensembl chr 1:96,086,635...96,090,616
|
|
G |
Fxyd3 |
FXYD domain-containing ion transport regulator 3 |
increases expression |
ISO |
Fluorouracil results in increased expression of FXYD3 mRNA |
CTD |
PMID:15152939 |
|
NCBI chr 1:86,305,531...86,312,455
|
|
G |
Fyn |
FYN proto-oncogene, Src family tyrosine kinase |
affects response to substance |
ISO |
FYN protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr20:44,322,635...44,514,498
Ensembl chr20:42,766,369...42,959,911
|
|
G |
Fzd2 |
frizzled class receptor 2 |
affects response to substance |
ISO |
FZD2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:88,061,988...88,063,898
Ensembl chr10:87,561,326...87,565,334
|
|
G |
G0s2 |
G0/G1switch 2 |
increases expression affects response to substance |
ISO |
Fluorouracil results in increased expression of G0S2 protein G0S2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
|
|
G |
Gabrb3 |
gamma-aminobutyric acid type A receptor subunit beta 3 |
increases expression |
ISO |
Fluorouracil results in increased expression of GABRB3 protein |
CTD |
PMID:21296659 |
|
NCBI chr 1:108,467,047...108,702,522
Ensembl chr 1:108,296,124...108,698,961
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression multiple interactions affects response to substance increases response to substance decreases expression |
ISO |
Fluorouracil results in increased expression of GADD45A mRNA; Fluorouracil results in increased expression of GADD45A protein TP53 protein affects the reaction [Fluorouracil results in increased expression of GADD45A mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of GADD45A mRNA] GADD45A affects the susceptibility to Fluorouracil GADD45A protein results in increased susceptibility to Fluorouracil GADD45A protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of GADD45A mRNA |
CTD |
PMID:15016801 PMID:15067352 PMID:15205334 PMID:16709241 PMID:16732331 PMID:17982676 PMID:19003803 PMID:19098008 PMID:19272435 PMID:22525470 PMID:30177839 More...
|
|
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
decreases response to substance multiple interactions affects response to substance |
ISO |
GADD45B protein results in decreased susceptibility to Fluorouracil IFNG protein inhibits the reaction [GADD45B protein results in decreased susceptibility to Fluorouracil] GADD45B protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16732331 PMID:17711513 |
|
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
increases expression |
ISO |
Fluorouracil results in increased expression of GADD45G mRNA |
CTD |
PMID:19272435 |
|
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
|
|
G |
Gal |
galanin and GMAP prepropeptide |
decreases expression |
ISO |
Fluorouracil results in decreased expression of GAL protein |
CTD |
PMID:21296659 |
|
NCBI chr 1:210,079,709...210,084,572
Ensembl chr 1:200,650,439...200,654,959
|
|
G |
Galnt3 |
polypeptide N-acetylgalactosaminyltransferase 3 |
affects response to substance |
ISO |
GALNT3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 3:71,150,559...71,187,321
Ensembl chr 3:50,742,512...50,766,268
|
|
G |
Gamt |
guanidinoacetate N-methyltransferase |
increases expression multiple interactions affects response to substance |
ISO |
Fluorouracil results in increased expression of GAMT protein GAMT mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of GAMT mRNA] GAMT protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15016801 PMID:15352031 PMID:16896004 |
|
NCBI chr 7:10,099,267...10,102,083
Ensembl chr 7:9,448,628...9,451,778
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
affects splicing decreases expression |
ISO |
Fluorouracil affects the splicing of GAPDH mRNA Fluorouracil results in decreased expression of GAPDH protein |
CTD |
PMID:17169984 PMID:21296659 |
|
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:157,962,343...157,966,235
|
|
G |
Gart |
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase |
increases expression |
ISO |
Fluorouracil results in increased expression of GART mRNA |
CTD |
PMID:19219653 |
|
NCBI chr11:44,351,841...44,377,086
Ensembl chr11:30,865,889...30,891,125
|
|
G |
Gast |
gastrin |
decreases response to substance |
ISO |
GAST protein modified form results in decreased susceptibility to Fluorouracil |
CTD |
PMID:16618411 |
|
NCBI chr10:85,264,832...85,269,393
Ensembl chr10:85,264,832...85,267,496
|
|
G |
Gata2 |
GATA binding protein 2 |
multiple interactions |
ISO |
Fluorouracil inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in decreased expression of CDH5 mRNA]; Fluorouracil inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in decreased expression of CDH5 protein]; Fluorouracil inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in increased expression of SPN mRNA]; Fluorouracil inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in increased expression of SPN protein] |
CTD |
PMID:31404653 |
|
NCBI chr 4:120,654,205...120,667,763
Ensembl chr 4:120,658,986...120,667,761
|
|
G |
Gata4 |
GATA binding protein 4 |
affects expression |
ISO |
Fluorouracil affects the expression of GATA4 protein |
CTD |
PMID:21296659 |
|
NCBI chr15:41,635,572...41,707,252
Ensembl chr15:37,459,601...37,505,636
|
|
G |
Gata6 |
GATA binding protein 6 |
affects expression |
ISO |
Fluorouracil affects the expression of GATA6 protein |
CTD |
PMID:21296659 |
|
NCBI chr18:2,460,909...2,492,322
Ensembl chr18:2,188,121...2,219,532
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
affects response to substance |
ISO |
GCLM protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gcsh |
glycine cleavage system protein H |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of GCSH mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr19:45,036,013...45,046,770
Ensembl chr19:45,036,011...45,046,792
|
|
G |
Gdf1 |
growth differentiation factor 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of GDF1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr16:19,097,309...19,112,519
Ensembl chr16:19,097,314...19,112,519
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression multiple interactions |
ISO |
Fluorouracil results in increased expression of GDF15 mRNA; Fluorouracil results in increased expression of GDF15 protein TP53 protein affects the reaction [Fluorouracil results in increased expression of GDF15 mRNA] |
CTD |
PMID:14665630 PMID:15016801 PMID:15205334 PMID:24737281 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gdf3 |
growth differentiation factor 3 |
affects expression |
ISO |
Fluorouracil affects the expression of GDF3 protein |
CTD |
PMID:21296659 |
|
NCBI chr 4:157,503,547...157,507,923
Ensembl chr 4:155,830,909...155,835,937
|
|
G |
Gem |
GTP binding protein overexpressed in skeletal muscle |
affects expression |
ISO |
Fluorouracil affects the expression of GEM mRNA |
CTD |
PMID:15205334 |
|
NCBI chr 5:25,214,309...25,225,222
Ensembl chr 5:25,214,309...25,225,222
|
|
G |
Gfap |
glial fibrillary acidic protein |
increases expression |
ISO |
Fluorouracil results in increased expression of GFAP protein |
CTD |
PMID:21296659 |
|
NCBI chr10:88,352,987...88,361,661
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Gfra1 |
GDNF family receptor alpha 1 |
multiple interactions |
ISO |
GFRA1 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473
|
|
G |
Gins1 |
GINS complex subunit 1 |
increases response to substance |
ISO |
GINS1 gene mutant form results in increased susceptibility to Fluorouracil |
CTD |
PMID:18984863 |
|
NCBI chr 3:139,724,513...139,745,930
Ensembl chr 3:139,724,490...139,745,936
|
|
G |
Gins2 |
GINS complex subunit 2 |
affects expression |
ISO |
Fluorouracil affects the expression of GINS2 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr19:48,626,770...48,639,523
Ensembl chr19:48,626,770...48,639,339
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
affects response to substance |
ISO |
GJA1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 PMID:16531325 |
|
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gjc1 |
gap junction protein, gamma 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in increased expression of GJC1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr10:88,262,840...88,285,646
Ensembl chr10:87,760,528...87,785,867
|
|
G |
Gla |
galactosidase, alpha |
affects response to substance |
ISO |
GLA protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr X:102,062,497...102,073,915
Ensembl chr X:97,768,996...97,780,664
|
|
G |
Gli1 |
GLI family zinc finger 1 |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of GLI1 mRNA GLI1 protein inhibits the reaction [Fluorouracil affects the localization of PTCH1 protein] |
CTD |
PMID:18776995 |
|
NCBI chr 7:65,042,237...65,054,888
Ensembl chr 7:63,156,926...63,169,251
|
|
G |
Glipr1 |
GLI pathogenesis-related 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of GLIPR1 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 7:47,487,342...47,498,974
Ensembl chr 7:47,487,345...47,498,429
|
|
G |
Gnb2 |
G protein subunit beta 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of GNB2 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr12:19,159,002...19,164,021
Ensembl chr12:19,158,973...19,164,019
|
|
G |
Gne |
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of GNE protein GNE protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 5:63,062,953...63,103,320
Ensembl chr 5:58,267,210...58,307,499
|
|
G |
Golph3 |
golgi phosphoprotein 3 |
increases response to substance |
ISO |
GOLPH3 protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:38828452 |
|
NCBI chr 2:61,348,030...61,376,051
Ensembl chr 2:61,348,030...61,376,049
|
|
G |
Gp1bb |
glycoprotein Ib platelet subunit beta |
affects expression |
ISO |
Fluorouracil affects the expression of GP1BB mRNA |
CTD |
PMID:16584549 |
|
NCBI chr11:95,882,561...95,883,738
Ensembl chr11:82,378,199...82,379,392
|
|
G |
Gpr132 |
G protein-coupled receptor 132 |
increases expression |
ISO |
Fluorouracil results in increased expression of GPR132 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 6:131,924,061...131,943,327
Ensembl chr 6:131,924,160...131,942,168
|
|
G |
Gpr137c |
G protein-coupled receptor 137C |
affects expression |
ISO |
Fluorouracil affects the expression of GPR137C mRNA |
CTD |
PMID:16584549 |
|
NCBI chr15:18,425,939...18,492,588
Ensembl chr15:18,426,223...18,490,807
|
|
G |
Gpr35 |
G protein-coupled receptor 35 |
affects response to substance increases expression |
ISO |
GPR35 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of GPR35 mRNA |
CTD |
PMID:15331170 |
|
NCBI chr 9:93,527,165...93,539,573
Ensembl chr 9:93,527,127...93,539,299
|
|
G |
Gpr87 |
G protein-coupled receptor 87 |
increases expression |
ISO |
Fluorouracil results in increased expression of GPR87 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 2:143,439,741...143,440,901
Ensembl chr 2:143,439,735...143,458,190
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions increases activity |
ISO EXP |
Fluorouracil inhibits the reaction [Diethylnitrosamine results in increased activity of GPT protein] Fluorouracil results in increased activity of GPT protein Fluorouracil inhibits the reaction [Diethylnitrosamine results in increased expression of GPT protein] |
CTD |
PMID:27836789 PMID:29678497 PMID:31129132 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
increases expression multiple interactions decreases activity |
ISO EXP |
Fluorouracil results in increased expression of GPX1 mRNA TP53 protein promotes the reaction [Fluorouracil results in increased expression of GPX1 mRNA] Fluorouracil results in decreased activity of GPX1 protein |
CTD |
PMID:17982676 PMID:29117755 |
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of GPX2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
decreases expression multiple interactions |
ISO EXP |
Fluorouracil results in decreased expression of GPX4 protein ferrostatin-1 inhibits the reaction [Fluorouracil results in decreased expression of GPX4 protein] |
CTD |
PMID:35101590 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Gramd4 |
GRAM domain containing 4 |
increases expression multiple interactions |
ISO |
Fluorouracil results in increased expression of GRAMD4 mRNA TP73 protein promotes the reaction [Fluorouracil results in increased expression of GRAMD4 mRNA] |
CTD |
PMID:21127500 |
|
NCBI chr 7:117,150,398...117,224,056
Ensembl chr 7:117,150,374...117,224,053
|
|
G |
Grb7 |
growth factor receptor bound protein 7 |
increases expression |
ISO |
Fluorouracil results in increased expression of GRB7 protein |
CTD |
PMID:21296659 |
|
NCBI chr10:83,443,387...83,453,057
Ensembl chr10:83,444,004...83,453,052
|
|
G |
Grhl3 |
grainyhead-like transcription factor 3 |
affects expression |
ISO |
Fluorouracil affects the expression of GRHL3 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 5:147,774,161...147,806,291
Ensembl chr 5:147,774,160...147,806,160
|
|
G |
Grina |
glutamate ionotropic receptor NMDA type subunit associated protein 1 |
affects expression |
ISO |
Fluorouracil affects the expression of GRINA mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 7:107,962,194...107,965,372
Ensembl chr 7:107,962,207...107,965,366
|
|
G |
Gspt1 |
G1 to S phase transition 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of GSPT1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr10:4,362,528...4,397,215
Ensembl chr10:4,362,510...4,397,198
|
|
G |
Gsr |
glutathione-disulfide reductase |
decreases activity |
ISO |
Fluorouracil results in decreased activity of GSR protein |
CTD |
PMID:32752303 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
affects response to substance |
ISO |
GSTA4 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 8:87,947,247...87,964,490
Ensembl chr 8:79,066,934...79,084,182
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
multiple interactions |
ISO |
[[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in increased expression of GSTM1 mRNA |
CTD |
PMID:32800223 |
|
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
increases expression multiple interactions |
ISO |
Fluorouracil results in increased expression of GSTP1 mRNA [Cisplatin co-treated with Fluorouracil] results in decreased expression of GSTP1 mRNA; GSTP1 gene polymorphism affects the susceptibility to [Fluorouracil co-treated with oxaliplatin]; GSTP1 gene polymorphism results in decreased susceptibility to [Fluorouracil co-treated with Cisplatin] |
CTD |
PMID:15205334 PMID:15213713 PMID:15737843 PMID:16622263 |
|
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of GSTT1 protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Gtpbp4 |
GTP binding protein 4 |
affects response to substance |
ISO |
GTPBP4 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr17:61,308,033...61,328,184
Ensembl chr17:61,308,014...61,418,009
|
|
G |
Gucy1b1 |
guanylate cyclase 1 soluble subunit beta 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of GUCY1B1 mRNA |
CTD |
PMID:19219653 |
|
NCBI chr 2:169,646,897...169,697,060
Ensembl chr 2:167,348,825...167,398,916
|
|
G |
H1f0 |
H1.0 linker histone |
affects expression |
ISO |
Fluorouracil affects the expression of H1F0 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr 7:110,592,834...110,594,694
Ensembl chr 7:110,592,208...110,594,694
|
|
G |
H2ax |
H2A.X variant histone |
affects expression increases phosphorylation multiple interactions |
ISO |
Fluorouracil affects the expression of H2AX mRNA Fluorouracil results in increased phosphorylation of H2AX protein [Fluorouracil co-treated with olaparib] results in increased phosphorylation of H2AX protein; [S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased expression of H2AX protein; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Fluorouracil co-treated with olaparib] results in increased phosphorylation of H2AX protein]; TP53 gene mutant form affects the reaction [benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Fluorouracil co-treated with olaparib] results in increased phosphorylation of H2AX protein]]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of H2AX mRNA] |
CTD |
PMID:15016801 PMID:16584549 PMID:25940438 PMID:26544897 PMID:34510228 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
G |
H2bc12 |
H2B clustered histone 12 |
decreases expression increases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of H2BC12 mRNA Fluorouracil results in increased expression of H2BC12 protein H2BC12 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 PMID:16101138 PMID:16217747 |
|
NCBI chr17:47,181,477...47,181,940
|
|
G |
H3-7l |
H3.7 histone like |
decreases expression |
ISO |
Fluorouracil results in decreased expression of H3-7 mRNA |
CTD |
PMID:16101138 |
|
NCBI chr 7:102,145,916...102,146,683
|
|
G |
H4c14 |
H4 clustered histone 14 |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of H4C2 mRNA TP53 protein affects the reaction [Fluorouracil results in decreased expression of H4C2 mRNA] |
CTD |
PMID:15016801 PMID:17039268 |
|
NCBI chr 2:186,520,468...186,520,863
Ensembl chr 2:183,825,994...183,832,048
|
|
G |
H4f3 |
H1.3 linker histone, cluster member |
increases expression |
ISO |
Fluorouracil results in increased expression of H1-3 protein |
CTD |
PMID:15585135 |
|
NCBI chr17:41,551,524...41,552,303
Ensembl chr17:41,529,667...41,552,334
|
|
G |
Hacd1 |
3-hydroxyacyl-CoA dehydratase 1 |
affects response to substance |
ISO |
HACD1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr17:77,081,508...77,106,114
Ensembl chr17:77,083,740...77,106,073
|
|
G |
Hand1 |
heart and neural crest derivatives expressed 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of HAND1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr10:42,006,646...42,009,213
Ensembl chr10:42,006,651...42,009,213
|
|
G |
Hand2 |
heart and neural crest derivatives expressed 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of HAND2 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr16:32,917,448...32,920,791
Ensembl chr16:32,917,823...32,919,891
|
|
G |
Hapln2 |
hyaluronan and proteoglycan link protein 2 |
affects expression |
ISO |
Fluorouracil affects the expression of HAPLN2 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 2:173,488,909...173,496,824
Ensembl chr 2:173,491,160...173,496,588
|
|
G |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of HBA1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr10:15,828,291...15,829,138
Ensembl chr10:15,307,815...15,338,392 Ensembl chr10:15,307,815...15,338,392
|
|
G |
Hbb |
hemoglobin subunit beta |
affects splicing |
ISO |
Fluorouracil affects the splicing of HBB mRNA |
CTD |
PMID:17169984 |
|
NCBI chr 1:167,662,310...167,663,721
Ensembl chr 1:158,120,200...158,252,012
|
|
G |
Hbb-b2 |
hemoglobin, beta adult minor chain |
increases expression |
ISO |
Fluorouracil results in increased expression of HBB-B2 protein |
CTD |
PMID:21296659 |
|
NCBI chr 1:158,243,696...158,245,076
Ensembl chr 1:158,120,200...158,252,012
|
|
G |
Hbe1 |
hemoglobin subunit epsilon 1 |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of HBE1 protein HBE1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 1:158,282,931...158,458,855
Ensembl chr 1:158,282,936...158,284,391
|
|
G |
Hbz |
hemoglobin subunit zeta |
decreases expression |
ISO |
Fluorouracil results in decreased expression of HBZ protein |
CTD |
PMID:21296659 |
|
NCBI chr10:15,343,821...15,345,301
Ensembl chr10:15,343,831...15,345,312
|
|
G |
Hdac1 |
histone deacetylase 1 |
multiple interactions |
ISO |
[HDAC1 protein co-treated with HDAC2 protein] promotes the reaction [TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of MBP mRNA]]; [HDAC1 protein co-treated with HDAC2 protein] promotes the reaction [TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of OLIG2 mRNA]]; Fluorouracil inhibits the reaction [TCF7L2 protein binds to HDAC1 protein] |
CTD |
PMID:25178657 |
|
NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:141,853,989...141,881,111
|
|
G |
Hdac2 |
histone deacetylase 2 |
multiple interactions increases response to substance |
ISO |
[HDAC1 protein co-treated with HDAC2 protein] promotes the reaction [TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of MBP mRNA]]; [HDAC1 protein co-treated with HDAC2 protein] promotes the reaction [TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of OLIG2 mRNA]]; Fluorouracil inhibits the reaction [TCF7L2 protein binds to HDAC2 protein] HDAC2 protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:25178657 PMID:35608750 |
|
NCBI chr20:42,101,815...42,126,486
Ensembl chr20:40,548,250...40,571,609
|
|
G |
Hdac3 |
histone deacetylase 3 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of HDAC3 mRNA |
CTD |
PMID:19272435 |
|
NCBI chr18:30,021,847...30,041,061
Ensembl chr18:29,770,636...29,793,856
|
|
G |
Hdac4 |
histone deacetylase 4 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of HDAC4 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 9:99,950,972...100,200,994
Ensembl chr 9:92,507,611...92,750,164
|
|
G |
Hdac7 |
histone deacetylase 7 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of HDAC7 mRNA |
CTD |
PMID:26272751 |
|
NCBI chr 7:128,923,918...128,961,926
Ensembl chr 7:128,923,920...128,962,072
|
|
G |
Hdac9 |
histone deacetylase 9 |
increases expression |
ISO |
Fluorouracil results in increased expression of HDAC9 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 6:56,489,472...57,351,654
Ensembl chr 6:50,763,590...51,625,333
|
|
G |
Hdgfl3 |
HDGF like 3 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of HDGFL3 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:135,822,600...135,876,719
Ensembl chr 1:135,827,549...135,876,719
|
|
G |
Herpud1 |
homocysteine inducible ER protein with ubiquitin like domain 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of HERPUD1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr19:10,604,360...10,624,168
Ensembl chr19:10,598,417...10,618,424
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
increases activity |
ISO |
Fluorouracil results in increased activity of HES1 protein |
CTD |
PMID:19147571 |
|
NCBI chr11:84,210,632...84,213,045
Ensembl chr11:70,705,764...70,708,192
|
|
G |
Hgf |
hepatocyte growth factor |
increases expression |
ISO |
Fluorouracil results in increased expression of HGF mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hic2 |
HIC ZBTB transcriptional repressor 2 |
affects response to substance |
ISO |
HIC2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr11:83,737,075...83,789,554
Ensembl chr11:83,738,874...83,767,484
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
affects localization multiple interactions decreases response to substance affects response to substance decreases uptake decreases expression increases expression |
ISO EXP |
Fluorouracil affects the localization of HIF1A protein Acetylcysteine inhibits the reaction [Fluorouracil affects the localization of HIF1A protein]; Cyclosporine inhibits the reaction [HIF1A protein results in decreased uptake of Fluorouracil] Fluorouracil results in decreased susceptibility to HIF1A protein; HIF1A results in decreased susceptibility to Fluorouracil HIF1A protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of HIF1A mRNA; Fluorouracil results in decreased expression of HIF1A protein Fluorouracil results in increased expression of HIF1A mRNA [diacerein co-treated with Fluorouracil] inhibits the reaction [Trichloroacetic Acid results in increased expression of HIF1A protein]; Fluorouracil inhibits the reaction [Trichloroacetic Acid results in increased expression of HIF1A protein] |
CTD |
PMID:16628086 PMID:17066447 PMID:17219956 PMID:27163855 PMID:34794354 PMID:37338137 PMID:39241941 More...
|
|
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hint1 |
histidine triad nucleotide binding protein 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of HINT1 protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr10:38,989,516...38,993,259
Ensembl chr 4:92,100,973...92,101,568
|
|
G |
Hk2 |
hexokinase 2 |
decreases expression multiple interactions affects response to substance |
ISO |
Fluorouracil results in decreased expression of HK2 protein HK2 protein affects the reaction [Fluorouracil results in increased activity of CASP3 protein] HK2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16595493 PMID:18772588 |
|
NCBI chr 4:116,792,258...116,841,275
Ensembl chr 4:115,234,509...115,283,530
|
|
G |
Hm13 |
histocompatibility minor 13 |
affects expression |
ISO |
Fluorouracil affects the expression of HM13 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 3:141,145,792...141,183,557
Ensembl chr 3:141,145,782...141,184,703
|
|
G |
Hmces |
5-hydroxymethylcytosine binding, ES cell specific |
affects response to substance |
ISO |
HMCES protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 4:120,392,812...120,415,616
Ensembl chr 4:120,366,542...120,415,616
|
|
G |
Hmg20b |
high mobility group 20 B |
decreases expression |
ISO |
Fluorouracil results in decreased expression of HMG20B mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 7:8,368,934...8,373,650
Ensembl chr 7:8,368,990...8,373,640
|
|
G |
Hmgb1 |
high mobility group box 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of HMG1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
|
|
G |
Hmgn5 |
high mobility group nucleosome binding domain 5 |
increases expression |
ISO |
Fluorouracil results in increased expression of HMGN5 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr X:74,085,871...74,094,488
Ensembl chr X:74,085,875...74,094,441 Ensembl chr 1:74,085,875...74,094,441
|
|
G |
Hmmr |
hyaluronan-mediated motility receptor |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of HMMR mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr10:25,635,249...25,665,389
Ensembl chr10:25,132,977...25,163,060
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression affects expression |
ISO EXP |
Fluorouracil results in increased expression of HMOX1 Fluorouracil affects the expression of HMOX1 mRNA |
CTD |
PMID:20722640 PMID:22954530 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnf1a |
HNF1 homeobox A |
affects expression |
ISO |
Fluorouracil affects the expression of HNF1A mRNA |
CTD |
PMID:34151400 |
|
NCBI chr12:47,299,171...47,333,457
Ensembl chr12:41,645,587...41,672,104
|
|
G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
affects expression |
ISO |
Fluorouracil affects the expression of HNF4A mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 3:172,606,220...172,667,758
Ensembl chr 3:152,186,787...152,248,320
|
|
G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of HNRNPA1 mRNA TP53 protein affects the reaction [Fluorouracil results in decreased expression of HNRNPA1 mRNA] |
CTD |
PMID:15016801 PMID:16101138 |
|
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
|
|
G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of HNRNPA2B1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 4:81,867,354...81,875,886
Ensembl chr 4:80,534,651...80,545,249
|
|
G |
Hnrnpc |
heterogeneous nuclear ribonucleoprotein C |
increases expression |
ISO |
Fluorouracil results in increased expression of HNRNPC protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr15:27,253,098...27,282,779
Ensembl chr15:24,779,450...24,809,183
|
|
G |
Hnrnpf |
heterogeneous nuclear ribonucleoprotein F |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of HNRNPF mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 4:151,083,262...151,104,464
Ensembl chr 4:151,083,062...151,109,038
|
|
G |
Hnrnph1 |
heterogeneous nuclear ribonucleoprotein H1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of HNRNPH1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr10:35,187,412...35,203,909
Ensembl chr10:34,693,555...34,702,846
|
|
G |
Hnrnpl |
heterogeneous nuclear ribonucleoprotein L |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of HNRNPL mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:93,226,373...93,239,084
Ensembl chr 1:84,100,879...84,111,553
|
|
G |
Hoxa1 |
homeobox A1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of HOXA1 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 4:81,255,814...81,258,587
Ensembl chr 4:81,255,883...81,258,504
|
|
G |
Hoxb3 |
homeo box B3 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of HOXB3 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr10:81,786,001...81,810,655
Ensembl chr10:81,299,357...81,313,107
|
|
G |
Hoxc11 |
homeobox C11 |
affects expression affects response to substance |
ISO |
Fluorouracil affects the expression of HOXC11 protein HOXC11 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15331170 |
|
NCBI chr 7:134,091,224...134,094,738
Ensembl chr 7:134,091,552...134,094,738
|
|
G |
Hoxd1 |
homeo box D1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of HOXD1 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 3:80,073,041...80,075,180
Ensembl chr 3:59,665,629...59,667,769
|
|
G |
Hpx |
hemopexin |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of HPX mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:169,344,647...169,352,155
Ensembl chr 1:159,932,755...159,940,328
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
increases expression |
ISO |
Fluorouracil results in increased expression of HRAS mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hs6st2 |
heparan sulfate 6-O-sulfotransferase 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of HS6ST2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr X:130,966,547...131,261,629
Ensembl chr X:130,968,385...131,261,492
|
|
G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
affects expression |
ISO |
Fluorouracil affects the expression of HSD17B2 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr19:62,662,320...62,733,944
Ensembl chr19:45,753,574...45,825,202
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of HSPA1B protein HSPA1B protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
|
|
G |
Hspa2 |
heat shock protein family A (Hsp70) member 2 |
increases expression affects response to substance |
ISO |
Fluorouracil results in increased expression of HSPA2 mRNA HSPA2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16101138 PMID:16217747 |
|
NCBI chr 6:100,864,172...100,866,946
Ensembl chr 6:95,128,350...95,131,287
|
|
G |
Hspa4 |
heat shock protein family A (Hsp70) member 4 |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of HSPA4 protein HSPA4 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr10:37,908,866...37,951,994
Ensembl chr10:37,408,025...37,449,001
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of HSPA5 mRNA; Fluorouracil results in decreased expression of HSPA5 protein |
CTD |
PMID:29879413 PMID:32535746 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
affects response to substance |
ISO |
HSPA8 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
multiple interactions decreases response to substance |
ISO |
HSPB1 protein affects the susceptibility to [Cisplatin co-treated with Fluorouracil co-treated with Leucovorin] HSPB1 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:18949417 PMID:19088045 |
|
NCBI chr12:26,430,640...26,432,301
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Hspb2 |
heat shock protein family B (small) member 2 |
increases phosphorylation multiple interactions |
ISO |
Fluorouracil results in increased phosphorylation of HSPB2 protein SB 203580 inhibits the reaction [Fluorouracil results in increased phosphorylation of HSPB2 protein] |
CTD |
PMID:18757417 |
|
NCBI chr 8:51,093,267...51,094,528
Ensembl chr 8:51,081,342...51,094,533
|
|
G |
Hspb8 |
heat shock protein family B (small) member 8 |
increases expression |
ISO |
Fluorouracil results in increased expression of HSPB8 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr12:45,835,899...45,866,449
Ensembl chr12:40,176,532...40,191,185
|
|
G |
Hspe1 |
heat shock protein family E (Hsp10) member 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of HSPE1 mRNA |
CTD |
PMID:15152939 |
|
NCBI chr 9:56,589,912...56,593,000
Ensembl chr 9:56,589,789...56,593,089
|
|
G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
multiple interactions increases response to substance |
ISO |
[Fluorouracil co-treated with irinotecan] results in increased expression of HTATIP2 mRNA HTATIP2 protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:16391804 PMID:16799960 |
|
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
|
|
G |
Htr7 |
5-hydroxytryptamine receptor 7 |
affects expression |
ISO |
Fluorouracil affects the expression of HTR7 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 1:233,636,442...233,761,063
Ensembl chr 1:233,636,452...233,760,626
|
|
G |
Htra1 |
HtrA serine peptidase 1 |
increases expression affects response to substance |
ISO |
Fluorouracil results in increased expression of HTRA1 protein HTRA1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 1:194,928,069...194,977,619
Ensembl chr 1:185,497,735...185,547,379
|
|
G |
Iapp |
islet amyloid polypeptide |
decreases expression |
ISO |
Fluorouracil results in decreased expression of IAPP protein |
CTD |
PMID:21296659 |
|
NCBI chr 4:176,968,097...176,975,363
Ensembl chr 4:175,237,115...175,242,920
|
|
G |
Id1 |
inhibitor of DNA binding 1 |
increases expression multiple interactions |
ISO |
Fluorouracil results in increased expression of ID1 mRNA TP53 protein promotes the reaction [Fluorouracil results in increased expression of ID1 mRNA] |
CTD |
PMID:16557594 |
|
NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:141,211,267...141,212,419
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
decreases expression affects response to substance increases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of ID2 protein ID2 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of ID2 mRNA TP53 protein promotes the reaction [Fluorouracil results in increased expression of ID2 mRNA] |
CTD |
PMID:15016739 PMID:15352031 PMID:16557594 PMID:25178657 |
|
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
|
|
G |
Id3 |
inhibitor of DNA binding 3 |
increases expression |
ISO |
Fluorouracil results in increased expression of ID3 mRNA |
CTD |
PMID:15205334 PMID:16557594 |
|
NCBI chr 5:153,656,253...153,657,860
Ensembl chr 5:148,372,762...148,374,349
|
|
G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
affects response to substance |
ISO |
IDI1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr17:66,539,761...66,547,524
Ensembl chr17:61,629,594...61,637,357
|
|
G |
Ier5 |
immediate early response 5 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in increased expression of IER5 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr13:67,270,134...67,272,226
Ensembl chr13:67,270,135...67,272,227
|
|
G |
Ifi27l2a |
interferon, alpha-inducible protein 27 like 2A |
multiple interactions |
ISO |
[Fluorouracil co-treated with irinotecan] results in increased expression of IFI27L2 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr 6:122,598,872...122,600,358
Ensembl chr 6:122,598,872...122,600,360
|
|
G |
Ifi35 |
interferon-induced protein 35 |
increases expression |
ISO |
Fluorouracil results in increased expression of IFI35 mRNA |
CTD |
PMID:16101138 |
|
NCBI chr10:86,381,023...86,389,279
Ensembl chr10:86,381,010...86,389,952
|
|
G |
Ifit2 |
interferon-induced protein with tetratricopeptide repeats 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of IFIT2 mRNA |
CTD |
PMID:16101138 |
|
NCBI chr 1:232,102,570...232,108,638
Ensembl chr 1:232,102,570...232,108,635
|
|
G |
Ifitm1 |
interferon induced transmembrane protein 1 |
decreases expression increases expression |
ISO |
Fluorouracil results in decreased expression of IFITM1 protein Fluorouracil results in increased expression of IFITM1 mRNA |
CTD |
PMID:16101138 PMID:16510598 PMID:17039268 PMID:21296659 |
|
NCBI chr 1:196,067,163...196,069,169
Ensembl chr 1:196,067,963...196,069,169
|
|
G |
Ifitm2 |
interferon induced transmembrane protein 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of IFITM2 protein |
CTD |
PMID:21296659 |
|
NCBI chr 1:196,051,539...196,052,719
Ensembl chr 1:196,051,537...196,052,741
|
|
G |
Ifna1 |
interferon, alpha 1 |
increases response to substance increases abundance multiple interactions |
ISO |
IFNA1 protein results in increased susceptibility to Fluorouracil IFNA1 protein results in increased abundance of Fluorouracil IFNA1 protein promotes the reaction [Fluorouracil results in decreased expression of FLT1 protein]; IFNA1 protein promotes the reaction [Fluorouracil results in decreased expression of RGS5 mRNA] [Fluorouracil co-treated with IFNA1 protein] results in decreased expression of BCL2L1 mRNA; [Fluorouracil co-treated with IFNA1 protein] results in decreased expression of CFLAR protein; ANGPT1 protein promotes the reaction [Fluorouracil results in increased expression of IFNA1 protein]; ANGPT2 protein promotes the reaction [Fluorouracil results in decreased expression of IFNA1 protein]; Fluorouracil promotes the reaction [IFNA1 protein results in increased expression of TP53AIP1 mRNA]; IFNA1 promotes the reaction [Fluorouracil results in decreased expression of BCL2L1 mRNA]; IFNA1 promotes the reaction [Fluorouracil results in increased cleavage of and results in increased activity of BID protein]; IFNA1 promotes the reaction [Fluorouracil results in increased expression of CASP8 protein]; IFNA1 protein promotes the reaction [Fluorouracil results in decreased expression of CFLAR mRNA]; IFNA1 protein promotes the reaction [Fluorouracil results in increased activity of CASP3 protein]; IFNA1 protein promotes the reaction [Fluorouracil results in increased activity of CASP8 protein]; IFNA1 protein promotes the reaction [Fluorouracil results in increased activity of CASP9 protein]; IFNA1 protein promotes the reaction [Fluorouracil results in increased expression of BAX mRNA]; IFNA1 protein promotes the reaction [Fluorouracil results in increased phosphorylation of TP53 protein]; VEGFA protein promotes the reaction [Fluorouracil results in decreased expression of IFNA1 protein] |
CTD |
PMID:16101138 PMID:16568373 PMID:17016659 PMID:17045692 PMID:17786339 PMID:17971768 PMID:18157009 PMID:21474236 More...
|
|
NCBI chr 5:108,143,240...108,143,809
Ensembl chr 5:103,097,356...103,097,925
|
|
G |
Ifnar1 |
interferon alpha and beta receptor subunit 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of IFNAR1 mRNA; Fluorouracil results in increased expression of IFNAR1 protein |
CTD |
PMID:17088986 |
|
NCBI chr11:44,211,769...44,238,206
Ensembl chr11:30,725,790...30,749,979
|
|
G |
Ifnar2 |
interferon alpha and beta receptor subunit 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of IFNAR2 mRNA; Fluorouracil results in increased expression of IFNAR2 protein |
CTD |
PMID:16101138 PMID:17088986 |
|
NCBI chr11:30,613,576...30,645,958
Ensembl chr11:30,613,767...30,668,124
|
|
G |
Ifnb1 |
interferon beta 1 |
multiple interactions increases response to substance |
ISO |
[Fluorouracil co-treated with IFNB1 protein] results in increased activity of CASP3 protein IFNB1 protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:15937643 PMID:16101138 PMID:18608205 PMID:18695887 |
|
NCBI chr 5:108,066,650...108,067,487
Ensembl chr 5:103,020,969...103,021,523
|
|
G |
Ifng |
interferon gamma |
multiple interactions increases abundance decreases expression |
ISO |
[IFNG protein results in increased expression of TYMP protein] which results in increased susceptibility to Fluorouracil; Fluorouracil promotes the reaction [IL18 protein modified form results in increased expression of IFNG protein]; IFNG protein inhibits the reaction [GADD45B protein results in decreased susceptibility to Fluorouracil] IFNG protein results in increased abundance of Fluorouracil LCS101 inhibits the reaction [Fluorouracil results in decreased expression of IFNG protein] |
CTD |
PMID:15162350 PMID:15301717 PMID:15754409 PMID:16568373 PMID:17711513 PMID:23637542 More...
|
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igf1 |
insulin-like growth factor 1 |
increases expression multiple interactions |
EXP ISO |
Fluorouracil results in increased expression of IGF1 mRNA [Fluorouracil co-treated with IGF1 protein] results in increased expression of MT2A mRNA; IGF1 protein inhibits the reaction [Fluorouracil results in decreased expression of MT2A protein]; IGF1 protein inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; IGF1 protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 mRNA]; IGF1 protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 protein] |
CTD |
PMID:16888818 PMID:28507149 |
|
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
multiple interactions |
ISO |
Fluorouracil promotes the reaction [Curcumin results in decreased phosphorylation of and results in decreased activity of IGF1R protein]; Fluorouracil results in decreased phosphorylation of and results in decreased activity of IGF1R protein |
CTD |
PMID:17918158 |
|
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of IGFBP2 protein |
CTD |
PMID:21296659 |
|
NCBI chr 9:81,864,811...81,892,179
Ensembl chr 9:74,415,546...74,442,937
|
|
G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
multiple interactions |
ISO |
IGFBP4 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr10:84,491,471...84,503,487
Ensembl chr10:83,989,591...84,007,225
|
|
G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of IGFBP5 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:74,448,382...74,465,156
|
|
G |
Igfbp6 |
insulin-like growth factor binding protein 6 |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of IGFBP6 protein IGFBP6 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 7:133,276,309...133,280,944
Ensembl chr 7:133,276,234...133,280,966
|
|
G |
Ihh |
Indian hedgehog signaling molecule |
decreases expression |
ISO |
Fluorouracil results in decreased expression of IHH mRNA; Fluorouracil results in decreased expression of IHH protein |
CTD |
PMID:25190613 |
|
NCBI chr 9:83,952,986...83,959,203
Ensembl chr 9:76,504,315...76,510,532
|
|
G |
Ikbip |
IKBKB interacting protein |
increases expression multiple interactions |
ISO |
Fluorouracil results in increased expression of IKBIP mRNA TP53 protein promotes the reaction [Fluorouracil results in increased expression of IKBIP mRNA] |
CTD |
PMID:17982676 |
|
NCBI chr 7:25,579,865...25,598,548
Ensembl chr 7:25,579,832...25,605,162
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
decreases expression |
ISO |
Fluorouracil results in decreased expression of IKBKB protein |
CTD |
PMID:30177839 |
|
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Il10 |
interleukin 10 |
multiple interactions decreases expression |
ISO EXP |
[Cyclophosphamide co-treated with Methotrexate co-treated with Fluorouracil] results in decreased expression of IL10 protein [Thymol co-treated with Fluorouracil] results in increased expression of IL10 protein Fluorouracil results in decreased expression of IL10 protein |
CTD |
PMID:31651976 PMID:34665902 PMID:38078205 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il12b |
interleukin 12B |
decreases expression |
ISO |
Fluorouracil results in decreased expression of IL12B protein |
CTD |
PMID:15754409 |
|
NCBI chr10:29,390,300...29,405,194
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il18 |
interleukin 18 |
multiple interactions affects expression |
ISO |
[Fluorouracil co-treated with irinotecan] results in decreased expression of IL18 mRNA; Fluorouracil promotes the reaction [IL18 protein modified form results in increased expression of IFNG protein]; Fluorouracil results in increased cleavage of and results in increased secretion of IL18 protein Fluorouracil affects the expression of IL18 mRNA |
CTD |
PMID:15162350 PMID:16391804 PMID:20421339 |
|
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
ISO |
[Cyclophosphamide co-treated with Methotrexate co-treated with Fluorouracil] results in decreased expression of IL1A protein |
CTD |
PMID:31651976 |
|
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
increases expression multiple interactions increases secretion |
ISO EXP |
Fluorouracil results in increased expression of IL1B mRNA; Fluorouracil results in increased expression of IL1B protein IL1B promoter polymorphism affects the susceptibility to [Fluorouracil co-treated with Cisplatin] [Cyclophosphamide co-treated with Methotrexate co-treated with Fluorouracil] results in decreased expression of IL1B protein; Hydroxychloroquine inhibits the reaction [Fluorouracil results in increased secretion of IL1B protein] [diacerein co-treated with Fluorouracil] inhibits the reaction [Trichloroacetic Acid results in increased expression of IL1B protein] |
CTD |
PMID:16820919 PMID:18523641 PMID:18535404 PMID:19528421 PMID:20844880 PMID:31651976 PMID:32314717 PMID:34794354 More...
|
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
multiple interactions |
ISO |
IL1RN protein affects the reaction [Fluorouracil results in increased expression of BAX protein]; IL1RN protein affects the reaction [Fluorouracil results in increased expression of CASP3 protein modified form]; IL1RN protein inhibits the reaction [Fluorouracil results in decreased expression of BCL2 protein]; IL1RN protein inhibits the reaction [Fluorouracil results in decreased expression of BCL2L1 protein] |
CTD |
PMID:20844880 |
|
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Il27ra |
interleukin 27 receptor subunit alpha |
affects response to substance |
ISO |
IL27RA protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr19:41,014,730...41,026,740
Ensembl chr19:24,109,972...24,121,938
|
|
G |
Il3 |
interleukin 3 |
multiple interactions |
ISO |
[Cyclophosphamide co-treated with Methotrexate co-treated with Fluorouracil] results in decreased expression of IL3 protein |
CTD |
PMID:31651976 |
|
NCBI chr10:38,906,460...38,908,810
Ensembl chr10:38,405,716...38,408,066
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression increases secretion |
ISO EXP |
3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Fluorouracil results in increased expression of IL6 mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Fluorouracil results in increased secretion of IL6 protein]; [Fluorouracil co-treated with IL6 protein] results in increased expression of MT2A mRNA; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Fluorouracil results in increased expression of IL6 mRNA]; IL6 promoter polymorphism affects the susceptibility to [Fluorouracil co-treated with Cisplatin]; IL6 protein inhibits the reaction [Fluorouracil results in decreased expression of MT2A protein]; IL6 protein inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; IL6 protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 mRNA]; IL6 protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 protein]; pyrazolanthrone inhibits the reaction [Fluorouracil results in increased expression of IL6 mRNA]; SB 203580 inhibits the reaction [Fluorouracil results in increased expression of IL6 mRNA] Fluorouracil inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of IL6 protein]; Thymol inhibits the reaction [Fluorouracil results in increased expression of IL6 protein] Fluorouracil promotes the reaction [Valsartan results in decreased secretion of IL6 protein] |
CTD |
PMID:16820919 PMID:18344199 PMID:18523641 PMID:25824412 PMID:28507149 PMID:34665902 PMID:35147423 PMID:35235860 More...
|
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il7 |
interleukin 7 |
affects expression |
ISO |
Fluorouracil affects the expression of IL7 mRNA |
CTD |
PMID:18344199 |
|
NCBI chr 2:96,142,523...96,186,282
Ensembl chr 2:94,234,766...94,280,075
|
|
G |
Impa2 |
inositol monophosphatase 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of IMPA2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr18:60,834,206...60,867,575
Ensembl chr18:60,834,246...60,865,641
|
|
G |
Impdh2 |
inosine monophosphate dehydrogenase 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of IMPDH2 mRNA |
CTD |
PMID:19219653 |
|
NCBI chr 8:109,256,705...109,261,365
Ensembl chr 8:109,256,728...109,261,359
|
|
G |
Inka2 |
inka box actin regulator 2 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in increased expression of INKA2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 2:193,185,275...193,200,643
Ensembl chr 2:193,185,275...193,200,642
|
|
G |
Inpp5e |
inositol polyphosphate-5-phosphatase E |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of INPP5E mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 3:29,614,868...29,627,542
Ensembl chr 3:9,216,776...9,229,450
|
|
G |
Ins2 |
insulin 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of INS2 protein |
CTD |
PMID:21296659 |
|
NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Insig1 |
insulin induced gene 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of INSIG1 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:7,315,495...7,323,952
|
|
G |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of IQGAP2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 2:26,894,836...27,170,270
Ensembl chr 2:26,894,825...27,170,279
|
|
G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
increases expression affects response to substance |
ISO |
Fluorouracil results in increased expression of IRAK1 mRNA IRAK1 affects the susceptibility to Fluorouracil |
CTD |
PMID:15067352 PMID:15109396 |
|
NCBI chr X:156,919,927...156,929,825
Ensembl chr X:151,768,777...151,778,521
|
|
G |
Ireb2 |
iron responsive element binding protein 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of IREB2 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 8:55,228,080...55,311,613
Ensembl chr 8:55,228,085...55,311,611
|
|
G |
Irf9 |
interferon regulatory factor 9 |
increases expression |
ISO |
Fluorouracil results in increased expression of IRF9 mRNA |
CTD |
PMID:16101138 PMID:17039268 |
|
NCBI chr15:33,065,422...33,071,881
Ensembl chr15:29,095,789...29,101,236
|
|
G |
Irgm |
immunity-related GTPase M |
affects response to substance |
ISO |
IRGM1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:18371424 |
|
NCBI chr10:33,734,640...33,742,720
Ensembl chr10:33,233,455...33,241,578
|
|
G |
Isg15 |
ISG15 ubiquitin-like modifier |
increases expression |
ISO |
Fluorouracil results in increased expression of ISG15 mRNA |
CTD |
PMID:16101138 PMID:16557594 |
|
NCBI chr 5:172,066,369...172,067,656
Ensembl chr 5:166,784,148...166,785,435
|
|
G |
Isl1 |
ISL LIM homeobox 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ISL1 protein |
CTD |
PMID:21296659 |
|
NCBI chr 2:49,813,618...49,823,442
Ensembl chr 2:48,080,522...48,095,584
|
|
G |
Itgav |
integrin subunit alpha V |
affects response to substance |
ISO |
ITGAV protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 3:68,838,514...68,926,653
Ensembl chr 3:68,838,189...68,926,639
|
|
G |
Itgb2 |
integrin subunit beta 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ITGB2 |
CTD |
PMID:15485462 |
|
NCBI chr20:11,061,009...11,097,242
Ensembl chr20:11,061,430...11,097,600
|
|
G |
Itgb4 |
integrin subunit beta 4 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ITGB4 mRNA |
CTD |
PMID:15205334 |
|
NCBI chr10:101,705,592...101,741,933
Ensembl chr10:101,206,665...101,243,012
|
|
G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ITPR1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 4:142,743,401...143,066,505
Ensembl chr 4:141,187,418...141,510,491
|
|
G |
Itsn1 |
intersectin 1 |
affects response to substance |
ISO |
ITSN1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr11:30,978,590...31,160,645
Ensembl chr11:30,978,590...31,160,645
|
|
G |
Jag1 |
jagged canonical Notch ligand 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of JAG1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 3:144,859,453...144,894,883
Ensembl chr 3:124,406,794...124,442,209
|
|
G |
Jmjd4 |
jumonji domain containing 4 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of JMJD4 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr10:44,234,465...44,242,754
Ensembl chr10:44,234,549...44,240,065
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
affects expression increases expression |
ISO |
Fluorouracil affects the expression of JUN mRNA Fluorouracil results in increased expression of JUN mRNA |
CTD |
PMID:15205334 PMID:16557594 PMID:17355264 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
increases expression multiple interactions |
ISO |
Fluorouracil results in increased expression of JUNB mRNA JUNB results in decreased susceptibility to [Fluorouracil co-treated with Capecitabine] |
CTD |
PMID:16557594 PMID:18678097 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Kansl1 |
KAT8 regulatory NSL complex subunit 1 |
multiple interactions |
ISO |
KANSL1 protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] |
CTD |
PMID:18927307 |
|
NCBI chr10:89,737,637...89,868,620
Ensembl chr10:89,237,667...89,366,951
|
|
G |
Kcna5 |
potassium voltage-gated channel subfamily A member 5 |
increases response to substance |
ISO |
KCNA5 protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:17428690 |
|
NCBI chr 4:161,040,853...161,044,311
Ensembl chr 4:159,350,097...159,357,697
|
|
G |
Kcnq2 |
potassium voltage-gated channel subfamily Q member 2 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of KCNQ2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 3:168,194,776...168,253,831
Ensembl chr 3:168,195,357...168,275,071
|
|
G |
Kctd12 |
potassium channel tetramerization domain containing 12 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of KCTD12 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr15:79,800,078...79,806,017
Ensembl chr15:79,801,191...79,806,282
|
|
G |
Kdm4b |
lysine demethylase 4B |
multiple interactions affects expression |
ISO |
KDM4B mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] Fluorouracil affects the expression of KDM4B mRNA |
CTD |
PMID:16896004 PMID:20421339 |
|
NCBI chr 9:1,158,737...1,237,233
Ensembl chr 9:1,158,752...1,236,543
|
|
G |
Kdm5a |
lysine demethylase 5A |
decreases expression |
ISO |
Fluorouracil results in decreased expression of KDM5A mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 4:153,565,909...153,643,912
Ensembl chr 4:153,565,846...153,642,422
|
|
G |
Kdr |
kinase insert domain receptor |
increases expression |
ISO |
Fluorouracil results in increased expression of KDR mRNA |
CTD |
PMID:26272751 |
|
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
affects response to substance |
ISO |
KEAP1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:18692501 |
|
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Khk |
ketohexokinase |
affects response to substance increases expression |
ISO |
KHK protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of KHK protein |
CTD |
PMID:15352031 |
|
NCBI chr 6:31,165,246...31,175,779
Ensembl chr 6:25,445,300...25,455,717
|
|
G |
Kiaa0040 |
KIAA0040 ortholog |
increases expression |
ISO |
Fluorouracil results in increased expression of KIAA0040 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr13:72,274,519...72,312,103
Ensembl chr13:72,274,552...72,312,103
|
|
G |
Kif14 |
kinesin family member 14 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of KIF14 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr13:47,926,975...47,990,598
Ensembl chr13:47,927,044...47,989,164
|
|
G |
Kif15 |
kinesin family member 15 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of KIF15 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 8:122,601,888...122,672,750
Ensembl chr 8:122,601,897...122,672,750
|
|
G |
Kif23 |
kinesin family member 23 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of KIF23 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 8:62,397,908...62,425,162
Ensembl chr 8:62,397,948...62,425,072
|
|
G |
Kif26b |
kinesin family member 26B |
decreases expression |
ISO |
Fluorouracil results in decreased expression of KIF26B mRNA |
CTD |
PMID:34151400 |
|
NCBI chr13:90,282,821...90,689,058
Ensembl chr13:90,283,404...90,682,811
|
|
G |
Kif2c |
kinesin family member 2C |
affects response to substance |
ISO |
KIF2C protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 5:130,637,347...130,662,680
Ensembl chr 5:130,637,347...130,662,637
|
|
G |
Kif3a |
kinesin family member 3a |
multiple interactions |
ISO |
KIF3A mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr10:38,226,388...38,263,062
Ensembl chr10:37,725,970...37,759,191
|
|
G |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
affects response to substance decreases expression |
ISO |
KIT protein mutant form affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of KIT protein |
CTD |
PMID:19100679 PMID:21296659 |
|
NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,548,877...32,624,652
|
|
G |
Kitlg |
KIT ligand |
increases expression |
ISO |
Fluorouracil results in increased expression of KITLG mRNA |
CTD |
PMID:19098008 |
|
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
|
|
G |
Klf4 |
KLF transcription factor 4 |
increases expression decreases response to substance |
ISO |
Fluorouracil results in increased expression of KLF4 mRNA KLF4 results in decreased susceptibility to Fluorouracil |
CTD |
PMID:16557594 PMID:17039268 PMID:21833590 |
|
NCBI chr 5:75,074,107...75,079,182
Ensembl chr 5:70,278,972...70,283,602
|
|
G |
Klf5 |
KLF transcription factor 5 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of KLF5 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr15:76,060,320...76,079,445
Ensembl chr15:76,064,258...76,079,445
|
|
G |
Klf6 |
KLF transcription factor 6 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of KLF6 mRNA |
CTD |
PMID:15205334 |
|
NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
|
|
G |
Klhl24 |
kelch-like family member 24 |
increases expression |
ISO |
Fluorouracil results in increased expression of KLHL24 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr11:80,843,621...80,877,649
Ensembl chr11:80,846,755...80,877,636
|
|
G |
Klhl7 |
kelch-like family member 7 |
affects response to substance |
ISO |
KLHL7 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 4:11,006,366...11,055,399
Ensembl chr 4:11,006,375...11,055,541
|
|
G |
Klhl9 |
kelch-like family member 9 |
affects response to substance |
ISO |
KLHL9 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 5:103,333,747...103,337,931
|
|
G |
Klk15 |
kallikrein-related peptidase 15 |
affects expression |
ISO |
Fluorouracil affects the expression of KLK15 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 1:94,699,422...94,706,626
Ensembl chr 1:94,703,158...94,706,329 Ensembl chr 1:94,703,158...94,706,329
|
|
G |
Klk6 |
kallikrein related-peptidase 6 |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of KLK6 protein KLK6 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 1:103,415,411...103,422,682
Ensembl chr 1:94,280,340...94,286,121
|
|
G |
Kmt2e |
lysine methyltransferase 2E |
affects response to substance |
ISO |
KMT2E protein affects the susceptibility to Fluorouracil |
CTD |
PMID:18818388 |
|
NCBI chr 4:12,550,570...12,655,329
Ensembl chr 4:11,658,979...11,727,373
|
|
G |
Kng1 |
kininogen 1 |
multiple interactions |
ISO |
[Fluorouracil co-treated with Irinotecan] results in decreased expression of KNG1 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr11:91,317,354...91,340,148
Ensembl chr11:77,812,752...77,835,555
|
|
G |
Kpna2 |
karyopherin subunit alpha 2 |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of KPNA2 mRNA TP53 protein affects the reaction [Fluorouracil results in decreased expression of KPNA2 mRNA] |
CTD |
PMID:15016801 PMID:17374387 |
|
NCBI chr10:92,433,678...92,445,841
Ensembl chr10:91,933,951...91,946,150
|
|
G |
Kpna3 |
karyopherin subunit alpha 3 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of KPNA3 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr15:35,536,310...35,610,066
Ensembl chr15:35,536,316...35,610,419
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
decreases expression increases expression |
ISO |
Fluorouracil results in decreased expression of KRAS protein Fluorouracil results in increased expression of KRAS mRNA mutant form |
CTD |
PMID:15585135 PMID:16803524 PMID:38423379 |
|
NCBI chr 4:179,916,255...179,949,613
|
|
G |
Krt1 |
keratin 1 |
affects expression |
ISO |
Fluorouracil affects the expression of KRT1 protein |
CTD |
PMID:21296659 |
|
NCBI chr 7:132,976,618...132,981,844
Ensembl chr 7:132,976,620...132,981,844
|
|
G |
Krt16 |
keratin 16 |
increases expression |
ISO |
Fluorouracil results in increased expression of KRT16 mRNA |
CTD |
PMID:19528421 |
|
NCBI chr10:85,168,357...85,171,816
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Krt17 |
keratin 17 |
affects expression |
ISO |
Fluorouracil affects the expression of KRT17 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr10:85,178,673...85,183,392
Ensembl chr10:85,178,675...85,183,392
|
|
G |
Krt18 |
keratin 18 |
multiple interactions affects expression |
ISO |
[Fluorouracil co-treated with irinotecan co-treated with vorinostat] results in increased cleavage of KRT18 protein Fluorouracil affects the expression of KRT18 mRNA |
CTD |
PMID:15754201 PMID:34151400 |
|
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166 Ensembl chr10:133,157,475...133,161,166
|
|
G |
Krt5 |
keratin 5 |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of KRT5 protein KRT5 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 7:132,846,132...132,851,861
Ensembl chr 7:132,846,136...132,851,850
|
|
G |
Krt86 |
keratin 86 |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of KRT86 protein KRT86 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 7:132,591,489...132,598,142
Ensembl chr 7:132,591,545...132,598,021
|
|
G |
L1cam |
L1 cell adhesion molecule |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of L1CAM protein L1CAM protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr X:156,748,597...156,775,116
Ensembl chr X:151,597,277...151,623,857
|
|
G |
L1td1 |
LINE-1 type transposase domain containing 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of L1TD1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 5:113,373,193...113,386,088
Ensembl chr 5:113,379,870...113,385,730
|
|
G |
Lama1 |
laminin subunit alpha 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of LAMA1 protein |
CTD |
PMID:21296659 |
|
NCBI chr 9:115,139,548...115,263,620
Ensembl chr 9:107,692,770...107,817,478
|
|
G |
Lamb1 |
laminin subunit beta 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of LAMB1 protein |
CTD |
PMID:21296659 |
|
NCBI chr 6:47,835,492...47,902,585
Ensembl chr 6:47,835,525...47,902,585
|
|
G |
Lamc1 |
laminin subunit gamma 1 |
affects response to substance decreases expression |
ISO |
LAMC1 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of LAMC1 protein |
CTD |
PMID:16217747 PMID:21296659 |
|
NCBI chr13:67,924,872...68,051,986
Ensembl chr13:65,374,372...65,501,492
|
|
G |
Larp4b |
La ribonucleoprotein 4B |
affects response to substance |
ISO |
LARP4B protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr17:61,138,663...61,217,423
Ensembl chr17:61,138,709...61,187,960
|
|
G |
Lasp1 |
LIM and SH3 protein 1 |
affects response to substance |
ISO |
LASP1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:83,290,820...83,331,989
Ensembl chr10:82,795,137...82,943,292
|
|
G |
Lcmt2 |
leucine carboxyl methyltransferase 2 |
multiple interactions increases response to substance |
ISO |
LCMT2 results in increased susceptibility to [pyrrolidine dithiocarbamic acid co-treated with Fluorouracil] LCMT2 results in increased susceptibility to Fluorouracil |
CTD |
PMID:9359698 |
|
NCBI chr 3:108,099,960...108,102,084
Ensembl chr 3:108,099,961...108,102,084
|
|
G |
Ldha |
lactate dehydrogenase A |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of LDHA mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
|
|
G |
Ldhb |
lactate dehydrogenase B |
affects response to substance |
ISO |
LDHB protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 4:175,428,382...175,446,403
Ensembl chr 4:175,428,385...175,446,403
|
|
G |
Lefty1 |
left right determination factor 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of LEFTY1 protein |
CTD |
PMID:21296659 |
|
NCBI chr13:92,649,226...92,659,722
Ensembl chr13:92,656,323...92,659,720
|
|
G |
Lgals3 |
galectin 3 |
affects response to substance decreases response to substance multiple interactions |
ISO EXP |
LGALS3 protein affects the susceptibility to Fluorouracil LGALS3 protein mutant form results in decreased susceptibility to Fluorouracil 5-fluorouracil inhibits the reaction [N-methyl-N-nitrosourea increases expression of Lgals3 protein in serum] |
CTD RGD |
PMID:16217747 PMID:21750908 PMID:28032729 |
RGD:150530464 |
NCBI chr15:23,099,795...23,111,731
Ensembl chr15:20,607,692...20,632,025
|
|
G |
Lgals3bp |
galectin 3 binding protein |
affects response to substance |
ISO |
LGALS3BP protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:103,619,912...103,629,251
Ensembl chr10:103,619,908...103,629,256
|
|
G |
Lgals7 |
galectin 7 |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of LGALS7 protein LGALS7 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 1:93,275,092...93,279,529
Ensembl chr 1:84,150,252...84,152,015
|
|
G |
Lgals8 |
galectin 8 |
multiple interactions |
ISO |
LGALS8 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] |
CTD |
PMID:17327601 |
|
NCBI chr17:62,716,368...62,744,272
Ensembl chr17:58,028,105...58,052,764
|
|
G |
Lgr4 |
leucine-rich repeat-containing G protein-coupled receptor 4 |
affects expression |
ISO |
Fluorouracil affects the expression of LGR4 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr 3:96,447,385...96,550,006
Ensembl chr 3:96,447,858...96,548,899
|
|
G |
Lgr5 |
leucine rich repeat containing G protein coupled receptor 5 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of LGR5 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 7:51,087,059...51,221,882
Ensembl chr 7:51,088,239...51,222,446
|
|
G |
Lhx1 |
LIM homeobox 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of LHX1 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr10:69,396,829...69,403,617
Ensembl chr10:69,396,829...69,403,617
|
|
G |
Lifr |
LIF receptor subunit alpha |
decreases expression |
ISO |
Fluorouracil results in decreased expression of LIFR protein |
CTD |
PMID:21296659 |
|
NCBI chr 2:57,951,787...58,020,357
Ensembl chr 2:56,250,120...56,286,699
|
|
G |
Lig1 |
DNA ligase 1 |
affects response to substance |
ISO |
LIG1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 1:74,165,688...74,204,400
Ensembl chr 1:74,165,842...74,204,413
|
|
G |
Limk1 |
LIM domain kinase 1 |
affects expression |
ISO |
Fluorouracil affects the expression of LIMK1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr12:22,026,697...22,060,605
Ensembl chr12:22,026,672...22,060,606
|
|
G |
Limk2 |
LIM domain kinase 2 |
affects response to substance |
ISO |
LIMK2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr14:78,208,182...78,286,106
Ensembl chr14:78,218,063...78,286,007
|
|
G |
Lin28a |
lin-28 homolog A |
increases expression |
ISO |
Fluorouracil results in increased expression of LIN28A protein |
CTD |
PMID:21296659 |
|
NCBI chr 5:146,227,119...146,244,122
Ensembl chr 5:146,227,119...146,244,122
|
|
G |
Liph |
lipase H |
decreases expression |
ISO |
Fluorouracil results in decreased expression of LIPH mRNA |
CTD |
PMID:16709241 |
|
NCBI chr11:79,032,229...79,081,625
Ensembl chr11:79,033,312...79,081,625
|
|
G |
Lmf1 |
lipase maturation factor 1 |
multiple interactions |
ISO |
[Fluorouracil co-treated with irinotecan] results in increased expression of LMF1 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr10:14,597,726...14,684,071
Ensembl chr10:14,597,594...14,684,119
|
|
G |
Lmna |
lamin A/C |
increases cleavage |
ISO |
Fluorouracil results in increased cleavage of LMNA protein |
CTD |
PMID:18497562 |
|
NCBI chr 2:176,237,564...176,265,301
Ensembl chr 2:173,939,751...173,960,423
|
|
G |
Lmnb1 |
lamin B1 |
affects response to substance decreases expression |
ISO |
LMNB1 affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of LMNB1 mRNA |
CTD |
PMID:15067352 PMID:34151400 |
|
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
|
|
G |
Lmnb2 |
lamin B2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of LMNB2 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 7:8,792,628...8,808,665
Ensembl chr 7:8,789,314...8,808,665
|
|
G |
Lpar6 |
lysophosphatidic acid receptor 6 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of LPAR6 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr15:48,416,548...48,418,357
Ensembl chr15:48,416,544...48,422,331
|
|
G |
Lpo |
lactoperoxidase |
decreases expression |
ISO |
Fluorouracil results in decreased expression of LPO mRNA |
CTD |
PMID:34748853 |
|
NCBI chr10:73,104,170...73,124,683
Ensembl chr10:72,606,944...72,626,535
|
|
G |
Lpxn |
leupaxin |
affects response to substance |
ISO |
LPXN protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 1:209,928,297...209,963,085
Ensembl chr 1:209,929,202...209,963,084
|
|
G |
Lratd1 |
LRAT domain containing 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of LRATD1 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 6:36,916,969...36,922,143
Ensembl chr 6:36,913,469...36,922,319
|
|
G |
Lrba |
LPS responsive beige-like anchor protein |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of LRBA mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 2:173,919,330...174,500,536
Ensembl chr 2:171,621,507...172,202,724
|
|
G |
Lrp8 |
LDL receptor related protein 8 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of LRP8 mRNA |
CTD |
PMID:16101138 |
|
NCBI chr 5:122,563,468...122,635,434
Ensembl chr 5:122,563,453...122,631,352
|
|
G |
Lss |
lanosterol synthase |
affects response to substance |
ISO |
LSS protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr20:12,090,641...12,118,230
Ensembl chr20:12,092,774...12,118,762
|
|
G |
Lxn |
latexin |
affects response to substance |
ISO |
LXN protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 2:151,727,556...151,733,426
Ensembl chr 2:151,727,102...151,733,460
|
|
G |
Ly6g6c |
lymphocyte antigen 6 family member G6C |
affects response to substance |
ISO |
LY6G6C protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr20:3,753,632...3,757,205
Ensembl chr20:3,753,632...3,758,867
|
|
G |
Ly6g6d |
lymphocyte antigen 6 family member G6D |
affects response to substance |
ISO |
LY6G6D protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr20:3,741,973...3,752,378
Ensembl chr20:3,737,459...3,752,248
|
|
G |
Lypla1 |
lysophospholipase 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of LYPLA1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 5:19,477,408...19,506,568
Ensembl chr 5:14,679,606...14,708,746
|
|
G |
M6pr |
mannose-6-phosphate receptor, cation dependent |
increases expression |
ISO |
Fluorouracil results in increased expression of M6PR protein |
CTD |
PMID:15585135 |
|
NCBI chr 4:155,501,080...155,510,219
Ensembl chr 4:155,500,921...155,510,216
|
|
G |
Macf1 |
microtubule-actin crosslinking factor 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of MACF1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 5:135,623,734...135,949,097
Ensembl chr 5:135,623,742...135,945,905
|
|
G |
Mad2l1 |
mitotic arrest deficient 2 like 1 |
affects expression decreases expression |
ISO |
Fluorouracil affects the expression of MAD2L1 mRNA Fluorouracil results in decreased expression of MAD2L1 mRNA |
CTD |
PMID:16557594 PMID:17039268 PMID:19272435 |
|
NCBI chr 4:95,906,692...95,918,885
Ensembl chr 4:95,906,817...95,913,470
|
|
G |
Mad2l2 |
mitotic arrest deficient 2 like 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of MAD2L2 protein |
CTD |
PMID:16803524 |
|
NCBI chr 5:158,563,545...158,576,698
Ensembl chr 5:158,563,567...158,576,693
|
|
G |
Madd |
MAP-kinase activating death domain |
affects expression |
ISO |
Fluorouracil affects the expression of MADD mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 3:97,570,141...97,613,688
Ensembl chr 3:77,114,314...77,157,701
|
|
G |
Maf |
MAF bZIP transcription factor |
increases expression |
ISO |
Fluorouracil results in increased expression of MAF mRNA |
CTD |
PMID:16557594 |
|
NCBI chr19:43,353,867...43,713,162
Ensembl chr19:43,360,342...43,712,365
|
|
G |
Maff |
MAF bZIP transcription factor F |
affects response to substance |
ISO |
MAFF protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:110,912,499...110,923,851
|
|
G |
Mageb2 |
MAGE family member B2 |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of MAGEB2 protein MAGEB2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr X:50,827,538...50,833,272
Ensembl chr X:50,827,563...50,833,151
|
|
G |
Maged1 |
MAGE family member D1 |
affects response to substance |
ISO |
MAGED1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 PMID:16217747 |
|
NCBI chr X:59,422,715...59,429,381
Ensembl chr X:59,422,717...59,429,364
|
|
G |
Malt1 |
MALT1 paracaspase |
increases expression affects response to substance |
ISO |
Fluorouracil results in increased expression of MALT1 mRNA MALT1 affects the susceptibility to Fluorouracil |
CTD |
PMID:15067352 PMID:15109396 |
|
NCBI chr18:61,212,290...61,266,272
Ensembl chr18:58,942,299...58,994,260
|
|
G |
Mamdc2 |
MAM domain containing 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of MAMDC2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 1:220,863,959...221,016,493
Ensembl chr 1:220,863,976...221,016,354
|
|
G |
Maml2 |
mastermind-like transcriptional coactivator 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of MAML2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 8:18,552,480...18,869,923
Ensembl chr 8:10,268,665...10,587,107
|
|
G |
Man1a1 |
mannosidase, alpha, class 1A, member 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of MAN1A1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr20:33,202,509...33,385,747
Ensembl chr20:33,202,517...33,385,824
|
|
G |
Manea |
mannosidase, endo-alpha |
affects expression |
ISO |
Fluorouracil affects the expression of MANEA mRNA |
CTD |
PMID:20421339 |
|
NCBI chr 5:40,196,373...40,218,540
Ensembl chr 5:40,196,396...40,218,459
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
affects response to substance |
ISO |
MAP1LC3B protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
|
|
G |
Map2 |
microtubule-associated protein 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of MAP2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 9:75,173,038...75,431,606
Ensembl chr 9:67,723,371...67,979,809
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
multiple interactions |
ISO |
[U 0126 results in decreased activity of MAP2K1 protein] results in increased susceptibility to [Fluorouracil co-treated with Cisplatin]; MAP2K1 protein results in decreased susceptibility to [Cisplatin co-treated with Fluorouracil] |
CTD |
PMID:21444628 |
|
NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
multiple interactions |
ISO |
[U 0126 results in decreased activity of MAP2K2 protein] results in increased susceptibility to [Fluorouracil co-treated with Cisplatin]; MAP2K2 protein results in decreased susceptibility to [Cisplatin co-treated with Fluorouracil] |
CTD |
PMID:21444628 |
|
NCBI chr 7:9,241,449...9,264,216
Ensembl chr 7:8,580,905...8,610,243
|
|
G |
Map2k7 |
mitogen activated protein kinase kinase 7 |
decreases expression |
ISO |
5-fluorouracil decreases expression of MAP2K7 protein in tongue squamous carcinoma cells |
RGD |
PMID:34411913 |
RGD:155630595 |
NCBI chr12:7,389,032...7,398,377
Ensembl chr12:2,591,219...2,604,222
|
|
G |
Map3k1 |
mitogen-activated protein kinase kinase kinase 1 |
affects expression |
ISO |
Fluorouracil affects the expression of MAP3K1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 2:45,081,889...45,150,555
Ensembl chr 2:43,350,098...43,414,463
|
|
G |
Map3k20 |
mitogen-activated protein kinase kinase kinase 20 |
affects expression |
ISO |
Fluorouracil affects the expression of MAP3K20 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 3:57,130,539...57,289,943
Ensembl chr 3:57,130,551...57,289,626
|
|
G |
Map4k5 |
mitogen-activated protein kinase kinase kinase kinase 5 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of MAP4K5 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 6:88,284,087...88,377,118
Ensembl chr 6:88,284,094...88,376,799
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases phosphorylation decreases phosphorylation |
ISO |
Fluorouracil inhibits the reaction [Cisplatin results in increased phosphorylation of MAPK1 protein]; Fluorouracil results in decreased expression of and results in decreased phosphorylation of MAPK1 protein; Nicotine inhibits the reaction [Fluorouracil results in increased phosphorylation of MAPK1 protein] Fluorouracil results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:21444628 PMID:24095863 PMID:37625625 PMID:39334374 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk13 |
mitogen activated protein kinase 13 |
increases expression |
ISO |
Fluorouracil results in increased expression of MAPK13 protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr20:6,836,979...6,847,197
Ensembl chr20:6,835,320...6,844,222
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation decreases phosphorylation |
ISO |
Fluorouracil inhibits the reaction [Cisplatin results in increased phosphorylation of MAPK3 protein]; Fluorouracil results in decreased expression of and results in decreased phosphorylation of MAPK3 protein; Nicotine inhibits the reaction [Fluorouracil results in increased phosphorylation of MAPK3 protein] Fluorouracil results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:21444628 PMID:24095863 PMID:37625625 PMID:39334374 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk7 |
mitogen-activated protein kinase 7 |
multiple interactions decreases response to substance |
ISO |
[BIX 02188 results in decreased activity of MAPK7] which results in increased susceptibility to Fluorouracil MAPK7 results in decreased susceptibility to Fluorouracil |
CTD |
PMID:22008504 |
|
NCBI chr10:46,170,264...46,176,262
Ensembl chr10:46,170,167...46,176,267
|
|
G |
Mapkap1 |
MAPK associated protein 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of MAPKAP1 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 3:17,715,813...17,918,387
Ensembl chr 3:17,715,834...17,918,384
|
|
G |
Mapt |
microtubule-associated protein tau |
multiple interactions |
ISO |
MAPT mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Marcks |
myristoylated alanine rich protein kinase C substrate |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of MARCKS mRNA MARCKS protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 PMID:17039268 |
|
NCBI chr20:42,240,185...42,245,882
Ensembl chr20:40,685,315...40,691,012
|
|
G |
Mars1 |
methionyl-tRNA synthetase 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of MARS1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 7:65,006,456...65,023,880
Ensembl chr 7:63,121,142...63,138,495
|
|
G |
Mast4 |
microtubule associated serine/threonine kinase family member 4 |
increases expression |
ISO |
Fluorouracil results in increased expression of MAST4 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 2:33,893,241...34,483,682
Ensembl chr 2:33,894,436...34,483,723
|
|
G |
Mbd4 |
methyl-CpG binding domain 4 DNA glycosylase |
increases metabolic processing |
ISO |
MBD4 protein results in increased metabolism of Fluorouracil |
CTD |
PMID:16885370 |
|
NCBI chr 4:150,565,646...150,577,433
Ensembl chr 4:148,894,280...148,904,982
|
|
G |
Mbnl1 |
muscleblind-like splicing regulator 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of MBNL1 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 2:146,789,570...146,964,136
Ensembl chr 2:144,670,285...144,814,368
|
|
G |
Mbp |
myelin basic protein |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of MBP mRNA; Fluorouracil results in decreased expression of MBP protein [HDAC1 protein co-treated with HDAC2 protein] promotes the reaction [TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of MBP mRNA]]; TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of MBP mRNA] |
CTD |
PMID:25178657 |
|
NCBI chr18:78,130,652...78,241,174
Ensembl chr18:75,855,878...75,966,404
|
|
G |
Mccc2 |
methylcrotonyl-CoA carboxylase subunit 2 |
multiple interactions |
ISO |
MCCC2 protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] |
CTD |
PMID:18927307 |
|
NCBI chr 2:33,039,044...33,110,092
Ensembl chr 2:31,304,932...31,375,972
|
|
G |
Mcf2 |
MCF.2 cell line derived transforming sequence |
increases expression |
ISO |
Fluorouracil results in increased expression of MCF2 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr X:138,414,077...138,514,828
Ensembl chr X:138,409,256...138,514,446
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
affects expression decreases response to substance multiple interactions decreases expression |
ISO |
Fluorouracil affects the expression of MCL1 protein MCL1 protein results in decreased susceptibility to Fluorouracil Apigenin promotes the reaction [Fluorouracil results in decreased expression of MCL1 mRNA]; Fluorouracil promotes the reaction [Apigenin results in decreased expression of MCL1 mRNA] |
CTD |
PMID:15262975 PMID:21036698 PMID:28025107 |
|
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
|
|
G |
Mcm10 |
minichromosome maintenance 10 replication initiation factor |
affects expression |
ISO |
Fluorouracil affects the expression of MCM10 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr17:73,263,788...73,288,346
Ensembl chr17:73,266,095...73,287,364
|
|
G |
Mcm2 |
minichromosome maintenance complex component 2 |
affects response to substance |
ISO |
MCM2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 4:121,346,434...121,360,962
Ensembl chr 4:121,346,434...121,360,847
|
|
G |
Mcm3 |
minichromosome maintenance complex component 3 |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of MCM3 mRNA TP53 protein affects the reaction [Fluorouracil results in decreased expression of MCM3 mRNA] |
CTD |
PMID:15016801 PMID:16709241 |
|
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314
|
|
G |
Mcm4 |
minichromosome maintenance complex component 4 |
affects expression |
ISO |
Fluorouracil affects the expression of MCM4 mRNA |
CTD |
PMID:15205334 |
|
NCBI chr11:85,258,443...85,272,144
Ensembl chr11:85,258,443...85,272,144
|
|
G |
Mcm6 |
minichromosome maintenance complex component 6 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of MCM6 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr13:39,826,745...39,851,937
Ensembl chr13:39,826,763...39,851,960
|
|
G |
Mcm7 |
minichromosome maintenance complex component 7 |
affects response to substance multiple interactions |
ISO |
MCM7 protein affects the susceptibility to Fluorouracil TP53 protein affects the reaction [Fluorouracil results in decreased expression of MCM7 mRNA] |
CTD |
PMID:15016801 PMID:15548681 |
|
NCBI chr12:17,042,207...17,049,470
Ensembl chr12:17,042,212...17,050,063
|
|
G |
Mcmbp |
minichromosome maintenance complex binding protein |
increases expression |
ISO |
Fluorouracil results in increased expression of MCMBP mRNA |
CTD |
PMID:17039268 |
|
NCBI chr 1:183,270,598...183,316,975
Ensembl chr 1:183,271,980...183,316,975
|
|
G |
Mdfi |
MyoD family inhibitor |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of MDFI protein MDFI protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 9:13,156,806...13,175,218
Ensembl chr 9:13,156,866...13,175,217
|
|
G |
Mdfic |
MyoD family inhibitor domain containing |
affects expression |
ISO |
Fluorouracil affects the expression of MDFIC mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 4:43,972,310...44,052,162
Ensembl chr 4:43,972,507...44,052,161
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
multiple interactions increases expression increases phosphorylation |
ISO |
Cadmium Chloride affects the reaction [Fluorouracil results in increased phosphorylation of MDM2 protein]; Fluorouracil promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of MDM2 protein]; TP53 protein promotes the reaction [Fluorouracil promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of MDM2 protein]]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of MDM2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of MDM2 protein] Fluorouracil results in increased expression of MDM2 mRNA; Fluorouracil results in increased expression of MDM2 protein; Fluorouracil results in increased expression of MDM2 protein modified form |
CTD |
PMID:14665630 PMID:15546879 PMID:16557594 PMID:16949053 PMID:17982676 PMID:18096571 PMID:19098008 PMID:22525470 PMID:25744307 PMID:28785074 PMID:30177839 More...
|
|
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Mdm4 |
MDM4 regulator of p53 |
multiple interactions |
ISO |
MDM4 results in decreased susceptibility to [Fluorouracil co-treated with Capecitabine] |
CTD |
PMID:18678097 |
|
NCBI chr13:44,432,596...44,516,165
Ensembl chr13:44,406,213...44,474,226
|
|
G |
Med13l |
mediator complex subunit 13L |
multiple interactions |
ISO |
MED13L mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr12:37,807,596...38,004,886
Ensembl chr12:37,808,285...38,004,473
|
|
G |
Mef2b |
myocyte enhancer factor 2B |
affects expression |
ISO |
Fluorouracil affects the expression of MEF2B mRNA |
CTD |
PMID:16584549 |
|
NCBI chr16:19,253,008...19,269,514
Ensembl chr16:19,253,010...19,268,967
|
|
G |
Melk |
maternal embryonic leucine zipper kinase |
affects response to substance multiple interactions |
ISO |
MELK protein affects the susceptibility to Fluorouracil MELK mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:15548681 PMID:16896004 |
|
NCBI chr 5:63,336,151...63,396,254
Ensembl chr 5:58,540,449...58,600,937
|
|
G |
Meox1 |
mesenchyme homeobox 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of MEOX1 mRNA |
CTD |
PMID:31711903 |
|
NCBI chr10:87,318,668...87,338,169
Ensembl chr10:86,818,478...86,837,660
|
|
G |
Mesp1 |
mesoderm posterior bHLH transcription factor 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of MESP1 mRNA |
CTD |
PMID:26272751 |
|
NCBI chr 1:143,147,671...143,149,189
Ensembl chr 1:133,738,357...133,739,875
|
|
G |
Mesp2 |
mesoderm posterior bHLH transcription factor 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of MESP2 mRNA |
CTD |
PMID:31711903 |
|
NCBI chr 1:133,756,601...133,759,207
Ensembl chr 1:133,756,601...133,759,198
|
|
G |
Metap2 |
methionyl aminopeptidase 2 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of METAP2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 7:28,412,429...28,440,458
Ensembl chr 7:28,411,608...28,440,434
|
|
G |
Metrn |
meteorin, glial cell differentiation regulator |
multiple interactions |
ISO |
METRN mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr10:14,816,684...14,818,702
Ensembl chr10:14,816,572...14,818,701
|
|
G |
Mfn1 |
mitofusin 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of MFN1 protein |
CTD |
PMID:30518710 |
|
NCBI chr 2:115,313,380...115,359,651
Ensembl chr 2:115,313,401...115,359,640
|
|
G |
Mfn2 |
mitofusin 2 |
affects expression increases expression |
ISO |
Fluorouracil affects the expression of MFN2 mRNA Fluorouracil results in increased expression of MFN2 protein |
CTD |
PMID:16584549 PMID:30518710 |
|
NCBI chr 5:163,587,463...163,617,363
Ensembl chr 5:158,304,287...158,335,342
|
|
G |
Mgat2 |
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase |
affects response to substance |
ISO |
MGAT2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 6:87,656,360...87,658,849
Ensembl chr 6:87,656,349...87,658,177
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
decreases expression decreases response to substance multiple interactions |
ISO |
Fluorouracil results in decreased expression of MGMT mRNA; Fluorouracil results in decreased expression of MGMT protein MGMT protein results in decreased susceptibility to Fluorouracil O(6)-benzylguanine inhibits the reaction [MGMT protein results in decreased susceptibility to Fluorouracil] |
CTD |
PMID:17487405 PMID:24737281 |
|
NCBI chr 1:201,140,832...201,367,481
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Micb |
MHC class I polypeptide-related sequence B |
affects response to substance |
ISO |
MICB protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:78,495,779...78,513,030
Ensembl chr 1:78,495,779...78,512,827
|
|
G |
Mill1 |
MHC I like leukocyte 1 |
affects response to substance |
ISO |
MICA protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:78,372,798...78,398,932
Ensembl chr 1:78,372,802...78,398,930
|
|
G |
Mir532 |
microRNA 532 |
multiple interactions |
ISO |
[Melatonin results in increased expression of MIR532] which results in increased susceptibility to Fluorouracil |
CTD |
PMID:37755321 |
|
NCBI chr X:17,919,185...17,919,263
Ensembl chr X:15,247,315...15,247,393
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
affects response to substance decreases expression affects expression |
ISO |
MKI67 mRNA affects the susceptibility to Fluorouracil; MKI67 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of MKI67; Fluorouracil results in decreased expression of MKI67 mRNA Fluorouracil results in decreased expression of MKI67 protein Fluorouracil affects the expression of MKI67 protein |
CTD |
PMID:11300326 PMID:15205334 PMID:15548681 PMID:16709241 PMID:18286688 PMID:21594360 PMID:36203040 More...
|
|
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mkx |
mohawk homeobox |
decreases expression |
ISO |
Fluorouracil results in decreased expression of MKX mRNA |
CTD |
PMID:16510598 |
|
NCBI chr17:59,772,113...59,851,160
Ensembl chr17:55,077,540...55,156,124
|
|
G |
Mlf1 |
myeloid leukemia factor 1 |
affects expression |
ISO |
Fluorouracil affects the expression of MLF1 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr 2:151,648,492...151,681,654
Ensembl chr 2:151,648,511...151,681,652
|
|
G |
Mlh1 |
mutL homolog 1 |
affects response to substance increases response to substance |
ISO |
MLH1 mRNA affects the susceptibility to Fluorouracil; MLH1 protein affects the susceptibility to Fluorouracil MLH1 protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:17914563 PMID:18497967 PMID:18949393 |
|
NCBI chr 8:120,074,871...120,112,109
Ensembl chr 8:111,196,468...111,233,617
|
|
G |
Mllt11 |
MLLT11, transcription factor 7 cofactor |
affects response to substance |
ISO |
MLLT11 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 2:182,795,790...182,804,960
Ensembl chr 2:182,795,790...182,797,199
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
multiple interactions increases expression |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of MMP1 mRNA] Fluorouracil results in increased expression of MMP1 mRNA |
CTD |
PMID:15016801 PMID:19528421 |
|
NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions decreases activity |
ISO |
MMP2 results in decreased susceptibility to [Fluorouracil co-treated with Capecitabine] Fluorouracil promotes the reaction [Valsartan results in decreased activity of MMP2 protein]; Valsartan promotes the reaction [Fluorouracil results in decreased activity of MMP2 protein] |
CTD |
PMID:18678097 PMID:35235860 |
|
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
multiple interactions |
ISO |
MMP3 promoter polymorphism affects the susceptibility to [Fluorouracil co-treated with Cisplatin] |
CTD |
PMID:15102660 |
|
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
affects expression increases expression multiple interactions |
ISO |
Fluorouracil affects the expression of MMP9 mRNA Fluorouracil results in increased expression of MMP9 protein Fluorouracil promotes the reaction [Valsartan results in decreased activity of MMP9 protein] |
CTD |
PMID:15205334 PMID:26310874 PMID:35235860 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mms19 |
MMS19 homolog, cytosolic iron-sulfur assembly component |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of MMS19 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:240,757,279...240,794,291
Ensembl chr 1:240,757,282...240,794,288
|
|
G |
Mnx1 |
motor neuron and pancreas homeobox 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of MNX1 protein |
CTD |
PMID:21296659 |
|
NCBI chr 4:6,541,645...6,546,604
Ensembl chr 4:5,866,506...5,871,465
|
|
G |
Morf4l2 |
mortality factor 4 like 2 |
decreases response to substance |
ISO |
MORF4L2 mRNA results in decreased susceptibility to Fluorouracil |
CTD |
PMID:18593893 |
|
NCBI chr X:100,082,562...100,093,658
Ensembl chr X:100,082,404...100,093,728
|
|
G |
Mpc2 |
mitochondrial pyruvate carrier 2 |
affects response to substance |
ISO |
MPC2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr13:80,261,143...80,280,668
Ensembl chr13:77,728,250...77,747,664
|
|
G |
Mpig6b |
megakaryocyte and platelet inhibitory receptor G6b |
affects response to substance |
ISO |
MPIG6B protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr20:3,757,396...3,761,024
Ensembl chr20:3,757,536...3,760,735
|
|
G |
Mpo |
myeloperoxidase |
increases activity multiple interactions increases expression |
EXP |
Fluorouracil results in increased activity of MPO protein Ascorbic Acid inhibits the reaction [Fluorouracil results in increased activity of MPO protein]; Silybin inhibits the reaction [Fluorouracil results in increased expression of MPO protein] |
CTD |
PMID:26921358 PMID:37335224 |
|
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mpp7 |
MAGUK p55 scaffold protein 7 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of MPP7 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr17:55,439,939...55,706,810
Ensembl chr17:55,442,696...55,706,748
|
|
G |
Mprip |
myosin phosphatase Rho interacting protein |
affects response to substance |
ISO |
MPRIP protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:44,453,949...44,573,843
Ensembl chr10:44,453,929...44,569,118
|
|
G |
Mr1 |
major histocompatibility complex, class I-related |
increases expression |
ISO |
Fluorouracil results in increased expression of MR1 mRNA |
CTD |
PMID:16101138 |
|
NCBI chr13:67,298,362...67,317,985
Ensembl chr13:67,299,585...67,317,970
|
|
G |
Mras |
muscle RAS oncogene homolog |
affects expression |
ISO |
Fluorouracil affects the expression of MRAS mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 8:108,823,374...108,886,104
Ensembl chr 8:99,944,036...99,996,408
|
|
G |
Msh2 |
mutS homolog 2 |
affects response to substance decreases expression |
ISO |
MSH2 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of MSH2 mRNA |
CTD |
PMID:16557594 PMID:16709241 PMID:18949393 |
|
NCBI chr 6:12,567,368...12,626,534
Ensembl chr 6:6,813,795...6,872,938
|
|
G |
Msx2 |
msh homeobox 2 |
affects response to substance decreases expression |
ISO |
MSX2 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of MSX2 protein |
CTD |
PMID:15352031 |
|
NCBI chr17:11,097,214...11,102,879
Ensembl chr17:11,097,103...11,102,879
|
|
G |
Mt-atp6 |
mitochondrially encoded ATP synthase membrane subunit 6 |
multiple interactions |
ISO |
[Fluorouracil co-treated with irinotecan] results in increased expression of ATP6 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr MT:7,919...8,599
Ensembl chr MT:7,919...8,599
|
|
G |
Mt1-ps3 |
metallothionein 1, pseudogene 3 |
increases expression affects response to substance |
ISO |
Fluorouracil results in increased expression of MT1E protein MT1E protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr17:74,786,652...74,787,040
Ensembl chr17:74,786,654...74,787,135
|
|
G |
Mt2 |
metallothionein 2 |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of MT2A protein [Fluorouracil co-treated with EGF protein] results in increased expression of MT2A mRNA; [Fluorouracil co-treated with IGF1 protein] results in increased expression of MT2A mRNA; [Fluorouracil co-treated with IL6 protein] results in increased expression of MT2A mRNA; [Fluorouracil co-treated with TGFB1 protein] results in increased expression of MT2A mRNA; EGF protein inhibits the reaction [Fluorouracil results in decreased expression of MT2A protein]; IGF1 protein inhibits the reaction [Fluorouracil results in decreased expression of MT2A protein]; IL6 protein inhibits the reaction [Fluorouracil results in decreased expression of MT2A protein]; MT2A protein affects the reaction [EGF protein inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]]; MT2A protein affects the reaction [EGF protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 protein]]; TGFB1 protein inhibits the reaction [Fluorouracil results in decreased expression of MT2A protein] |
CTD |
PMID:28507149 |
|
NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mtap |
methylthioadenosine phosphorylase |
decreases expression |
ISO |
Fluorouracil results in decreased expression of MTAP mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 5:108,990,270...109,036,494
Ensembl chr 5:103,873,020...103,939,406
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
multiple interactions affects response to substance increases metabolic processing increases response to substance |
ISO |
MTHFR gene polymorphism results in increased susceptibility to [Fluorouracil co-treated with Leucovorin] MTHFR gene polymorphism affects the susceptibility to Fluorouracil; MTHFR protein affects the susceptibility to Fluorouracil; MTHFR protein affects the susceptibility to Fluorouracil analog MTHFR protein results in increased metabolism of Fluorouracil MTHFR gene polymorphism results in increased susceptibility to Fluorouracil |
CTD |
PMID:15608557 PMID:15735113 PMID:16399440 PMID:16785472 PMID:17047490 PMID:18034621 PMID:18633250 PMID:19203896 More...
|
|
NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:158,465,296...158,483,797
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions decreases expression |
ISO |
rebamipide inhibits the reaction [Fluorouracil results in decreased expression of MTOR protein modified form] Fluorouracil results in decreased expression of MTOR mRNA; Fluorouracil results in decreased expression of MTOR protein modified form |
CTD |
PMID:29054700 PMID:34748853 |
|
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Mttp |
microsomal triglyceride transfer protein |
decreases expression |
ISO |
Fluorouracil results in decreased expression of MTTP mRNA |
CTD |
PMID:32535746 |
|
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
|
|
G |
Mtus1 |
microtubule associated scaffold protein 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of MTUS1 mRNA |
CTD |
PMID:19272435 |
|
NCBI chr16:57,905,991...58,051,466
Ensembl chr16:51,253,562...51,347,793
|
|
G |
Mvp |
major vault protein |
multiple interactions increases expression |
ISO |
[[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in increased expression of MVP mRNA; Fluorouracil promotes the reaction [YBX1 protein binds to MVP promoter] Fluorouracil results in increased expression of MVP mRNA; Fluorouracil results in increased expression of MVP protein |
CTD |
PMID:15750632 PMID:32800223 |
|
NCBI chr 1:191,025,259...191,052,866
Ensembl chr 1:181,594,734...181,622,380
|
|
G |
Mxi1 |
MAX interactor 1, dimerization protein |
affects response to substance |
ISO |
MXI1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:262,329,274...262,389,037
Ensembl chr 1:252,323,303...252,383,681
|
|
G |
Myb |
MYB proto-oncogene, transcription factor |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of MYB mRNA MYB protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15235111 PMID:15548681 PMID:16557594 |
|
NCBI chr 1:15,939,771...15,973,367
Ensembl chr 1:15,939,761...15,973,057
|
|
G |
Mybl2 |
MYB proto-oncogene like 2 |
increases expression affects response to substance |
ISO |
Fluorouracil results in increased expression of MYBL2 mRNA MYBL2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 PMID:16557594 |
|
NCBI chr 3:151,705,254...151,733,714
Ensembl chr 3:151,705,288...151,733,708
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases expression affects response to substance decreases response to substance multiple interactions increases expression affects expression |
ISO |
Fluorouracil results in decreased expression of MYC mRNA; Fluorouracil results in decreased expression of MYC protein MYC protein affects the susceptibility to Fluorouracil MYC protein results in decreased susceptibility to Fluorouracil [Cadmium Chloride co-treated with Fluorouracil] affects the expression of MYC protein; [Fluorouracil co-treated with Cadmium Chloride] affects the expression of MYC mRNA; TP53 protein promotes the reaction [Fluorouracil results in decreased expression of MYC mRNA] Fluorouracil results in increased expression of MYC protein Fluorouracil affects the expression of MYC mRNA |
CTD |
PMID:15585135 PMID:16557594 PMID:16709241 PMID:16803524 PMID:17628013 PMID:18802399 PMID:23941782 PMID:26272751 PMID:34151400 More...
|
|
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Mycl |
MYCL proto-oncogene, bHLH transcription factor |
decreases expression |
ISO |
Fluorouracil results in decreased expression of MYCL mRNA |
CTD |
PMID:19272435 |
|
NCBI chr 5:135,274,713...135,281,584
Ensembl chr 5:135,274,748...135,281,582
|
|
G |
Mycn |
MYCN proto-oncogene, bHLH transcription factor |
decreases expression |
ISO |
Fluorouracil results in decreased expression of MYCN mRNA |
CTD |
PMID:19272435 |
|
NCBI chr 6:35,717,764...35,723,590
Ensembl chr 6:35,717,764...35,723,590
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
increases expression multiple interactions |
EXP |
Fluorouracil results in increased expression of MYD88 protein Bosentan inhibits the reaction [Fluorouracil results in increased expression of MYD88 protein] |
CTD |
PMID:34800596 |
|
NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Myf5 |
myogenic factor 5 |
affects expression |
ISO |
Fluorouracil affects the expression of MYF5 protein |
CTD |
PMID:21296659 |
|
NCBI chr 7:44,689,407...44,692,638
Ensembl chr 7:42,802,946...42,806,177
|
|
G |
Myl4 |
myosin, light chain 4 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of MYL4 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr10:89,949,733...89,985,308
Ensembl chr10:89,449,443...89,485,363
|
|
G |
Myl9 |
myosin light chain 9 |
affects response to substance |
ISO |
MYL9 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 3:165,742,020...165,748,409
Ensembl chr 3:145,281,937...145,288,333
|
|
G |
Mylip |
myosin regulatory light chain interacting protein |
affects expression |
ISO |
Fluorouracil affects the expression of MYLIP mRNA |
CTD |
PMID:16584549 |
|
NCBI chr17:19,286,649...19,308,295
Ensembl chr17:19,286,650...19,308,295
|
|
G |
Myo1e |
myosin IE |
increases expression |
ISO |
Fluorouracil results in increased expression of MYO1E protein |
CTD |
PMID:15331170 |
|
NCBI chr 8:70,887,934...71,080,180
Ensembl chr 8:70,887,870...71,080,169
|
|
G |
Myo6 |
myosin VI |
affects response to substance |
ISO |
MYO6 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 8:89,967,351...90,122,219
Ensembl chr 8:81,087,139...81,239,292
|
|
G |
Myod1 |
myogenic differentiation 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of MYOD1 protein |
CTD |
PMID:21296659 |
|
NCBI chr 1:106,021,161...106,023,871
Ensembl chr 1:96,884,948...96,887,554
|
|
G |
Myof |
myoferlin |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of MYOF protein MYOF protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 1:235,673,666...235,822,413
Ensembl chr 1:235,673,666...235,822,334
|
|
G |
Naf1 |
nuclear assembly factor 1 ribonucleoprotein |
decreases expression |
ISO |
Fluorouracil results in decreased expression of NAF1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr16:22,837,583...22,868,320
Ensembl chr16:22,837,588...22,868,293
|
|
G |
Naip6 |
NLR family, apoptosis inhibitory protein 6 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of NAIP mRNA |
CTD |
PMID:16101138 |
|
NCBI chr 2:31,507,423...31,559,098
Ensembl chr 2:31,507,424...31,570,542
|
|
G |
Nanog |
Nanog homeobox |
affects expression decreases expression |
ISO |
Fluorouracil affects the expression of NANOG protein Fluorouracil results in decreased expression of NANOG mRNA |
CTD |
PMID:21296659 PMID:24737281 |
|
NCBI chr 4:155,943,737...155,951,116
Ensembl chr 4:155,943,737...155,951,116
|
|
G |
Nasp |
nuclear autoantigenic sperm protein |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of NASP mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 5:135,294,599...135,319,992
Ensembl chr 5:130,057,363...130,082,928
|
|
G |
Nbl1 |
NBL1, DAN family BMP antagonist |
decreases expression |
ISO |
Fluorouracil results in decreased expression of NBL1 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 5:151,318,752...151,329,948
Ensembl chr 5:151,318,754...151,338,719
|
|
G |
Nbn |
nibrin |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of NBN mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 5:34,256,678...34,291,163
Ensembl chr 5:29,459,457...29,494,150
|
|
G |
Ncapg |
non-SMC condensin I complex, subunit G |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of NCAPG mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr14:69,616,473...69,645,445
Ensembl chr14:65,404,163...65,432,902
|
|
G |
Ncl |
nucleolin |
affects splicing |
ISO |
Fluorouracil affects the splicing of NCL mRNA |
CTD |
PMID:17169984 |
|
NCBI chr 9:94,447,559...94,456,083
Ensembl chr 9:86,998,019...87,008,136
|
|
G |
Ncor1 |
nuclear receptor co-repressor 1 |
multiple interactions |
ISO |
NCOR1 protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] |
CTD |
PMID:18927307 |
|
NCBI chr10:46,999,536...47,142,294
Ensembl chr10:46,999,536...47,141,032
|
|
G |
Ndufa10 |
NADH:ubiquinone oxidoreductase subunit A10 |
affects response to substance increases expression |
ISO |
NDUFA10 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of NDUFA10 protein |
CTD |
PMID:15548681 PMID:15585135 PMID:16803524 |
|
NCBI chr 9:100,454,498...100,490,023
Ensembl chr 9:93,007,042...93,042,560
|
|
G |
Ndufa4 |
Ndufa4, mitochondrial complex associated |
affects expression |
ISO |
Fluorouracil affects the expression of NDUFA4 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 4:40,968,391...40,975,559
Ensembl chr 4:40,002,216...40,023,920
|
|
G |
Ndufa6 |
NADH:ubiquinone oxidoreductase subunit A6 |
affects expression |
ISO |
Fluorouracil affects the expression of NDUFA6 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 7:115,746,460...115,750,317
Ensembl chr 7:113,866,382...113,870,239
|
|
G |
Ndufab1 |
NADH:ubiquinone oxidoreductase subunit AB1 |
affects expression |
ISO |
Fluorouracil affects the expression of NDUFAB1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 1:186,075,933...186,091,843
Ensembl chr 1:176,644,703...176,658,099
|
|
G |
Ndufaf1 |
NADH:ubiquinone oxidoreductase complex assembly factor 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of NDUFAF1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 3:106,639,025...106,650,549
Ensembl chr 3:106,639,851...106,650,212
|
|
G |
Ndufaf3 |
NADH:ubiquinone oxidoreductase complex assembly factor 3 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of NDUFAF3 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 8:109,261,362...109,263,194
Ensembl chr 8:109,261,363...109,263,194
|
|
G |
Ndufaf4 |
NADH:ubiquinone oxidoreductase complex assembly factor 4 |
affects expression |
ISO |
Fluorouracil affects the expression of NDUFAF4 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 5:38,605,169...38,610,341
Ensembl chr 5:38,605,153...38,610,336
|
|
G |
Ndufb10 |
NADH:ubiquinone oxidoreductase subunit B10 |
affects expression |
ISO |
Fluorouracil affects the expression of NDUFB10 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr10:14,253,805...14,255,966
Ensembl chr10:13,749,275...13,751,442
|
|
G |
Ndufb2 |
NADH:ubiquinone oxidoreductase subunit B2 |
increases expression |
ISO |
Fluorouracil results in increased expression of NDUFB2 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 4:69,334,307...69,341,394
Ensembl chr15:46,536,062...46,536,851 Ensembl chr 4:46,536,062...46,536,851
|
|
G |
Ndufb9 |
NADH:ubiquinone oxidoreductase subunit B9 |
affects expression |
ISO |
Fluorouracil affects the expression of NDUFB9 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 7:92,370,423...92,376,841
Ensembl chr 7:90,436,621...90,488,009
|
|
G |
Ndufc1 |
NADH:ubiquinone oxidoreductase subunit C1 |
affects expression |
ISO |
Fluorouracil affects the expression of NDUFC1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 2:135,447,067...135,450,950
Ensembl chr 2:135,447,119...135,450,874
|
|
G |
Ndufv1 |
NADH:ubiquinone oxidoreductase core subunit V1 |
affects expression |
ISO |
Fluorouracil affects the expression of NDUFV1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 1:210,729,856...210,735,103
Ensembl chr 1:201,299,985...201,305,466
|
|
G |
Ndufv3 |
NADH:ubiquinone oxidoreductase subunit V3 |
increases expression |
ISO |
Fluorouracil results in increased expression of NDUFV3 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr20:9,613,786...9,622,941
Ensembl chr20:9,612,431...9,623,074 Ensembl chr13:9,612,431...9,623,074
|
|
G |
Nedd4 |
NEDD4 E3 ubiquitin protein ligase |
affects response to substance |
ISO |
NEDD4 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 8:73,384,095...73,468,951
Ensembl chr 8:73,383,695...73,468,951
|
|
G |
Nek1 |
NIMA-related kinase 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of NEK1 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr16:28,998,229...29,125,426
Ensembl chr16:28,998,231...29,117,723
|
|
G |
Nek2 |
NIMA-related kinase 2 |
multiple interactions decreases expression |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of NEK2 mRNA] |
CTD |
PMID:15016801 PMID:19272435 |
|
NCBI chr13:103,405,818...103,419,063
Ensembl chr13:103,405,819...103,419,051
|
|
G |
Nek4 |
NIMA-related kinase 4 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of NEK4 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr16:6,151,292...6,200,280
Ensembl chr16:6,144,959...6,188,932
|
|
G |
Nek6 |
NIMA-related kinase 6 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of NEK6 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr 3:22,284,269...22,356,302
Ensembl chr 3:22,284,279...22,395,990
|
|
G |
Nek9 |
NIMA-related kinase 9 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of NEK9 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 6:104,944,056...104,984,538
Ensembl chr 6:104,944,056...104,984,538
|
|
G |
Nes |
nestin |
decreases expression |
ISO |
Fluorouracil results in decreased expression of NES mRNA; Fluorouracil results in decreased expression of NES protein |
CTD |
PMID:21296659 PMID:26272751 |
|
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
|
|
G |
Neto2 |
neuropilin and tolloid like 2 |
affects response to substance |
ISO |
NETO2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr19:21,344,299...21,415,524
Ensembl chr19:21,344,289...21,417,023
|
|
G |
Neurod1 |
neuronal differentiation 1 |
affects expression decreases expression |
ISO |
Fluorouracil affects the expression of NEUROD1 mRNA Fluorouracil results in decreased expression of NEUROD1 protein |
CTD |
PMID:16584549 PMID:21296659 |
|
NCBI chr 3:84,766,483...84,770,454
Ensembl chr 3:64,359,395...64,363,649
|
|
G |
Neurog2 |
neurogenin 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of NEUROG2 mRNA |
CTD |
PMID:31711903 |
|
NCBI chr 2:216,092,709...216,095,276
Ensembl chr 2:216,093,363...216,094,154
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
affects response to substance decreases response to substance affects expression decreases expression multiple interactions affects localization |
ISO EXP |
NFE2L2 protein affects the susceptibility to Fluorouracil NFE2L2 protein results in decreased susceptibility to Fluorouracil NFE2L2 results in decreased susceptibility to Fluorouracil Fluorouracil affects the expression of NFE2L2 mRNA Fluorouracil results in decreased expression of NFE2L2 protein Ascorbic Acid promotes the reaction [Fluorouracil affects the localization of NFE2L2 protein] |
CTD |
PMID:18692501 PMID:20722640 PMID:21489257 PMID:26921358 PMID:34151400 PMID:35101590 More...
|
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfe2l3 |
NFE2 like bZIP transcription factor 3 |
increases expression |
ISO |
Fluorouracil results in increased expression of NFE2L3 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 4:80,506,756...80,534,629
Ensembl chr 4:80,506,756...80,534,629
|
|
G |
Nfib |
nuclear factor I/B |
decreases expression |
ISO |
Fluorouracil results in decreased expression of NFIB mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 5:96,759,208...96,974,001
Ensembl chr 5:96,764,653...96,975,479
|
|
G |
Nfic |
nuclear factor I/C |
increases expression |
ISO |
Fluorouracil results in increased expression of NFIC mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 7:8,278,210...8,309,936
Ensembl chr 7:8,253,361...8,309,936
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions decreases response to substance increases phosphorylation affects localization |
ISO EXP |
[N(1),N(11)-diethylnorspermine co-treated with Fluorouracil] affects the localization of NFKB1 protein; [N(1),N(11)-diethylnorspermine co-treated with Fluorouracil] results in decreased expression of [NFKB1 protein binds to RELA protein]; resveratrol inhibits the reaction [Fluorouracil results in increased phosphorylation of NFKB1 protein] NFKB1 protein results in decreased susceptibility to Fluorouracil Ascorbic Acid inhibits the reaction [Fluorouracil affects the localization of NFKB1 protein] |
CTD |
PMID:15548681 PMID:16637064 PMID:26310874 PMID:26921358 |
|
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
affects activity decreases degradation increases expression multiple interactions decreases expression increases phosphorylation |
ISO |
Fluorouracil affects the activity of NFKBIA protein Fluorouracil results in decreased degradation of NFKBIA protein Fluorouracil results in increased expression of NFKBIA protein [N(1),N(11)-diethylnorspermine co-treated with Fluorouracil] results in decreased expression of NFKBIA protein; Fluorouracil results in increased phosphorylation of and results in increased activity of NFKBIA protein; Resveratrol inhibits the reaction [Fluorouracil results in increased phosphorylation of NFKBIA protein] Curcumin inhibits the reaction [Fluorouracil results in decreased expression of NFKBIA protein] |
CTD |
PMID:10891390 PMID:12941601 PMID:16337965 PMID:16637064 PMID:16929163 PMID:26310874 PMID:27194111 More...
|
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nfya |
nuclear transcription factor Y subunit alpha |
multiple interactions |
ISO |
Fluorouracil inhibits the reaction [NFYA protein binds to UBE2C promoter]; Fluorouracil promotes the reaction [NFYA protein binds to UBE2C promoter]; TP53 protein mutant form affects the reaction [Fluorouracil promotes the reaction [NFYA protein binds to UBE2C promoter]] |
CTD |
PMID:27129209 |
|
NCBI chr 9:20,085,067...20,111,521
Ensembl chr 9:12,586,259...12,613,898
|
|
G |
Nfyb |
nuclear transcription factor Y subunit beta |
affects expression multiple interactions |
ISO |
Fluorouracil affects the expression of NFYB mRNA Fluorouracil promotes the reaction [NFYB protein binds to UBE2C promoter]; TP53 protein mutant form affects the reaction [Fluorouracil promotes the reaction [NFYB protein binds to UBE2C promoter]] |
CTD |
PMID:20421339 PMID:27129209 |
|
NCBI chr 7:22,852,543...22,868,116
Ensembl chr 7:20,964,993...20,980,565
|
|
G |
Ngfr |
nerve growth factor receptor |
increases response to substance |
ISO |
TNFRSF10B protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:15374982 |
|
NCBI chr10:81,012,077...81,030,305
Ensembl chr10:80,515,299...80,533,518
|
|
G |
Ninj1 |
ninjurin 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in increased expression of NINJ1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr17:15,452,804...15,461,684
Ensembl chr17:15,452,813...15,461,704
|
|
G |
Nipsnap2 |
nipsnap homolog 2 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of NIPSNAP2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr12:32,542,171...32,580,345
Ensembl chr12:26,911,723...26,944,166
|
|
G |
Nkain1 |
Sodium/potassium transporting ATPase interacting 1 |
multiple interactions |
ISO |
NKAIN1 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr 5:142,747,702...142,792,665
Ensembl chr 5:142,747,505...142,791,863
|
|
G |
Nkiras1 |
NFKB inhibitor interacting Ras-like 1 |
affects expression |
ISO |
Fluorouracil affects the expression of NKIRAS1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr15:7,493,531...7,503,758
Ensembl chr15:7,493,531...7,503,854
|
|
G |
Nme1 |
NME/NM23 nucleoside diphosphate kinase 1 |
affects response to substance |
ISO |
NME1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr10:79,403,939...79,426,620
Ensembl chr10:78,906,083...78,916,408
|
|
G |
Nme4 |
NME/NM23 nucleoside diphosphate kinase 4 |
affects response to substance |
ISO |
NME4 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:15,114,624...15,118,479
Ensembl chr10:15,002,926...15,118,479
|
|
G |
Nodal |
nodal growth differentiation factor |
decreases expression |
ISO |
Fluorouracil results in decreased expression of NODAL protein |
CTD |
PMID:21296659 |
|
NCBI chr20:29,368,436...29,376,837
Ensembl chr20:29,368,436...29,376,837
|
|
G |
Nog |
noggin |
decreases expression |
ISO |
Fluorouracil results in decreased expression of NOG protein |
CTD |
PMID:21296659 |
|
NCBI chr10:74,625,874...74,627,501
Ensembl chr10:74,128,712...74,130,339
|
|
G |
Nom1 |
nucleolar protein with MIF4G domain 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of NOM1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 4:5,891,220...5,910,741
Ensembl chr 4:5,892,909...5,909,709
|
|
G |
Nos2 |
nitric oxide synthase 2 |
increases expression multiple interactions |
ISO EXP |
Fluorouracil results in increased expression of NOS2 protein Fluorouracil inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; Fluorouracil inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; Fluorouracil results in increased expression of and results in increased activity of NOS2 protein Fluorouracil inhibits the reaction [Diethylnitrosamine results in increased expression of NOS2 mRNA] |
CTD |
PMID:12150722 PMID:16724238 PMID:18069768 PMID:31129132 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nos3 |
nitric oxide synthase 3 |
multiple interactions decreases expression |
EXP |
Bosentan inhibits the reaction [Fluorouracil results in decreased expression of NOS3 protein]; Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased expression of NOS3 mRNA] |
CTD |
PMID:31129132 PMID:34800596 |
|
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Notch1 |
notch receptor 1 |
multiple interactions |
ISO |
[Fluorouracil co-treated with Chloroquine] results in increased expression of NOTCH1 protein |
CTD |
PMID:29917191 |
|
NCBI chr 3:29,676,040...29,721,613
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Npm1 |
nucleophosmin 1 |
decreases response to substance |
ISO |
NPM1 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:24736981 |
|
NCBI chr10:17,741,512...17,751,626
Ensembl chr10:17,739,941...17,751,645 Ensembl chr X:17,739,941...17,751,645
|
|
G |
Npm3 |
nucleophosmin/nucleoplasmin, 3 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of NPM3 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 1:244,595,638...244,597,623
Ensembl chr 1:244,595,644...244,597,591
|
|
G |
Nppa |
natriuretic peptide A |
increases expression |
ISO |
Fluorouracil results in increased expression of NPPA protein |
CTD |
PMID:21296659 |
|
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of NQO1 protein |
CTD |
PMID:35101590 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1d2 |
nuclear receptor subfamily 1, group D, member 2 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of NR1D2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr15:7,524,257...7,550,553
Ensembl chr15:7,524,257...7,550,553
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
affects expression |
ISO |
Fluorouracil affects the expression of NR4A1 mRNA |
CTD |
PMID:15205334 PMID:16557594 |
|
NCBI chr 7:134,247,153...134,268,044
Ensembl chr 7:132,374,840...132,389,297
|
|
G |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
affects expression |
ISO |
Fluorouracil affects the expression of NR5A2 protein |
CTD |
PMID:21296659 |
|
NCBI chr13:50,865,253...50,985,107
Ensembl chr13:48,316,301...48,433,326
|
|
G |
Nr6a1 |
nuclear receptor subfamily 6, group A, member 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of NR6A1 protein |
CTD |
PMID:21296659 |
|
NCBI chr 3:22,495,109...22,683,132
Ensembl chr 3:22,496,943...22,683,131
|
|
G |
Nrg1 |
neuregulin 1 |
affects response to substance |
ISO |
NRG1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr16:65,954,084...67,007,484
Ensembl chr16:59,250,854...60,296,884
|
|
G |
Nrip1 |
nuclear receptor interacting protein 1 |
multiple interactions decreases expression |
ISO |
[Fluorouracil co-treated with irinotecan] results in increased expression of NRIP1 mRNA Fluorouracil results in decreased expression of NRIP1 mRNA |
CTD |
PMID:16391804 PMID:16510598 |
|
NCBI chr11:28,382,835...28,466,483
Ensembl chr11:14,895,553...14,981,761
|
|
G |
Nrp1 |
neuropilin 1 |
decreases response to substance |
ISO |
NRP1 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:15956974 |
|
NCBI chr19:73,256,557...73,411,705
Ensembl chr19:56,359,455...56,513,633
|
|
G |
Nt5c1a |
5'-nucleotidase, cytosolic IA |
decreases response to substance multiple interactions |
ISO |
NT5C1A protein results in decreased susceptibility to Fluorouracil NT5C1A protein results in decreased susceptibility to [Fluorouracil co-treated with Cladribine] |
CTD |
PMID:16362297 |
|
NCBI chr 5:135,473,107...135,494,400
Ensembl chr 5:135,473,231...135,499,338
|
|
G |
Nt5e |
5' nucleotidase, ecto |
increases expression |
ISO |
Fluorouracil results in increased expression of NT5E mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 8:98,150,925...98,195,646
Ensembl chr 8:89,270,696...89,314,881
|
|
G |
Nt5m |
5',3'-nucleotidase, mitochondrial |
increases expression |
ISO |
Fluorouracil results in increased expression of NT5M mRNA |
CTD |
PMID:19219653 |
|
NCBI chr10:44,652,845...44,680,549
Ensembl chr10:44,652,975...44,679,150
|
|
G |
Ntn4 |
netrin 4 |
increases expression |
ISO |
Fluorouracil results in increased expression of NTN4 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr 7:28,186,611...28,300,390
Ensembl chr 7:28,186,611...28,300,390
|
|
G |
Ntrk2 |
neurotrophic receptor tyrosine kinase 2 |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of NTRK2 protein NTRK2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
|
|
G |
Nts |
neurotensin |
affects response to substance |
ISO |
NTS protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 7:37,564,944...37,574,350
Ensembl chr 7:37,564,533...37,574,423
|
|
G |
Ntsr1 |
neurotensin receptor 1 |
affects response to substance decreases expression |
ISO |
NTSR1 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of NTSR1 protein |
CTD |
PMID:15352031 |
|
NCBI chr 3:187,983,778...188,033,934
Ensembl chr 3:167,606,215...167,656,377
|
|
G |
Nucks1 |
nuclear casein kinase and cyclin-dependent kinase substrate 1 |
multiple interactions decreases expression |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of NUCKS1 mRNA] Fluorouracil results in decreased expression of NUCKS1 protein |
CTD |
PMID:15016801 PMID:15585135 PMID:16803524 |
|
NCBI chr13:43,345,091...43,374,316
Ensembl chr13:43,345,115...43,370,229
|
|
G |
Nupr1 |
nuclear protein 1, transcriptional regulator |
affects expression |
ISO |
Fluorouracil affects the expression of NUPR1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 1:190,643,866...190,645,901
Ensembl chr 1:181,213,368...181,215,281
|
|
G |
Oas2 |
2'-5' oligoadenylate synthetase 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of OAS2 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr12:41,464,568...41,492,036
Ensembl chr12:35,806,759...35,829,371
|
|
G |
Odc1 |
ornithine decarboxylase 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ODC1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
|
|
G |
Ogfrl1 |
opioid growth factor receptor-like 1 |
affects response to substance |
ISO |
OGFRL1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 9:25,828,865...25,842,424
Ensembl chr 9:25,828,869...25,842,352
|
|
G |
Olfm1 |
olfactomedin 1 |
increases expression affects response to substance |
ISO |
Fluorouracil results in increased expression of OLFM1 protein OLFM1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 3:11,520,522...11,558,240
Ensembl chr 3:11,520,729...11,558,239
|
|
G |
Olfm4 |
olfactomedin 4 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of OLFM4 protein |
CTD |
PMID:36203040 |
|
NCBI chr15:55,385,100...55,429,687
Ensembl chr15:55,407,148...55,429,681
|
|
G |
Olig2 |
oligodendrocyte transcription factor 2 |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of OLIG2 mRNA; Fluorouracil results in decreased expression of OLIG2 protein [HDAC1 protein co-treated with HDAC2 protein] promotes the reaction [TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of OLIG2 mRNA]]; TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of OLIG2 mRNA] |
CTD |
PMID:21296659 PMID:25178657 |
|
NCBI chr11:30,475,510...30,478,886
Ensembl chr11:30,475,398...30,480,152
|
|
G |
Olig3 |
oligodendrocyte transcription factor 3 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of OLIG3 mRNA |
CTD |
PMID:31711903 |
|
NCBI chr 1:14,081,259...14,083,336
Ensembl chr 1:14,081,328...14,082,149
|
|
G |
Optn |
optineurin |
affects response to substance increases expression |
ISO |
OPTN protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of OPTN mRNA |
CTD |
PMID:16101138 PMID:16217747 PMID:17039268 |
|
NCBI chr17:78,118,847...78,169,543
Ensembl chr17:73,209,575...73,260,251
|
|
G |
Orc3 |
origin recognition complex, subunit 3 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ORC3 mRNA |
CTD |
PMID:19272435 |
|
NCBI chr 5:49,123,758...49,181,552
Ensembl chr 5:49,126,955...49,181,633
|
|
G |
Orc6 |
origin recognition complex, subunit 6 |
increases expression |
ISO |
Fluorouracil results in increased expression of ORC6 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr19:21,757,867...21,765,638
Ensembl chr19:21,757,866...21,765,662
|
|
G |
Otx2 |
orthodenticle homeobox 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of OTX2 mRNA |
CTD |
PMID:30518710 |
|
NCBI chr15:21,942,233...21,953,034
Ensembl chr15:21,943,191...21,953,416
|
|
G |
Oxct1 |
3-oxoacid CoA transferase 1 |
multiple interactions affects response to substance |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of OXCT1 mRNA] OXCT1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15016801 PMID:16217747 |
|
NCBI chr 2:54,963,964...55,112,303
Ensembl chr 2:53,236,368...53,384,714
|
|
G |
P4hb |
prolyl 4-hydroxylase subunit beta |
decreases expression |
ISO |
Fluorouracil results in decreased expression of P4HB mRNA |
CTD |
PMID:32535746 |
|
NCBI chr10:105,836,972...105,848,583
Ensembl chr10:105,836,982...105,848,500
|
|
G |
Pafah1b1 |
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PAFAH1B1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr10:60,031,441...60,090,259
Ensembl chr10:59,534,117...59,591,808
|
|
G |
Paics |
phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase |
increases expression |
ISO |
Fluorouracil results in increased expression of PAICS mRNA |
CTD |
PMID:19219653 |
|
NCBI chr14:31,553,355...31,586,843
Ensembl chr14:31,173,541...31,232,635
|
|
G |
Paip1 |
poly(A) binding protein interacting protein 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PAIP1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 2:51,523,190...51,550,241
Ensembl chr 2:51,522,921...51,550,241
|
|
G |
Pank1 |
pantothenate kinase 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of PANK1 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 1:241,737,371...241,808,126
Ensembl chr 1:232,328,430...232,396,829
|
|
G |
Paqr8 |
progestin and adipoQ receptor family member 8 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of PAQR8 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr 9:23,312,521...23,362,175
Ensembl chr 9:23,312,585...23,362,340
|
|
G |
Pard3 |
par-3 family cell polarity regulator |
affects response to substance |
ISO |
PARD3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr19:55,080,282...55,630,111
Ensembl chr19:55,080,282...55,629,778
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases expression multiple interactions increases cleavage affects expression |
ISO |
Fluorouracil results in increased expression of PARP1; Fluorouracil results in increased expression of PARP1 mRNA 3-methyladenine promotes the reaction [Fluorouracil results in increased cleavage of and results in increased activity of PARP1 protein]; Fluorouracil results in increased cleavage of and results in increased activity of PARP1 protein 3-methyladenine promotes the reaction [Fluorouracil results in increased cleavage of and results in increased activity of PARP1 protein]; [Fluorouracil co-treated with Genistein] results in increased cleavage of PARP1 protein; [S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased cleavage of PARP1 protein; [SM-1 compound co-treated with Fluorouracil] results in increased expression of PARP1 protein; benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased cleavage of PARP1 protein]; Celecoxib inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; EGF protein inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; Fluorouracil promotes the reaction [gambogic acid results in decreased expression of PARP1 mRNA]; Fluorouracil promotes the reaction [gambogic acid results in increased cleavage of PARP1 protein]; Fluorouracil results in increased cleavage of and results in increased activity of PARP1 protein; IGF1 protein inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; IL6 protein inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; MT2A protein affects the reaction [EGF protein inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]]; Nicotine inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; S100A11 mutant form promotes the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; SM-1 compound promotes the reaction [Fluorouracil results in increased expression of PARP1 mRNA]; TGFB1 protein inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; TNFRSF10B mutant form inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; TP53 protein promotes the reaction [Fluorouracil results in increased cleavage of PARP1 protein] Fluorouracil affects the expression of PARP1 mRNA |
CTD |
PMID:11300326 PMID:15896711 PMID:15996812 PMID:16525653 PMID:17461495 PMID:17982676 PMID:19084572 PMID:19116755 PMID:19816940 PMID:21036698 PMID:24095863 PMID:25940438 PMID:26544897 PMID:28507149 PMID:28599477 PMID:32270916 PMID:34151400 More...
|
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Parp14 |
poly (ADP-ribose) polymerase family, member 14 |
increases expression |
ISO |
Fluorouracil results in increased expression of PARP14 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr11:64,902,848...64,934,916
Ensembl chr11:64,902,785...64,934,916
|
|
G |
Pax3 |
paired box 3 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of PAX3 mRNA |
CTD |
PMID:31711903 |
|
NCBI chr 9:79,567,455...79,664,042
Ensembl chr 9:79,568,634...79,664,042
|
|
G |
Pax6 |
paired box 6 |
increases expression decreases expression |
ISO |
Fluorouracil results in increased expression of PAX6 protein Fluorouracil results in decreased expression of PAX6 mRNA |
CTD |
PMID:21296659 PMID:30518710 |
|
NCBI chr 3:112,590,034...112,611,771
Ensembl chr 3:92,135,637...92,157,014
|
|
G |
Pbx3 |
PBX homeobox 3 |
affects response to substance |
ISO |
PBX3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 3:17,488,691...17,682,412
Ensembl chr 3:17,488,693...17,682,791
|
|
G |
Pcdha5 |
protocadherin alpha 5 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of PCDHA5 protein |
CTD |
PMID:15585135 PMID:16803524 |
|
Ensembl chr18:28,581,225...28,846,211
|
|
G |
Pclaf |
PCNA clamp associated factor |
multiple interactions decreases expression |
ISO |
[Fluorouracil co-treated with irinotecan] results in decreased expression of PCLAF mRNA Fluorouracil results in decreased expression of PCLAF mRNA |
CTD |
PMID:16391804 PMID:17039268 |
|
NCBI chr 8:66,420,606...66,432,994
Ensembl chr 8:66,420,587...66,432,994 Ensembl chr 8:66,420,587...66,432,994
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression increases expression multiple interactions |
ISO EXP |
Fluorouracil results in decreased expression of PCNA protein Fluorouracil results in increased expression of PCNA mRNA Probucol inhibits the reaction [Fluorouracil results in decreased expression of PCNA protein] [diacerein co-treated with Fluorouracil] inhibits the reaction [Trichloroacetic Acid results in increased expression of PCNA protein]; Fluorouracil inhibits the reaction [Trichloroacetic Acid results in increased expression of PCNA protein] |
CTD |
PMID:16557594 PMID:16709241 PMID:18205257 PMID:19272435 PMID:29678497 PMID:34794354 PMID:39334374 More...
|
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pcolce2 |
procollagen C-endopeptidase enhancer 2 |
affects response to substance |
ISO |
PCOLCE2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 8:96,193,461...96,251,116
Ensembl chr 8:96,193,461...96,251,114
|
|
G |
Pdap1 |
PDGFA associated protein 1 |
decreases expression increases expression |
ISO |
Fluorouracil results in decreased expression of PDAP1 mRNA Fluorouracil results in increased expression of PDAP1 protein |
CTD |
PMID:15585135 PMID:16709241 PMID:16803524 |
|
NCBI chr12:9,470,652...9,480,880
Ensembl chr12:9,470,574...9,535,374
|
|
G |
Pdcd1lg2 |
programmed cell death 1 ligand 2 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PDCD1LG2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:227,158,941...227,223,938
Ensembl chr 1:227,158,941...227,223,938
|
|
G |
Pdcd4 |
programmed cell death 4 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of PDCD4 mRNA |
CTD |
PMID:15109396 |
|
NCBI chr 1:252,921,342...252,944,278
Ensembl chr 1:252,921,392...252,944,275
|
|
G |
Pdcd6ip |
programmed cell death 6 interacting protein |
decreases expression |
ISO |
Fluorouracil results in decreased expression of PDCD6IP mRNA |
CTD |
PMID:17039268 |
|
NCBI chr 8:122,469,223...122,524,993
Ensembl chr 8:113,590,998...113,646,773
|
|
G |
Pdf |
peptide deformylase (mitochondrial) |
increases expression decreases response to substance |
ISO |
Fluorouracil results in increased expression of PDF mRNA; Fluorouracil results in increased expression of PDF protein PDF protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:16510598 |
|
NCBI chr19:34,949,408...34,951,621
Ensembl chr19:34,948,256...34,951,515
|
|
G |
Pdia4 |
protein disulfide isomerase family A, member 4 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of PDIA4 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 4:78,134,144...78,153,191
Ensembl chr 4:76,803,198...76,822,107
|
|
G |
Pdlim5 |
PDZ and LIM domain 5 |
affects response to substance |
ISO |
PDLIM5 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 2:230,952,251...231,120,329
Ensembl chr 2:230,952,248...231,120,275
|
|
G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of IPF1 protein |
CTD |
PMID:21296659 |
|
NCBI chr12:12,793,957...12,799,156
Ensembl chr12:7,757,865...7,763,064
|
|
G |
Pdxp |
pyridoxal phosphatase |
decreases expression |
ISO |
Fluorouracil results in decreased expression of PDXP mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 7:112,352,971...112,358,419
Ensembl chr 7:110,472,515...110,477,963
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of PECAM1 mRNA; Fluorouracil results in decreased expression of PECAM1 protein Probucol inhibits the reaction [Fluorouracil results in decreased expression of PECAM1 mRNA]; Probucol inhibits the reaction [Fluorouracil results in decreased expression of PECAM1 protein] |
CTD |
PMID:19272435 PMID:21296659 |
|
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:91,590,521...91,652,116
|
|
G |
Peg10 |
paternally expressed 10 |
affects response to substance |
ISO |
PEG10 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 4:32,842,441...32,855,639
Ensembl chr 4:32,848,493...32,852,621
|
|
G |
Per1 |
period circadian regulator 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of PER1 mRNA |
CTD |
PMID:18329632 |
|
NCBI chr10:54,299,002...54,313,804
Ensembl chr10:53,805,535...53,814,431
|
|
G |
Per2 |
period circadian regulator 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of PER2 mRNA |
CTD |
PMID:18329632 |
|
NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:92,007,296...92,049,459
|
|
G |
Pfn2 |
profilin 2 |
increases expression affects response to substance multiple interactions |
ISO |
Fluorouracil results in increased expression of PFN2 protein PFN2 protein affects the susceptibility to Fluorouracil TP53 protein affects the reaction [Fluorouracil results in decreased expression of PFN2 mRNA] |
CTD |
PMID:15016801 PMID:15352031 |
|
NCBI chr 2:142,067,102...142,072,938
Ensembl chr 2:142,067,104...142,072,938
|
|
G |
Pglyrp1 |
peptidoglycan recognition protein 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PGLYRP1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:78,531,815...78,537,001
Ensembl chr 1:78,531,815...78,537,001
|
|
G |
Pgr |
progesterone receptor |
affects expression |
ISO |
Fluorouracil affects the expression of PGR mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Phip |
pleckstrin homology domain interacting protein |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PHIP mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 8:92,656,890...92,771,098
Ensembl chr 8:83,781,465...83,894,283
|
|
G |
Phlda3 |
pleckstrin homology-like domain, family A, member 3 |
increases expression |
ISO |
Fluorouracil results in increased expression of PHLDA3 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr13:47,193,250...47,196,335
Ensembl chr13:47,193,086...47,196,335
|
|
G |
Phyh |
phytanoyl-CoA 2-hydroxylase |
affects response to substance |
ISO |
PHYH protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr17:78,238,747...78,255,645
Ensembl chr17:73,329,082...73,346,409
|
|
G |
Pi4kb |
phosphatidylinositol 4-kinase beta |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PI4KB mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 2:182,540,377...182,572,684
Ensembl chr 2:182,540,567...182,588,488
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
decreases expression |
ISO |
Fluorouracil results in decreased expression of PIK3CA mRNA mutant form |
CTD |
PMID:38423379 |
|
NCBI chr 2:117,103,643...117,177,411
Ensembl chr 2:115,174,984...115,249,032
|
|
G |
Pir |
pirin |
affects response to substance decreases expression |
ISO |
PIR protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of PIR protein |
CTD |
PMID:15352031 |
|
NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218
|
|
G |
Pisd |
phosphatidylserine decarboxylase |
affects response to substance |
ISO |
PISD protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr14:77,941,927...77,991,021
Ensembl chr14:77,941,948...77,991,003
|
|
G |
Pla2g4a |
phospholipase A2 group 4A |
affects response to substance |
ISO |
PLA2G4A protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr13:64,427,921...64,572,352
Ensembl chr13:61,877,813...62,022,266
|
|
G |
Plat |
plasminogen activator, tissue type |
increases expression |
ISO |
Fluorouracil results in increased expression of PLAT mRNA |
CTD |
PMID:16101138 |
|
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:69,240,585...69,268,223
|
|
G |
Plau |
plasminogen activator, urokinase |
affects expression increases expression |
ISO |
Fluorouracil affects the expression of PLAU mRNA Fluorouracil results in increased expression of PLAU mRNA |
CTD |
PMID:16584549 PMID:24737281 |
|
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Plcg1 |
phospholipase C, gamma 1 |
decreases response to substance |
ISO |
PLCG1 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:17531112 |
|
NCBI chr 3:169,805,299...169,836,040
Ensembl chr 3:149,385,587...149,416,330
|
|
G |
Plekhb1 |
pleckstrin homology domain containing B1 |
increases expression |
ISO |
Fluorouracil results in increased expression of PLEKHB1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 1:154,998,798...155,013,094
Ensembl chr 1:154,998,800...155,016,142
|
|
G |
Plekho1 |
pleckstrin homology domain containing O1 |
affects response to substance |
ISO |
PLEKHO1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 2:183,544,487...183,552,928
Ensembl chr 2:183,544,499...183,552,785
|
|
G |
Plin2 |
perilipin 2 |
affects response to substance |
ISO |
PLIN2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
|
|
G |
Plin3 |
perilipin 3 |
affects response to substance |
ISO |
PLIN3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 9:1,111,178...1,123,057
Ensembl chr 9:1,102,366...1,123,147
|
|
G |
Plk1 |
polo-like kinase 1 |
increases expression multiple interactions decreases expression |
ISO |
Fluorouracil results in increased expression of PLK1 protein TP53 protein affects the reaction [Fluorouracil results in decreased expression of PLK1 mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in increased expression of PLK1 protein] Fluorouracil results in decreased expression of PLK mRNA; Fluorouracil results in decreased expression of PLK1 mRNA |
CTD |
PMID:15016801 PMID:15205334 PMID:16709241 |
|
NCBI chr 1:186,147,658...186,157,637
Ensembl chr 1:176,716,420...176,726,400
|
|
G |
Plk2 |
polo-like kinase 2 |
increases expression multiple interactions |
ISO |
Fluorouracil results in increased expression of PLK2 mRNA TP53 protein affects the reaction [Fluorouracil results in increased expression of PLK2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of PLK2 mRNA] |
CTD |
PMID:15016801 PMID:17982676 |
|
NCBI chr 2:43,702,536...43,708,305
Ensembl chr 2:41,969,176...41,974,947
|
|
G |
Plk3 |
polo-like kinase 3 |
increases expression |
ISO |
Fluorouracil results in increased expression of PLK3 protein |
CTD |
PMID:14665630 |
|
NCBI chr 5:135,843,725...135,848,900
Ensembl chr 5:130,607,142...130,612,317
|
|
G |
Plod2 |
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 |
increases expression affects response to substance decreases expression |
ISO |
Fluorouracil results in increased expression of PLOD2 protein PLOD2 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of PLOD2 mRNA |
CTD |
PMID:15352031 PMID:16557594 |
|
NCBI chr 8:101,964,318...102,047,022
Ensembl chr 8:93,084,513...93,167,255
|
|
G |
Plp2 |
proteolipid protein 2 |
affects response to substance |
ISO |
PLP2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr X:17,506,153...17,509,552
Ensembl chr X:14,834,231...14,838,514
|
|
G |
Plrg1 |
pleiotropic regulator 1 |
multiple interactions |
ISO |
[Fluorouracil co-treated with irinotecan] results in increased expression of PLRG1 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr 2:168,408,139...168,424,470
Ensembl chr 2:168,408,124...168,424,522
|
|
G |
Plscr1 |
phospholipid scramblase 1 |
affects response to substance |
ISO |
PLSCR1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 8:92,784,279...92,804,698
Ensembl chr 8:92,784,356...92,804,692
|
|
G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
affects response to substance multiple interactions |
ISO |
PMAIP1 protein affects the susceptibility to Fluorouracil TP53 protein affects the reaction [Fluorouracil results in increased expression of PMAIP1 mRNA] |
CTD |
PMID:15016801 PMID:16217747 |
|
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
|
|
G |
Pmf1 |
polyamine-modulated factor 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PMF1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 2:173,848,074...173,868,272
Ensembl chr 2:173,848,074...173,868,270
|
|
G |
Pnma2 |
PNMA family member 2 |
affects response to substance |
ISO |
PNMA2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr15:41,111,942...41,119,649
Ensembl chr15:41,112,009...41,121,427
|
|
G |
Pnp |
purine nucleoside phosphorylase |
affects response to substance |
ISO |
PNP protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr15:26,644,147...26,651,808
Ensembl chr15:24,170,602...24,203,986
|
|
G |
Pnpla6 |
patatin-like phospholipase domain containing 6 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of PNPLA6 mRNA |
CTD |
PMID:26272751 |
|
NCBI chr12:1,574,387...1,603,735
Ensembl chr12:1,560,363...1,603,734
|
|
G |
Pnrc1 |
proline-rich nuclear receptor coactivator 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of PNRC1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 5:47,647,070...47,657,832
Ensembl chr 5:47,647,071...47,650,161
|
|
G |
Podxl |
podocalyxin-like |
decreases expression |
ISO |
Fluorouracil results in decreased expression of PODXL protein |
CTD |
PMID:21296659 |
|
NCBI chr 4:60,135,124...60,181,829
Ensembl chr 4:60,135,109...60,181,899
|
|
G |
Pola1 |
DNA polymerase alpha 1, catalytic subunit |
decreases expression |
ISO |
Fluorouracil results in decreased expression of POLA1 mRNA |
CTD |
PMID:19219653 |
|
NCBI chr X:58,034,617...58,348,612
Ensembl chr X:58,034,619...58,348,536
|
|
G |
Pola2 |
DNA polymerase alpha 2, accessory subunit |
affects response to substance |
ISO |
POLA2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 1:203,227,183...203,251,350
Ensembl chr 1:203,203,388...203,251,348
|
|
G |
Pole2 |
DNA polymerase epsilon 2, accessory subunit |
affects response to substance |
ISO |
POLE2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 6:87,674,702...87,712,723
Ensembl chr 6:87,674,702...87,699,305
|
|
G |
Polg |
DNA polymerase gamma, catalytic subunit |
affects response to substance |
ISO |
POLG protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 1:142,792,119...142,808,933
Ensembl chr 1:133,382,766...133,398,567
|
|
G |
Postn |
periostin |
decreases response to substance |
ISO |
POSTN protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:15731169 |
|
NCBI chr 2:140,677,774...140,709,304
Ensembl chr 2:138,527,696...138,559,099
|
|
G |
Pou5f1 |
POU class 5 homeobox 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of POU5F1 protein Fluorouracil results in decreased expression of POU5F1 mRNA |
CTD |
PMID:21296659 PMID:24737281 |
|
NCBI chr20:3,227,836...3,232,598
Ensembl chr20:3,223,129...3,227,891
|
|
G |
Ppa2 |
inorganic pyrophosphatase 2 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PPA2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 2:221,800,791...221,878,079
Ensembl chr 2:221,800,842...221,878,081
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of PPARG protein PPARG protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppfibp1 |
PPFIA binding protein 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of PPFIBP1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 4:179,807,579...179,951,428
Ensembl chr 4:179,808,794...179,951,428
|
|
G |
Ppie |
peptidylprolyl isomerase E |
increases expression |
ISO |
Fluorouracil results in increased expression of PPIE protein |
CTD |
PMID:16803524 |
|
NCBI chr 5:135,406,172...135,419,332
Ensembl chr 5:135,406,176...135,419,235
|
|
G |
Ppm1d |
protein phosphatase, Mg2+/Mn2+ dependent, 1D |
increases expression multiple interactions |
ISO |
Fluorouracil results in increased expression of PPM1D mRNA; Fluorouracil results in increased expression of PPM1D protein TP53 protein affects the reaction [Fluorouracil results in increased expression of PPM1D mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of PPM1D mRNA] |
CTD |
PMID:14665630 PMID:15016801 PMID:17982676 |
|
NCBI chr10:70,670,026...70,706,030
Ensembl chr10:70,172,603...70,208,607
|
|
G |
Ppp1ca |
protein phosphatase 1 catalytic subunit alpha |
affects response to substance |
ISO |
PPP1CA protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:201,485,117...201,488,734
Ensembl chr 1:201,485,085...201,497,327
|
|
G |
Ppp1cc |
protein phosphatase 1 catalytic subunit gamma |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PPP1CC mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr12:40,043,822...40,061,301
Ensembl chr12:34,383,072...34,400,553
|
|
G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
increases expression affects response to substance |
ISO |
Fluorouracil results in increased expression of PPP1R15A mRNA PPP1R15A protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15331170 PMID:16709241 |
|
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
|
|
G |
Ppp1r17 |
protein phosphatase 1, regulatory subunit 17 |
increases expression |
ISO |
Fluorouracil results in increased expression of PPP1R17 protein |
CTD |
PMID:16803524 |
|
NCBI chr 4:85,213,595...85,230,607
Ensembl chr 4:85,213,887...85,230,603
|
|
G |
Ppp1r1b |
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
increases response to substance |
ISO |
PPP1R1B protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:17470401 |
|
NCBI chr10:83,347,731...83,356,775
Ensembl chr10:83,347,731...83,356,775
|
|
G |
Ppp1r2 |
protein phosphatase 1, regulatory (inhibitor) subunit 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of PPP1R2 mRNA |
CTD |
PMID:16557594 PMID:17039268 |
|
NCBI chr11:69,472,676...69,494,468
Ensembl chr11:69,472,555...69,494,463
|
|
G |
Ppp2cb |
protein phosphatase 2 catalytic subunit beta |
increases expression |
ISO |
Fluorouracil results in increased expression of PPP2CB mRNA |
CTD |
PMID:16709241 |
|
NCBI chr16:65,261,178...65,282,658
Ensembl chr16:58,558,122...58,579,576
|
|
G |
Ppp3ca |
protein phosphatase 3 catalytic subunit alpha |
multiple interactions increases expression |
ISO |
[Fluorouracil co-treated with irinotecan] results in increased expression of PPP3CA mRNA; PPP3CA protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] Fluorouracil results in increased expression of PPP3CA protein |
CTD |
PMID:15585135 PMID:16391804 PMID:16803524 PMID:18927307 |
|
NCBI chr 2:227,839,058...228,113,560
Ensembl chr 2:225,165,766...225,438,974
|
|
G |
Prc1 |
protein regulator of cytokinesis 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of PRC1 mRNA |
CTD |
PMID:17374387 PMID:19272435 |
|
NCBI chr 1:143,659,312...143,681,019
Ensembl chr 1:134,250,081...134,271,765
|
|
G |
Prdm14 |
PR/SET domain 14 |
affects expression |
ISO |
Fluorouracil affects the expression of PRDM14 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 5:6,082,163...6,092,712
Ensembl chr 5:6,082,442...6,092,712
|
|
G |
Prepl |
prolyl endopeptidase-like |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PREPL mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 6:9,580,367...9,609,957
Ensembl chr 6:9,580,217...9,607,772
|
|
G |
Prim1 |
DNA primase subunit 1 |
affects response to substance |
ISO |
PRIM1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 7:446,342...462,526
Ensembl chr 7:431,805...462,526
|
|
G |
Prkag2 |
protein kinase AMP-activated non-catalytic subunit gamma 2 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PRKAG2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 4:10,744,695...10,985,939
Ensembl chr 4:10,010,890...10,252,142
|
|
G |
Prkci |
protein kinase C, iota |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PRKCI mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 2:114,250,398...114,310,784
Ensembl chr 2:112,321,929...112,382,352
|
|
G |
Prkcz |
protein kinase C, zeta |
affects expression |
ISO |
Fluorouracil affects the expression of PRKCZ mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 5:171,101,774...171,212,694
Ensembl chr 5:165,819,466...165,930,367
|
|
G |
Prkdc |
protein kinase, DNA-activated, catalytic subunit |
multiple interactions |
ISO |
PRKDC mRNA results in increased susceptibility to [Fluorouracil co-treated with Cisplatin]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PRKDC mRNA] |
CTD |
PMID:15016801 PMID:18546291 |
|
NCBI chr11:98,544,952...98,762,499
Ensembl chr11:85,040,792...85,257,952
|
|
G |
Prnp |
prion protein |
decreases response to substance |
ISO |
PRNP protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:15386405 |
|
NCBI chr 3:139,639,076...139,654,420
Ensembl chr 3:119,177,485...119,203,937
|
|
G |
Proc |
protein C, inactivator of coagulation factors Va and VIIIa |
decreases activity |
ISO |
Fluorouracil results in decreased activity of PROC protein |
CTD |
PMID:2297659 |
|
NCBI chr18:23,764,367...23,774,816
Ensembl chr18:23,764,368...23,775,133
|
|
G |
Procr |
protein C receptor |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in increased expression of PROCR mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 3:144,254,596...144,258,863
Ensembl chr 3:144,254,380...144,258,903
|
|
G |
Prodh2 |
proline dehydrogenase 2 |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of PRODH2 protein PRODH2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 1:85,753,558...85,767,165
Ensembl chr 1:85,753,644...85,767,162
|
|
G |
Prom1 |
prominin 1 |
affects response to substance increases expression |
ISO |
PROM1 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of PROM1 protein |
CTD |
PMID:15352031 |
|
NCBI chr14:71,202,303...71,307,008
Ensembl chr14:66,990,160...67,094,527
|
|
G |
Prpf18 |
pre-mRNA processing factor 18 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of PRPF18 mRNA |
CTD |
PMID:16101138 |
|
NCBI chr17:73,630,560...73,661,210
Ensembl chr17:73,630,571...73,690,979
|
|
G |
Prps1 |
phosphoribosyl pyrophosphate synthetase 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of PRPS1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr X:104,132,139...104,154,191
Ensembl chr X:104,132,141...104,154,187
|
|
G |
Prps2 |
phosphoribosyl pyrophosphate synthetase 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of PRPS2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr X:26,975,915...27,013,184
Ensembl chr X:26,976,061...27,013,181
|
|
G |
Prr13 |
proline rich 13 |
multiple interactions |
ISO |
[Fluorouracil co-treated with irinotecan] results in increased expression of PRR13 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr 7:133,592,511...133,595,817
Ensembl chr 7:133,592,490...133,601,005
|
|
G |
Prrg1 |
proline rich and Gla domain 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of PRRG1 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr X:42,494,256...42,606,612
Ensembl chr X:42,494,256...42,606,588
|
|
G |
Prrx1 |
paired related homeobox 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of PRRX1 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr13:75,600,777...75,671,896
Ensembl chr13:75,601,706...75,670,866
|
|
G |
Psmb10 |
proteasome 20S subunit beta 10 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of PSMB10 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr19:33,830,958...33,833,442
Ensembl chr19:33,827,229...33,833,626
|
|
G |
Psmc3ip |
PSMC3 interacting protein |
affects expression |
ISO |
Fluorouracil affects the expression of PSMC3IP mRNA |
CTD |
PMID:20421339 |
|
NCBI chr10:86,024,281...86,027,928
Ensembl chr10:86,023,950...86,027,423
|
|
G |
Psrc1 |
proline and serine rich coiled-coil 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of PSRC1 mRNA |
CTD |
PMID:17374387 |
|
NCBI chr 2:196,022,361...196,026,874
Ensembl chr 2:196,022,361...196,026,874
|
|
G |
Ptch1 |
patched 1 |
affects localization multiple interactions decreases expression |
ISO |
Fluorouracil affects the localization of PTCH1 protein [Fluorouracil co-treated with irinotecan] results in increased expression of PTCH1 mRNA; GLI1 protein inhibits the reaction [Fluorouracil affects the localization of PTCH1 protein] Fluorouracil results in decreased expression of PTCH1 mRNA; Fluorouracil results in decreased expression of PTCH1 protein |
CTD |
PMID:16391804 PMID:18776995 PMID:25190613 |
|
NCBI chr17:1,548,449...1,613,461
Ensembl chr17:1,542,877...1,607,333
|
|
G |
Pten |
phosphatase and tensin homolog |
decreases expression increases expression |
ISO |
Fluorouracil results in decreased expression of PTEN mRNA Fluorouracil results in increased expression of PTEN mRNA |
CTD |
PMID:17039268 PMID:24737281 |
|
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Ptgr1 |
prostaglandin reductase 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of PTGR1 protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions decreases expression increases expression increases response to substance |
ISO EXP |
[Cisplatin co-treated with Fluorouracil] affects the expression of PTGS2 protein; [Fluorouracil co-treated with Curcumin] results in decreased expression of PTGS2 protein; [Fluorouracil results in increased expression of PTGS2 protein] which results in increased abundance of and results in increased secretion of Dinoprostone; [Genistein inhibits the reaction [Fluorouracil results in increased expression of PTGS2 protein]] which results in decreased abundance of Dinoprostone; acadesine inhibits the reaction [[Fluorouracil results in increased expression of PTGS2 protein] which results in increased abundance of and results in increased secretion of Dinoprostone]; acadesine inhibits the reaction [Fluorouracil results in increased expression of PTGS2 protein]; Curcumin promotes the reaction [Fluorouracil results in decreased phosphorylation of and results in decreased activity of PTGS2 protein]; Fluorouracil results in decreased phosphorylation of and results in decreased activity of PTGS2 protein; Genistein inhibits the reaction [Fluorouracil results in increased expression of PTGS2 protein]; PTGS2 protein inhibits the reaction [Fluorouracil results in increased activity of CASP3 protein]; PTGS2 protein inhibits the reaction [Fluorouracil results in increased activity of CASP9 protein] Fluorouracil results in decreased expression of PTGS2 mRNA; Fluorouracil results in decreased expression of PTGS2 protein Fluorouracil results in increased expression of PTGS2 mRNA; Fluorouracil results in increased expression of PTGS2 protein PTGS2 protein results in increased susceptibility to Fluorouracil Fluorouracil promotes the reaction [resveratrol results in decreased expression of PTGS2 protein]; resveratrol promotes the reaction [Fluorouracil results in decreased expression of PTGS2 protein] Ascorbic Acid inhibits the reaction [Fluorouracil results in increased expression of PTGS2 protein]; Thymol inhibits the reaction [Fluorouracil results in increased expression of PTGS2 protein] |
CTD |
PMID:12414664 PMID:15205334 PMID:15846114 PMID:15896711 PMID:16322294 PMID:16340194 PMID:16793607 PMID:17918158 PMID:25936796 PMID:26921358 PMID:29678497 PMID:34665902 PMID:35101590 More...
|
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptk2 |
protein tyrosine kinase 2 |
decreases response to substance affects expression decreases phosphorylation |
ISO |
PTK2 protein results in decreased susceptibility to Fluorouracil Fluorouracil affects the expression of PTK2 mRNA Fluorouracil results in decreased phosphorylation of PTK2 protein |
CTD |
PMID:16179862 PMID:34151400 PMID:37625625 |
|
NCBI chr 7:107,015,730...107,220,865
Ensembl chr 7:105,126,728...105,331,783
|
|
G |
Ptprk |
protein tyrosine phosphatase, receptor type, K |
affects response to substance |
ISO |
PTPRK protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:18,557,091...19,056,297
Ensembl chr 1:16,850,576...17,103,605
|
|
G |
Pttg1 |
PTTG1 regulator of sister chromatid separation, securin |
increases expression multiple interactions decreases expression |
ISO |
Fluorouracil results in increased expression of PTTG1 protein TP53 protein affects the reaction [Fluorouracil results in decreased expression of PTTG1 mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in increased expression of PTTG1 protein] |
CTD |
PMID:15016801 PMID:15205334 PMID:16557594 PMID:17039268 PMID:19272435 |
|
NCBI chr10:28,394,940...28,406,410
Ensembl chr10:27,893,689...27,904,837
|
|
G |
Pum1 |
pumilio RNA-binding family member 1 |
affects expression |
ISO |
Fluorouracil affects the expression of PUM1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 5:148,120,712...148,238,468
Ensembl chr 5:142,837,127...142,954,039
|
|
G |
Pura |
purine rich element binding protein A |
affects expression |
ISO |
Fluorouracil affects the expression of PURA mRNA |
CTD |
PMID:16584549 |
|
NCBI chr18:27,885,071...27,905,509
Ensembl chr18:27,884,556...27,905,513
|
|
G |
Purg |
purine-rich element binding protein G |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PURG mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr16:58,732,327...58,763,356
Ensembl chr16:58,720,335...58,763,359
|
|
G |
Pvt1 |
Pvt1 oncogene |
decreases expression |
ISO |
Fluorouracil results in decreased expression of PVT1 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 7:93,656,528...93,879,938
|
|
G |
Pwp2 |
PWP2, small subunit processome component |
increases expression |
ISO |
Fluorouracil results in increased expression of PWP2 mRNA |
CTD |
PMID:19272435 |
|
NCBI chr20:10,499,332...10,512,965
Ensembl chr20:10,499,363...10,513,640
|
|
G |
Pxmp2 |
peroxisomal membrane protein 2 |
affects expression |
ISO |
Fluorouracil affects the expression of PXMP2 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr12:46,394,051...46,404,561
Ensembl chr12:46,394,193...46,404,557
|
|
G |
Qsox1 |
quiescin sulfhydryl oxidase 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of QSOX1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr13:70,500,060...70,537,711
Ensembl chr13:67,949,780...67,987,459
|
|
G |
R3hdm2 |
R3H domain containing 2 |
affects expression |
ISO |
Fluorouracil affects the expression of R3HDM2 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 7:65,097,685...65,225,863
Ensembl chr 7:63,232,346...63,340,540
|
|
G |
Rab11a |
RAB11a, member RAS oncogene family |
decreases expression |
ISO |
Fluorouracil results in decreased expression of RAB11A mRNA |
CTD |
PMID:17039268 |
|
NCBI chr 8:65,223,698...65,246,461
Ensembl chr 8:65,222,949...65,246,525
|
|
G |
Rab20 |
RAB20, member RAS oncogene family |
affects response to substance |
ISO |
RAB20 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr16:78,019,337...78,043,529
Ensembl chr16:78,019,337...78,043,529
|
|
G |
Rab21 |
RAB21, member RAS oncogene family |
affects expression |
ISO |
Fluorouracil affects the expression of RAB21 mRNA |
CTD |
PMID:15205334 |
|
NCBI chr 7:52,790,158...52,814,943
Ensembl chr 7:50,904,057...50,928,839
|
|
G |
Rab25 |
RAB25, member RAS oncogene family |
affects expression |
ISO |
Fluorouracil affects the expression of RAB25 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr 2:174,000,323...174,006,422
Ensembl chr 2:174,000,323...174,006,422
|
|
G |
Rab8a |
RAB8A, member RAS oncogene family |
decreases expression |
ISO |
Fluorouracil results in decreased expression of RAB8A mRNA |
CTD |
PMID:16709241 |
|
NCBI chr16:17,688,049...17,709,412
Ensembl chr16:17,654,034...17,675,678
|
|
G |
Rad23b |
RAD23 homolog B, nucleotide excision repair protein |
affects response to substance increases expression |
ISO |
RAD23B affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of RAD23B mRNA |
CTD |
PMID:15067352 PMID:15109396 |
|
NCBI chr 5:70,090,232...70,128,340
Ensembl chr 5:70,090,232...70,128,319
|
|
G |
Rad51c |
RAD51 paralog C |
affects expression |
ISO |
Fluorouracil affects the expression of RAD51C mRNA |
CTD |
PMID:20421339 |
|
NCBI chr10:72,702,299...72,728,980
Ensembl chr10:72,205,032...72,231,248
|
|
G |
Rad54b |
RAD54 homolog B |
decreases expression |
ISO |
Fluorouracil results in decreased expression of RAD54B mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 5:25,032,112...25,104,630
Ensembl chr 5:25,032,066...25,104,616
|
|
G |
Raf1 |
Raf-1 proto-oncogene, serine/threonine kinase |
increases expression decreases expression |
ISO |
Fluorouracil results in increased expression of RAF1 mRNA Fluorouracil results in decreased expression of RAF1 protein |
CTD |
PMID:15152939 PMID:21296659 |
|
NCBI chr 4:150,352,158...150,412,813
Ensembl chr 4:148,679,530...148,740,317
|
|
G |
Ramp1 |
receptor activity modifying protein 1 |
decreases expression multiple interactions affects response to substance |
ISO |
Fluorouracil results in decreased expression of RAMP1 protein RAMP1 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] RAMP1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 PMID:16896004 |
|
NCBI chr 9:91,765,481...91,816,152
Ensembl chr 9:91,781,285...91,816,151
|
|
G |
Ranbp1 |
RAN binding protein 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of RANBP1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr11:96,246,912...96,255,145
Ensembl chr11:82,742,600...82,750,838
|
|
G |
Rarres2 |
retinoic acid receptor responder 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of RARRES2 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 4:78,853,450...78,856,652
Ensembl chr 4:77,522,535...77,525,556
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
affects expression increases phosphorylation affects response to substance multiple interactions |
ISO |
Fluorouracil affects the expression of RB1 mRNA Fluorouracil results in increased phosphorylation of RB1 protein RB1 protein affects the susceptibility to Fluorouracil; RB1 protein modified form affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of and results in increased phosphorylation of RB1 protein; RB1 results in decreased susceptibility to [Fluorouracil co-treated with Capecitabine] |
CTD |
PMID:9930367 PMID:15064736 PMID:15205334 PMID:17207318 PMID:17640669 PMID:18383818 PMID:18678097 More...
|
|
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rbbp4 |
RB binding protein 4, chromatin remodeling factor |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of RBBP4 mRNA RBBP4 results in decreased susceptibility to [Fluorouracil co-treated with Capecitabine] |
CTD |
PMID:16557594 PMID:18678097 |
|
NCBI chr 5:141,655,863...141,675,157
Ensembl chr 5:141,638,421...141,675,284 Ensembl chr 2:141,638,421...141,675,284
|
|
G |
Rbm14 |
RNA binding motif protein 14 |
increases expression |
ISO |
Fluorouracil results in increased expression of RBM14 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 1:202,076,940...202,105,688
Ensembl chr 1:202,078,287...202,105,665 Ensembl chr 1:202,078,287...202,105,665
|
|
G |
Rbm5 |
RNA binding motif protein 5 |
affects response to substance |
ISO |
RBM5 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 8:108,420,220...108,449,481
Ensembl chr 8:108,420,222...108,449,430
|
|
G |
Rbp1 |
retinol binding protein 1 |
affects response to substance decreases expression |
ISO |
RBP1 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of RBP1 protein |
CTD |
PMID:15352031 |
|
NCBI chr 8:99,025,218...99,046,740
Ensembl chr 8:99,025,206...99,046,743
|
|
G |
Rbpj |
recombination signal binding protein for immunoglobulin kappa J region |
multiple interactions |
ISO |
[Fluorouracil co-treated with irinotecan] results in decreased expression of RBPJ mRNA |
CTD |
PMID:16391804 |
|
NCBI chr14:61,551,366...61,736,220
Ensembl chr14:57,338,507...57,523,353
|
|
G |
Rcbtb2 |
RCC1 and BTB domain containing protein 2 |
affects expression |
ISO |
Fluorouracil affects the expression of RCBTB2 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr15:48,319,809...48,364,441
Ensembl chr15:48,323,866...48,383,750
|
|
G |
Rcc1 |
regulator of chromosome condensation 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of RCC1 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 5:144,526,025...144,544,445
Ensembl chr 5:144,526,025...144,544,577
|
|
G |
Rdx |
radixin |
affects expression |
ISO |
Fluorouracil affects the expression of RDX mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 8:52,379,494...52,437,673
Ensembl chr 8:52,379,494...52,437,678
|
|
G |
Recql4 |
RecQ like helicase 4 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of RECQL4 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 7:110,304,092...110,311,426
Ensembl chr 7:108,423,455...108,430,619
|
|
G |
Reg4 |
regenerating family member 4 |
decreases response to substance |
ISO |
REG4 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:17237819 |
|
NCBI chr 2:185,818,946...185,833,252
Ensembl chr 2:185,821,210...185,833,353
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions decreases expression affects response to substance affects expression decreases response to substance increases phosphorylation increases expression |
ISO EXP |
[N(1),N(11)-diethylnorspermine co-treated with Fluorouracil] affects the localization of RELA protein; [N(1),N(11)-diethylnorspermine co-treated with Fluorouracil] results in decreased expression of [NFKB1 protein binds to RELA protein]; Fluorouracil affects the localization of and affects the activity of RELA protein; resveratrol inhibits the reaction [Fluorouracil results in increased phosphorylation of RELA protein] Fluorouracil results in decreased expression of RELA protein RELA protein affects the susceptibility to Fluorouracil Fluorouracil affects the expression of RELA protein Fluorouracil inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein] RELA protein results in decreased susceptibility to Fluorouracil Bosentan inhibits the reaction [Fluorouracil results in increased expression of RELA protein]; Thymol inhibits the reaction [Fluorouracil results in increased expression of RELA protein] |
CTD |
PMID:12941601 PMID:15548681 PMID:16637064 PMID:16680372 PMID:16724238 PMID:18535404 PMID:19003803 PMID:22905237 PMID:26310874 PMID:34665902 PMID:34800596 More...
|
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Reps1 |
RALBP1 associated Eps domain containing 1 |
multiple interactions |
ISO |
REPS1 protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] |
CTD |
PMID:18927307 |
|
NCBI chr 1:12,697,742...12,775,562
Ensembl chr 1:12,697,747...12,775,561
|
|
G |
Rest |
RE1-silencing transcription factor |
affects expression decreases expression |
ISO |
Fluorouracil affects the expression of REST mRNA Fluorouracil results in decreased expression of REST protein |
CTD |
PMID:16584549 PMID:21296659 |
|
NCBI chr14:31,213,415...31,233,451
Ensembl chr14:30,862,553...30,894,354
|
|
G |
Rev1 |
REV1, DNA directed polymerase |
affects expression |
ISO |
Fluorouracil affects the expression of REV1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 9:40,278,100...40,351,764
Ensembl chr 9:40,278,101...40,351,576
|
|
G |
Rfc2 |
replication factor C subunit 2 |
affects response to substance |
ISO |
RFC2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr12:22,120,449...22,133,576
Ensembl chr12:22,120,010...22,133,557
|
|
G |
Rfc3 |
replication factor C subunit 3 |
affects response to substance |
ISO |
RFC3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr12:1,000,987...1,011,778
Ensembl chr12:1,000,994...1,011,778
|
|
G |
Rfc4 |
replication factor C subunit 4 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of RFC4 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr11:77,749,642...77,764,123
Ensembl chr11:77,749,638...77,764,122
|
|
G |
Rgs1 |
regulator of G-protein signaling 1 |
affects expression |
ISO |
Fluorouracil affects the expression of RGS1 mRNA |
CTD |
PMID:15205334 |
|
NCBI chr13:56,018,546...56,022,889
Ensembl chr13:56,018,554...56,022,984
|
|
G |
Rgs13 |
regulator of G-protein signaling 13 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of RGS13 protein |
CTD |
PMID:16803524 |
|
NCBI chr13:55,922,290...55,955,753
Ensembl chr13:55,922,395...55,955,648
|
|
G |
Rgs16 |
regulator of G-protein signaling 16 |
affects expression |
ISO |
Fluorouracil affects the expression of RGS16 mRNA |
CTD |
PMID:15205334 |
|
NCBI chr13:65,887,668...65,892,862
Ensembl chr13:65,887,530...65,892,857
|
|
G |
Rgs2 |
regulator of G-protein signaling 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of RGS2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr13:58,350,063...58,352,666
Ensembl chr13:55,798,829...55,802,385
|
|
G |
Rgs4 |
regulator of G-protein signaling 4 |
affects response to substance |
ISO |
RGS4 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr13:84,469,593...84,475,884
Ensembl chr13:81,936,775...81,943,068
|
|
G |
Rgs5 |
regulator of G-protein signaling 5 |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of RGS5 mRNA IFNA1 protein promotes the reaction [Fluorouracil results in decreased expression of RGS5 mRNA] |
CTD |
PMID:18157009 |
|
NCBI chr13:81,848,254...81,885,053
Ensembl chr13:81,836,304...81,885,518
|
|
G |
Rhbdl2 |
rhomboid like 2 |
affects response to substance |
ISO |
RHBDL2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 5:136,037,560...136,081,970
Ensembl chr 5:136,037,305...136,081,969
|
|
G |
Rhoa |
ras homolog family member A |
decreases response to substance |
ISO |
RHOA protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:15448013 |
|
NCBI chr 8:117,870,548...117,904,303
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Ripk1 |
receptor interacting serine/threonine kinase 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of RIPK1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr17:31,044,983...31,077,167
Ensembl chr17:30,839,650...30,871,824
|
|
G |
Rit1 |
Ras-like without CAAX 1 |
affects response to substance |
ISO |
RIT1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 2:174,180,742...174,195,455
Ensembl chr 2:174,180,848...174,195,455
|
|
G |
Rnase4 |
ribonuclease A family member 4 |
affects response to substance |
ISO |
RNASE4 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr15:24,312,765...24,330,112
Ensembl chr15:24,312,464...24,330,117
|
|
G |
Rnd2 |
Rho family GTPase 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of RND2 mRNA |
CTD |
PMID:16101138 |
|
NCBI chr10:86,899,395...86,902,992
Ensembl chr10:86,399,148...86,402,742
|
|
G |
Rnf34 |
ring finger protein 34 |
multiple interactions decreases response to substance |
ISO |
[Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2 mRNA; [Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2 protein; [Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2L1 mRNA; [Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2L1 protein; [Fluorouracil co-treated with RNF34 protein] results in increased expression of BIRC5 protein; [Fluorouracil co-treated with RNF34 protein] results in increased expression of FAS protein; BAY 11-7085 inhibits the reaction [[Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2 mRNA]; BAY 11-7085 inhibits the reaction [[Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2L1 mRNA]; RNF34 protein inhibits the reaction [Fluorouracil results in increased activity of CASP3 protein]; RNF34 protein inhibits the reaction [Fluorouracil results in increased activity of CASP9 protein] RNF34 protein results in decreased susceptibility to Fluorouracil; RNF34 protein results in decreased susceptibility to Fluorouracil analog |
CTD |
PMID:16080519 PMID:16270526 PMID:16407826 PMID:16596200 |
|
NCBI chr12:33,703,655...33,724,606
Ensembl chr12:33,703,673...33,724,586
|
|
G |
Rnf4 |
ring finger protein 4 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of RNF4 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr14:76,401,292...76,423,270
Ensembl chr14:76,401,299...76,422,566
|
|
G |
Rpl10a |
ribosomal protein L10A |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of RPL10A mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr20:6,388,800...6,391,358
Ensembl chr20:6,385,823...6,391,357 Ensembl chr 9:6,385,823...6,391,357
|
|
G |
Rpl23 |
ribosomal protein L23 |
increases expression |
ISO |
Fluorouracil results in increased expression of RPL23 mRNA |
CTD |
PMID:15152939 |
|
NCBI chr10:82,771,878...82,775,840
Ensembl chr10:82,771,538...82,775,870
|
|
G |
Rpl24 |
ribosomal protein L24 |
affects response to substance |
ISO |
RPL24 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr11:44,653,937...44,659,346
Ensembl chr11:44,653,937...44,659,370
|
|
G |
Rpl3 |
ribosomal protein L3 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of RPL3 protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr 7:111,622,255...111,627,640
Ensembl chr 7:111,621,610...111,636,468
|
|
G |
Rpl37 |
ribosomal protein L37 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of RPL37 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 2:54,215,469...54,217,429
Ensembl chr 2:54,215,469...54,217,442
|
|
G |
Rpl6 |
ribosomal protein L6 |
decreases response to substance |
ISO |
RPL6 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:15846068 |
|
NCBI chr12:35,347,493...35,352,011
Ensembl chr12:35,347,497...35,351,921
|
|
G |
Rprd1b |
regulation of nuclear pre-mRNA domain containing 1B |
increases expression affects response to substance |
ISO |
Fluorouracil results in increased expression of RPRD1B mRNA RPRD1B protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15331170 |
|
NCBI chr 3:146,682,975...146,729,251
Ensembl chr 3:146,682,922...146,786,452
|
|
G |
Rps26 |
ribosomal protein S26 |
affects expression |
ISO |
Fluorouracil affects the expression of RPS26 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 7:1,057,332...1,058,882
Ensembl chr X:107,822,178...107,822,525
|
|
G |
Rps27l |
ribosomal protein S27-like |
decreases expression increases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of RPS27L protein Fluorouracil results in increased expression of RPS27L mRNA TP53 protein affects the reaction [Fluorouracil results in increased expression of RPS27L mRNA] |
CTD |
PMID:15016801 PMID:16557594 PMID:18056458 |
|
NCBI chr 8:67,562,483...67,567,418
Ensembl chr 8:67,562,483...67,567,418 Ensembl chr12:67,562,483...67,567,418 Ensembl chr 2:67,562,483...67,567,418
|
|
G |
Rps28 |
ribosomal protein S28 |
increases expression |
ISO |
Fluorouracil results in increased expression of RPS28 mRNA |
CTD |
PMID:15152939 |
|
NCBI chr 7:14,607,801...14,609,170
Ensembl chr 7:14,607,801...14,609,170 Ensembl chr16:14,607,801...14,609,170 Ensembl chr16:14,607,801...14,609,170
|
|
G |
Rras |
RAS related |
affects response to substance |
ISO |
RRAS protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:95,500,582...95,504,362
Ensembl chr 1:95,500,566...95,504,357
|
|
G |
Rrbp1 |
ribosome binding protein 1 |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of RRBP1 protein RRBP1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 3:131,314,996...131,376,930
Ensembl chr 3:131,314,998...131,376,981
|
|
G |
Rrm1 |
ribonucleotide reductase catalytic subunit M1 |
increases expression |
ISO |
Fluorouracil results in increased expression of RRM1 protein |
CTD |
PMID:15331170 |
|
NCBI chr 1:166,235,904...166,260,206
Ensembl chr 1:156,823,960...156,848,261
|
|
G |
Rrm2 |
ribonucleotide reductase regulatory subunit M2 |
affects expression decreases expression increases expression affects response to substance multiple interactions |
ISO |
Fluorouracil affects the expression of RRM2 mRNA Fluorouracil results in decreased expression of RRM2 mRNA Fluorouracil results in increased expression of RRM2 mRNA RRM2 protein affects the susceptibility to Fluorouracil RRM2 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:15205334 PMID:15548681 PMID:16557594 PMID:16584549 PMID:16709241 PMID:16896004 PMID:17039268 More...
|
|
NCBI chr 6:47,044,755...47,075,370
Ensembl chr 6:41,340,557...41,346,773
|
|
G |
Rrm2b |
ribonucleotide reductase regulatory TP53 inducible subunit M2B |
decreases response to substance multiple interactions increases expression |
ISO |
RRM2B protein results in decreased susceptibility to Fluorouracil TP53 protein affects the reaction [Fluorouracil results in increased expression of RRM2B mRNA] |
CTD |
PMID:15016801 PMID:15890238 PMID:16557594 PMID:21704725 |
|
NCBI chr 7:70,962,008...70,993,726
Ensembl chr 7:69,078,291...69,108,633
|
|
G |
Rrp15 |
ribosomal RNA processing 15 homolog |
decreases expression |
ISO |
Fluorouracil results in decreased expression of RRP15 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr13:98,276,276...98,299,357
Ensembl chr13:98,276,134...98,299,370
|
|
G |
Rsrc2 |
arginine and serine rich coiled-coil 2 |
increases expression affects response to substance |
ISO |
Fluorouracil results in increased expression of RSRC2 mRNA RSRC2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15331170 |
|
NCBI chr12:32,839,840...32,859,820
Ensembl chr12:32,839,809...32,859,799
|
|
G |
RT1-CE5 |
RT1 class I, locus CE5 |
increases expression |
ISO |
Fluorouracil results in increased expression of HLA-F mRNA |
CTD |
PMID:16101138 |
|
NCBI chr20:3,407,880...3,484,130
|
|
G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of HLA-G mRNA |
CTD |
PMID:16101138 |
|
NCBI chr20:1,329,227...1,333,394
Ensembl chr20:1,287,521...1,328,117
|
|
G |
Rtkn |
rhotekin |
multiple interactions decreases response to substance |
ISO |
Curcumin inhibits the reaction [RTKN protein results in decreased susceptibility to Fluorouracil] |
CTD |
PMID:15480428 |
|
NCBI chr 4:115,640,813...115,657,952
Ensembl chr 4:115,640,774...115,657,952
|
|
G |
Runx2 |
RUNX family transcription factor 2 |
affects expression |
ISO |
Fluorouracil affects the expression of RUNX2 mRNA |
CTD |
PMID:24704097 |
|
NCBI chr 9:23,661,278...23,990,248
Ensembl chr 9:16,167,482...16,492,167
|
|
G |
S100a10 |
S100 calcium binding protein A10 |
increases expression |
ISO |
Fluorouracil results in increased expression of S100A10 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 2:179,221,012...179,229,659
Ensembl chr 2:179,220,887...179,229,661
|
|
G |
S100a11 |
S100 calcium binding protein A11 |
increases expression multiple interactions increases response to substance |
ISO |
Fluorouracil results in increased expression of S100A11 mRNA [S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased activity of CASP3 protein; [S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased cleavage of PARP1 protein; [S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased expression of H2AX protein; benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased cleavage of PARP1 protein]; S100A11 mutant form promotes the reaction [Fluorouracil results in increased cleavage of PARP1 protein] |
CTD |
PMID:19272435 PMID:25940438 |
|
NCBI chr 2:179,191,688...179,197,098
Ensembl chr 2:179,191,715...179,197,044
|
|
G |
S100a2 |
S100 calcium binding protein A2 |
affects response to substance decreases expression multiple interactions affects expression increases expression |
ISO |
S100A2 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of S100A2 protein TP53 protein affects the reaction [Fluorouracil results in increased expression of S100A2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of S100A2 mRNA] Fluorouracil affects the expression of S100A2 mRNA |
CTD |
PMID:15016801 PMID:15352031 PMID:16584549 PMID:17982676 |
|
NCBI chr 2:176,077,081...176,078,325
|
|
G |
S100a3 |
S100 calcium binding protein A3 |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of S100A3 protein S100A3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 2:176,034,283...176,089,702
Ensembl chr 2:176,049,520...176,089,702
|
|
G |
S100a4 |
S100 calcium-binding protein A4 |
affects response to substance decreases expression |
ISO |
S100A4 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of S100A4 protein |
CTD |
PMID:15352031 |
|
NCBI chr 2:178,388,529...178,390,838
Ensembl chr 2:176,091,804...176,093,254
|
|
G |
Samhd1 |
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 |
affects expression |
ISO |
Fluorouracil affects the expression of SAMHD1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 3:145,761,549...145,794,420
Ensembl chr 3:145,761,558...145,794,386
|
|
G |
Sap30 |
Sin3A associated protein 30 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SAP30 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr16:32,747,777...32,753,114
Ensembl chr16:32,747,734...32,753,112
|
|
G |
Sat1 |
spermidine/spermine N1-acetyl transferase 1 |
multiple interactions decreases response to substance increases expression |
ISO |
[Fluorouracil co-treated with N(1),N(11)-diethylnorspermine] results in increased expression of SAT1 mRNA; [Fluorouracil co-treated with N(1),N(11)-diethylnorspermine] results in increased expression of SAT1 protein; [N(1), N(12)-diethylspermine co-treated with Fluorouracil] results in increased activity of SAT1 protein; [N(1),N(11)-diethylnorspermine co-treated with Fluorouracil] results in increased expression of SAT1 mRNA; TP53 protein affects the reaction [Fluorouracil results in increased expression of SAT1 mRNA] SAT1 mRNA results in decreased susceptibility to Fluorouracil |
CTD |
PMID:15152939 PMID:16510598 PMID:16557594 PMID:16637064 PMID:17237273 PMID:21814787 More...
|
|
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
|
|
G |
Scamp3 |
secretory carrier membrane protein 3 |
multiple interactions |
ISO |
[Fluorouracil co-treated with irinotecan] results in decreased expression of SCAMP3 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr 2:174,583,124...174,588,984
Ensembl chr 2:174,570,653...174,588,985
|
|
G |
Sccpdh |
saccharopine dehydrogenase (putative) |
increases expression |
ISO |
Fluorouracil results in increased expression of SCCPDH mRNA |
CTD |
PMID:16101138 |
|
NCBI chr13:91,400,120...91,421,875
Ensembl chr13:91,400,190...91,422,222
|
|
G |
Scd |
stearoyl-CoA desaturase |
increases expression decreases expression affects response to substance multiple interactions |
ISO |
Fluorouracil results in increased expression of SCD mRNA Fluorouracil results in decreased expression of SCD mRNA SCD protein affects the susceptibility to Fluorouracil TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of SCD mRNA] |
CTD |
PMID:16217747 PMID:17039268 PMID:17982676 |
|
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Scg2 |
secretogranin II |
decreases expression affects response to substance increases expression |
ISO |
Fluorouracil results in decreased expression of SCG2 protein SCG2 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of SCG2 mRNA |
CTD |
PMID:15352031 PMID:24737281 |
|
NCBI chr 9:80,803,074...80,808,646
Ensembl chr 9:80,803,075...80,821,097
|
|
G |
Scn2b |
sodium voltage-gated channel beta subunit 2 |
affects expression |
ISO |
Fluorouracil affects the expression of SCN2B mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 8:45,425,629...45,437,765
Ensembl chr 8:45,425,629...45,437,765
|
|
G |
Scnn1a |
sodium channel epithelial 1 subunit alpha |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of SCNN1A protein SCNN1A protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 4:159,809,187...159,832,409
Ensembl chr 4:158,122,962...158,146,181
|
|
G |
Scnn1b |
sodium channel epithelial 1 subunit beta |
affects expression |
ISO |
Fluorouracil affects the expression of SCNN1B mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 1:185,861,326...185,915,717
Ensembl chr 1:176,430,103...176,484,451
|
|
G |
Scube2 |
signal peptide, CUB domain and EGF like domain containing 2 |
multiple interactions |
ISO |
SCUBE2 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr 1:163,831,876...163,899,925
Ensembl chr 1:163,832,015...163,899,393
|
|
G |
Sdccag8 |
SHH signaling and ciliogenesis regulator SDCCAG8 |
increases expression |
ISO |
Fluorouracil results in increased expression of SDCCAG8 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr13:88,754,521...88,979,363
Ensembl chr13:88,754,626...89,097,111
|
|
G |
Sdha |
succinate dehydrogenase complex flavoprotein subunit A |
affects response to substance |
ISO |
SDHA protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 1:30,764,553...30,789,523
Ensembl chr 1:28,940,164...28,961,535
|
|
G |
Sdhd |
succinate dehydrogenase complex subunit D |
affects expression |
ISO |
Fluorouracil affects the expression of SDHD mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 8:59,841,090...59,850,641
Ensembl chr 8:50,944,704...50,954,238
|
|
G |
Sec14l1 |
SEC14-like lipid binding 1 |
affects response to substance |
ISO |
SEC14L1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:102,319,920...102,367,070
Ensembl chr10:102,319,920...102,367,068
|
|
G |
Sec23a |
Sec23 homolog A, COPII coat complex component |
affects response to substance |
ISO |
SEC23A protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 6:82,393,699...82,442,594
Ensembl chr 6:76,658,427...76,706,035
|
|
G |
Sec31a |
SEC31 homolog A, COPII coat complex component |
affects response to substance |
ISO |
SEC31A protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr14:9,214,324...9,269,281
Ensembl chr14:9,214,349...9,269,273
|
|
G |
Sec31b |
SEC31 homolog B, COPII coat complex component |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SEC31B mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:243,376,283...243,404,557
Ensembl chr 1:243,378,456...243,404,557
|
|
G |
Selenop |
selenoprotein P |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SELENOP mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 2:54,225,736...54,236,022
Ensembl chr 2:52,498,339...52,508,852
|
|
G |
Sema3a |
semaphorin 3A |
increases expression |
ISO |
Fluorouracil results in increased expression of SEMA3A mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 4:21,282,398...21,754,834
Ensembl chr 4:21,287,982...21,494,432
|
|
G |
Sephs1 |
selenophosphate synthetase 1 |
affects response to substance |
ISO |
SEPHS1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr17:73,354,435...73,382,803
Ensembl chr17:73,356,530...73,382,593
|
|
G |
Sephs2 |
selenophosphate synthetase 2 |
affects response to substance |
ISO |
SEPHS2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:181,893,146...181,895,464
Ensembl chr 1:181,892,599...181,895,497
|
|
G |
Septin9 |
septin 9 |
affects expression |
ISO |
Fluorouracil affects the expression of SEPTIN9 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr10:102,908,557...103,077,789
Ensembl chr10:102,409,711...102,579,055
|
|
G |
Serf2 |
small EDRK-rich factor 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of SERF2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 3:108,426,960...108,430,736
Ensembl chr 3:108,426,887...108,430,724
|
|
G |
Serpina5 |
serpin family A member 5 |
increases expression |
ISO |
Fluorouracil results in increased expression of SERPINA5 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr 6:123,009,224...123,028,412
Ensembl chr 6:123,023,306...123,028,407
|
|
G |
Serpina7 |
serpin family A member 7 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SERPINA7 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr X:107,452,044...107,510,958
Ensembl chr X:102,663,405...102,669,040
|
|
G |
Serpinb2 |
serpin family B member 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of SERPINB2 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr13:24,051,933...24,065,032
Ensembl chr13:23,541,400...23,550,408
|
|
G |
Serpinb3a |
serpin family B member 3A |
decreases expression |
ISO |
Fluorouracil results in decreased expression of SERPINB4 protein |
CTD |
PMID:16803524 |
|
NCBI chr13:23,755,690...23,766,188
Ensembl chr13:23,236,972...23,246,985
|
|
G |
Serpinb5 |
serpin family B member 5 |
multiple interactions increases expression increases response to substance |
ISO |
[Fluorouracil co-treated with irinotecan] results in decreased expression of SERPINB5 mRNA; TP53 protein affects the reaction [Fluorouracil results in increased expression of SERPINB5 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of SERPINB5 mRNA] SERPINB5 protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:15016801 PMID:16331619 PMID:16391804 PMID:17982676 |
|
NCBI chr13:22,985,557...23,005,756
Ensembl chr13:22,985,557...23,005,756
|
|
G |
Serpind1 |
serpin family D member 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SERPIND1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr11:83,664,517...83,675,593
Ensembl chr11:83,664,518...83,675,519
|
|
G |
Serpine2 |
serpin family E member 2 |
multiple interactions |
ISO |
SERPINE2 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] |
CTD |
PMID:17327601 |
|
NCBI chr 9:81,124,746...81,188,866
Ensembl chr 9:81,124,804...81,188,826
|
|
G |
Serpini1 |
serpin family I member 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of SERPINI1 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 2:160,346,403...160,433,135
Ensembl chr 2:160,346,758...160,433,135
|
|
G |
Sertad1 |
SERTA domain containing 1 |
multiple interactions increases expression |
ISO |
TP53 protein affects the reaction [Fluorouracil results in increased expression of SERTAD1 mRNA] |
CTD |
PMID:15016801 PMID:16557594 PMID:16584549 |
|
NCBI chr 1:82,775,692...82,778,961
Ensembl chr 1:82,775,252...82,779,091
|
|
G |
Sesn1 |
sestrin 1 |
multiple interactions increases expression |
ISO |
TP53 protein affects the reaction [Fluorouracil results in increased expression of SESN1 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of SESN1 mRNA] Fluorouracil results in increased expression of SESN1 mRNA; Fluorouracil results in increased expression of SESN1 protein |
CTD |
PMID:14665630 PMID:15016801 PMID:17982676 PMID:22525470 |
|
NCBI chr20:46,876,918...46,970,010
Ensembl chr20:45,294,871...45,387,697
|
|
G |
Sesn2 |
sestrin 2 |
multiple interactions increases expression |
ISO |
TP53 protein affects the reaction [Fluorouracil results in increased expression of SESN2 mRNA] |
CTD |
PMID:15016801 PMID:22525470 |
|
NCBI chr 5:149,986,304...150,005,255
Ensembl chr 5:144,701,530...144,721,260
|
|
G |
Set |
Set nuclear proto-oncogene |
decreases expression |
ISO |
Fluorouracil results in decreased expression of SET mRNA |
CTD |
PMID:19272435 |
|
NCBI chr 3:33,732,319...33,743,433
Ensembl chr 3:13,335,041...13,363,567
|
|
G |
Setd5 |
SET domain containing 5 |
affects expression |
ISO |
Fluorouracil affects the expression of SETD5 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 4:146,217,172...146,294,896
Ensembl chr 4:146,217,180...146,294,894
|
|
G |
Sez6l |
seizure related 6 homolog like |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SEZ6L mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr12:44,064,901...44,221,814
Ensembl chr12:44,064,935...44,219,663
|
|
G |
Sf3b3 |
splicing factor 3b, subunit 3 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SF3B3 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr19:38,782,749...38,820,271
Ensembl chr19:38,783,040...38,820,245
|
|
G |
Sfn |
stratifin |
multiple interactions affects expression increases expression |
ISO |
SFN protein affects the susceptibility to [Fluorouracil co-treated with Cisplatin]; TP53 protein affects the reaction [Fluorouracil results in increased expression of SFN mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of SFN mRNA] Fluorouracil affects the expression of SFN mRNA |
CTD |
PMID:15016801 PMID:15999354 PMID:16557594 PMID:16584549 PMID:17982676 |
|
NCBI chr 5:151,110,582...151,111,854
Ensembl chr 5:145,826,201...145,831,314
|
|
G |
Sfrp2 |
secreted frizzled-related protein 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of SFRP2 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 2:169,089,517...169,097,064
Ensembl chr 2:169,089,517...169,097,063
|
|
G |
Sgce |
sarcoglycan, epsilon |
affects response to substance |
ISO |
SGCE protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 4:32,771,477...32,842,238
Ensembl chr 4:32,771,477...32,842,254
|
|
G |
Shh |
sonic hedgehog signaling molecule |
decreases expression increases expression |
ISO |
Fluorouracil results in decreased expression of SHH mRNA Fluorouracil results in increased expression of SHH mRNA |
CTD |
PMID:18776995 PMID:26272751 |
|
NCBI chr 4:7,687,872...7,697,025
Ensembl chr 4:6,954,017...6,963,170
|
|
G |
Shisa9 |
shisa family member 9 |
increases expression |
ISO |
Fluorouracil results in increased expression of SHISA9 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr10:3,335,616...3,629,334
Ensembl chr10:3,337,979...3,627,773
|
|
G |
Shmt2 |
serine hydroxymethyltransferase 2 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SHMT2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 7:65,244,247...65,249,580
Ensembl chr 7:63,358,961...63,364,236
|
|
G |
Siglec1 |
sialic acid binding Ig like lectin 1 |
multiple interactions |
ISO |
[Fluorouracil co-treated with irinotecan] results in increased expression of SIGLEC1 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr 3:118,287,988...118,307,125
Ensembl chr 3:118,287,988...118,306,850
|
|
G |
Sirt4 |
sirtuin 4 |
increases expression |
ISO |
Fluorouracil results in increased expression of SIRT4 mRNA; Fluorouracil results in increased expression of SIRT4 protein |
CTD |
PMID:39241941 |
|
NCBI chr12:41,125,533...41,139,440
Ensembl chr12:41,131,262...41,139,439
|
|
G |
Skic8 |
SKI8 subunit of superkiller complex |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SKIC8 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 8:55,103,542...55,120,837
Ensembl chr 8:55,103,545...55,120,813
|
|
G |
Slc13a5 |
solute carrier family 13 member 5 |
decreases response to substance |
ISO |
SLC13A5 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:32634519 |
|
NCBI chr10:57,364,806...57,389,500
Ensembl chr10:56,866,249...56,890,945
|
|
G |
Slc15a1 |
solute carrier family 15 member 1 |
decreases activity decreases expression |
ISO |
Fluorouracil results in decreased activity of SLC15A1 protein Fluorouracil results in decreased expression of SLC15A1 mRNA |
CTD |
PMID:16253763 |
|
NCBI chr15:98,537,641...98,582,544
Ensembl chr15:98,537,641...98,582,545
|
|
G |
Slc16a1 |
solute carrier family 16 member 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of SLC16A1 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 2:194,805,556...194,832,966
Ensembl chr 2:192,124,289...192,144,611
|
|
G |
Slc16a6 |
solute carrier family 16, member 6 |
decreases expression increases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of SLC16A6 protein Fluorouracil results in increased expression of SLC16A6 mRNA SLC16A6 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 PMID:16510598 |
|
NCBI chr10:94,923,888...94,946,990
Ensembl chr10:94,426,244...94,448,779
|
|
G |
Slc22a7 |
solute carrier family 22 member 7 |
increases transport |
ISO |
SLC22A7 protein results in increased transport of Fluorouracil |
CTD |
PMID:15901346 |
|
NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
increases transport |
ISO |
SLC22A8 protein results in increased transport of Fluorouracil |
CTD |
PMID:15100168 |
|
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
|
|
G |
Slc25a23 |
solute carrier family 25 member 23 |
affects expression |
ISO |
Fluorouracil affects the expression of SLC25A23 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 9:1,882,636...1,898,369
Ensembl chr 9:1,882,621...1,898,561
|
|
G |
Slc25a27 |
solute carrier family 25, member 27 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of SLC25A27 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 9:17,306,898...17,333,942
Ensembl chr 9:17,307,023...17,332,731
|
|
G |
Slc29a1 |
solute carrier family 29 member 1 |
multiple interactions increases expression affects response to substance decreases response to substance |
ISO |
4-nitrobenzylthioinosine inhibits the reaction [SLC29A1 protein results in decreased susceptibility to Fluorouracil]; Fluorouracil promotes the reaction [SLC29A1 protein results in increased uptake of Gemcitabine] Fluorouracil results in increased expression of SLC29A1; Fluorouracil results in increased expression of SLC29A1 mRNA SLC29A1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 PMID:16868479 PMID:17695509 PMID:18383843 |
|
NCBI chr 9:22,897,099...22,911,640
Ensembl chr 9:15,399,612...15,414,203
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
decreases expression increases expression decreases activity |
ISO |
Fluorouracil results in decreased expression of SLC2A1 mRNA Fluorouracil results in increased expression of SLC2A1 mRNA Fluorouracil results in decreased activity of SLC2A1 protein |
CTD |
PMID:16253763 PMID:16595493 |
|
NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc2a2 |
solute carrier family 2 member 2 |
multiple interactions increases expression |
ISO |
Fluorouracil promotes the reaction [SLC2A2 protein results in increased uptake of 3-O-Methylglucose]; Phloretin inhibits the reaction [Fluorouracil promotes the reaction [SLC2A2 protein results in increased uptake of 3-O-Methylglucose]] Fluorouracil results in increased expression of SLC2A2 mRNA; Fluorouracil results in increased expression of SLC2A2 protein |
CTD |
PMID:15986457 |
|
NCBI chr 2:113,537,884...113,568,422
Ensembl chr 2:111,611,774...111,639,933
|
|
G |
Slc2a3 |
solute carrier family 2 member 3 |
affects response to substance |
ISO |
SLC2A3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 4:157,632,887...157,698,034
Ensembl chr 4:155,960,946...156,025,472
|
|
G |
Slc35f5 |
solute carrier family 35, member F5 |
affects response to substance |
ISO |
SLC35F5 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16477629 |
|
NCBI chr13:36,992,118...37,028,549
Ensembl chr13:36,992,205...37,028,538
|
|
G |
Slc3a2 |
solute carrier family 3 member 2 |
increases expression affects response to substance |
ISO |
Fluorouracil results in increased expression of SLC3A2 mRNA SLC3A2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15331170 |
|
NCBI chr 1:215,033,601...215,048,064
Ensembl chr 1:205,604,468...205,618,931
|
|
G |
Slc47a1 |
solute carrier family 47 member 1 |
affects response to substance |
ISO |
SLC47A1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:46,533,580...46,590,128
Ensembl chr10:46,034,122...46,087,637
|
|
G |
Slc48a1 |
solute carrier family 48 member 1 |
affects expression |
ISO |
Fluorouracil affects the expression of SLC48A1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 7:128,915,136...128,923,929
Ensembl chr 7:128,915,195...128,923,024
|
|
G |
Slc5a1 |
solute carrier family 5 member 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of SLC5A1 protein |
CTD |
PMID:15986457 |
|
NCBI chr14:77,553,990...77,618,589
Ensembl chr14:77,553,843...77,618,547
|
|
G |
Slc9a3 |
solute carrier family 9 member A3 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of SLC9A3 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 1:30,953,215...30,996,209
Ensembl chr 1:29,124,674...29,167,417
|
|
G |
Slco2a1 |
solute carrier organic anion transporter family, member 2a1 |
affects expression |
ISO |
Fluorouracil affects the expression of SLCO2A1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 8:103,588,916...103,672,546
Ensembl chr 8:103,588,916...103,672,546
|
|
G |
Smad4 |
SMAD family member 4 |
multiple interactions |
ISO |
SMAD4 results in decreased susceptibility to [Fluorouracil co-treated with alpha-Tocopherol] |
CTD |
PMID:20562578 |
|
NCBI chr18:69,518,988...69,549,684
Ensembl chr18:67,243,742...67,274,438
|
|
G |
Smarca1 |
SNF2 related chromatin remodeling ATPase 1 |
affects response to substance increases expression |
ISO |
SMARCA1 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of SMARCA1 protein |
CTD |
PMID:15352031 PMID:16217747 |
|
NCBI chr X:126,980,201...127,066,385
Ensembl chr X:126,994,947...127,066,347
|
|
G |
Smchd1 |
structural maintenance of chromosomes flexible hinge domain containing 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of SMCHD1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 9:111,243,445...111,387,272
Ensembl chr 9:111,247,702...111,349,665
|
|
G |
Smim10l2a |
small integral membrane protein 10 like 2A |
decreases expression |
ISO |
Fluorouracil results in decreased expression of SMIM10L2A mRNA |
CTD |
PMID:34151400 |
|
NCBI chr X:134,151,325...134,154,647
|
|
G |
Smim14 |
small integral membrane protein 14 |
increases expression |
ISO |
Fluorouracil results in increased expression of SMIM14 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr14:42,783,361...42,829,762
Ensembl chr14:42,783,332...42,829,760
|
|
G |
Smo |
smoothened, frizzled class receptor |
decreases expression |
ISO |
Fluorouracil results in decreased expression of SMO mRNA; Fluorouracil results in decreased expression of SMO protein |
CTD |
PMID:18776995 PMID:25190613 |
|
NCBI chr 4:59,311,084...59,341,280
Ensembl chr 4:58,343,529...58,373,829
|
|
G |
Smox |
spermine oxidase |
multiple interactions |
ISO |
[Oxaliplatin co-treated with Fluorouracil] results in increased expression of and results in increased activity of SMOX protein; [Oxaliplatin co-treated with Fluorouracil] results in increased expression of SMOX mRNA |
CTD |
PMID:17987291 |
|
NCBI chr 3:118,731,814...118,767,242
Ensembl chr 3:118,731,900...118,765,710 Ensembl chr X:118,731,900...118,765,710
|
|
G |
Sms |
spermine synthase |
increases expression multiple interactions |
ISO |
Fluorouracil results in increased expression of SMS mRNA TP53 protein affects the reaction [Fluorouracil results in decreased expression of SMS mRNA] |
CTD |
PMID:15016801 PMID:15152939 |
|
NCBI chr X:41,331,693...41,387,713
Ensembl chr X:37,516,931...37,570,822 Ensembl chr 3:37,516,931...37,570,822
|
|
G |
Smurf1 |
SMAD specific E3 ubiquitin protein ligase 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of SMURF1 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr12:14,748,717...14,840,273
Ensembl chr12:9,635,025...9,726,519
|
|
G |
Snai2 |
snail family transcriptional repressor 2 |
increases expression multiple interactions |
ISO |
Fluorouracil results in increased expression of SNAI2 protein resveratrol inhibits the reaction [Fluorouracil results in increased expression of SNAI2 protein] |
CTD |
PMID:26310874 |
|
NCBI chr11:86,182,788...86,186,203
Ensembl chr11:86,181,909...86,186,200
|
|
G |
Snap29 |
synaptosome associated protein 29 |
increases expression |
ISO |
Fluorouracil results in increased expression of SNAP29 protein |
CTD |
PMID:16803524 |
|
NCBI chr11:97,082,721...97,113,195
Ensembl chr11:83,578,489...83,608,958
|
|
G |
Snapc1 |
small nuclear RNA activating complex, polypeptide 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of SNAPC1 protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr 6:92,684,785...92,710,772
Ensembl chr 6:92,684,752...92,707,746
|
|
G |
Snord22 |
small nucleolar RNA, C/D box 22 |
increases expression |
ISO |
Fluorouracil results in increased expression of SNORD22 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr11:9,097,799...9,097,923
Ensembl chr11:9,097,799...9,097,923
|
|
G |
Snrnp48 |
small nuclear ribonucleoprotein U11/U12 subunit 48 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of SNRNP48 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr17:26,596,266...26,616,058
Ensembl chr17:26,596,275...26,616,040
|
|
G |
Snrpa1 |
small nuclear ribonucleoprotein polypeptide A' |
multiple interactions |
ISO |
SNRPA1 protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] |
CTD |
PMID:18927307 |
|
NCBI chr 1:119,641,402...119,654,653
Ensembl chr 1:119,638,481...119,654,653
|
|
G |
Sntb1 |
syntrophin, beta 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of SNTB1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 7:87,060,926...87,329,315
Ensembl chr 7:87,060,926...87,329,315
|
|
G |
Snx6 |
sorting nexin 6 |
affects response to substance |
ISO |
SNX6 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 6:72,230,950...72,274,157
Ensembl chr 6:72,229,870...72,315,911
|
|
G |
Soat1 |
sterol O-acyltransferase 1 |
affects response to substance |
ISO |
SOAT1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr13:71,105,178...71,147,776
Ensembl chr13:68,552,317...68,597,494
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of SOCS1 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr10:5,389,574...5,391,265
Ensembl chr10:4,882,560...4,884,383
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions increases expression decreases activity |
ISO EXP |
casticin promotes the reaction [Fluorouracil results in increased expression of SOD1 protein]; Fluorouracil promotes the reaction [casticin results in increased expression of SOD1 protein] Fluorouracil results in decreased activity of SOD1 protein |
CTD |
PMID:29117755 PMID:32270916 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
ISO |
[irinotecan co-treated with Fluorouracil] results in increased activity of SOD2 protein |
CTD |
PMID:15886469 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sox17 |
SRY-box transcription factor 17 |
decreases expression decreases localization |
ISO |
Fluorouracil results in decreased expression of SOX17 protein Fluorouracil results in decreased localization of SOX17 protein Fluorouracil results in decreased expression of SOX17 mRNA |
CTD |
PMID:21296659 PMID:24154490 PMID:24737281 |
|
NCBI chr 5:15,016,660...15,022,228
Ensembl chr 5:15,016,731...15,022,228
|
|
G |
Sox18 |
SRY-box transcription factor 18 |
affects response to substance |
ISO |
SOX18 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 3:168,785,488...168,787,290
Ensembl chr 3:168,785,490...168,787,290
|
|
G |
Sox2 |
SRY-box transcription factor 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of SOX2 protein |
CTD |
PMID:21296659 |
|
NCBI chr 2:119,465,131...119,467,542
Ensembl chr 2:117,536,929...117,539,338
|
|
G |
Sox4 |
SRY-box transcription factor 4 |
increases expression |
ISO |
Fluorouracil results in increased expression of SOX4 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr17:35,876,298...35,881,004
Ensembl chr17:35,667,537...35,673,665
|
|
G |
Sp1 |
Sp1 transcription factor |
multiple interactions |
ISO |
Fluorouracil promotes the reaction [[TP53 protein binds to SP1 protein] which binds to CDKN1A promoter]; SP1 protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] |
CTD |
PMID:15489892 PMID:18927307 |
|
NCBI chr 7:135,419,864...135,450,513
Ensembl chr 7:133,541,491...133,571,961
|
|
G |
Sp3 |
Sp3 transcription factor |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SP3 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 3:57,811,855...57,857,150
Ensembl chr 3:57,812,075...57,860,342
|
|
G |
Spag5 |
sperm associated antigen 5 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SPAG5 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr10:63,693,300...63,714,813
Ensembl chr10:63,198,768...63,216,745
|
|
G |
Sparc |
secreted protein acidic and cysteine rich |
multiple interactions increases response to substance affects expression |
ISO |
[decitabine affects the methylation of SPARC promoter] which affects the susceptibility to Fluorouracil SPARC protein results in increased susceptibility to Fluorouracil Fluorouracil affects the expression of SPARC mRNA |
CTD |
PMID:15902309 PMID:18458674 PMID:24704097 |
|
NCBI chr10:40,017,065...40,038,816
Ensembl chr10:39,516,406...39,538,396
|
|
G |
Spata25 |
spermatogenesis associated 25 |
increases expression |
ISO |
Fluorouracil results in increased expression of SPATA25 protein |
CTD |
PMID:15331170 |
|
NCBI chr 3:153,562,479...153,566,508
Ensembl chr 3:153,562,528...153,564,480
|
|
G |
Spink4 |
serine peptidase inhibitor, Kazal type 4 |
affects expression |
ISO |
Fluorouracil affects the expression of SPINK4 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 5:56,043,936...56,064,841
Ensembl chr 5:55,981,624...56,064,795
|
|
G |
Spn |
sialophorin |
multiple interactions |
ISO |
Fluorouracil inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in increased expression of SPN mRNA]; Fluorouracil inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in increased expression of SPN protein] |
CTD |
PMID:31404653 |
|
NCBI chr 1:181,746,937...181,759,564
Ensembl chr 1:181,746,429...181,759,628
|
|
G |
Spock1 |
sparc/osteonectin, cwcv and kazal like domains proteoglycan 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of SPOCK1 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr17:6,741,504...7,221,685
Ensembl chr17:6,742,273...7,224,935
|
|
G |
Spon1 |
spondin 1 |
affects expression |
ISO |
Fluorouracil affects the expression of SPON1 mRNA |
CTD |
PMID:15205334 |
|
NCBI chr 1:167,929,049...168,228,239
Ensembl chr 1:167,928,972...168,228,226
|
|
G |
Sprr1a |
small proline-rich protein 1A |
increases expression |
ISO |
Fluorouracil results in increased expression of SPRR1A mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 2:178,055,096...178,057,012
Ensembl chr 2:178,055,096...178,057,063
|
|
G |
Sprr1b |
small proline-rich protein 1B |
affects expression |
ISO |
Fluorouracil affects the expression of SPRR1B mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 2:178,008,844...178,010,742
Ensembl chr 2:178,009,130...178,009,567
|
|
G |
Sprr3 |
small proline-rich protein 3 |
affects expression |
ISO |
Fluorouracil affects the expression of SPRR3 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 2:178,027,743...178,028,501
Ensembl chr 2:178,027,425...178,029,891
|
|
G |
Spry1 |
sprouty RTK signaling antagonist 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of SPRY1 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr 2:120,557,256...120,561,917
Ensembl chr 2:120,556,706...120,566,189
|
|
G |
Sptan1 |
spectrin, alpha, non-erythrocytic 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of SPTAN1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 3:13,241,164...13,306,047
Ensembl chr 3:13,241,217...13,306,046
|
|
G |
Sqle |
squalene epoxidase |
decreases expression |
ISO |
Fluorouracil results in decreased expression of SQLE mRNA |
CTD |
PMID:15205334 |
|
NCBI chr 7:92,758,175...92,773,049
Ensembl chr 7:90,868,011...90,883,618
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
increases phosphorylation affects response to substance decreases expression |
ISO |
Fluorouracil results in increased phosphorylation of SRC protein SRC protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of SRC protein |
CTD |
PMID:18794807 PMID:39334374 |
|
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
affects expression |
ISO |
Fluorouracil affects the expression of SREBF1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Srebf2 |
sterol regulatory element binding transcription factor 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of SREBF2 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 7:115,542,774...115,600,945
Ensembl chr 7:113,663,202...113,720,848
|
|
G |
Sri |
sorcin |
decreases response to substance |
ISO |
SRI protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:18423116 |
|
NCBI chr 4:25,973,493...25,997,879
Ensembl chr 4:25,966,750...25,998,077
|
|
G |
Srp19 |
signal recognition particle 19 |
multiple interactions |
ISO |
[Fluorouracil co-treated with irinotecan] results in decreased expression of SRP19 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr18:25,931,734...25,937,974
Ensembl chr18:25,931,589...25,938,017
|
|
G |
Srp72 |
signal recognition particle 72 |
increases expression |
ISO |
Fluorouracil results in increased expression of SRP72 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr14:31,168,175...31,195,717
Ensembl chr14:31,168,293...31,195,729
|
|
G |
Srp9 |
signal recognition particle 9 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SRP9 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr13:93,832,580...93,840,720
Ensembl chr13:93,832,580...93,840,720
|
|
G |
Srrm1 |
serine and arginine repetitive matrix 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of SRRM1 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 5:152,843,167...152,875,554
Ensembl chr 5:147,559,514...147,591,849
|
|
G |
Srsf11 |
serine and arginine rich splicing factor 11 |
increases expression |
ISO |
Fluorouracil results in increased expression of SRSF11 protein |
CTD |
PMID:15331170 |
|
NCBI chr 2:247,074,623...247,101,460
Ensembl chr 2:247,074,631...247,101,425
|
|
G |
Srsf6 |
serine and arginine rich splicing factor 6 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SRSF6 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 3:172,009,072...172,014,395
Ensembl chr 3:151,589,535...151,594,860
|
|
G |
Sst |
somatostatin |
increases expression |
ISO |
Fluorouracil results in increased expression of SST protein |
CTD |
PMID:21296659 |
|
NCBI chr11:76,956,896...76,958,173
Ensembl chr11:76,956,896...76,958,173
|
|
G |
Stard7 |
StAR-related lipid transfer domain containing 7 |
affects expression |
ISO |
Fluorouracil affects the expression of STARD7 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 3:114,487,161...114,515,828
Ensembl chr 3:114,485,600...114,515,813
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of STAT1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
increases expression decreases phosphorylation affects response to substance |
ISO |
Fluorouracil results in increased expression of STAT3 mRNA Fluorouracil results in decreased phosphorylation of STAT3 protein STAT3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15682485 PMID:15730734 PMID:16557594 PMID:18161298 PMID:18205257 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Stau1 |
staufen double-stranded RNA binding protein 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of STAU1 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 3:176,099,053...176,144,947
Ensembl chr 3:155,680,000...155,725,909
|
|
G |
Stbd1 |
starch binding domain 1 |
affects response to substance |
ISO |
STBD1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr14:15,754,769...15,758,174
Ensembl chr14:15,469,582...15,477,443
|
|
G |
Stk38 |
serine/threonine kinase 38 |
affects response to substance |
ISO |
STK38 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr20:7,034,245...7,067,803
Ensembl chr20:7,034,242...7,068,198
|
|
G |
Stk4 |
serine/threonine kinase 4 |
multiple interactions |
ISO |
STK4 protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] |
CTD |
PMID:18927307 |
|
NCBI chr 3:173,165,238...173,247,135
Ensembl chr 3:152,745,681...152,827,744
|
|
G |
Stom |
stomatin |
decreases expression |
ISO |
Fluorouracil results in decreased expression of STOM mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 3:18,645,058...18,667,343
Ensembl chr 3:18,644,378...18,667,354
|
|
G |
Stx5 |
syntaxin 5 |
multiple interactions |
ISO |
[Fluorouracil co-treated with irinotecan] results in increased expression of STX5 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr 1:205,637,401...205,653,563
Ensembl chr 1:205,637,413...205,653,563
|
|
G |
Stxbp4 |
syntaxin binding protein 4 |
affects expression |
ISO |
Fluorouracil affects the expression of STXBP4 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr10:75,798,938...75,955,817
Ensembl chr10:75,305,463...75,458,663
|
|
G |
Sufu |
SUFU negative regulator of hedgehog signaling |
decreases expression |
ISO |
Fluorouracil results in decreased expression of SUFU mRNA |
CTD |
PMID:18776995 |
|
NCBI chr 1:255,199,108...255,296,983
Ensembl chr 1:245,257,768...245,355,577
|
|
G |
Supv3l1 |
Suv3 like RNA helicase |
decreases expression |
ISO |
Fluorouracil results in decreased expression of SUPV3L1 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr20:30,378,542...30,399,076
Ensembl chr20:30,378,550...30,399,054
|
|
G |
Swap70 |
switching B-cell complex subunit SWAP70 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of SWAP70 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 1:164,267,588...164,328,796
Ensembl chr 1:164,267,609...164,328,794
|
|
G |
Sycp3 |
synaptonemal complex protein 3 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of SYCP3 protein |
CTD |
PMID:21296659 |
|
NCBI chr 7:22,874,055...22,888,512
Ensembl chr 7:22,874,055...22,888,511
|
|
G |
Sympk |
symplekin scaffold protein |
decreases expression |
ISO |
Fluorouracil results in decreased expression of SYMPK mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 1:78,672,372...78,700,684
Ensembl chr 1:78,672,378...78,700,684
|
|
G |
Syncrip |
synaptotagmin binding, cytoplasmic RNA interacting protein |
decreases expression |
ISO |
Fluorouracil results in decreased expression of SYNCRIP mRNA |
CTD |
PMID:17039268 |
|
NCBI chr 8:89,402,487...89,435,517
Ensembl chr 8:89,402,866...89,435,515
|
|
G |
Syp |
synaptophysin |
increases expression |
ISO |
Fluorouracil results in increased expression of SYP protein |
CTD |
PMID:21296659 |
|
NCBI chr X:17,521,348...17,536,449
Ensembl chr X:14,849,444...14,864,745
|
|
G |
Sytl2 |
synaptotagmin-like 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of SYTL2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 1:144,272,870...144,379,310
Ensembl chr 1:144,273,360...144,379,222
|
|
G |
Taf3 |
TATA-box binding protein associated factor 3 |
affects expression |
ISO |
Fluorouracil affects the expression of TAF3 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr17:68,455,389...68,608,367
Ensembl chr17:68,423,909...68,608,367
|
|
G |
Taf5l1 |
TATA-box binding protein associated factor 5 like 1 |
multiple interactions |
ISO |
[Fluorouracil co-treated with irinotecan] results in decreased expression of TAF5L mRNA |
CTD |
PMID:16391804 |
|
NCBI chr19:51,991,704...52,011,001
Ensembl chr19:51,991,708...52,011,295
|
|
G |
Tagln |
transgelin |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of TAGLN protein TAGLN protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 PMID:16217747 |
|
NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668
|
|
G |
Tank |
TRAF family member-associated NFKB activator |
increases expression |
ISO |
Fluorouracil results in increased expression of TANK protein |
CTD |
PMID:16803524 |
|
NCBI chr 3:46,114,230...46,190,270
Ensembl chr 3:46,114,274...46,190,264
|
|
G |
Taok3 |
TAO kinase 3 |
affects response to substance |
ISO |
TAOK3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr12:39,312,354...39,473,656
Ensembl chr12:39,314,027...39,461,244
|
|
G |
Tap1 |
transporter 1, ATP binding cassette subfamily B member |
multiple interactions increases expression |
ISO |
TP53 protein promotes the reaction [Fluorouracil results in increased expression of TAP1 mRNA] |
CTD |
PMID:17982676 PMID:20737486 |
|
NCBI chr20:4,658,171...4,668,543
Ensembl chr20:4,656,263...4,666,901
|
|
G |
Tap2 |
transporter 2, ATP binding cassette subfamily B member |
increases expression |
ISO |
Fluorouracil results in increased expression of TAP2 mRNA |
CTD |
PMID:20737486 |
|
NCBI chr20:4,638,257...4,652,296
Ensembl chr20:4,636,357...4,650,407
|
|
G |
Tat |
tyrosine aminotransferase |
decreases expression |
ISO |
Fluorouracil results in decreased expression of TAT protein |
CTD |
PMID:21296659 |
|
NCBI chr19:54,856,604...54,867,168
Ensembl chr19:37,947,112...37,958,031
|
|
G |
Tax1bp3 |
Tax1 binding protein 3 |
increases expression |
ISO |
Fluorouracil results in increased expression of TAX1BP3 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr10:57,795,845...57,800,363
Ensembl chr10:57,795,382...57,800,363
|
|
G |
Tbcd |
tubulin folding cofactor D |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of TBCD mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr10:106,717,340...106,874,126
Ensembl chr10:106,717,367...106,874,122
|
|
G |
Tbce |
tubulin folding cofactor E |
affects response to substance |
ISO |
TBCE protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr17:51,290,143...51,336,090
Ensembl chr17:51,290,202...51,336,089
|
|
G |
Tbrg4 |
transforming growth factor beta regulator 4 |
increases expression |
ISO |
Fluorouracil results in increased expression of TBRG4 mRNA |
CTD |
PMID:19272435 |
|
NCBI chr14:81,481,977...81,490,781
Ensembl chr14:81,481,981...81,490,756
|
|
G |
Tbxt |
T-box transcription factor T |
decreases expression |
ISO |
Fluorouracil results in decreased expression of T protein |
CTD |
PMID:21296659 |
|
NCBI chr 1:54,845,674...54,859,340
Ensembl chr 1:52,298,099...52,305,864
|
|
G |
Tcf15 |
transcription factor 15 |
increases expression |
ISO |
Fluorouracil results in increased expression of TCF15 mRNA |
CTD |
PMID:31711903 |
|
NCBI chr 3:140,638,984...140,644,766
Ensembl chr 3:140,638,984...140,644,766
|
|
G |
Tcf19 |
transcription factor 19 |
affects response to substance increases expression |
ISO |
TCF19 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of TCF19 mRNA |
CTD |
PMID:15331170 |
|
NCBI chr20:3,218,756...3,222,861
Ensembl chr20:3,218,693...3,223,271
|
|
G |
Tcf3 |
transcription factor 3 |
affects expression |
ISO |
Fluorouracil affects the expression of TCF3 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 7:9,931,251...9,952,994
Ensembl chr 7:9,280,571...9,302,314
|
|
G |
Tcf7l2 |
transcription factor 7 like 2 |
multiple interactions decreases expression |
ISO |
TCF7L2 results in decreased susceptibility to [Fluorouracil co-treated with Capecitabine] Fluorouracil results in decreased expression of TCF7L2 mRNA; Fluorouracil results in decreased expression of TCF7L2 protein [HDAC1 protein co-treated with HDAC2 protein] promotes the reaction [TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of MBP mRNA]]; [HDAC1 protein co-treated with HDAC2 protein] promotes the reaction [TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of OLIG2 mRNA]]; Fluorouracil inhibits the reaction [TCF7L2 protein binds to HDAC1 protein]; Fluorouracil inhibits the reaction [TCF7L2 protein binds to HDAC2 protein]; TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of MBP mRNA]; TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of OLIG2 mRNA] |
CTD |
PMID:18678097 PMID:25178657 |
|
NCBI chr 1:264,791,335...264,984,225
Ensembl chr 1:254,786,091...254,978,967
|
|
G |
Tek |
TEK receptor tyrosine kinase |
increases expression |
ISO |
Fluorouracil results in increased expression of TEK mRNA |
CTD |
PMID:15817675 |
|
NCBI chr 5:114,722,815...114,849,535
Ensembl chr 5:109,607,077...109,733,804
|
|
G |
Terf2 |
telomeric repeat binding factor 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of TERF2 protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr19:34,976,963...35,005,813
Ensembl chr19:34,977,471...35,005,819
|
|
G |
Tert |
telomerase reverse transcriptase |
multiple interactions decreases activity decreases expression decreases response to substance affects response to substance |
ISO |
[Fluorouracil co-treated with Gemcitabine] results in decreased activity of TERT protein; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TERT mRNA] Fluorouracil results in decreased activity of TERT protein Fluorouracil results in decreased expression of TERT mRNA; Fluorouracil results in decreased expression of TERT mRNA alternative form; Fluorouracil results in decreased expression of TERT protein modified form TERT mRNA results in decreased susceptibility to Fluorouracil TERT protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15003732 PMID:15016801 PMID:15608686 PMID:16455633 PMID:16929163 PMID:17923759 PMID:17996122 PMID:18396642 PMID:21296659 More...
|
|
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:29,637,506...29,659,561
|
|
G |
Tfcp2l1 |
transcription factor CP2-like 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of TFCP2L1 protein |
CTD |
PMID:21296659 |
|
NCBI chr13:29,733,813...29,793,870
Ensembl chr13:29,733,840...29,793,870
|
|
G |
Tfdp1 |
transcription factor Dp-1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of TFDP1 mRNA |
CTD |
PMID:16510598 PMID:34151400 |
|
NCBI chr16:82,864,220...82,903,166
Ensembl chr16:76,162,043...76,200,817
|
|
G |
Tff1 |
trefoil factor 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of TFF1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr20:9,237,095...9,240,956
Ensembl chr20:9,235,736...9,239,597
|
|
G |
Tfpi |
tissue factor pathway inhibitor |
affects response to substance |
ISO |
TFPI protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 3:89,939,862...89,989,253
Ensembl chr 3:69,533,156...69,576,880
|
|
G |
Tfrc |
transferrin receptor |
multiple interactions increases expression |
ISO EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of TFRC mRNA] Fluorouracil results in increased expression of TFRC protein ferrostatin-1 inhibits the reaction [Fluorouracil results in increased expression of TFRC protein] |
CTD |
PMID:15016801 PMID:35101590 |
|
NCBI chr11:81,668,478...81,690,318
Ensembl chr11:68,163,413...68,185,257
|
|
G |
Tgfa |
transforming growth factor alpha |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in increased expression of TGFA mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 4:120,175,549...120,258,342
Ensembl chr 4:118,618,269...118,700,894
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
increases expression affects response to substance multiple interactions |
ISO EXP |
Fluorouracil results in increased expression of TGFB1 mRNA TGFB1 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of TGFB1 mRNA; Fluorouracil results in increased expression of TGFB1 protein Thymol inhibits the reaction [Fluorouracil results in increased expression of TGFB1 mRNA]; Thymol inhibits the reaction [Fluorouracil results in increased expression of TGFB1 protein] [Fluorouracil co-treated with TGFB1 protein] results in increased expression of MT2A mRNA; TGFB1 protein inhibits the reaction [Fluorouracil results in decreased expression of MT2A protein]; TGFB1 protein inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; TGFB1 protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 mRNA]; TGFB1 protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 protein] |
CTD |
PMID:16217747 PMID:16557594 PMID:16888818 PMID:18344199 PMID:28507149 PMID:34665902 More...
|
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
affects response to substance decreases response to substance |
ISO |
TGFB2 protein affects the susceptibility to Fluorouracil TGFB2 gene polymorphism results in decreased susceptibility to Fluorouracil |
CTD |
PMID:16217747 PMID:18941179 |
|
NCBI chr13:100,691,540...100,793,227
Ensembl chr13:98,160,087...98,261,405
|
|
G |
Tgfbi |
transforming growth factor, beta induced |
affects response to substance |
ISO |
TGFBI protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr17:7,960,885...7,990,234
Ensembl chr17:7,955,603...7,985,240
|
|
G |
Tgfbr3 |
transforming growth factor beta receptor 3 |
increases expression |
ISO |
Fluorouracil results in increased expression of TGFBR3 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr14:2,634,294...2,810,269
Ensembl chr14:2,489,397...2,663,341
|
|
G |
Th |
tyrosine hydroxylase |
affects expression |
ISO |
Fluorouracil affects the expression of TH protein |
CTD |
PMID:21296659 |
|
NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Thbs1 |
thrombospondin 1 |
multiple interactions increases expression affects expression affects response to substance |
ISO |
EGR1 protein affects the reaction [Fluorouracil results in increased expression of THBS1 mRNA]; EGR1 protein affects the reaction [Fluorouracil results in increased expression of THBS1 protein]; Fluorouracil promotes the reaction [EGR1 protein binds to THBS1 promoter]; SB 203580 inhibits the reaction [Fluorouracil results in increased expression of THBS1 mRNA] Fluorouracil results in increased expression of THBS1 mRNA; Fluorouracil results in increased expression of THBS1 protein Fluorouracil affects the expression of THBS1 mRNA THBS1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15205334 PMID:16217747 PMID:18757417 |
|
NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:105,056,292...105,071,440
|
|
G |
Thnsl2 |
threonine synthase-like 2 |
multiple interactions |
ISO |
THNSL2 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr 4:103,112,974...103,132,122
Ensembl chr 4:103,112,963...103,132,017
|
|
G |
Thoc1 |
THO complex subunit 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of THOC1 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr18:983,824...1,019,123
Ensembl chr18:983,824...1,019,114
|
|
G |
Thsd7a |
thrombospondin type 1 domain containing 7A |
increases expression |
ISO |
Fluorouracil results in increased expression of THSD7A mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 4:40,461,124...40,899,345
Ensembl chr 4:40,460,814...40,899,583
|
|
G |
Tial1 |
Tia1 cytotoxic granule-associated RNA binding protein-like 1 |
affects response to substance |
ISO |
TIAL1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 1:183,008,358...183,045,092
Ensembl chr 1:183,009,253...183,031,637
|
|
G |
Tigar |
TP53 induced glycolysis regulatory phosphatase |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in increased expression of TIGAR mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 4:161,613,306...161,632,248
Ensembl chr 4:159,927,139...159,946,029 Ensembl chr 6:159,927,139...159,946,029
|
|
G |
Timeless |
timeless circadian regulator |
affects response to substance |
ISO |
TIMELESS protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 7:654,804...678,769
Ensembl chr 7:654,822...678,738
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
increases expression |
ISO |
Fluorouracil results in increased expression of TIMP3 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 7:19,408,539...19,459,558
Ensembl chr 7:17,521,919...17,571,839
|
|
G |
Tinf2 |
TERF1 interacting nuclear factor 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of TINF2 mRNA |
CTD |
PMID:19272435 |
|
NCBI chr15:29,170,663...29,178,015
Ensembl chr15:29,170,652...29,176,984
|
|
G |
Tjp3 |
tight junction protein 3 |
affects expression |
ISO |
Fluorouracil affects the expression of TJP3 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 7:8,427,650...8,446,279
Ensembl chr 7:8,432,811...8,446,279
|
|
G |
Tk1 |
thymidine kinase 1 |
affects expression multiple interactions affects response to substance |
ISO |
Fluorouracil affects the expression of TK1 mRNA Fluorouracil promotes the reaction [geraniol results in decreased expression of TK1 mRNA] TK1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15374632 PMID:15548681 PMID:16557594 |
|
NCBI chr10:103,533,449...103,544,818
Ensembl chr10:103,031,521...103,046,920
|
|
G |
Tk2 |
thymidine kinase 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of TK2 mRNA |
CTD |
PMID:19219653 |
|
NCBI chr19:708,859...731,786
Ensembl chr19:708,891...730,924
|
|
G |
Tlr3 |
toll-like receptor 3 |
increases expression multiple interactions |
ISO |
Fluorouracil results in increased expression of TLR3 mRNA TP53 protein affects the reaction [Fluorouracil results in increased expression of TLR3 mRNA] |
CTD |
PMID:18779317 PMID:20367642 |
|
NCBI chr16:53,554,916...53,572,321
Ensembl chr16:46,822,039...46,836,545
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions increases expression |
EXP |
Bosentan inhibits the reaction [Fluorouracil results in increased expression of TLR4 protein] |
CTD |
PMID:34800596 |
|
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tlr9 |
toll-like receptor 9 |
increases secretion multiple interactions |
ISO |
Fluorouracil results in increased secretion of TLR9 protein Hydroxychloroquine inhibits the reaction [Fluorouracil results in increased secretion of TLR9 protein] |
CTD |
PMID:32314717 |
|
NCBI chr 8:115,743,407...115,747,523
Ensembl chr 8:106,864,680...106,868,796
|
|
G |
Tmem150c |
transmembrane protein 150C |
decreases expression |
ISO |
Fluorouracil results in decreased expression of TMEM150C mRNA |
CTD |
PMID:24737281 |
|
NCBI chr14:9,454,999...9,525,300
Ensembl chr14:9,508,515...9,525,298
|
|
G |
Tmem184b |
transmembrane protein 184B |
affects response to substance |
ISO |
TMEM184B protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 7:110,925,092...110,967,975
Ensembl chr 7:110,925,092...110,967,943
|
|
G |
Tmem33 |
transmembrane protein 33 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of TMEM33 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr14:40,888,485...40,910,715
Ensembl chr14:40,885,712...40,910,715
|
|
G |
Tmem40 |
transmembrane protein 40 |
affects expression |
ISO |
Fluorouracil affects the expression of TMEM40 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 4:148,791,509...148,819,287
Ensembl chr 4:148,791,505...148,823,665
|
|
G |
Tmem74 |
transmembrane protein 74 |
increases expression |
ISO |
Fluorouracil results in increased expression of TMEM74 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 7:76,814,000...76,822,633
Ensembl chr 7:74,931,694...74,937,934
|
|
G |
Tmem9b |
TMEM9 domain family, member B |
affects expression |
ISO |
Fluorouracil affects the expression of TMEM9B mRNA |
CTD |
PMID:20421339 |
|
NCBI chr 1:163,755,307...163,783,880
Ensembl chr 1:163,764,433...163,783,278
|
|
G |
Tmsb10 |
thymosin, beta 10 |
increases expression |
ISO |
Fluorouracil results in increased expression of TMSB10 mRNA |
CTD |
PMID:15152939 |
|
NCBI chr 4:105,009,959...105,011,095
Ensembl chr 4:105,009,212...105,011,028
|
|
G |
Tmsb15b2 |
thymosin beta 15B2 |
affects response to substance |
ISO |
TMSB15A affects the susceptibility to Fluorouracil |
CTD |
PMID:15067352 |
|
NCBI chr X:100,298,705...100,300,820
Ensembl chr X:100,298,514...100,300,886
|
|
G |
Tmsb4x |
thymosin beta 4, X-linked |
increases expression |
ISO |
Fluorouracil results in increased expression of TMSB4X mRNA |
CTD |
PMID:15152939 |
|
NCBI chr X:27,144,666...27,146,667
Ensembl chr X:27,128,610...27,146,667 Ensembl chr10:27,128,610...27,146,667
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
ISO EXP |
TNF promoter polymorphism affects the susceptibility to [Fluorouracil co-treated with Cisplatin] Fluorouracil results in increased expression of TNF mRNA; Fluorouracil results in increased expression of TNF protein Fluorouracil inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of TNF protein]; Silybin inhibits the reaction [Fluorouracil results in increased expression of TNF protein]; Thymol inhibits the reaction [Fluorouracil results in increased expression of TNF mRNA]; Thymol inhibits the reaction [Fluorouracil results in increased expression of TNF protein] [Cyclophosphamide co-treated with Methotrexate co-treated with Fluorouracil] results in decreased expression of TNF protein |
CTD |
PMID:16820919 PMID:18344199 PMID:18523641 PMID:18535404 PMID:25824412 PMID:31651976 PMID:34665902 PMID:37335224 PMID:38078205 More...
|
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
increases expression |
ISO |
Fluorouracil results in increased expression of TNFAIP3 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 1:15,528,921...15,543,993
Ensembl chr 1:13,709,206...13,725,282
|
|
G |
Tnfrsf10b |
TNF receptor superfamily member 10b |
increases expression multiple interactions |
ISO |
Fluorouracil results in increased expression of TNFRSF10A mRNA; Fluorouracil results in increased expression of TNFRSF10A protein [[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in decreased expression of TNFRSF10A mRNA |
CTD |
PMID:15585621 PMID:26544897 PMID:32800223 PMID:34151400 |
|
NCBI chr15:51,249,883...51,278,091
Ensembl chr15:44,840,386...44,867,467
|
|
G |
Tnfrsf11b |
TNF receptor superfamily member 11B |
increases expression |
ISO |
Fluorouracil results in increased expression of TNFRSF11B mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:85,566,520...85,594,538
|
|
G |
Tnfrsf18 |
TNF receptor superfamily member 18 |
increases expression |
ISO |
Fluorouracil results in increased expression of TNFRSF18 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 5:171,901,734...171,904,578
Ensembl chr 5:166,618,969...166,622,353
|
|
G |
Tnfrsf19 |
TNF receptor superfamily member 19 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of TNFRSF19 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr15:35,092,206...35,158,472
Ensembl chr15:35,092,206...35,180,795
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
affects expression |
ISO |
Fluorouracil affects the expression of TNFRSF1A mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:158,150,820...158,163,591
|
|
G |
Tnfrsf1b |
TNF receptor superfamily member 1B |
affects response to substance |
ISO |
TNFRSF1B protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16477629 |
|
NCBI chr 5:162,356,250...162,387,411
Ensembl chr 5:157,070,642...157,104,206
|
|
G |
Tnfrsf22 |
tumor necrosis factor receptor superfamily, member 22 |
increases expression |
ISO |
Fluorouracil results in increased expression of TNFRSF10C protein |
CTD |
PMID:15585621 |
|
NCBI chr 1:208,269,844...208,285,823
Ensembl chr 1:198,840,453...198,856,309
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
multiple interactions increases expression increases abundance increases response to substance increases activity affects expression |
ISO |
[Fluorouracil co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein; [Fluorouracil results in decreased expression of CFLAR protein] which results in increased susceptibility to TNFSF10 protein; CFLAR protein alternative form inhibits the reaction [Fluorouracil results in increased activity of TNFSF10 protein]; CFLAR protein inhibits the reaction [Fluorouracil results in increased susceptibility to TNFSF10 protein]; Fluorouracil promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP3 protein]; Fluorouracil promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP8 protein]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of TNFSF10 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of TNFSF10 protein]; XIAP protein inhibits the reaction [Fluorouracil results in increased susceptibility to TNFSF10 protein] Fluorouracil results in increased expression of TNFSF10 mRNA; Fluorouracil results in increased expression of TNFSF10 protein TNFSF10 results in increased abundance of Fluorouracil Fluorouracil affects the expression of TNFSF10 mRNA |
CTD |
PMID:11750847 PMID:15120327 PMID:16373718 PMID:19106633 PMID:20876774 PMID:34151400 More...
|
|
NCBI chr 2:112,136,550...112,155,903
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Tnfsf13 |
TNF superfamily member 13 |
increases expression |
ISO |
Fluorouracil results in increased expression of TNFSF13 mRNA |
CTD |
PMID:18423122 PMID:20003335 |
|
NCBI chr10:54,898,805...54,901,815
Ensembl chr10:54,400,065...54,403,042
|
|
G |
Tnni1 |
troponin I1, slow skeletal type |
multiple interactions increases expression |
EXP |
Bosentan inhibits the reaction [Fluorouracil results in increased expression of TNNI1 protein] |
CTD |
PMID:34800596 |
|
NCBI chr13:47,229,217...47,241,640
Ensembl chr13:47,229,216...47,241,644
|
|
G |
Tnni3 |
troponin I3, cardiac type |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of TNNI3 protein TNNI3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 1:78,342,571...78,346,255
Ensembl chr 1:69,299,900...69,303,580
|
|
G |
Tnnt1 |
troponin T1, slow skeletal type |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of TNNT1 protein TNNT1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 1:69,306,362...69,316,721
Ensembl chr 1:69,306,362...69,316,721
|
|
G |
Tns3 |
tensin 3 |
affects response to substance |
ISO |
TNS3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr14:83,173,649...83,405,671
Ensembl chr14:83,173,649...83,405,998
|
|
G |
Tob1 |
transducer of ErbB-2.1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in increased expression of TOB1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr10:79,659,993...79,662,031
Ensembl chr10:79,160,154...79,165,215
|
|
G |
Top1 |
DNA topoisomerase I |
affects response to substance decreases expression |
ISO |
TOP1 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of TOP1 mRNA |
CTD |
PMID:16709241 PMID:18509181 |
|
NCBI chr 3:169,713,195...169,796,330
Ensembl chr 3:149,293,403...149,376,623
|
|
G |
Top2a |
DNA topoisomerase II alpha |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of TOP2A mRNA TOP2A protein affects the susceptibility to [Cyclophosphamide co-treated with Epirubicin co-treated with Fluorouracil]; TOP2A protein affects the susceptibility to [Fluorouracil co-treated with Epirubicin co-treated with Cyclophosphamide]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TOP2A mRNA] |
CTD |
PMID:15016801 PMID:15205334 PMID:16557594 PMID:16682728 PMID:18465341 PMID:19272435 More...
|
|
NCBI chr10:84,441,954...84,473,093
Ensembl chr10:83,945,735...83,976,874
|
|
G |
Topbp1 |
DNA topoisomerase II binding protein 1 |
affects response to substance |
ISO |
TOPBP1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 8:103,887,805...103,931,662
Ensembl chr 8:103,887,865...103,931,674
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions decreases degradation increases activity increases expression affects response to substance increases response to substance decreases expression decreases response to substance increases phosphorylation affects phosphorylation increases acetylation affects activity |
ISO EXP |
[[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in decreased expression of TP53 mRNA; [CHEK1 protein co-treated with TP53 protein] affects the susceptibility to Fluorouracil; [Fluorouracil co-treated with Genistein] results in increased expression of TP53 mRNA; [Fluorouracil co-treated with olaparib] results in increased expression of TP53 protein; [Fluorouracil results in increased acetylation of TP53 protein mutant form] which results in increased expression of UBE2C protein; [nutlin 3 results in increased stability of TP53 protein] which results in increased susceptibility to Fluorouracil; [TP53 affects the expression of TYMS] which affects the susceptibility to Fluorouracil; anacardic acid inhibits the reaction [[Fluorouracil results in increased acetylation of TP53 protein mutant form] which results in increased expression of UBE2C protein]; Cadmium Chloride affects the reaction [Fluorouracil affects the phosphorylation of TP53 protein]; Cadmium Chloride affects the reaction [Fluorouracil results in increased expression of TP53 mRNA]; Cadmium Chloride affects the reaction [Fluorouracil results in increased phosphorylation of TP53 protein]; Cycloheximide inhibits the reaction [Fluorouracil results in increased expression of TP53 protein]; Fluorouracil affects the reaction [Cadmium Chloride affects the phosphorylation of TP53 protein]; Fluorouracil affects the reaction [Cadmium Chloride results in increased expression of TP53 mRNA]; Fluorouracil promotes the reaction [[Doxorubicin co-treated with Paclitaxel] results in increased expression of TP53 protein]; Fluorouracil promotes the reaction [[TP53 protein binds to SP1 protein] which binds to CDKN1A promoter]; Fluorouracil promotes the reaction [allose results in increased expression of TP53 protein]; Fluorouracil promotes the reaction [andrographolide results in increased expression of TP53]; Fluorouracil promotes the reaction [TP53 protein binds to CES2 intron]; Fluorouracil promotes the reaction [TP53 protein mutant form binds to UBE2C promoter]; Fluorouracil results in increased expression of and results in increased phosphorylation of TP53 protein; Fluorouracil results in increased phosphorylation of and results in increased activity of TP53 protein; Genistein promotes the reaction [Fluorouracil results in increased expression of TP53 protein]; IFNA1 protein promotes the reaction [Fluorouracil results in increased phosphorylation of TP53 protein]; N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in increased expression of TP53 protein]; Pravastatin inhibits the reaction [Fluorouracil results in decreased degradation of TP53 protein]; TP53 affects the reaction [Resveratrol affects the reaction [Fluorouracil results in increased activity of CASP6 protein]]; TP53 gene mutant form affects the reaction [benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Fluorouracil co-treated with olaparib] results in increased phosphorylation of H2AX protein]]; TP53 protein affects the reaction [CHEK1 protein affects the susceptibility to Fluorouracil]; TP53 protein affects the reaction [Fluorouracil promotes the reaction [E2F4 protein binds to UBE2C promoter]]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of AARS1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ACKR3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ACTL8 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ACY1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ADAM10 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ADAM3A mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ADAMTS9 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of AGR2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ALG3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ANLN mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ANP32E mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of AP3S1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ARMCX1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ASAH1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ATP5F1D mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ATXN10 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of BCAT1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of BNIP3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of BOP1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CA14 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CAD mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CANX mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CBS mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CCNB1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CCNB2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CCND2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CD52 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CD8A mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CDC20 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CDKN3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CHEK1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CHRNA4 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CLTC mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of COL6A3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CP mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CPD mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CRYGS mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CRYL1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CSE1L mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CUTC mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CYC1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of DCK mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of DCLK1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of DCXR mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of DIMT1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of DLC1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of DLK1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of DTYMK mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of EGFR protein]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of EHF mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of EIF4E mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of EIPR1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of EP400 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ETF1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ETS1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of FAH mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of FAM107B mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of FKBP5 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of GAMT mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of GCSH mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of GDF1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of GPX2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of GSPT1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of GYG2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of H2AX mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of H4C2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of HAND1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of HBA1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of HDGFL3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of HERPUD1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of HMG1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of HMMR mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of HNRNPA1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of HNRNPA2B1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of HNRNPF mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of HNRNPH1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of HNRNPL mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of HPX mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of IFI16 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of INPP5E mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of IQGAP2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ITPR1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of KCNQ2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of KIF15 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of KIF23 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of KLF5 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of KPNA2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of L1TD1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of LDHA mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of LRBA mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of LYPLA1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of MACF1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of MAP4K5 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of MARS1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of MCM3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of MCM6 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of MCM7 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of METAP2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of MMP1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of MMS19 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of NASP mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of NBN mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of NCAPG mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of NEK2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of NIPSNAP2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of NR1D2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of NUCKS1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ODC1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of OXCT1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PAFAH1B1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PAIP1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PDCD1LG2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PFN2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PGLYRP1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PHIP mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PI4KB mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PLK1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PMF1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PMS2P4 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PPA2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PPP1CC mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PREPL mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PRKAG2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PRKCI mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PRKDC mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PTTG1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PTTG3P mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PURG mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of QSOX1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of RANBP1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of RECQL4 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of RFC4 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of RPL10A mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SAH mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SAP30 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SEC31B mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SELENOP mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SERPINA7 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SERPIND1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SEZ6L mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SF3B3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SHMT2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SIGLEC9 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SKIC8 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SMS mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SP3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SPAG5 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SRP9 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SRSF6 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TBCD mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TERT mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TFF1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TFRC mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TOP2A mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TRAP1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TROAP mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TSPO mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TUBA4B mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TXNIP mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TXNRD3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of UBE2C mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of UBE2S mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of UGT8 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of UQCRB mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of USH2A mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of VANGL2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of WARS1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of WEE1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of WTAP mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of YARS1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ZIM2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ZMYND8 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ZNF266 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of ANXA2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of ATF3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of BBC3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of BBC3 protein]; TP53 protein affects the reaction [Fluorouracil results in increased expression of BDKRB2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of BTG2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of CDKN1A mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of CES2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of CNK mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of CYFIP2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of DUSP14 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of DUSP5 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of EPHA2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of FAS mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of FAS protein]; TP53 protein affects the reaction [Fluorouracil results in increased expression of FDXR mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of FMOD mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of GADD45A mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of GDF15 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of GJC1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of ID2B mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of IER5 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of INKA2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of NINJ1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of PLK2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of PMAIP1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of PPM1D mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of PROCR mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of RPS27L mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of RRM2B mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of S100A2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of SAT1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of SERPINB5 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of SERTAD1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of SESN1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of SESN2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of SFN mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of TGFA mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of TIGAR mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of TLR3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of TNFRSF10D mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of TOB1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of TP53I3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of TP53INP1 mRNA]; TP53 protein affects the susceptibility to [Fluorouracil co-treated with Cisplatin]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of ANLN mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of BRCA1 mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of CCNA2 protein]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of CCNB1 mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of CCNB1 protein]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of CCND1 protein]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of CRYZ mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of SCD mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of UBE2C mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of UBE2C protein]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of VEGFA mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in increased cleavage of and results in increased activity of CASP9 protein]; TP53 protein inhibits the reaction [Fluorouracil results in increased expression of CHEK1 protein]; TP53 protein inhibits the reaction [Fluorouracil results in increased expression of EEF1A1 mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in increased expression of PLK1 protein]; TP53 protein inhibits the reaction [Fluorouracil results in increased expression of PTTG1 protein]; TP53 protein inhibits the reaction [N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in decreased expression of CCNA2 protein]]; TP53 protein inhibits the reaction [N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in decreased expression of CCNB1 protein]]; TP53 protein inhibits the reaction [N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in increased cleavage of and results in increased activity of CASP9 protein]]; TP53 protein mutant form affects the reaction [Fluorouracil promotes the reaction [NFYA protein binds to UBE2C promoter]]; TP53 protein mutant form affects the reaction [Fluorouracil promotes the reaction [NFYB protein binds to UBE2C promoter]]; TP53 protein promotes the reaction [Fluorouracil promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of CDKN1A protein]]; TP53 protein promotes the reaction [Fluorouracil promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of MDM2 protein]]; TP53 protein promotes the reaction [Fluorouracil results in decreased expression of ECT2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in decreased expression of MYC mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of BTG2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of CASP8 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of CASP8 protein]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of CCNG1 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of CDKN1A mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of CDKN1A protein]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of CYFIP2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of DDB2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of DRAM1 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of FAS protein]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of FDXR mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of FDXR protein]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of GADD45A mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of GPX1 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of ID1 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of ID2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of IKBIP mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of MDM2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of MDM2 protein]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of PLK2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of PPM1D mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of S100A2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of SERPINB5 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of SESN1 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of SFN mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of TAP1 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of TNFRSF10B mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of TNFSF10 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of TNFSF10 protein]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of TP53I3 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of TP53INP1 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of TRIAP1 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of ZMAT3 mRNA]; TP53 protein promotes the reaction [N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in increased expression of FAS protein]]; TP53 protein results in increased susceptibility to [Cisplatin co-treated with Fluorouracil]; TP53 protein results in increased susceptibility to [Fluorouracil co-treated with Cisplatin]; TP53 results in increased susceptibility to [Poly I-C co-treated with Fluorouracil] Fluorouracil results in increased activity of TP53 protein Fluorouracil results in increased expression of TP53; Fluorouracil results in increased expression of TP53 mRNA; Fluorouracil results in increased expression of TP53 protein; Fluorouracil results in increased expression of TP53 protein modified form TP53 gene polymorphism affects the susceptibility to Fluorouracil; TP53 protein affects the susceptibility to Fluorouracil TP53 protein results in increased susceptibility to Fluorouracil; TP53 results in increased susceptibility to Fluorouracil ferrostatin-1 inhibits the reaction [Fluorouracil results in increased expression of TRP53 protein]; Fluorouracil promotes the reaction [Acetaminophen results in increased phosphorylation of TP53 protein]; Tetrachlorodibenzodioxin inhibits the reaction [Fluorouracil results in increased expression of TP53 protein] Fluorouracil results in increased expression of TP53 protein; Fluorouracil results in increased expression of TRP53 protein Fluorouracil results in increased activity of TRP53 protein TRP53 results in increased susceptibility to Fluorouracil Fluorouracil results in decreased expression of TP53 mRNA TP53 promoter mutant form results in decreased susceptibility to Fluorouracil Fluorouracil promotes the reaction [Luteolin results in increased expression of TRP53 protein]; Luteolin promotes the reaction [Fluorouracil results in increased expression of TRP53 protein] Fluorouracil affects the activity of TP53 protein |
CTD |
PMID:9050858 PMID:9192825 PMID:11750847 PMID:12082016 PMID:12792779 PMID:14646558 PMID:14665630 PMID:14704126 PMID:15016801 PMID:15041737 PMID:15152939 PMID:15161716 PMID:15254702 PMID:15459018 PMID:15489892 PMID:15534911 PMID:15546879 PMID:15608686 PMID:15625077 PMID:15865071 PMID:15896711 PMID:15999354 PMID:16077963 PMID:16168113 PMID:16330492 PMID:16557594 PMID:16584549 PMID:16686938 PMID:16709241 PMID:16949053 PMID:16963839 PMID:17056233 PMID:17339891 PMID:17634554 PMID:17637740 PMID:17699798 PMID:17971768 PMID:17982676 PMID:18497562 PMID:18498133 PMID:18600534 PMID:18698031 PMID:18779317 PMID:18930000 PMID:19010883 PMID:19015155 PMID:19097688 PMID:19098008 PMID:19106633 PMID:20367642 PMID:21205074 PMID:22445862 PMID:22525470 PMID:22966307 PMID:23056627 PMID:23941782 PMID:25744307 PMID:26544897 PMID:27129209 PMID:29879413 PMID:30177839 PMID:31288002 PMID:32800223 PMID:34151400 PMID:35101590 PMID:35435491 More...
|
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp53i3 |
tumor protein p53 inducible protein 3 |
affects response to substance multiple interactions increases expression |
ISO |
TP53I3 protein affects the susceptibility to Fluorouracil TP53 protein affects the reaction [Fluorouracil results in increased expression of TP53I3 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of TP53I3 mRNA] Fluorouracil results in increased expression of TP53I3 mRNA; Fluorouracil results in increased expression of TP53I3 protein |
CTD |
PMID:14665630 PMID:15016801 PMID:15205334 PMID:16217747 PMID:16557594 PMID:16709241 PMID:17982676 More...
|
|
NCBI chr 6:27,818,327...27,825,753
|
|
G |
Tp53inp1 |
tumor protein p53 inducible nuclear protein 1 |
multiple interactions increases expression |
ISO |
TP53 protein affects the reaction [Fluorouracil results in increased expression of TP53INP1 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of TP53INP1 mRNA] |
CTD |
PMID:15016801 PMID:16510598 PMID:16557594 PMID:17039268 PMID:17982676 |
|
NCBI chr 5:29,051,267...29,069,486
Ensembl chr 5:24,260,568...24,267,968
|
|
G |
Tp73 |
tumor protein p73 |
affects response to substance multiple interactions |
ISO |
TP73 protein affects the susceptibility to Fluorouracil TP73 protein promotes the reaction [Fluorouracil results in increased expression of GRAMD4 mRNA] |
CTD |
PMID:18714155 PMID:21127500 |
|
NCBI chr 5:169,903,801...169,988,075
Ensembl chr 5:164,621,377...164,681,128
|
|
G |
Tpi1 |
triosephosphate isomerase 1 |
decreases expression affects response to substance |
ISO |
Fluorouracil results in decreased expression of TPI1 mRNA TPI1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16510598 PMID:18309519 |
|
NCBI chr 4:159,301,558...159,305,088
Ensembl chr 4:157,615,386...157,619,541
|
|
G |
Tpm1 |
tropomyosin 1 |
affects response to substance |
ISO |
TPM1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 8:76,516,654...76,543,661
Ensembl chr 8:67,635,479...67,662,802
|
|
G |
Tpmt |
thiopurine S-methyltransferase |
multiple interactions |
ISO |
TPMT protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] |
CTD |
PMID:18927307 |
|
NCBI chr17:17,644,088...17,662,709
Ensembl chr17:17,644,173...17,662,709
|
|
G |
Tpp1 |
tripeptidyl peptidase 1 |
affects expression |
ISO |
Fluorouracil affects the expression of TPP1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 1:160,097,984...160,104,108
Ensembl chr 1:160,096,833...160,104,129
|
|
G |
Tpp2 |
tripeptidyl peptidase 2 |
affects localization |
ISO |
Fluorouracil affects the localization of TPP2 protein |
CTD |
PMID:20643100 |
|
NCBI chr 9:46,046,712...46,128,157
Ensembl chr 9:46,046,632...46,128,157
|
|
G |
Tpst2 |
tyrosylprotein sulfotransferase 2 |
affects response to substance |
ISO |
TPST2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr12:44,321,875...44,363,892
Ensembl chr12:44,321,875...44,362,329
|
|
G |
Tpt1 |
tumor protein, translationally-controlled 1 |
decreases response to substance |
ISO |
TPT1 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:15262975 |
|
NCBI chr15:51,156,728...51,159,629
Ensembl chr15:51,146,154...51,159,625
|
|
G |
Tradd |
TNFRSF1A-associated via death domain |
affects expression |
ISO |
Fluorouracil affects the expression of TRADD mRNA |
CTD |
PMID:34151400 |
|
NCBI chr19:50,046,057...50,048,158
Ensembl chr19:33,136,138...33,142,638
|
|
G |
Traf2 |
Tnf receptor-associated factor 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of TRAF2 |
CTD |
PMID:10891390 |
|
NCBI chr 3:28,740,098...28,764,752
Ensembl chr 3:8,341,951...8,366,538
|
|
G |
Trap1 |
TNF receptor-associated protein 1 |
multiple interactions affects expression |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of TRAP1 mRNA] Fluorouracil affects the expression of TRAP1 mRNA |
CTD |
PMID:15016801 PMID:34151400 |
|
NCBI chr10:11,971,259...12,005,306
Ensembl chr10:11,464,821...11,498,981
|
|
G |
Triap1 |
TP53 regulated inhibitor of apoptosis 1 |
increases expression multiple interactions |
ISO |
Fluorouracil results in increased expression of TRIAP1 mRNA TP53 protein promotes the reaction [Fluorouracil results in increased expression of TRIAP1 mRNA] |
CTD |
PMID:17982676 |
|
NCBI chr12:41,267,534...41,270,053
Ensembl chr12:41,267,549...41,270,042
|
|
G |
Trib2 |
tribbles pseudokinase 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of TRIB2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 6:38,545,971...38,570,349
Ensembl chr 6:38,545,975...38,569,370
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
affects expression |
ISO |
Fluorouracil affects the expression of TRIB3 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
|
|
G |
Trim2 |
tripartite motif-containing 2 |
affects response to substance |
ISO |
TRIM2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 2:171,798,654...171,950,193
Ensembl chr 2:169,500,634...169,652,927
|
|
G |
Triobp |
TRIO and F-actin binding protein |
affects response to substance |
ISO |
TRIOBP protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 7:110,505,916...110,569,301
Ensembl chr 7:110,506,248...110,562,474
|
|
G |
Troap |
trophinin associated protein |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of TROAP mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 7:130,233,534...130,242,369
Ensembl chr 7:130,234,544...130,242,365
|
|
G |
Tsc2 |
TSC complex subunit 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of TSC2 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr10:14,125,679...14,160,317
Ensembl chr10:13,621,136...13,655,951
|
|
G |
Tshb |
thyroid stimulating hormone subunit beta |
affects expression |
ISO |
Fluorouracil affects the expression of TSHB protein |
CTD |
PMID:17649788 |
|
NCBI chr 2:192,913,171...192,918,054
Ensembl chr 2:190,224,676...190,229,559
|
|
G |
Tshz1 |
teashirt zinc finger homeobox 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of TSHZ1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr18:77,376,399...77,452,815
Ensembl chr18:77,377,394...77,453,509
|
|
G |
Tspan8 |
tetraspanin 8 |
multiple interactions |
ISO |
[Fluorouracil co-treated with irinotecan] results in decreased expression of TSPAN8 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr 7:51,444,946...51,479,360
Ensembl chr 7:51,445,074...51,479,356
|
|
G |
Tspo |
translocator protein |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of TSPO mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 7:116,600,214...116,610,461
Ensembl chr 7:114,720,188...114,730,450
|
|
G |
Tsr1 |
TSR1, ribosome maturation factor |
decreases expression |
ISO |
Fluorouracil results in decreased expression of TSR1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr10:59,760,420...59,771,868
Ensembl chr10:59,760,409...59,771,864
|
|
G |
Tst |
thiosulfate sulfurtransferase |
affects response to substance |
ISO |
TST protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 7:109,948,061...109,955,378
Ensembl chr 7:109,948,062...109,957,216
|
|
G |
Ttyh2 |
tweety family member 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of TTYH2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr10:100,208,129...100,252,505
Ensembl chr10:99,709,007...99,753,444
|
|
G |
Tuba8 |
tubulin, alpha 8 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of TUBA8 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr 4:154,440,045...154,456,918
Ensembl chr 4:154,440,074...154,456,917
|
|
G |
Tubb2a |
tubulin, beta 2A class IIa |
decreases expression |
ISO |
Fluorouracil results in decreased expression of TUBB2A mRNA |
CTD |
PMID:33770205 |
|
NCBI chr17:31,002,186...31,006,057
Ensembl chr17:30,747,503...30,800,714
|
|
G |
Tubb3 |
tubulin, beta 3 class III |
decreases expression |
ISO |
Fluorouracil results in decreased expression of TUBB3 mRNA |
CTD |
PMID:19272435 |
|
NCBI chr19:68,365,687...68,374,741
Ensembl chr19:51,457,184...51,466,243
|
|
G |
Tubb4b |
tubulin, beta 4B class IVb |
affects response to substance |
ISO |
TUBB4B protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 3:28,435,999...28,438,455
Ensembl chr 3:8,037,799...8,040,296
|
|
G |
Tubb5 |
tubulin, beta 5 class I |
decreases expression |
ISO |
Fluorouracil results in decreased expression of TUBB mRNA |
CTD |
PMID:17039268 |
|
NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940
|
|
G |
Tubd1 |
tubulin, delta 1 |
affects response to substance |
ISO |
TUBD1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:71,367,936...71,391,387
Ensembl chr10:71,368,133...71,391,266
|
|
G |
Txnip |
thioredoxin interacting protein |
multiple interactions increases expression affects response to substance |
ISO |
[allose co-treated with Fluorouracil] results in increased expression of TXNIP protein; Fluorouracil promotes the reaction [allose results in increased expression of TXNIP mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TXNIP mRNA] Fluorouracil results in increased expression of TXNIP mRNA TXNIP protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15016801 PMID:15548681 PMID:18930000 |
|
NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:184,092,991...184,096,886
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
decreases expression decreases activity |
ISO |
Fluorouracil results in decreased expression of TXNRD1 mRNA Fluorouracil results in decreased activity of TXNRD1 protein |
CTD |
PMID:19219653 PMID:31288002 |
|
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Txnrd3 |
thioredoxin reductase 3 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of TXNRD3 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 4:122,072,548...122,112,493
Ensembl chr 4:122,072,548...122,112,491
|
|
G |
Tymp |
thymidine phosphorylase |
multiple interactions decreases expression affects response to substance decreases response to substance |
ISO |
[Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMP protein; [IFNG protein results in increased expression of TYMP protein] which results in increased susceptibility to Fluorouracil; acetylleucyl-leucyl-norleucinal inhibits the reaction [[Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMP protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMP protein]; TYMP mRNA affects the susceptibility to [irinotecan co-treated with Fluorouracil co-treated with Leucovorin] Fluorouracil results in decreased expression of TYMP mRNA TYMP protein affects the susceptibility to Fluorouracil TYMP mRNA results in decreased susceptibility to Fluorouracil |
CTD |
PMID:15041737 PMID:15301717 PMID:15538739 PMID:15655543 PMID:16160472 PMID:16525674 PMID:16568373 PMID:17454858 PMID:21444628 More...
|
|
NCBI chr 7:122,318,396...122,323,716
Ensembl chr 7:120,438,770...120,443,874 Ensembl chr 7:120,438,770...120,443,874
|
|
G |
Tyms |
thymidylate synthetase |
multiple interactions affects expression decreases activity increases activity decreases response to substance affects response to substance increases response to substance increases expression decreases expression |
ISO EXP |
[Arsenic Trioxide co-treated with Fluorouracil co-treated with Leucovorin] results in decreased expression of TYMS mRNA; [Cisplatin co-treated with Fluorouracil] results in decreased expression of TYMS mRNA; [Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMS protein; [SU 9516 results in decreased expression of TYMS] which results in increased susceptibility to Fluorouracil; [TP53 affects the expression of TYMS] which affects the susceptibility to Fluorouracil; [trichostatin A results in decreased expression of TYMS protein] which results in increased susceptibility to Fluorouracil; [wogonin co-treated with Fluorouracil] results in increased expression of TYMS mRNA; acetylleucyl-leucyl-norleucinal inhibits the reaction [[Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMS protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMS protein]; Dichlororibofuranosylbenzimidazole inhibits the reaction [Fluorouracil results in increased expression of TYMS protein]; Docetaxel inhibits the reaction [Fluorouracil results in increased activity of TYMS protein]; Docetaxel inhibits the reaction [Fluorouracil results in increased expression of TYMS mRNA]; Fluorouracil inhibits the reaction [[Doxorubicin co-treated with Paclitaxel] results in decreased expression of TYMS protein]; Fluorouracil promotes the reaction [Docetaxel results in decreased expression of TYMS protein]; Fluorouracil promotes the reaction [geraniol results in decreased expression of TYMS mRNA]; gambogic acid inhibits the reaction [Fluorouracil results in increased expression of TYMS mRNA]; TYMS 3' UTR polymorphism affects the susceptibility to [Fluorouracil co-treated with Oxaliplatin]; TYMS gene polymorphism affects the susceptibility to [Fluorouracil co-treated with Oxaliplatin]; TYMS gene polymorphism results in decreased susceptibility to [Fluorouracil co-treated with Cisplatin]; TYMS gene polymorphism results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with Cisplatin co-treated with Paclitaxel]; TYMS mRNA affects the susceptibility to [Irinotecan co-treated with Fluorouracil co-treated with Leucovorin]; TYMS promoter polymorphism results in increased susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with Oxaliplatin co-treated with Docetaxel]; TYMS protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin] Fluorouracil affects the expression of TYMS mRNA; Fluorouracil affects the expression of TYMS protein Fluorouracil results in decreased activity of TYMS protein TYMS 3' UTR mutant form results in decreased susceptibility to Fluorouracil; TYMS 5' UTR polymorphism results in decreased susceptibility to Fluorouracil; TYMS gene polymorphism results in decreased susceptibility to Fluorouracil; TYMS mRNA results in decreased susceptibility to Fluorouracil; TYMS protein results in decreased susceptibility to Fluorouracil; TYMS results in decreased susceptibility to Fluorouracil TYMS affects the susceptibility to Fluorouracil; TYMS gene polymorphism affects the susceptibility to Fluorouracil; TYMS mRNA affects the susceptibility to Fluorouracil; TYMS promoter polymorphism affects the susceptibility to Fluorouracil; TYMS protein affects the susceptibility to Fluorouracil; TYMS protein affects the susceptibility to Fluorouracil analog TYMS gene polymorphism results in increased susceptibility to Fluorouracil; TYMS mRNA results in increased susceptibility to Fluorouracil; TYMS protein results in increased susceptibility to Fluorouracil; TYMS results in increased susceptibility to Fluorouracil Fluorouracil results in increased expression of TYMS mRNA; Fluorouracil results in increased expression of TYMS protein Fluorouracil results in decreased expression of TYMS [Fluorouracil results in decreased activity of TYMS protein] which results in decreased abundance of Thymidine Monophosphate; [Fluorouracil results in decreased activity of TYMS protein] which results in increased abundance of 2'-deoxyuridylic acid; Leucovorin promotes the reaction [Fluorouracil results in decreased expression of TYMS]; Thymidine inhibits the reaction [Fluorouracil results in decreased expression of TYMS] Fluorouracil results in decreased expression of TYMS protein |
CTD |
PMID:2537495 PMID:7763285 PMID:8060136 PMID:9050858 PMID:9299594 PMID:10482907 PMID:12739060 PMID:14970324 PMID:15067352 PMID:15109396 PMID:15213713 PMID:15239142 PMID:15246190 PMID:15374632 PMID:15446554 PMID:15538739 PMID:15548681 PMID:15608557 PMID:15655543 PMID:15735113 PMID:15737843 PMID:15770397 PMID:15788669 PMID:15865071 PMID:15890242 PMID:15918040 PMID:15993511 PMID:16160472 PMID:16168113 PMID:16267625 PMID:16282729 PMID:16424979 PMID:16557585 PMID:16568373 PMID:16584549 PMID:16596248 PMID:16622263 PMID:17016601 PMID:17018589 PMID:17047489 PMID:17172411 PMID:17203168 PMID:17330233 PMID:17339891 PMID:17377791 PMID:17454858 PMID:17520254 PMID:17609664 PMID:18197934 PMID:18383874 PMID:18425338 PMID:18448328 PMID:18490900 PMID:18505590 PMID:18507058 PMID:18593893 PMID:18600534 PMID:18607850 PMID:18633250 PMID:18661526 PMID:18676755 PMID:18722050 PMID:18794807 PMID:18986760 PMID:19020767 PMID:19074750 PMID:19082493 PMID:19084572 PMID:19105824 PMID:19219653 PMID:20501625 PMID:20570612 PMID:20714149 PMID:21444628 PMID:21814787 PMID:23056627 PMID:29258758 PMID:35608750 More...
|
|
NCBI chr 9:120,760,057...120,776,149
Ensembl chr 9:113,313,452...113,329,536
|
|
G |
Tyrp1 |
tyrosinase-related protein 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of TYRP1 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 5:95,280,982...95,299,516
Ensembl chr 5:95,280,982...95,299,516
|
|
G |
U2surp |
U2 snRNP-associated SURP domain containing |
decreases expression |
ISO |
Fluorouracil results in decreased expression of U2SURP mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 8:96,018,932...96,075,795
Ensembl chr 8:96,022,957...96,075,691
|
|
G |
Ube2c |
ubiquitin-conjugating enzyme E2C |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of UBE2C mRNA; Fluorouracil results in decreased expression of UBE2C protein [Fluorouracil results in increased acetylation of TP53 protein mutant form] which results in increased expression of UBE2C protein; anacardic acid inhibits the reaction [[Fluorouracil results in increased acetylation of TP53 protein mutant form] which results in increased expression of UBE2C protein]; CDKN1A protein affects the reaction [Fluorouracil promotes the reaction [E2F4 protein binds to UBE2C promoter]]; CDKN1A protein affects the reaction [Fluorouracil results in decreased expression of UBE2C protein]; Fluorouracil inhibits the reaction [NFYA protein binds to UBE2C promoter]; Fluorouracil promotes the reaction [E2F4 protein binds to UBE2C promoter]; Fluorouracil promotes the reaction [EP300 protein binds to UBE2C promoter]; Fluorouracil promotes the reaction [NFYA protein binds to UBE2C promoter]; Fluorouracil promotes the reaction [NFYB protein binds to UBE2C promoter]; Fluorouracil promotes the reaction [TP53 protein mutant form binds to UBE2C promoter]; TP53 protein affects the reaction [Fluorouracil promotes the reaction [E2F4 protein binds to UBE2C promoter]]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of UBE2C mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of UBE2C mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of UBE2C protein]; TP53 protein mutant form affects the reaction [Fluorouracil promotes the reaction [NFYA protein binds to UBE2C promoter]]; TP53 protein mutant form affects the reaction [Fluorouracil promotes the reaction [NFYB protein binds to UBE2C promoter]] |
CTD |
PMID:16557594 PMID:17039268 PMID:17374387 PMID:27129209 |
|
NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339
|
|
G |
Ube2s |
ubiquitin-conjugating enzyme E2S |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of UBE2S mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:69,028,853...69,032,914
Ensembl chr 1:69,028,750...69,032,914
|
|
G |
Ube2t |
ubiquitin-conjugating enzyme E2T |
affects expression |
ISO |
Fluorouracil affects the expression of UBE2T mRNA |
CTD |
PMID:16557594 |
|
NCBI chr13:46,403,352...46,413,854
Ensembl chr13:46,403,375...46,414,835
|
|
G |
Uchl1 |
ubiquitin C-terminal hydrolase L1 |
affects response to substance |
ISO |
UCHL1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr14:41,838,859...41,849,743
Ensembl chr14:41,485,031...41,495,590
|
|
G |
Uck2 |
uridine-cytidine kinase 2 |
affects response to substance decreases expression |
ISO |
UCK2 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of UCK2 mRNA |
CTD |
PMID:15548681 PMID:19219653 |
|
NCBI chr13:81,913,732...81,971,036
Ensembl chr13:79,383,846...79,438,352
|
|
G |
Ucp2 |
uncoupling protein 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of UCP2 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:154,839,209...154,845,611
|
|
G |
Ugdh |
UDP-glucose 6-dehydrogenase |
affects response to substance |
ISO |
UGDH protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr14:43,202,480...43,226,002
Ensembl chr14:42,848,854...42,872,354
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
multiple interactions |
ISO |
UGT1A1 gene polymorphism affects the susceptibility to [Fluorouracil co-treated with irinotecan] |
CTD |
PMID:18797458 |
|
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt8 |
UDP glycosyltransferase 8 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of UGT8 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 2:216,938,884...217,007,167
Ensembl chr 2:214,264,483...214,332,660
|
|
G |
Umps |
uridine monophosphate synthetase |
multiple interactions increases response to substance affects response to substance decreases response to substance |
ISO |
[docetaxel co-treated with Fluorouracil] results in increased expression of UMPS mRNA; Fluorouracil inhibits the reaction [wogonin results in decreased expression of UMPS mRNA]; Fluorouracil promotes the reaction [docetaxel results in increased expression of UMPS protein]; Fluorouracil promotes the reaction [gambogic acid results in increased expression of UMPS mRNA] Fluorouracil results in increased susceptibility to UMPS protein UMPS affects the susceptibility to Fluorouracil; UMPS mRNA affects the susceptibility to Fluorouracil; UMPS protein affects the susceptibility to Fluorouracil UMPS protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:15548681 PMID:16477629 PMID:16557585 PMID:16757204 PMID:17237621 PMID:17303323 PMID:17854773 PMID:19020740 PMID:19020767 PMID:19082440 PMID:19084572 PMID:20570612 More...
|
|
NCBI chr11:80,311,269...80,321,678
Ensembl chr11:66,806,045...66,821,903
|
|
G |
Unc13b |
unc-13 homolog B |
affects expression |
ISO |
Fluorouracil affects the expression of UNC13B mRNA |
CTD |
PMID:20421339 |
|
NCBI chr 5:57,288,999...57,504,110
Ensembl chr 5:57,289,227...57,502,926
|
|
G |
Unc5b |
unc-5 netrin receptor B |
affects expression |
ISO |
Fluorouracil affects the expression of UNC5B mRNA |
CTD |
PMID:16584549 |
|
NCBI chr20:28,697,726...28,764,474
Ensembl chr20:28,697,726...28,764,537
|
|
G |
Ung |
uracil-DNA glycosylase |
affects expression affects response to substance |
ISO |
Fluorouracil affects the expression of UNG protein UNG protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16951200 PMID:18714155 |
|
NCBI chr12:48,145,838...48,154,789
Ensembl chr12:42,485,276...42,494,206
|
|
G |
Upp1 |
uridine phosphorylase 1 |
increases expression affects response to substance multiple interactions |
ISO |
Fluorouracil results in increased expression of UPP1 mRNA; Fluorouracil results in increased expression of UPP1 protein UPP1 affects the susceptibility to Fluorouracil [UPP1 protein results in increased metabolism of Uridine] which affects the susceptibility to Fluorouracil UPP1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15067352 PMID:15109396 PMID:15331170 PMID:15772079 PMID:24737281 |
|
NCBI chr14:83,809,495...83,829,299
Ensembl chr14:83,809,960...83,829,462
|
|
G |
Uprt |
uracil phosphoribosyltransferase homolog |
increases metabolic processing |
ISO |
UPRT protein results in increased metabolism of Fluorouracil |
CTD |
PMID:18575323 |
|
NCBI chr X:73,582,267...73,612,488
Ensembl chr X:69,516,738...69,546,797
|
|
G |
Uqcr10 |
ubiquinol-cytochrome c reductase, complex III subunit X |
affects expression |
ISO |
Fluorouracil affects the expression of UQCR10 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr14:79,566,151...79,569,017
Ensembl chr14:79,566,157...79,569,003
|
|
G |
Uqcr11 |
ubiquinol-cytochrome c reductase, complex III subunit XI |
increases expression |
ISO |
Fluorouracil results in increased expression of UQCR11 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 7:9,305,042...9,309,753
Ensembl chr 7:9,305,058...9,309,750
|
|
G |
Uqcrb |
ubiquinol-cytochrome c reductase binding protein |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of UQCRB mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 7:65,700,016...65,705,382
Ensembl chr 7:63,814,797...63,820,150
|
|
G |
Uqcrc2 |
ubiquinol cytochrome c reductase core protein 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of UQCRC2 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 1:184,599,240...184,629,804
Ensembl chr 1:175,167,894...175,199,453
|
|
G |
Uqcrfs1 |
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 |
affects expression |
ISO |
Fluorouracil affects the expression of UQCRFS1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr17:34,173,787...34,190,952
Ensembl chr17:33,977,921...33,982,479
|
|
G |
Uqcrh |
ubiquinol-cytochrome c reductase hinge protein |
affects expression |
ISO |
Fluorouracil affects the expression of UQCRH mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 5:134,782,687...134,790,882
Ensembl chr 5:129,545,984...129,554,242
|
|
G |
Urod |
uroporphyrinogen decarboxylase |
decreases response to substance |
ISO |
UROD protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:21270338 |
|
NCBI chr 5:135,701,294...135,705,380
Ensembl chr 5:130,455,217...130,468,808
|
|
G |
Ush2a |
usherin |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of USH2A mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr13:102,368,783...103,035,230
Ensembl chr13:99,837,445...100,503,922
|
|
G |
Usp14 |
ubiquitin specific peptidase 14 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of USP14 protein |
CTD |
PMID:16803524 |
|
NCBI chr18:1,018,111...1,057,727
Ensembl chr18:1,019,400...1,057,519
|
|
G |
Usp9x |
ubiquitin specific peptidase 9, X-linked |
affects response to substance |
ISO |
USP9X protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr X:9,588,825...9,726,993
Ensembl chr X:9,588,825...9,696,711
|
|
G |
Utp3 |
UTP3, small subunit processome component |
multiple interactions |
ISO |
[Fluorouracil co-treated with irinotecan] results in increased expression of UTP3 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr14:19,515,716...19,517,370
Ensembl chr14:19,515,669...19,517,396
|
|
G |
Uxt |
ubiquitously-expressed, prefoldin-like chaperone |
increases expression |
ISO |
Fluorouracil results in increased expression of UXT protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr X:3,679,630...3,691,944
Ensembl chr X:1,126,162...1,138,663
|
|
G |
Vangl2 |
VANGL planar cell polarity protein 2 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of VANGL2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr13:84,462,731...84,489,404
Ensembl chr13:84,465,527...84,489,378
|
|
G |
Vasp |
vasodilator-stimulated phosphoprotein |
multiple interactions decreases expression |
ISO |
Fluorouracil promotes the reaction [resveratrol results in decreased expression of VASP protein]; resveratrol promotes the reaction [Fluorouracil results in decreased expression of VASP protein] |
CTD |
PMID:25936796 |
|
NCBI chr 1:78,910,009...78,925,791
Ensembl chr 1:78,910,011...78,925,061
|
|
G |
Vat1 |
vesicle amine transport 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of VAT1 mRNA |
CTD |
PMID:16101138 |
|
NCBI chr10:86,389,549...86,397,167
Ensembl chr10:86,389,545...86,397,224
|
|
G |
Vav3 |
vav guanine nucleotide exchange factor 3 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of VAV3 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 2:197,011,901...197,354,321
Ensembl chr 2:197,011,831...197,354,321
|
|
G |
Vcl |
vinculin |
affects response to substance |
ISO |
VCL protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr15:3,315,069...3,404,891
Ensembl chr15:3,265,815...3,355,606
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases expression increases expression multiple interactions decreases response to substance |
ISO EXP |
Fluorouracil results in decreased expression of VEGFA mRNA; Fluorouracil results in decreased expression of VEGFA protein Fluorouracil results in increased expression of VEGFA mRNA TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of VEGFA mRNA]; VEGFA protein promotes the reaction [Fluorouracil results in decreased expression of IFNA1 protein] VEGFA mRNA results in decreased susceptibility to Fluorouracil; VEGFA protein results in decreased susceptibility to Fluorouracil Fluorouracil results in increased expression of VEGFA protein Fluorouracil promotes the reaction [Resveratrol results in decreased expression of VEGFA protein]; Fluorouracil promotes the reaction [Valsartan results in decreased expression of VEGFA mRNA]; Resveratrol promotes the reaction [Fluorouracil results in decreased expression of VEGFA protein]; Valsartan promotes the reaction [Fluorouracil results in decreased expression of VEGFA mRNA] [diacerein co-treated with Fluorouracil] inhibits the reaction [Trichloroacetic Acid results in increased expression of VEGFA protein] |
CTD |
PMID:15817675 PMID:17039268 PMID:17786339 PMID:17982676 PMID:18494554 PMID:25936796 PMID:26272751 PMID:29678497 PMID:34794354 PMID:35235860 More...
|
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vgf |
VGF nerve growth factor inducible |
increases expression |
ISO |
Fluorouracil results in increased expression of VGF mRNA |
CTD |
PMID:24737281 |
|
NCBI chr12:19,637,313...19,645,123
Ensembl chr12:19,637,320...19,640,341
|
|
G |
Vim |
vimentin |
increases expression multiple interactions |
ISO |
Fluorouracil results in increased expression of VIM protein resveratrol inhibits the reaction [Fluorouracil results in increased expression of VIM protein] |
CTD |
PMID:26310874 |
|
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Vpreb3 |
V-set pre-B cell surrogate light chain 3 |
affects expression |
ISO |
Fluorouracil affects the expression of VPREB3 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr20:12,717,421...12,718,785
Ensembl chr20:12,716,779...12,719,520
|
|
G |
Vps35 |
VPS35 retromer complex component |
affects expression |
ISO |
Fluorouracil affects the expression of VPS35 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr19:37,938,989...37,974,887
Ensembl chr19:21,765,749...21,801,618
|
|
G |
Vps37a |
VPS37A subunit of ESCRT-I |
increases response to substance |
ISO |
VPS37A protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:31152734 |
|
NCBI chr16:51,736,170...51,775,384
Ensembl chr16:51,737,481...51,775,390
|
|
G |
Vps52 |
VPS52 subunit of GARP complex |
decreases expression |
ISO |
Fluorouracil results in decreased expression of VPS52 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr20:4,920,715...4,931,685
Ensembl chr20:4,860,843...4,931,665
|
|
G |
Wars1 |
tryptophanyl-tRNA synthetase 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of WARS1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 6:127,776,088...127,807,273
Ensembl chr 6:127,776,090...127,807,269
|
|
G |
Wbp4 |
WW domain binding protein 4 |
affects expression |
ISO |
Fluorouracil affects the expression of WBP4 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr15:54,862,700...54,890,668
Ensembl chr15:54,862,843...54,890,647
|
|
G |
Wdr4 |
WD repeat domain 4 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of WDR4 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr20:9,587,205...9,611,434
Ensembl chr20:9,587,207...9,603,581
|
|
G |
Wee1 |
WEE1 G2 checkpoint kinase |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of WEE1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:164,173,681...164,197,688
Ensembl chr 1:164,174,779...164,197,688
|
|
G |
Wnt3 |
Wnt family member 3 |
increases expression |
ISO |
Fluorouracil results in increased expression of WNT3 mRNA |
CTD |
PMID:26272751 |
|
NCBI chr10:89,180,224...89,224,195
Ensembl chr10:88,680,248...88,724,099
|
|
G |
Wnt5a |
Wnt family member 5A |
increases expression multiple interactions |
ISO EXP |
Fluorouracil results in increased expression of WNT5A mRNA 5-fluorouracil inhibits the reaction [N-methyl-N-nitrosourea increases expression of Wnt5a mRNA in colon] |
CTD RGD |
PMID:31711903 PMID:28032729 |
RGD:150530464 |
NCBI chr16:3,702,300...3,724,860
Ensembl chr16:3,697,032...3,718,234
|
|
G |
Wnt8a |
Wnt family member 8A |
decreases expression |
ISO |
Fluorouracil results in decreased expression of WNT8A mRNA |
CTD |
PMID:24737281 |
|
NCBI chr18:26,411,833...26,417,426
Ensembl chr18:26,137,690...26,143,283
|
|
G |
Wt1 |
WT1 transcription factor |
decreases expression |
ISO |
Fluorouracil results in decreased expression of WT1 protein |
CTD |
PMID:21296659 |
|
NCBI chr 3:112,019,721...112,068,454
Ensembl chr 3:91,567,001...91,613,643
|
|
G |
Wtap |
WT1 associated protein |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of WTAP mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:47,665,965...47,691,067
Ensembl chr 1:47,665,965...47,691,065
|
|
G |
Xaf1 |
XIAP associated factor 1 |
increases response to substance multiple interactions increases expression |
ISO |
XAF1 protein results in increased susceptibility to Fluorouracil EGF protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 mRNA]; EGF protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 protein]; IGF1 protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 mRNA]; IGF1 protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 protein]; IL6 protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 mRNA]; IL6 protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 protein]; MT2A protein affects the reaction [EGF protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 protein]]; TGFB1 protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 mRNA]; TGFB1 protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 protein] Fluorouracil results in increased expression of XAF1 mRNA; Fluorouracil results in increased expression of XAF1 protein |
CTD |
PMID:15843754 PMID:17570219 PMID:18544999 PMID:28507149 |
|
NCBI chr10:56,917,378...56,929,791
Ensembl chr10:56,917,121...56,929,770
|
|
G |
Xbp1 |
X-box binding protein 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of XBP1 mRNA |
CTD |
PMID:15205334 |
|
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
increases expression affects response to substance multiple interactions decreases expression |
ISO |
Fluorouracil results in increased expression of XIAP mRNA; Fluorouracil results in increased expression of XIAP protein XIAP affects the susceptibility to Fluorouracil [[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in increased expression of XIAP mRNA; [SM-1 compound co-treated with Fluorouracil] results in decreased expression of XIAP mRNA; Fluorouracil promotes the reaction [Arsenic Trioxide results in decreased expression of XIAP protein]; SM-1 compound promotes the reaction [Fluorouracil results in decreased expression of XIAP mRNA]; XIAP protein inhibits the reaction [Fluorouracil results in increased susceptibility to TNFSF10 protein] |
CTD |
PMID:16628085 PMID:20876774 PMID:22963400 PMID:28599477 PMID:32800223 |
|
NCBI chr X:125,756,107...125,803,979
Ensembl chr X:120,897,907...120,934,700
|
|
G |
Xist |
X inactive specific transcript |
affects expression |
ISO |
Fluorouracil affects the expression of XIST protein |
CTD |
PMID:21296659 |
|
NCBI chr X:68,474,987...68,492,500
|
|
G |
Xrcc1 |
X-ray repair cross complementing 1 |
multiple interactions |
ISO |
XRCC1 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with Cisplatin]; XRCC1 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with oxaliplatin] |
CTD |
PMID:22452940 |
|
NCBI chr 1:89,268,721...89,296,619
Ensembl chr 1:80,141,207...80,168,701
|
|
G |
Xrcc3 |
X-ray repair cross complementing 3 |
multiple interactions |
ISO |
XRCC3 gene polymorphism affects the susceptibility to [Cisplatin co-treated with Fluorouracil] |
CTD |
PMID:21347786 |
|
NCBI chr 6:136,684,558...136,694,822
Ensembl chr 6:130,863,959...130,872,444
|
|
G |
Xrcc5 |
X-ray repair cross complementing 5 |
multiple interactions |
ISO |
XRCC5 mRNA results in increased susceptibility to [Fluorouracil co-treated with Cisplatin] |
CTD |
PMID:18546291 |
|
NCBI chr 9:73,955,216...74,044,020
Ensembl chr 9:73,955,216...74,044,018
|
|
G |
Xrcc6 |
X-ray repair cross complementing 6 |
multiple interactions |
ISO |
XRCC6 mRNA results in increased susceptibility to [Fluorouracil co-treated with Cisplatin]; XRCC6 protein results in increased susceptibility to [Fluorouracil co-treated with Cisplatin] |
CTD |
PMID:18546291 |
|
NCBI chr 7:113,542,992...113,563,762
Ensembl chr 7:113,543,057...113,563,762
|
|
G |
Yars1 |
tyrosyl-tRNA synthetase 1 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of YARS1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 5:146,820,163...146,848,377
Ensembl chr 5:141,535,759...141,563,833
|
|
G |
Yars2 |
tyrosyl-tRNA synthetase 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of YARS2 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr11:84,632,350...84,638,138
Ensembl chr11:84,624,369...84,638,125
|
|
G |
Ybx1 |
Y box binding protein 1 |
multiple interactions |
ISO |
Fluorouracil promotes the reaction [YBX1 protein binds to MVP promoter] |
CTD |
PMID:15750632 |
|
NCBI chr 5:132,882,137...132,898,885
Ensembl chr 5:132,882,145...132,898,862
|
|
G |
Yes1 |
YES proto-oncogene 1, Src family tyrosine kinase |
affects response to substance |
ISO |
YES1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 9:113,200,256...113,275,942
Ensembl chr 9:113,200,256...113,299,837
|
|
G |
Yif1a |
Yip1 interacting factor homolog A, membrane trafficking protein |
affects response to substance |
ISO |
YIF1A protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:202,394,923...202,399,125
Ensembl chr 1:202,394,897...202,399,427
|
|
G |
Ywhab |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta |
increases expression |
ISO |
Fluorouracil results in increased expression of YWHAB mRNA |
CTD |
PMID:19272435 |
|
NCBI chr 3:152,659,663...152,682,105
Ensembl chr 3:152,659,651...152,682,105
|
|
G |
Ywhae |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon |
decreases expression |
ISO |
Fluorouracil results in decreased expression of YWHAE mRNA |
CTD |
PMID:16709241 |
|
NCBI chr10:60,584,665...60,622,352
Ensembl chr10:60,584,652...60,671,589
|
|
G |
Ywhah |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta |
decreases response to substance |
ISO |
YWHAH protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:30572915 |
|
NCBI chr14:81,920,819...81,930,202
Ensembl chr14:77,696,333...77,705,741
|
|
G |
Zbtb18 |
zinc finger and BTB domain containing 18 |
increases expression |
ISO |
Fluorouracil results in increased expression of ZBTB18 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr13:89,439,501...89,447,958
Ensembl chr13:89,439,420...89,448,862
|
|
G |
Zbtb20 |
zinc finger and BTB domain containing 20 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ZBTB20 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr11:57,052,129...57,791,214
Ensembl chr11:57,072,880...57,510,210
|
|
G |
Zbtb7a |
zinc finger and BTB domain containing 7a |
affects response to substance decreases expression |
ISO |
ZBTB7A protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of ZBTB7A protein |
CTD |
PMID:15352031 |
|
NCBI chr 7:8,561,015...8,578,243
Ensembl chr 7:8,563,779...8,576,539
|
|
G |
Zc3h3 |
zinc finger CCCH type containing 3 |
affects expression |
ISO |
Fluorouracil affects the expression of ZC3H3 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 7:107,440,694...107,525,451
Ensembl chr 7:107,440,694...107,525,451
|
|
G |
Zdhhc9 |
zinc finger DHHC-type palmitoyltransferase 9 |
increases expression |
ISO |
Fluorouracil results in increased expression of ZDHHC9 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr X:127,352,340...127,388,245
Ensembl chr X:127,352,345...127,388,245
|
|
G |
Zfp263 |
zinc finger protein 263 |
affects expression |
ISO |
Fluorouracil affects the expression of ZNF263 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr10:11,764,424...11,774,324
Ensembl chr10:11,764,427...11,771,235
|
|
G |
Zfp282 |
zinc finger protein 282 |
increases expression |
ISO |
Fluorouracil results in increased expression of ZNF282 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr 4:76,884,996...76,910,250
Ensembl chr 4:76,884,924...76,911,370
|
|
G |
Zfp367 |
zinc finger protein 367 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ZNF367 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr17:965,161...984,290
Ensembl chr17:965,161...984,287
|
|
G |
Zfp42 |
zinc finger protein 42 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ZFP42 protein |
CTD |
PMID:21296659 |
|
NCBI chr16:48,836,463...48,845,443
Ensembl chr16:48,836,648...48,845,401 Ensembl chr 4:48,836,648...48,845,401
|
|
G |
Zfp473 |
zinc finger protein 473 |
affects response to substance increases expression |
ISO |
ZNF473 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of ZNF473 mRNA |
CTD |
PMID:15331170 |
|
NCBI chr 1:95,222,683...95,243,328
Ensembl chr 1:95,223,433...95,243,325
|
|
G |
Zfp518a |
zinc finger protein 518A |
affects expression |
ISO |
Fluorouracil affects the expression of ZFP518A mRNA |
CTD |
PMID:20421339 |
|
NCBI chr 1:239,719,305...239,744,978
Ensembl chr 1:239,719,505...239,744,979
|
|
G |
Zfp532 |
zinc finger protein 532 |
affects response to substance |
ISO |
ZNF532 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr18:59,080,082...59,203,672
Ensembl chr18:59,092,789...59,203,666
|
|
G |
Zfp637 |
zinc finger protein 637 |
multiple interactions |
ISO |
ZNF32 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] |
CTD |
PMID:17327601 |
|
NCBI chr 4:150,984,940...151,010,079
Ensembl chr 4:150,984,541...151,011,874
|
|
G |
Zkscan3 |
zinc finger with KRAB and SCAN domains 3 |
decreases response to substance |
ISO |
ZKSCAN3 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:18519692 |
|
NCBI chr17:43,217,168...43,232,828
Ensembl chr17:43,217,222...43,232,827
|
|
G |
Zmat3 |
zinc finger, matrin type 3 |
multiple interactions increases expression |
ISO |
TP53 protein promotes the reaction [Fluorouracil results in increased expression of ZMAT3 mRNA] |
CTD |
PMID:17982676 |
|
NCBI chr 2:115,106,046...115,136,888
Ensembl chr 2:115,106,966...115,136,863
|
|
G |
Zmynd8 |
zinc finger, MYND-type containing 8 |
multiple interactions |
ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ZMYND8 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 3:154,528,917...154,629,532
Ensembl chr 3:154,529,043...154,628,463
|
|
G |
Znf408 |
zinc finger protein 408 |
multiple interactions |
ISO |
[Fluorouracil co-treated with irinotecan] results in increased expression of ZNF408 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr 3:77,615,595...77,621,325
Ensembl chr 3:77,616,808...77,621,055
|
|
G |
Znf829l-ps1 |
zinc finger protein 829 like, pseudogene 1 |
multiple interactions |
ISO |
ZNF582 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] |
CTD |
PMID:17327601 |
|
NCBI chr 1:67,533,324...67,558,764
|
|
G |
Zrsr2 |
zinc finger (CCCH type), RNA binding motif and serine/arginine rich 2 |
multiple interactions |
ISO |
ZRSR2 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] |
CTD |
PMID:17327601 |
|
NCBI chr X:30,547,424...30,571,613
Ensembl chr X:30,547,536...30,570,125
|
|
G |
Zscan18 |
zinc finger and SCAN domain containing 18 |
affects response to substance |
ISO |
ZSCAN18 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:73,332,883...73,349,846
Ensembl chr 1:73,332,889...73,345,897
|
|